Index,CASRN,Chemical.Name,Source,Toxicity.Value,Organ,Reference,Effect,Dose.Converted,X.Doses,Dose,Dose.Unit1,Dose.Unit2,Final.Dose,N.Animal,Obs.Animal,Species,Strain,Sex,Effect.Sex,Route,No.Days,Duration,Duration.type
1,50180,Cyclophosphamide (Anhydrous),CalEPA,0.61,bladder,Schmahl D and Habs M (1979). Carcinogenic action of low-dose cyclophosphamide given orally to Sprague-Dawley rats in a lifetime experiment. Int. J. Cancer 23: 706-712.,transitional cell carcinomas of the urinary bladder,Dose,5,0,mg/kg/day (hydrated),mg/kg/day (hydrated),0,72,0,Rat,Sprague-Dawley,M/F,Both,Oral drinking water,5,156,Weeks
1,50180,Cyclophosphamide (Anhydrous),CalEPA,0.61,bladder,Schmahl D and Habs M (1979). Carcinogenic action of low-dose cyclophosphamide given orally to Sprague-Dawley rats in a lifetime experiment. Int. J. Cancer 23: 706-712.,transitional cell carcinomas of the urinary bladder,Dose,5,0.31,mg/kg/day (hydrated),mg/kg/day (hydrated),0.221428571,71,2,Rat,Sprague-Dawley,M/F,Both,Oral drinking water,5,156,Weeks
1,50180,Cyclophosphamide (Anhydrous),CalEPA,0.61,bladder,Schmahl D and Habs M (1979). Carcinogenic action of low-dose cyclophosphamide given orally to Sprague-Dawley rats in a lifetime experiment. Int. J. Cancer 23: 706-712.,transitional cell carcinomas of the urinary bladder,Dose,5,0.63,mg/kg/day (hydrated),mg/kg/day (hydrated),0.45,73,2,Rat,Sprague-Dawley,M/F,Both,Oral drinking water,5,156,Weeks
1,50180,Cyclophosphamide (Anhydrous),CalEPA,0.61,bladder,Schmahl D and Habs M (1979). Carcinogenic action of low-dose cyclophosphamide given orally to Sprague-Dawley rats in a lifetime experiment. Int. J. Cancer 23: 706-712.,transitional cell carcinomas of the urinary bladder,Dose,5,1.25,mg/kg/day (hydrated),mg/kg/day (hydrated),0.892857143,68,5,Rat,Sprague-Dawley,M/F,Both,Oral drinking water,5,156,Weeks
1,50180,Cyclophosphamide (Anhydrous),CalEPA,0.61,bladder,Schmahl D and Habs M (1979). Carcinogenic action of low-dose cyclophosphamide given orally to Sprague-Dawley rats in a lifetime experiment. Int. J. Cancer 23: 706-712.,transitional cell carcinomas of the urinary bladder,Dose,5,2.5,mg/kg/day (hydrated),mg/kg/day (hydrated),1.785714286,58,8,Rat,Sprague-Dawley,M/F,Both,Oral drinking water,5,156,Weeks
2,50282,Estradiol 17B,CalEPA,39,mammary glands,"Highman B, Greenman DL, Norvell MJ, Farmer J and Shellenberger TE (1980). Neoplastic and preneoplasttc lesIons induced 10 female C3H mice by diets containing
diethylstilbestrol or 17beta-estradiol. J. Environ. Pathol. Toxicol. 4: 81-95.",mammary gland adenocarcinomas,Dose,4,0,ppb,ppb,0,227,51,Mouse,C3H,F,Both,Oral diet,NA,105,Weeks
2,50282,Estradiol 17B,CalEPA,39,mammary glands,"Highman B, Greenman DL, Norvell MJ, Farmer J and Shellenberger TE (1980). Neoplastic and preneoplasttc lesIons induced 10 female C3H mice by diets containing
diethylstilbestrol or 17beta-estradiol. J. Environ. Pathol. Toxicol. 4: 81-95.",mammary gland adenocarcinomas,Dose,4,100,ppb,ppb,0.017280453,202,49,Mouse,C3H,F,Both,Oral diet,NA,105,Weeks
2,50282,Estradiol 17B,CalEPA,39,mammary glands,"Highman B, Greenman DL, Norvell MJ, Farmer J and Shellenberger TE (1980). Neoplastic and preneoplasttc lesIons induced 10 female C3H mice by diets containing
diethylstilbestrol or 17beta-estradiol. J. Environ. Pathol. Toxicol. 4: 81-95.",mammary gland adenocarcinomas,Dose,4,1000,ppb,ppb,0.172804533,195,45,Mouse,C3H,F,Both,Oral diet,NA,105,Weeks
2,50282,Estradiol 17B,CalEPA,39,mammary glands,"Highman B, Greenman DL, Norvell MJ, Farmer J and Shellenberger TE (1980). Neoplastic and preneoplasttc lesIons induced 10 female C3H mice by diets containing
diethylstilbestrol or 17beta-estradiol. J. Environ. Pathol. Toxicol. 4: 81-95.",mammary gland adenocarcinomas,Dose,4,5000,ppb,ppb,0.864022663,207,58,Mouse,C3H,F,Both,Oral diet,NA,105,Weeks
3,50293,DDT,IRIS,0.34,liver,"Cabral, J.R.P., R.K. Hall, L. Rossi, S.A. Bronczyk and P. Shubik. 1982. Effects of long-term intake of DDT on rats. Tumorigenesis. 68: 11-17.",liver-cell tumors,Conv,4,0,mg/kg/day,ppm,0,38,0,Rat,Porton,M/F,F,Oral diet,NA,144,Weeks
3,50293,DDT,IRIS,0.34,liver,"Cabral, J.R.P., R.K. Hall, L. Rossi, S.A. Bronczyk and P. Shubik. 1982. Effects of long-term intake of DDT on rats. Tumorigenesis. 68: 11-17.",liver-cell tumors,Conv,4,6,mg/kg/day,ppm,6,30,2,Rat,Porton,M/F,F,Oral diet,NA,144,Weeks
3,50293,DDT,IRIS,0.34,liver,"Cabral, J.R.P., R.K. Hall, L. Rossi, S.A. Bronczyk and P. Shubik. 1982. Effects of long-term intake of DDT on rats. Tumorigenesis. 68: 11-17.",liver-cell tumors,Conv,4,12,mg/kg/day,ppm,12,30,4,Rat,Porton,M/F,F,Oral diet,NA,144,Weeks
3,50293,DDT,IRIS,0.34,liver,"Cabral, J.R.P., R.K. Hall, L. Rossi, S.A. Bronczyk and P. Shubik. 1982. Effects of long-term intake of DDT on rats. Tumorigenesis. 68: 11-17.",liver-cell tumors,Conv,4,24,mg/kg/day,ppm,24,38,7,Rat,Porton,M/F,F,Oral diet,NA,144,Weeks
4,50293,DDT,IRIS,0.34,liver,"Terracini, B., M.C. Testa, J.R. Cabral and N. Day. 1973. The effects of long-term feeding of DDT
to BALB/c mice. Int. J. Cancer. 11: 747-764.",benign liver tumors,Dose,4,0,ppm diet,,0,107,2,Mouse,BALB/C,M/F,M,Oral diet,NA,2,Generations
4,50293,DDT,IRIS,0.34,liver,"Terracini, B., M.C. Testa, J.R. Cabral and N. Day. 1973. The effects of long-term feeding of DDT
to BALB/c mice. Int. J. Cancer. 11: 747-764.",benign liver tumors,Dose,4,2,ppm diet,,0.343163539,112,3,Mouse,BALB/C,M/F,M,Oral diet,NA,2,Generations
4,50293,DDT,IRIS,0.34,liver,"Terracini, B., M.C. Testa, J.R. Cabral and N. Day. 1973. The effects of long-term feeding of DDT
to BALB/c mice. Int. J. Cancer. 11: 747-764.",benign liver tumors,Dose,4,20,ppm diet,,3.431635389,106,1,Mouse,BALB/C,M/F,M,Oral diet,NA,2,Generations
4,50293,DDT,IRIS,0.34,liver,"Terracini, B., M.C. Testa, J.R. Cabral and N. Day. 1973. The effects of long-term feeding of DDT
to BALB/c mice. Int. J. Cancer. 11: 747-764.",benign liver tumors,Dose,4,250,ppm diet,,42.89544236,106,15,Mouse,BALB/C,M/F,M,Oral diet,NA,2,Generations
5,50293,DDT,IRIS,0.34,liver,"Tomatis, L. and V. Turusov. 1975. Studies on the carcinogenicity of DDT. Gann Monograph
Cancer Res. 17: 219-241.",benign liver tumors,Dose,5,0,ppm,ppm,0,348,104,Mouse,CF-1,M/F,M,Oral diet,NA,130,Weeks
5,50293,DDT,IRIS,0.34,liver,"Tomatis, L. and V. Turusov. 1975. Studies on the carcinogenicity of DDT. Gann Monograph
Cancer Res. 17: 219-241.",benign liver tumors,Dose,5,2,ppm,ppm,0.343163539,362,181,Mouse,CF-1,M/F,M,Oral diet,NA,130,Weeks
5,50293,DDT,IRIS,0.34,liver,"Tomatis, L. and V. Turusov. 1975. Studies on the carcinogenicity of DDT. Gann Monograph
Cancer Res. 17: 219-241.",benign liver tumors,Dose,5,10,ppm,ppm,1.715817694,367,184,Mouse,CF-1,M/F,M,Oral diet,NA,130,Weeks
5,50293,DDT,IRIS,0.34,liver,"Tomatis, L. and V. Turusov. 1975. Studies on the carcinogenicity of DDT. Gann Monograph
Cancer Res. 17: 219-241.",benign liver tumors,Dose,5,50,ppm,ppm,8.579088472,396,257,Mouse,CF-1,M/F,M,Oral diet,NA,130,Weeks
5,50293,DDT,IRIS,0.34,liver,"Tomatis, L. and V. Turusov. 1975. Studies on the carcinogenicity of DDT. Gann Monograph
Cancer Res. 17: 219-241.",benign liver tumors,Dose,5,250,ppm,ppm,42.89544236,372,298,Mouse,CF-1,M/F,M,Oral diet,NA,130,Weeks
6,50293,DDT,IRIS,0.34,liver,"Tomatis, L. and V. Turusov. 1975. Studies on the carcinogenicity of DDT. Gann Monograph
Cancer Res. 17: 219-241.",benign liver tumors,Dose,5,0,ppm,ppm,0,363,18,Mouse,CF-1,M/F,F,Oral diet,NA,130,Weeks
6,50293,DDT,IRIS,0.34,liver,"Tomatis, L. and V. Turusov. 1975. Studies on the carcinogenicity of DDT. Gann Monograph
Cancer Res. 17: 219-241.",benign liver tumors,Dose,5,2,ppm,ppm,0.345609065,354,18,Mouse,CF-1,M/F,F,Oral diet,NA,130,Weeks
6,50293,DDT,IRIS,0.34,liver,"Tomatis, L. and V. Turusov. 1975. Studies on the carcinogenicity of DDT. Gann Monograph
Cancer Res. 17: 219-241.",benign liver tumors,Dose,5,10,ppm,ppm,1.728045326,370,37,Mouse,CF-1,M/F,F,Oral diet,NA,130,Weeks
6,50293,DDT,IRIS,0.34,liver,"Tomatis, L. and V. Turusov. 1975. Studies on the carcinogenicity of DDT. Gann Monograph
Cancer Res. 17: 219-241.",benign liver tumors,Dose,5,50,ppm,ppm,8.640226629,349,45,Mouse,CF-1,M/F,F,Oral diet,NA,130,Weeks
6,50293,DDT,IRIS,0.34,liver,"Tomatis, L. and V. Turusov. 1975. Studies on the carcinogenicity of DDT. Gann Monograph
Cancer Res. 17: 219-241.",benign liver tumors,Dose,5,250,ppm,ppm,43.20113314,334,200,Mouse,CF-1,M/F,F,Oral diet,NA,130,Weeks
7,50293,DDT,IRIS,0.34,liver,"Turusov, V.S., N.E. Day, L. Tomatis, E. Gati and R.T. Charles. 1973. Tumors in CF-1 mice
exposed for six consecutive generations to DDT. J. Natl. Cancer Inst. 51: 983-998.",benign liver tumors,Dose,5,0,ppm,ppm,0,328,97,Mouse,CF-1,M/F,M,Oral diet,NA,6,Generations
7,50293,DDT,IRIS,0.34,liver,"Turusov, V.S., N.E. Day, L. Tomatis, E. Gati and R.T. Charles. 1973. Tumors in CF-1 mice
exposed for six consecutive generations to DDT. J. Natl. Cancer Inst. 51: 983-998.",benign liver tumors,Dose,5,2,ppm,ppm,0.343163539,354,179,Mouse,CF-1,M/F,M,Oral diet,NA,6,Generations
7,50293,DDT,IRIS,0.34,liver,"Turusov, V.S., N.E. Day, L. Tomatis, E. Gati and R.T. Charles. 1973. Tumors in CF-1 mice
exposed for six consecutive generations to DDT. J. Natl. Cancer Inst. 51: 983-998.",benign liver tumors,Dose,5,10,ppm,ppm,1.715817694,362,181,Mouse,CF-1,M/F,M,Oral diet,NA,6,Generations
7,50293,DDT,IRIS,0.34,liver,"Turusov, V.S., N.E. Day, L. Tomatis, E. Gati and R.T. Charles. 1973. Tumors in CF-1 mice
exposed for six consecutive generations to DDT. J. Natl. Cancer Inst. 51: 983-998.",benign liver tumors,Dose,5,50,ppm,ppm,8.579088472,383,214,Mouse,CF-1,M/F,M,Oral diet,NA,6,Generations
7,50293,DDT,IRIS,0.34,liver,"Turusov, V.S., N.E. Day, L. Tomatis, E. Gati and R.T. Charles. 1973. Tumors in CF-1 mice
exposed for six consecutive generations to DDT. J. Natl. Cancer Inst. 51: 983-998.",benign liver tumors,Dose,5,250,ppm,ppm,42.89544236,350,301,Mouse,CF-1,M/F,M,Oral diet,NA,6,Generations
8,50293,DDT,IRIS,0.34,liver,"Turusov, V.S., N.E. Day, L. Tomatis, E. Gati and R.T. Charles. 1973. Tumors in CF-1 mice
exposed for six consecutive generations to DDT. J. Natl. Cancer Inst. 51: 983-998.",benign liver tumors,Dose,5,0,ppm,ppm,0,340,16,Mouse,CF-1,M/F,F,Oral diet,NA,6,Generations
8,50293,DDT,IRIS,0.34,liver,"Turusov, V.S., N.E. Day, L. Tomatis, E. Gati and R.T. Charles. 1973. Tumors in CF-1 mice
exposed for six consecutive generations to DDT. J. Natl. Cancer Inst. 51: 983-998.",benign liver tumors,Dose,5,2,ppm,ppm,0.345609065,339,12,Mouse,CF-1,M/F,F,Oral diet,NA,6,Generations
8,50293,DDT,IRIS,0.34,liver,"Turusov, V.S., N.E. Day, L. Tomatis, E. Gati and R.T. Charles. 1973. Tumors in CF-1 mice
exposed for six consecutive generations to DDT. J. Natl. Cancer Inst. 51: 983-998.",benign liver tumors,Dose,5,10,ppm,ppm,1.728045326,355,32,Mouse,CF-1,M/F,F,Oral diet,NA,6,Generations
8,50293,DDT,IRIS,0.34,liver,"Turusov, V.S., N.E. Day, L. Tomatis, E. Gati and R.T. Charles. 1973. Tumors in CF-1 mice
exposed for six consecutive generations to DDT. J. Natl. Cancer Inst. 51: 983-998.",benign liver tumors,Dose,5,50,ppm,ppm,8.640226629,328,43,Mouse,CF-1,M/F,F,Oral diet,NA,6,Generations
8,50293,DDT,IRIS,0.34,liver,"Turusov, V.S., N.E. Day, L. Tomatis, E. Gati and R.T. Charles. 1973. Tumors in CF-1 mice
exposed for six consecutive generations to DDT. J. Natl. Cancer Inst. 51: 983-998.",benign liver tumors,Dose,5,250,ppm,ppm,43.20113314,293,192,Mouse,CF-1,M/F,F,Oral diet,NA,6,Generations
9,50328,Benzo(a)pyrene,CalEPA,12,stomach/forestomach,"Neal J and Rigdon RH. 1967. Gastric tumors in mice fed benzo[a]pyrene: a quantitative study. Texas Reports Biol Med 25:553-557.

U.S. Environmental Protection Agency (US EPA). 1984. Health Effects Assessment for Benzo[a]pyrene. EPA 540/1-86-022. Environmental Criteria and Assessment Office, Cincinnati, OH.",gastric tumors,Dose,10,0,,ppm,0,289,0,Mouse,CFW,M/F,Both,Oral diet,NA,6-Apr,Months
9,50328,Benzo(a)pyrene,CalEPA,12,stomach/forestomach,"Neal J and Rigdon RH. 1967. Gastric tumors in mice fed benzo[a]pyrene: a quantitative study. Texas Reports Biol Med 25:553-557.

U.S. Environmental Protection Agency (US EPA). 1984. Health Effects Assessment for Benzo[a]pyrene. EPA 540/1-86-022. Environmental Criteria and Assessment Office, Cincinnati, OH.",gastric tumors,Dose,10,0.078,,ppm,0.172176309,25,0,Mouse,CFW,M/F,Both,Oral diet,NA,6-Apr,Months
9,50328,Benzo(a)pyrene,CalEPA,12,stomach/forestomach,"Neal J and Rigdon RH. 1967. Gastric tumors in mice fed benzo[a]pyrene: a quantitative study. Texas Reports Biol Med 25:553-557.

U.S. Environmental Protection Agency (US EPA). 1984. Health Effects Assessment for Benzo[a]pyrene. EPA 540/1-86-022. Environmental Criteria and Assessment Office, Cincinnati, OH.",gastric tumors,Dose,10,0.781,,ppm,1.721763085,24,0,Mouse,CFW,M/F,Both,Oral diet,NA,6-Apr,Months
9,50328,Benzo(a)pyrene,CalEPA,12,stomach/forestomach,"Neal J and Rigdon RH. 1967. Gastric tumors in mice fed benzo[a]pyrene: a quantitative study. Texas Reports Biol Med 25:553-557.

U.S. Environmental Protection Agency (US EPA). 1984. Health Effects Assessment for Benzo[a]pyrene. EPA 540/1-86-022. Environmental Criteria and Assessment Office, Cincinnati, OH.",gastric tumors,Dose,10,1.563,,ppm,3.443526171,23,1,Mouse,CFW,M/F,Both,Oral diet,NA,6-Apr,Months
9,50328,Benzo(a)pyrene,CalEPA,12,stomach/forestomach,"Neal J and Rigdon RH. 1967. Gastric tumors in mice fed benzo[a]pyrene: a quantitative study. Texas Reports Biol Med 25:553-557.

U.S. Environmental Protection Agency (US EPA). 1984. Health Effects Assessment for Benzo[a]pyrene. EPA 540/1-86-022. Environmental Criteria and Assessment Office, Cincinnati, OH.",gastric tumors,Dose,10,2.344,,ppm,5.165289256,37,0,Mouse,CFW,M/F,Both,Oral diet,NA,6-Apr,Months
9,50328,Benzo(a)pyrene,CalEPA,12,stomach/forestomach,"Neal J and Rigdon RH. 1967. Gastric tumors in mice fed benzo[a]pyrene: a quantitative study. Texas Reports Biol Med 25:553-557.

U.S. Environmental Protection Agency (US EPA). 1984. Health Effects Assessment for Benzo[a]pyrene. EPA 540/1-86-022. Environmental Criteria and Assessment Office, Cincinnati, OH.",gastric tumors,Dose,10,3.126,,ppm,6.887052342,40,1,Mouse,CFW,M/F,Both,Oral diet,NA,6-Apr,Months
9,50328,Benzo(a)pyrene,CalEPA,12,stomach/forestomach,"Neal J and Rigdon RH. 1967. Gastric tumors in mice fed benzo[a]pyrene: a quantitative study. Texas Reports Biol Med 25:553-557.

U.S. Environmental Protection Agency (US EPA). 1984. Health Effects Assessment for Benzo[a]pyrene. EPA 540/1-86-022. Environmental Criteria and Assessment Office, Cincinnati, OH.",gastric tumors,Dose,10,3.516,,ppm,7.747933884,40,4,Mouse,CFW,M/F,Both,Oral diet,NA,6-Apr,Months
9,50328,Benzo(a)pyrene,CalEPA,12,stomach/forestomach,"Neal J and Rigdon RH. 1967. Gastric tumors in mice fed benzo[a]pyrene: a quantitative study. Texas Reports Biol Med 25:553-557.

U.S. Environmental Protection Agency (US EPA). 1984. Health Effects Assessment for Benzo[a]pyrene. EPA 540/1-86-022. Environmental Criteria and Assessment Office, Cincinnati, OH.",gastric tumors,Dose,10,3.908,,ppm,8.608815427,34,24,Mouse,CFW,M/F,Both,Oral diet,NA,6-Apr,Months
9,50328,Benzo(a)pyrene,CalEPA,12,stomach/forestomach,"Neal J and Rigdon RH. 1967. Gastric tumors in mice fed benzo[a]pyrene: a quantitative study. Texas Reports Biol Med 25:553-557.

U.S. Environmental Protection Agency (US EPA). 1984. Health Effects Assessment for Benzo[a]pyrene. EPA 540/1-86-022. Environmental Criteria and Assessment Office, Cincinnati, OH.",gastric tumors,Dose,10,7.815,,ppm,17.21763085,23,19,Mouse,CFW,M/F,Both,Oral diet,NA,6-Apr,Months
9,50328,Benzo(a)pyrene,CalEPA,12,stomach/forestomach,"Neal J and Rigdon RH. 1967. Gastric tumors in mice fed benzo[a]pyrene: a quantitative study. Texas Reports Biol Med 25:553-557.

U.S. Environmental Protection Agency (US EPA). 1984. Health Effects Assessment for Benzo[a]pyrene. EPA 540/1-86-022. Environmental Criteria and Assessment Office, Cincinnati, OH.",gastric tumors,Dose,10,19.538,,ppm,43.04407713,73,66,Mouse,CFW,M/F,Both,Oral diet,NA,6-Apr,Months
10,50328,Benzo(a)pyrene,IRIS,7.3,combined,"Brune, H., R.P. Deutsch-Wenzel, M. Habs, S. Ivankovic and D. Schmahl. 1981. Investigation of the tumorigenic response to benzo[a]pyrene in aqueous caffeine solution applied orally to Sprague-Dawley rats. J. Cancer Res. Clin. Oncol. 102(2): 153-157.","forestomach, larynx and esophagus, papillomas and carcinomas (combined)",Dose,3,0,ppm,ppm,0,64,3,Rat,Sprague-Dawley,M/F,Both,Oral diet,NA,,Duration
10,50328,Benzo(a)pyrene,IRIS,7.3,combined,"Brune, H., R.P. Deutsch-Wenzel, M. Habs, S. Ivankovic and D. Schmahl. 1981. Investigation of the tumorigenic response to benzo[a]pyrene in aqueous caffeine solution applied orally to Sprague-Dawley rats. J. Cancer Res. Clin. Oncol. 102(2): 153-157.","forestomach, larynx and esophagus, papillomas and carcinomas (combined)",Dose,3,6,ppm,ppm,0.438053097,64,3,Rat,Sprague-Dawley,M/F,Both,Oral diet,NA,,Duration
10,50328,Benzo(a)pyrene,IRIS,7.3,combined,"Brune, H., R.P. Deutsch-Wenzel, M. Habs, S. Ivankovic and D. Schmahl. 1981. Investigation of the tumorigenic response to benzo[a]pyrene in aqueous caffeine solution applied orally to Sprague-Dawley rats. J. Cancer Res. Clin. Oncol. 102(2): 153-157.","forestomach, larynx and esophagus, papillomas and carcinomas (combined)",Dose,3,39,ppm,ppm,2.847345133,64,10,Rat,Sprague-Dawley,M/F,Both,Oral diet,NA,,Duration
11,50328,Benzo(a)pyrene,IRIS,7.3,stomach/forestomach,"Neal, J. and R.H. Rigdon. 1967. Gastric tumors in mice fed benzo[a]pyrene -- A quantitative study. Tex. Rep. Biol. Med. 25(4): 553-557","forestomach, squamous cell papillomas and carcinomas",Dose,10,0,ppm,ppm,0,289,0,Mouse,Swiss,Unspecified,Both,Oral diet,NA,up to 197,Days
11,50328,Benzo(a)pyrene,IRIS,7.3,stomach/forestomach,"Neal, J. and R.H. Rigdon. 1967. Gastric tumors in mice fed benzo[a]pyrene -- A quantitative study. Tex. Rep. Biol. Med. 25(4): 553-557","forestomach, squamous cell papillomas and carcinomas",Dose,10,1,ppm,ppm,0.172176309,25,0,Mouse,Swiss,Unspecified,Both,Oral diet,NA,up to 197,Days
11,50328,Benzo(a)pyrene,IRIS,7.3,stomach/forestomach,"Neal, J. and R.H. Rigdon. 1967. Gastric tumors in mice fed benzo[a]pyrene -- A quantitative study. Tex. Rep. Biol. Med. 25(4): 553-557","forestomach, squamous cell papillomas and carcinomas",Dose,10,10,ppm,ppm,1.721763085,24,0,Mouse,Swiss,Unspecified,Both,Oral diet,NA,up to 197,Days
11,50328,Benzo(a)pyrene,IRIS,7.3,stomach/forestomach,"Neal, J. and R.H. Rigdon. 1967. Gastric tumors in mice fed benzo[a]pyrene -- A quantitative study. Tex. Rep. Biol. Med. 25(4): 553-557","forestomach, squamous cell papillomas and carcinomas",Dose,10,20,ppm,ppm,3.443526171,23,1,Mouse,Swiss,Unspecified,Both,Oral diet,NA,up to 197,Days
11,50328,Benzo(a)pyrene,IRIS,7.3,stomach/forestomach,"Neal, J. and R.H. Rigdon. 1967. Gastric tumors in mice fed benzo[a]pyrene -- A quantitative study. Tex. Rep. Biol. Med. 25(4): 553-557","forestomach, squamous cell papillomas and carcinomas",Dose,10,30,ppm,ppm,5.165289256,37,0,Mouse,Swiss,Unspecified,Both,Oral diet,NA,up to 197,Days
11,50328,Benzo(a)pyrene,IRIS,7.3,stomach/forestomach,"Neal, J. and R.H. Rigdon. 1967. Gastric tumors in mice fed benzo[a]pyrene -- A quantitative study. Tex. Rep. Biol. Med. 25(4): 553-557","forestomach, squamous cell papillomas and carcinomas",Dose,10,40,ppm,ppm,6.887052342,40,1,Mouse,Swiss,Unspecified,Both,Oral diet,NA,up to 197,Days
11,50328,Benzo(a)pyrene,IRIS,7.3,stomach/forestomach,"Neal, J. and R.H. Rigdon. 1967. Gastric tumors in mice fed benzo[a]pyrene -- A quantitative study. Tex. Rep. Biol. Med. 25(4): 553-557","forestomach, squamous cell papillomas and carcinomas",Dose,10,45,ppm,ppm,7.747933884,40,4,Mouse,Swiss,Unspecified,Both,Oral diet,NA,up to 197,Days
11,50328,Benzo(a)pyrene,IRIS,7.3,stomach/forestomach,"Neal, J. and R.H. Rigdon. 1967. Gastric tumors in mice fed benzo[a]pyrene -- A quantitative study. Tex. Rep. Biol. Med. 25(4): 553-557","forestomach, squamous cell papillomas and carcinomas",Dose,10,50,ppm,ppm,8.608815427,34,24,Mouse,Swiss,Unspecified,Both,Oral diet,NA,up to 197,Days
11,50328,Benzo(a)pyrene,IRIS,7.3,stomach/forestomach,"Neal, J. and R.H. Rigdon. 1967. Gastric tumors in mice fed benzo[a]pyrene -- A quantitative study. Tex. Rep. Biol. Med. 25(4): 553-557","forestomach, squamous cell papillomas and carcinomas",Dose,10,100,ppm,ppm,17.21763085,23,19,Mouse,Swiss,Unspecified,Both,Oral diet,NA,up to 197,Days
11,50328,Benzo(a)pyrene,IRIS,7.3,stomach/forestomach,"Neal, J. and R.H. Rigdon. 1967. Gastric tumors in mice fed benzo[a]pyrene -- A quantitative study. Tex. Rep. Biol. Med. 25(4): 553-557","forestomach, squamous cell papillomas and carcinomas",Dose,10,250,ppm,ppm,43.04407713,73,66,Mouse,Swiss,Unspecified,Both,Oral diet,NA,up to 197,Days
12,50555,Reserpine,CalEPA,11,adrenal glands,"National Cancer Institute (NCI, 1982). Bioassay of Reserpine for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 193. NTIS Publication
No. PB 83165761. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant adrenal tumors,Dose,3,0,ppm,ppm,0,48,3,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
12,50555,Reserpine,CalEPA,11,adrenal glands,"National Cancer Institute (NCI, 1982). Bioassay of Reserpine for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 193. NTIS Publication
No. PB 83165761. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant adrenal tumors,Dose,3,5,ppm,ppm,0.394736842,49,18,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
12,50555,Reserpine,CalEPA,11,adrenal glands,"National Cancer Institute (NCI, 1982). Bioassay of Reserpine for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 193. NTIS Publication
No. PB 83165761. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant adrenal tumors,Dose,3,10,ppm,ppm,0.789473684,48,24,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
13,51796,Urethane,CalEPA,1,lung,"Schmähl D, Port R, Wahrendorf J. 1977. A dose-response study on urethane carcinogenicity in rats and mice. Int J Cancer, 19:77-80.",pulmonary adenoma,Dose,5,0,mg/kg,mg/kg,0,40,0,Mouse,NMRI,M/F,M,Oral drinking water,NA,,Duration
13,51796,Urethane,CalEPA,1,lung,"Schmähl D, Port R, Wahrendorf J. 1977. A dose-response study on urethane carcinogenicity in rats and mice. Int J Cancer, 19:77-80.",pulmonary adenoma,Dose,5,0.1,mg/kg,mg/kg,0.1,40,6,Mouse,NMRI,M/F,M,Oral drinking water,NA,,Duration
13,51796,Urethane,CalEPA,1,lung,"Schmähl D, Port R, Wahrendorf J. 1977. A dose-response study on urethane carcinogenicity in rats and mice. Int J Cancer, 19:77-80.",pulmonary adenoma,Dose,5,0.5,mg/kg,mg/kg,0.5,40,14,Mouse,NMRI,M/F,M,Oral drinking water,NA,,Duration
13,51796,Urethane,CalEPA,1,lung,"Schmähl D, Port R, Wahrendorf J. 1977. A dose-response study on urethane carcinogenicity in rats and mice. Int J Cancer, 19:77-80.",pulmonary adenoma,Dose,5,2.5,mg/kg,mg/kg,2.5,40,14,Mouse,NMRI,M/F,M,Oral drinking water,NA,,Duration
13,51796,Urethane,CalEPA,1,lung,"Schmähl D, Port R, Wahrendorf J. 1977. A dose-response study on urethane carcinogenicity in rats and mice. Int J Cancer, 19:77-80.",pulmonary adenoma,Dose,5,12.5,mg/kg,mg/kg,12.5,40,14,Mouse,NMRI,M/F,M,Oral drinking water,NA,,Duration
14,52244,Tris(1-aziridinyl)phosphine sulfide,CalEPA,12,blood,"National Cancer Institute (NCI, 1978). Bioassay ofTris(1-aziridinyI)phosphine Sulfide (Thiotepa) for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 58. NTIS Publication No. PB 285702. US Department of Health, Education and Welfare (DHEW), NCI Carcinogenesis Testing Program, Bethesda, MD.",leukemia (combined lymphocytic and granulocytic),Dose,3,0,mg/kg bw,mg/kg bw,0,19,0,Rat,Sprague-Dawley,M/F,M,Other,NA,104,Weeks
14,52244,Tris(1-aziridinyl)phosphine sulfide,CalEPA,12,blood,"National Cancer Institute (NCI, 1978). Bioassay ofTris(1-aziridinyI)phosphine Sulfide (Thiotepa) for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 58. NTIS Publication No. PB 285702. US Department of Health, Education and Welfare (DHEW), NCI Carcinogenesis Testing Program, Bethesda, MD.",leukemia (combined lymphocytic and granulocytic),Dose,3,0.7,mg/kg bw,mg/kg bw,0.7,37,5,Rat,Sprague-Dawley,M/F,M,Other,NA,104,Weeks
14,52244,Tris(1-aziridinyl)phosphine sulfide,CalEPA,12,blood,"National Cancer Institute (NCI, 1978). Bioassay ofTris(1-aziridinyI)phosphine Sulfide (Thiotepa) for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 58. NTIS Publication No. PB 285702. US Department of Health, Education and Welfare (DHEW), NCI Carcinogenesis Testing Program, Bethesda, MD.",leukemia (combined lymphocytic and granulocytic),Dose,3,1.4,mg/kg bw,mg/kg bw,1.4,30,6,Rat,Sprague-Dawley,M/F,M,Other,NA,104,Weeks
15,52244,Tris(1-aziridinyl)phosphine sulfide,CalEPA,12,female repro,"National Cancer Institute (NCI, 1978). Bioassay ofTris(1-aziridinyI)phosphine Sulfide (Thiotepa) for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 58. NTIS Publication No. PB 285702. US Department of Health, Education and Welfare (DHEW), NCI Carcinogenesis Testing Program, Bethesda, MD.",uterine adenocarcinoma,Dose,3,0,mg/kg-bw,mg/kg-bw,0,20,0,Rat,Sprague-Dawley,M/F,F,Other,NA,104,Weeks
15,52244,Tris(1-aziridinyl)phosphine sulfide,CalEPA,12,female repro,"National Cancer Institute (NCI, 1978). Bioassay ofTris(1-aziridinyI)phosphine Sulfide (Thiotepa) for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 58. NTIS Publication No. PB 285702. US Department of Health, Education and Welfare (DHEW), NCI Carcinogenesis Testing Program, Bethesda, MD.",uterine adenocarcinoma,Dose,3,0.7,mg/kg-bw,mg/kg-bw,0.7,30,2,Rat,Sprague-Dawley,M/F,F,Other,NA,104,Weeks
15,52244,Tris(1-aziridinyl)phosphine sulfide,CalEPA,12,female repro,"National Cancer Institute (NCI, 1978). Bioassay ofTris(1-aziridinyI)phosphine Sulfide (Thiotepa) for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 58. NTIS Publication No. PB 285702. US Department of Health, Education and Welfare (DHEW), NCI Carcinogenesis Testing Program, Bethesda, MD.",uterine adenocarcinoma,Dose,3,1.4,mg/kg-bw,mg/kg-bw,1.4,32,7,Rat,Sprague-Dawley,M/F,F,Other,NA,104,Weeks
16,53963,2-Acetylaminofluorene,CalEPA,3.8,liver,"Ogiso T, Tatematsu M, Tamano S, Tsuda H and Ito N (1985). Comparative effects of carcinogens on the induction of placental glutathione S-transferase-positive liver nodull:s in a short-term assay and of hepatocellular carcinomas in a long-term assay.
Toxicol. Pathol. 13: 257-265.",hepatocellular carcinoma,Conv,4,0,mg/kg/day,% diet,0,30,0,Rat,Fischer 344,M,Both,Oral diet,NA,104,Weeks
16,53963,2-Acetylaminofluorene,CalEPA,3.8,liver,"Ogiso T, Tatematsu M, Tamano S, Tsuda H and Ito N (1985). Comparative effects of carcinogens on the induction of placental glutathione S-transferase-positive liver nodull:s in a short-term assay and of hepatocellular carcinomas in a long-term assay.
Toxicol. Pathol. 13: 257-265.",hepatocellular carcinoma,Conv,4,0.13,mg/kg/day,% diet,0.13,23,3,Rat,Fischer 344,M,Both,Oral diet,NA,104,Weeks
16,53963,2-Acetylaminofluorene,CalEPA,3.8,liver,"Ogiso T, Tatematsu M, Tamano S, Tsuda H and Ito N (1985). Comparative effects of carcinogens on the induction of placental glutathione S-transferase-positive liver nodull:s in a short-term assay and of hepatocellular carcinomas in a long-term assay.
Toxicol. Pathol. 13: 257-265.",hepatocellular carcinoma,Conv,4,0.58,mg/kg/day,% diet,0.58,27,26,Rat,Fischer 344,M,Both,Oral diet,NA,104,Weeks
16,53963,2-Acetylaminofluorene,CalEPA,3.8,liver,"Ogiso T, Tatematsu M, Tamano S, Tsuda H and Ito N (1985). Comparative effects of carcinogens on the induction of placental glutathione S-transferase-positive liver nodull:s in a short-term assay and of hepatocellular carcinomas in a long-term assay.
Toxicol. Pathol. 13: 257-265.",hepatocellular carcinoma,Conv,4,2.74,mg/kg/day,% diet,2.74,23,23,Rat,Fischer 344,M,Both,Oral diet,NA,104,Weeks
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,0,ppm water,ppm water,0,240,1,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,0.033,ppm water,ppm water,0.004088496,60,1,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,0.066,ppm water,ppm water,0.008176991,60,0,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,0.132,ppm water,ppm water,0.016353982,60,5,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,0.264,ppm water,ppm water,0.032707965,60,2,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,0.528,ppm water,ppm water,0.065415929,60,4,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,1.056,ppm water,ppm water,0.130831858,60,8,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,1.584,ppm water,ppm water,0.196247788,60,14,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,2.112,ppm water,ppm water,0.261663717,60,7,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,2.64,ppm water,ppm water,0.327079646,60,17,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,3.168,ppm water,ppm water,0.392495575,60,17,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,4.224,ppm water,ppm water,0.523327434,60,26,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,5.28,ppm water,ppm water,0.654159292,60,26,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,6.336,ppm water,ppm water,0.78499115,60,30,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,8.448,ppm water,ppm water,1.046654867,60,25,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
17,55185,N-Nitrosodiethylamine,CalEPA,36,liver,"Peto R, Gray R, Brantom P and Grasso, P. 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethyl-nitrosamine: An unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.",fatal liver tumors,Dose,16,16.896,ppm water,ppm water,2.093309735,60,44,Rat,Colworth,M/F,M,Oral drinking water,NA,lifetime,Duration
18,55630,Nitroglycerin,PPRTV,0.017,liver,"Ellis III, H.V., C.B. Hong, C.C. Lee et al. 1984. Subacute and chronic tox",hepatocellular tumors (combined),HEq,4,0,mg/kg-day,% in feed,0,24,1,Rat,CD,M/F,M,Oral diet,NA,24,Months
18,55630,Nitroglycerin,PPRTV,0.017,liver,"Ellis III, H.V., C.B. Hong, C.C. Lee et al. 1984. Subacute and chronic tox",hepatocellular tumors (combined),HEq,4,0.96,mg/kg-day,% in feed,0.96,28,0,Rat,CD,M/F,M,Oral diet,NA,24,Months
18,55630,Nitroglycerin,PPRTV,0.017,liver,"Ellis III, H.V., C.B. Hong, C.C. Lee et al. 1984. Subacute and chronic tox",hepatocellular tumors (combined),HEq,4,9.8,mg/kg-day,% in feed,9.8,26,4,Rat,CD,M/F,M,Oral diet,NA,24,Months
18,55630,Nitroglycerin,PPRTV,0.017,liver,"Ellis III, H.V., C.B. Hong, C.C. Lee et al. 1984. Subacute and chronic tox",hepatocellular tumors (combined),HEq,4,107,mg/kg-day,% in feed,107,21,15,Rat,CD,M/F,M,Oral diet,NA,24,Months
19,55630,Nitroglycerin,PPRTV,0.017,liver,"Ellis III, H.V., C.B. Hong, C.C. Lee et al. 1984. Subacute and chronic tox",hepatocellular tumors (combined),HEq,4,0,mg/kg-day,% in feed,0,29,0,Rat,CD,M/F,F,Oral diet,NA,24,Months
19,55630,Nitroglycerin,PPRTV,0.017,liver,"Ellis III, H.V., C.B. Hong, C.C. Lee et al. 1984. Subacute and chronic tox",hepatocellular tumors (combined),HEq,4,1.1,mg/kg-day,% in feed,1.1,32,1,Rat,CD,M/F,F,Oral diet,NA,24,Months
19,55630,Nitroglycerin,PPRTV,0.017,liver,"Ellis III, H.V., C.B. Hong, C.C. Lee et al. 1984. Subacute and chronic tox",hepatocellular tumors (combined),HEq,4,10.5,mg/kg-day,% in feed,10.5,28,3,Rat,CD,M/F,F,Oral diet,NA,24,Months
19,55630,Nitroglycerin,PPRTV,0.017,liver,"Ellis III, H.V., C.B. Hong, C.C. Lee et al. 1984. Subacute and chronic tox",hepatocellular tumors (combined),HEq,4,107,mg/kg-day,% in feed,107,25,16,Rat,CD,M/F,F,Oral diet,NA,24,Months
20,55630,Nitroglycerin,PPRTV,0.017,male repro,"Ellis III, H.V., C.B. Hong, C.C. Lee et al. 1984. Subacute and chronic tox",testicular interstitial cell tumors,Conv,4,0,mg/kg-day,% in feed,0,24,2,Rat,CD,M/F,M,Oral diet,NA,24,Months
20,55630,Nitroglycerin,PPRTV,0.017,male repro,"Ellis III, H.V., C.B. Hong, C.C. Lee et al. 1984. Subacute and chronic tox",testicular interstitial cell tumors,Conv,4,3.04,mg/kg-day,% in feed,3.04,28,1,Rat,CD,M/F,M,Oral diet,NA,24,Months
20,55630,Nitroglycerin,PPRTV,0.017,male repro,"Ellis III, H.V., C.B. Hong, C.C. Lee et al. 1984. Subacute and chronic tox",testicular interstitial cell tumors,Conv,4,31.5,mg/kg-day,% in feed,31.5,26,3,Rat,CD,M/F,M,Oral diet,NA,24,Months
20,55630,Nitroglycerin,PPRTV,0.017,male repro,"Ellis III, H.V., C.B. Hong, C.C. Lee et al. 1984. Subacute and chronic tox",testicular interstitial cell tumors,Conv,4,363,mg/kg-day,% in feed,363,21,11,Rat,CD,M/F,M,Oral diet,NA,24,Months
21,56531,Diethylstilbestrol,CalEPA,350,mammary glands,"Gass GH, Coats D and Graham N (1964). Carcinogenic dose-response curve to oral diethylstilbestrol. J. Nat. Cancer Inst. 33: 971-977.",Mammary gland tumors.,Dose,8,0,ppb diet,ppb diet,0,121,40,Mouse,C3H,F,Both,Oral diet,NA,85,Weeks
21,56531,Diethylstilbestrol,CalEPA,350,mammary glands,"Gass GH, Coats D and Graham N (1964). Carcinogenic dose-response curve to oral diethylstilbestrol. J. Nat. Cancer Inst. 33: 971-977.",Mammary gland tumors.,Dose,8,6.25,ppb diet,ppb diet,0.001080028,56,27,Mouse,C3H,F,Both,Oral diet,NA,85,Weeks
21,56531,Diethylstilbestrol,CalEPA,350,mammary glands,"Gass GH, Coats D and Graham N (1964). Carcinogenic dose-response curve to oral diethylstilbestrol. J. Nat. Cancer Inst. 33: 971-977.",Mammary gland tumors.,Dose,8,12.5,ppb diet,ppb diet,0.002160057,60,26,Mouse,C3H,F,Both,Oral diet,NA,85,Weeks
21,56531,Diethylstilbestrol,CalEPA,350,mammary glands,"Gass GH, Coats D and Graham N (1964). Carcinogenic dose-response curve to oral diethylstilbestrol. J. Nat. Cancer Inst. 33: 971-977.",Mammary gland tumors.,Dose,8,25,ppb diet,ppb diet,0.004320113,60,26,Mouse,C3H,F,Both,Oral diet,NA,85,Weeks
21,56531,Diethylstilbestrol,CalEPA,350,mammary glands,"Gass GH, Coats D and Graham N (1964). Carcinogenic dose-response curve to oral diethylstilbestrol. J. Nat. Cancer Inst. 33: 971-977.",Mammary gland tumors.,Dose,8,50,ppb diet,ppb diet,0.008640227,68,36,Mouse,C3H,F,Both,Oral diet,NA,85,Weeks
21,56531,Diethylstilbestrol,CalEPA,350,mammary glands,"Gass GH, Coats D and Graham N (1964). Carcinogenic dose-response curve to oral diethylstilbestrol. J. Nat. Cancer Inst. 33: 971-977.",Mammary gland tumors.,Dose,8,100,ppb diet,ppb diet,0.017280453,64,42,Mouse,C3H,F,Both,Oral diet,NA,85,Weeks
21,56531,Diethylstilbestrol,CalEPA,350,mammary glands,"Gass GH, Coats D and Graham N (1964). Carcinogenic dose-response curve to oral diethylstilbestrol. J. Nat. Cancer Inst. 33: 971-977.",Mammary gland tumors.,Dose,8,500,ppb diet,ppb diet,0.086402266,59,50,Mouse,C3H,F,Both,Oral diet,NA,85,Weeks
21,56531,Diethylstilbestrol,CalEPA,350,mammary glands,"Gass GH, Coats D and Graham N (1964). Carcinogenic dose-response curve to oral diethylstilbestrol. J. Nat. Cancer Inst. 33: 971-977.",Mammary gland tumors.,Dose,8,1000,ppb diet,ppb diet,0.172804533,58,50,Mouse,C3H,F,Both,Oral diet,NA,85,Weeks
22,59892,n-Nitrosomorpholine,CalEPA,6.7,respiratory system,"Ketkar MB, Holste J, Preussmann R and Althoff J. 1983. Carcinogenic effect of nitrosomorpholine administered in the drinking water to Syrian golden hamsters. Cancer Lett 17:333-338.",tumors of the respiratory system,Dose,4,0,mg/kg-day,mg/kg-day,0,50,0,Hamster,Golden Syrian,M/F,F,Oral drinking water,NA,,Duration
22,59892,n-Nitrosomorpholine,CalEPA,6.7,respiratory system,"Ketkar MB, Holste J, Preussmann R and Althoff J. 1983. Carcinogenic effect of nitrosomorpholine administered in the drinking water to Syrian golden hamsters. Cancer Lett 17:333-338.",tumors of the respiratory system,Dose,4,1.36,mg/kg-day,mg/kg-day,1.36,28,14,Hamster,Golden Syrian,M/F,F,Oral drinking water,NA,,Duration
22,59892,n-Nitrosomorpholine,CalEPA,6.7,respiratory system,"Ketkar MB, Holste J, Preussmann R and Althoff J. 1983. Carcinogenic effect of nitrosomorpholine administered in the drinking water to Syrian golden hamsters. Cancer Lett 17:333-338.",tumors of the respiratory system,Dose,4,6.82,mg/kg-day,mg/kg-day,6.82,30,16,Hamster,Golden Syrian,M/F,F,Oral drinking water,NA,,Duration
22,59892,n-Nitrosomorpholine,CalEPA,6.7,respiratory system,"Ketkar MB, Holste J, Preussmann R and Althoff J. 1983. Carcinogenic effect of nitrosomorpholine administered in the drinking water to Syrian golden hamsters. Cancer Lett 17:333-338.",tumors of the respiratory system,Dose,4,13.6,mg/kg-day,mg/kg-day,13.6,30,22,Hamster,Golden Syrian,M/F,F,Oral drinking water,NA,,Duration
23,61825,Amitrole,CalEPA,0.94,thyroid,"Steinhoff D, Weber H, Mohr U and Boehme K (1983). Evaluation of amitrole (aminotriazole) for potential carcinogenicity in orally dosed rats, mice, and golden hamsters. Toxicol. Appl. Pharmacol. 69: 161-169",thyroid tumors,Dose,4,0,ppm,ppm,0,75,7,Rat,Wistar,M/F,F,Oral diet,NA,165,Weeks
23,61825,Amitrole,CalEPA,0.94,thyroid,"Steinhoff D, Weber H, Mohr U and Boehme K (1983). Evaluation of amitrole (aminotriazole) for potential carcinogenicity in orally dosed rats, mice, and golden hamsters. Toxicol. Appl. Pharmacol. 69: 161-169",thyroid tumors,Dose,4,1,ppm,ppm,0.084175084,75,13,Rat,Wistar,M/F,F,Oral diet,NA,165,Weeks
23,61825,Amitrole,CalEPA,0.94,thyroid,"Steinhoff D, Weber H, Mohr U and Boehme K (1983). Evaluation of amitrole (aminotriazole) for potential carcinogenicity in orally dosed rats, mice, and golden hamsters. Toxicol. Appl. Pharmacol. 69: 161-169",thyroid tumors,Dose,4,10,ppm,ppm,0.841750842,75,12,Rat,Wistar,M/F,F,Oral diet,NA,165,Weeks
23,61825,Amitrole,CalEPA,0.94,thyroid,"Steinhoff D, Weber H, Mohr U and Boehme K (1983). Evaluation of amitrole (aminotriazole) for potential carcinogenicity in orally dosed rats, mice, and golden hamsters. Toxicol. Appl. Pharmacol. 69: 161-169",thyroid tumors,Dose,4,100,ppm,ppm,8.417508418,75,72,Rat,Wistar,M/F,F,Oral diet,NA,165,Weeks
24,62442,Phenacetin,CalEPA,0.0022,nasal passages,"Isaka H, Yoshii H, Otsuji A, Koike M, Nagai Y, Koura M, Sugiyasu K and Kanabayashi T (1979). Tumors of Sprague-Dawley rats induced by long-term feeding of phenacetin. Gann 70: 29-36.",nasal adenocarcinomas,Dose,3,0,% diet,% diet,0,19,0,Rat,Sprague-Dawley,M/F,M,Oral diet,NA,104,Weeks
24,62442,Phenacetin,CalEPA,0.0022,nasal passages,"Isaka H, Yoshii H, Otsuji A, Koike M, Nagai Y, Koura M, Sugiyasu K and Kanabayashi T (1979). Tumors of Sprague-Dawley rats induced by long-term feeding of phenacetin. Gann 70: 29-36.",nasal adenocarcinomas,Dose,3,1.25,% diet,% diet,860.4206501,22,8,Rat,Sprague-Dawley,M/F,M,Oral diet,NA,104,Weeks
24,62442,Phenacetin,CalEPA,0.0022,nasal passages,"Isaka H, Yoshii H, Otsuji A, Koike M, Nagai Y, Koura M, Sugiyasu K and Kanabayashi T (1979). Tumors of Sprague-Dawley rats induced by long-term feeding of phenacetin. Gann 70: 29-36.",nasal adenocarcinomas,Dose,3,2.5,% diet,% diet,1720.8413,27,7,Rat,Sprague-Dawley,M/F,M,Oral diet,NA,104,Weeks
25,62533,Aniline,CalEPA,0.0057,spleen,Chemical Industry Institute of Toxicology (CIIT) 1982. Aniline hydrochloride: 104-week chronic toxicity study in rats. Final report,splenic tumors,HEq,4,0,mg/kg-day,ppm,0,64,0,Rat,CD,M/F,M,Oral diet,NA,2,Years
25,62533,Aniline,CalEPA,0.0057,spleen,Chemical Industry Institute of Toxicology (CIIT) 1982. Aniline hydrochloride: 104-week chronic toxicity study in rats. Final report,splenic tumors,HEq,4,1.23,mg/kg-day,ppm,1.23,90,0,Rat,CD,M/F,M,Oral diet,NA,2,Years
25,62533,Aniline,CalEPA,0.0057,spleen,Chemical Industry Institute of Toxicology (CIIT) 1982. Aniline hydrochloride: 104-week chronic toxicity study in rats. Final report,splenic tumors,HEq,4,3.69,mg/kg-day,ppm,3.69,90,1,Rat,CD,M/F,M,Oral diet,NA,2,Years
25,62533,Aniline,CalEPA,0.0057,spleen,Chemical Industry Institute of Toxicology (CIIT) 1982. Aniline hydrochloride: 104-week chronic toxicity study in rats. Final report,splenic tumors,HEq,4,12.29,mg/kg-day,ppm,12.29,90,31,Rat,CD,M/F,M,Oral diet,NA,2,Years
26,62533,Aniline,IRIS,0.0057,spleen,CIIT (Chemical Industry Institute of Toxicology). 1982. 104-Week chronic toxicity study in rats: Aniline hydrochloride. Final report.,"spleen, combined fibrosarcoma, stromal sarcoma, capsular sarcoma and hemangiosarcoma",HEq,4,0,mg/kg-day,ppm,0,64,0,Rat,CD,M/F,M,Oral diet,NA,2,Years
26,62533,Aniline,IRIS,0.0057,spleen,CIIT (Chemical Industry Institute of Toxicology). 1982. 104-Week chronic toxicity study in rats: Aniline hydrochloride. Final report.,"spleen, combined fibrosarcoma, stromal sarcoma, capsular sarcoma and hemangiosarcoma",HEq,4,1.23,mg/kg-day,ppm,1.23,90,0,Rat,CD,M/F,M,Oral diet,NA,2,Years
26,62533,Aniline,IRIS,0.0057,spleen,CIIT (Chemical Industry Institute of Toxicology). 1982. 104-Week chronic toxicity study in rats: Aniline hydrochloride. Final report.,"spleen, combined fibrosarcoma, stromal sarcoma, capsular sarcoma and hemangiosarcoma",HEq,4,3.69,mg/kg-day,ppm,3.69,90,1,Rat,CD,M/F,M,Oral diet,NA,2,Years
26,62533,Aniline,IRIS,0.0057,spleen,CIIT (Chemical Industry Institute of Toxicology). 1982. 104-Week chronic toxicity study in rats: Aniline hydrochloride. Final report.,"spleen, combined fibrosarcoma, stromal sarcoma, capsular sarcoma and hemangiosarcoma",HEq,4,12.29,mg/kg-day,ppm,12.29,90,31,Rat,CD,M/F,M,Oral diet,NA,2,Years
27,62737,Dichlorvos,IRIS,0.29,blood,"NTP (National Toxicology Program). 1986b. Two-year gavage study of dichlorvos in rats. Unpublished report prepared by Southern Research Institute, May 23. Study No. 05049. NTP, Research Triangle Park, NC.","leukemia, all types",Dose,3,0,ppm,ppm,0,50,11,Rat,Fischer 344,M/F,M,Oral gavage,5,2,Years
27,62737,Dichlorvos,IRIS,0.29,blood,"NTP (National Toxicology Program). 1986b. Two-year gavage study of dichlorvos in rats. Unpublished report prepared by Southern Research Institute, May 23. Study No. 05049. NTP, Research Triangle Park, NC.","leukemia, all types",Dose,3,80,ppm,ppm,2.857142857,50,20,Rat,Fischer 344,M/F,M,Oral gavage,5,2,Years
27,62737,Dichlorvos,IRIS,0.29,blood,"NTP (National Toxicology Program). 1986b. Two-year gavage study of dichlorvos in rats. Unpublished report prepared by Southern Research Institute, May 23. Study No. 05049. NTP, Research Triangle Park, NC.","leukemia, all types",Dose,3,160,ppm,ppm,5.714285714,50,21,Rat,Fischer 344,M/F,M,Oral gavage,5,2,Years
28,62737,Dichlorvos,IRIS,0.29,pancreas,"NTP (National Toxicology Program). 1986a. Two-year mouse gavage study. Unpublished report prepared by Southern Research Institute, May 23. Study No. 05049. NTP, Research Triangle Park, NC.",Pancreatic tumors (pancreatic acinar adenoma),Dose,3,0,ppm,ppm,0,50,16,Mouse,B6C3F1,M/F,M,Oral gavage,5,104,Weeks
28,62737,Dichlorvos,IRIS,0.29,pancreas,"NTP (National Toxicology Program). 1986a. Two-year mouse gavage study. Unpublished report prepared by Southern Research Institute, May 23. Study No. 05049. NTP, Research Triangle Park, NC.",Pancreatic tumors (pancreatic acinar adenoma),Dose,3,80,ppm,ppm,9.804672539,49,25,Mouse,B6C3F1,M/F,M,Oral gavage,5,104,Weeks
28,62737,Dichlorvos,IRIS,0.29,pancreas,"NTP (National Toxicology Program). 1986a. Two-year mouse gavage study. Unpublished report prepared by Southern Research Institute, May 23. Study No. 05049. NTP, Research Triangle Park, NC.",Pancreatic tumors (pancreatic acinar adenoma),Dose,3,160,ppm,ppm,19.60934508,50,30,Mouse,B6C3F1,M/F,M,Oral gavage,5,104,Weeks
29,62737,Dichlorvos,IRIS,0.29,pancreas,"NTP (National Toxicology Program). 1986b. Two-year gavage study of dichlorvos in rats. Unpublished report prepared by Southern Research Institute, May 23. Study No. 05049. NTP, Research Triangle Park, NC.",pancreatic acinar adenoma,Dose,3,0,ppm,ppm,0,50,16,Rat,Fischer 344,M/F,M,Oral gavage,5,2,Years
29,62737,Dichlorvos,IRIS,0.29,pancreas,"NTP (National Toxicology Program). 1986b. Two-year gavage study of dichlorvos in rats. Unpublished report prepared by Southern Research Institute, May 23. Study No. 05049. NTP, Research Triangle Park, NC.",pancreatic acinar adenoma,Dose,3,80,ppm,ppm,2.857142857,49,25,Rat,Fischer 344,M/F,M,Oral gavage,5,2,Years
29,62737,Dichlorvos,IRIS,0.29,pancreas,"NTP (National Toxicology Program). 1986b. Two-year gavage study of dichlorvos in rats. Unpublished report prepared by Southern Research Institute, May 23. Study No. 05049. NTP, Research Triangle Park, NC.",pancreatic acinar adenoma,Dose,3,160,ppm,ppm,5.714285714,50,30,Rat,Fischer 344,M/F,M,Oral gavage,5,2,Years
30,62737,Dichlorvos,IRIS,0.29,stomach/forestomach,"NTP (National Toxicology Program). 1986a. Two-year mouse gavage study. Unpublished report prepared by Southern Research Institute, May 23. Study No. 05049. NTP, Research Triangle Park, NC.","forestomach tumors (papilloma, squamous and squamous cell carcinoma)",HEq,3,0,mg/kg/day,ppm,0,49,5,Mouse,B6C3F1,M/F,F,Oral gavage,5,104,Weeks
30,62737,Dichlorvos,IRIS,0.29,stomach/forestomach,"NTP (National Toxicology Program). 1986a. Two-year mouse gavage study. Unpublished report prepared by Southern Research Institute, May 23. Study No. 05049. NTP, Research Triangle Park, NC.","forestomach tumors (papilloma, squamous and squamous cell carcinoma)",HEq,3,15.75,mg/kg/day,ppm,15.75,49,6,Mouse,B6C3F1,M/F,F,Oral gavage,5,104,Weeks
30,62737,Dichlorvos,IRIS,0.29,stomach/forestomach,"NTP (National Toxicology Program). 1986a. Two-year mouse gavage study. Unpublished report prepared by Southern Research Institute, May 23. Study No. 05049. NTP, Research Triangle Park, NC.","forestomach tumors (papilloma, squamous and squamous cell carcinoma)",HEq,3,31.5,mg/kg/day,ppm,31.5,50,19,Mouse,B6C3F1,M/F,F,Oral gavage,5,104,Weeks
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,0,ppm water,ppm water,0,240,1,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,0.033,ppm water,ppm water,0.00453169,60,1,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,0.066,ppm water,ppm water,0.00906338,60,0,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,0.132,ppm water,ppm water,0.018126761,60,2,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,0.264,ppm water,ppm water,0.036253521,60,3,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,0.528,ppm water,ppm water,0.072507042,60,5,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,1.056,ppm water,ppm water,0.145014085,60,5,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,1.584,ppm water,ppm water,0.217521127,60,27,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,2.112,ppm water,ppm water,0.290028169,60,33,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,2.64,ppm water,ppm water,0.362535211,60,44,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,3.168,ppm water,ppm water,0.435042254,60,48,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,4.224,ppm water,ppm water,0.580056338,60,53,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,5.28,ppm water,ppm water,0.725070423,60,52,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,6.336,ppm water,ppm water,0.870084507,60,51,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,8.448,ppm water,ppm water,1.160112676,60,55,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
31,62759,N-Nitrosodimethylamine,CalEPA,16,liver,"Peto R, Gray R, Brantom P and Grasso P. April, 1982. Effects on two tonnes of inbred rats of chronic ingestion of diethyl- or dimethylnitrosoamine: an unusually detailed dose-response study. Imperial Cancer Res Fund, Cancer Studies Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.

Peto R and Gray R. 1984. Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3,6 or 20 weeks) and of species (rats, mice or hamsters). In: N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57. ONeill IK, Von Borstel RC, Miller CT, Long J, Bartsch H eds., International Agency for Research on Cancer, Lyon, pp.501-512.",fatal liver tumor,Dose,16,16.896,ppm water,ppm water,2.320225352,60,58,Rat,Colworth,M/F,F,Oral drinking water,NA,lifetime,Duration
32,67721,Hexachloroethane,CalEPA,0.039,liver,"National Cancer Institute (NCI, 1978). Bioassay of Hexachloroetluzne for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 68. NTIS Publication No. PB 90170895. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",liver hepatocellular carcinomas,Dose,3,0,mg/kg-day (TWA),mg/kg-day (TWA),0,60,2,Mouse,B6C3F1,M/F,F,Oral gavage,5,90,Weeks
32,67721,Hexachloroethane,CalEPA,0.039,liver,"National Cancer Institute (NCI, 1978). Bioassay of Hexachloroetluzne for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 68. NTIS Publication No. PB 90170895. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",liver hepatocellular carcinomas,Dose,3,590,mg/kg-day (TWA),mg/kg-day (TWA),421.4285714,50,20,Mouse,B6C3F1,M/F,F,Oral gavage,5,90,Weeks
32,67721,Hexachloroethane,CalEPA,0.039,liver,"National Cancer Institute (NCI, 1978). Bioassay of Hexachloroetluzne for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 68. NTIS Publication No. PB 90170895. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",liver hepatocellular carcinomas,Dose,3,1179,mg/kg-day (TWA),mg/kg-day (TWA),842.1428571,49,15,Mouse,B6C3F1,M/F,F,Oral gavage,5,90,Weeks
33,67721,Hexachloroethane,IRIS,0.04,kidneys,"NTP. (National Toxicology Program). (1989). Toxicology and carcinogenesis studies of hexachloroethane (CAS no. 67-72-1) in F344/N rats (gavage studies). (NTP TR 361). Research Triangle Park, NC: U.S. Department of Health and Human Services, National Toxicology Program. http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr361.pdf (PDF) (122 pp, 6M).",Renal adenomas and carcinomas (combined),Dose,3,0,mg/kg/day,,0,50,1,Rat,Fischer 344,M/F,M,Oral gavage,5,103,Weeks
33,67721,Hexachloroethane,IRIS,0.04,kidneys,"NTP. (National Toxicology Program). (1989). Toxicology and carcinogenesis studies of hexachloroethane (CAS no. 67-72-1) in F344/N rats (gavage studies). (NTP TR 361). Research Triangle Park, NC: U.S. Department of Health and Human Services, National Toxicology Program. http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr361.pdf (PDF) (122 pp, 6M).",Renal adenomas and carcinomas (combined),Dose,3,7.1,mg/kg/day,,5.071428571,50,2,Rat,Fischer 344,M/F,M,Oral gavage,5,103,Weeks
33,67721,Hexachloroethane,IRIS,0.04,kidneys,"NTP. (National Toxicology Program). (1989). Toxicology and carcinogenesis studies of hexachloroethane (CAS no. 67-72-1) in F344/N rats (gavage studies). (NTP TR 361). Research Triangle Park, NC: U.S. Department of Health and Human Services, National Toxicology Program. http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr361.pdf (PDF) (122 pp, 6M).",Renal adenomas and carcinomas (combined),Dose,3,14.3,mg/kg/day,,10.21428571,50,7,Rat,Fischer 344,M/F,M,Oral gavage,5,103,Weeks
34,70257,n-Methyl-n-Nitro-n-Nitrosoguanidine,CalEPA,8.3,gastrointestinal,"Lijinsky W and Reuber MD (1984). Comparison of nitrosocimetidine with nitrosomethylnitroguanidine in chronic feeding tests in rats. Cancer Res. 44: 447-449.

Arffman EJL, Rasmussen KS and Hansen FN (1981). Effect of some fatty acid methyl esters on gastrointestinal carcinogenesis by N-methyl-N'-nitro-N-nitrosoguanidine in rats. J. Nat. Cancer Inst. 67: 1071-1075.",gastrointestinal tract tumors Arffman et al. (1981),Dose,3,0,mg/L,mg/L,0,30,0,Rat,Wistar,M,Both,Oral drinking water,NA,32,Weeks
34,70257,n-Methyl-n-Nitro-n-Nitrosoguanidine,CalEPA,8.3,gastrointestinal,"Lijinsky W and Reuber MD (1984). Comparison of nitrosocimetidine with nitrosomethylnitroguanidine in chronic feeding tests in rats. Cancer Res. 44: 447-449.

Arffman EJL, Rasmussen KS and Hansen FN (1981). Effect of some fatty acid methyl esters on gastrointestinal carcinogenesis by N-methyl-N'-nitro-N-nitrosoguanidine in rats. J. Nat. Cancer Inst. 67: 1071-1075.",gastrointestinal tract tumors Arffman et al. (1981),Dose,3,20,mg/L,mg/L,2.467532468,30,12,Rat,Wistar,M,Both,Oral drinking water,NA,32,Weeks
34,70257,n-Methyl-n-Nitro-n-Nitrosoguanidine,CalEPA,8.3,gastrointestinal,"Lijinsky W and Reuber MD (1984). Comparison of nitrosocimetidine with nitrosomethylnitroguanidine in chronic feeding tests in rats. Cancer Res. 44: 447-449.

Arffman EJL, Rasmussen KS and Hansen FN (1981). Effect of some fatty acid methyl esters on gastrointestinal carcinogenesis by N-methyl-N'-nitro-N-nitrosoguanidine in rats. J. Nat. Cancer Inst. 67: 1071-1075.",gastrointestinal tract tumors Arffman et al. (1981),Dose,3,83,mg/L,mg/L,10.24025974,30,25,Rat,Wistar,M,Both,Oral drinking water,NA,32,Weeks
35,72559,"p,p'-DDE",CalEPA,0.34,liver,"NCI (National Cancer Institute). 1978. Bioassay of DDT, TDE and p,p'-DDE for possible carcinogenicity. NCI Report No. 131. DHEW Publ. No. (NIH) 78-1386.","hepatocellular carcinomas, hepatomas",HEq,3,0,mg/kg-day,ppm diet,0,19,0,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
35,72559,"p,p'-DDE",CalEPA,0.34,liver,"NCI (National Cancer Institute). 1978. Bioassay of DDT, TDE and p,p'-DDE for possible carcinogenicity. NCI Report No. 131. DHEW Publ. No. (NIH) 78-1386.","hepatocellular carcinomas, hepatomas",HEq,3,0.9,mg/kg-day,ppm diet,0.9,41,7,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
35,72559,"p,p'-DDE",CalEPA,0.34,liver,"NCI (National Cancer Institute). 1978. Bioassay of DDT, TDE and p,p'-DDE for possible carcinogenicity. NCI Report No. 131. DHEW Publ. No. (NIH) 78-1386.","hepatocellular carcinomas, hepatomas",HEq,3,1.584,mg/kg-day,ppm diet,1.584,47,17,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
36,72559,"p,p'-DDE",CalEPA,0.34,liver,"Rossi, L., O. Barbieri, M. Sanguineti, J.R.P. Cabral, P. Bruzzi and L. Santi. 1983. Carcinogenicity study with technical-grade DDT and DDE in hamsters. Cancer Res. 43: 776-781.",neoplastic nodules (hepatomas),HEq,3,0,mg/kg-day,ppm diet,0,42,0,Hamster,Golden Syrian,M/F,M,Oral diet,NA,76,Weeks
36,72559,"p,p'-DDE",CalEPA,0.34,liver,"Rossi, L., O. Barbieri, M. Sanguineti, J.R.P. Cabral, P. Bruzzi and L. Santi. 1983. Carcinogenicity study with technical-grade DDT and DDE in hamsters. Cancer Res. 43: 776-781.",neoplastic nodules (hepatomas),HEq,3,4.79,mg/kg-day,ppm diet,4.79,39,4,Hamster,Golden Syrian,M/F,M,Oral diet,NA,76,Weeks
36,72559,"p,p'-DDE",CalEPA,0.34,liver,"Rossi, L., O. Barbieri, M. Sanguineti, J.R.P. Cabral, P. Bruzzi and L. Santi. 1983. Carcinogenicity study with technical-grade DDT and DDE in hamsters. Cancer Res. 43: 776-781.",neoplastic nodules (hepatomas),HEq,3,9.57,mg/kg-day,ppm diet,9.57,39,6,Hamster,Golden Syrian,M/F,M,Oral diet,NA,76,Weeks
37,72559,"p,p'-DDE",CalEPA,0.34,liver,"Rossi, L., O. Barbieri, M. Sanguineti, J.R.P. Cabral, P. Bruzzi and L. Santi. 1983. Carcinogenicity study with technical-grade DDT and DDE in hamsters. Cancer Res. 43: 776-781.","hepatocellular carcinomas, hepatomas",HEq,3,0,mg/kg-day,ppm diet,0,31,0,Hamster,Golden Syrian,M/F,F,Oral diet,NA,76,Weeks
37,72559,"p,p'-DDE",CalEPA,0.34,liver,"Rossi, L., O. Barbieri, M. Sanguineti, J.R.P. Cabral, P. Bruzzi and L. Santi. 1983. Carcinogenicity study with technical-grade DDT and DDE in hamsters. Cancer Res. 43: 776-781.","hepatocellular carcinomas, hepatomas",HEq,3,4.79,mg/kg-day,ppm diet,4.79,30,7,Hamster,Golden Syrian,M/F,F,Oral diet,NA,76,Weeks
37,72559,"p,p'-DDE",CalEPA,0.34,liver,"Rossi, L., O. Barbieri, M. Sanguineti, J.R.P. Cabral, P. Bruzzi and L. Santi. 1983. Carcinogenicity study with technical-grade DDT and DDE in hamsters. Cancer Res. 43: 776-781.","hepatocellular carcinomas, hepatomas",HEq,3,9.57,mg/kg-day,ppm diet,9.57,39,8,Hamster,Golden Syrian,M/F,F,Oral diet,NA,76,Weeks
38,72559,"p,p'-DDE",IRIS,0.34,liver,"NCI (National Cancer Institute). 1978. Bioassay of DDT, TDE and p,p'-DDE for possible carcinogenicity. NCI Report No. 131. DHEW Publ. No. (NIH) 78-1386.",hepatocellular carcinomas,HEq,3,0,mg/kg/day,ppm,0,19,0,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
38,72559,"p,p'-DDE",IRIS,0.34,liver,"NCI (National Cancer Institute). 1978. Bioassay of DDT, TDE and p,p'-DDE for possible carcinogenicity. NCI Report No. 131. DHEW Publ. No. (NIH) 78-1386.",hepatocellular carcinomas,HEq,3,0.9,mg/kg/day,ppm,0.9,41,7,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
38,72559,"p,p'-DDE",IRIS,0.34,liver,"NCI (National Cancer Institute). 1978. Bioassay of DDT, TDE and p,p'-DDE for possible carcinogenicity. NCI Report No. 131. DHEW Publ. No. (NIH) 78-1386.",hepatocellular carcinomas,HEq,3,1.584,mg/kg/day,ppm,1.584,47,17,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
39,72559,"p,p'-DDE",IRIS,0.34,liver,"NCI (National Cancer Institute). 1978. Bioassay of DDT, TDE and p,p'-DDE for possible carcinogenicity. NCI Report No. 131. DHEW Publ. No. (NIH) 78-1386.",hepatocellular carcinomas,HEq,3,0,mg/kg/day,ppm,0,19,0,Mouse,B6C3F1,M/F,F,Oral diet,NA,78,Weeks
39,72559,"p,p'-DDE",IRIS,0.34,liver,"NCI (National Cancer Institute). 1978. Bioassay of DDT, TDE and p,p'-DDE for possible carcinogenicity. NCI Report No. 131. DHEW Publ. No. (NIH) 78-1386.",hepatocellular carcinomas,HEq,3,0.9,mg/kg/day,ppm,0.9,47,19,Mouse,B6C3F1,M/F,F,Oral diet,NA,78,Weeks
39,72559,"p,p'-DDE",IRIS,0.34,liver,"NCI (National Cancer Institute). 1978. Bioassay of DDT, TDE and p,p'-DDE for possible carcinogenicity. NCI Report No. 131. DHEW Publ. No. (NIH) 78-1386.",hepatocellular carcinomas,HEq,3,1.584,mg/kg/day,ppm,1.584,48,34,Mouse,B6C3F1,M/F,F,Oral diet,NA,78,Weeks
40,72559,"p,p'-DDE",IRIS,0.34,liver,"Rossi, L., O. Barbieri, M. Sanguineti, J.R.P. Cabral, P. Bruzzi and L. Santi. 1983. Carcinogenicity study with technical-grade DDT and DDE in hamsters. Cancer Res. 43: 776-781.",neoplastic nodules (hepatomas),HEq,3,0,mg/kg/day,ppm,0,42,0,Hamster,Golden Syrian,M/F,M,Oral diet,NA,128,Weeks
40,72559,"p,p'-DDE",IRIS,0.34,liver,"Rossi, L., O. Barbieri, M. Sanguineti, J.R.P. Cabral, P. Bruzzi and L. Santi. 1983. Carcinogenicity study with technical-grade DDT and DDE in hamsters. Cancer Res. 43: 776-781.",neoplastic nodules (hepatomas),HEq,3,4.79,mg/kg/day,ppm,4.79,39,4,Hamster,Golden Syrian,M/F,M,Oral diet,NA,128,Weeks
40,72559,"p,p'-DDE",IRIS,0.34,liver,"Rossi, L., O. Barbieri, M. Sanguineti, J.R.P. Cabral, P. Bruzzi and L. Santi. 1983. Carcinogenicity study with technical-grade DDT and DDE in hamsters. Cancer Res. 43: 776-781.",neoplastic nodules (hepatomas),HEq,3,9.57,mg/kg/day,ppm,9.57,39,6,Hamster,Golden Syrian,M/F,M,Oral diet,NA,128,Weeks
41,72559,"p,p'-DDE",IRIS,0.34,liver,"Rossi, L., O. Barbieri, M. Sanguineti, J.R.P. Cabral, P. Bruzzi and L. Santi. 1983. Carcinogenicity study with technical-grade DDT and DDE in hamsters. Cancer Res. 43: 776-781.",neoplastic nodules (hepatomas),HEq,3,0,mg/kg/day,ppm,0,31,0,Hamster,Golden Syrian,M/F,F,Oral diet,NA,128,Weeks
41,72559,"p,p'-DDE",IRIS,0.34,liver,"Rossi, L., O. Barbieri, M. Sanguineti, J.R.P. Cabral, P. Bruzzi and L. Santi. 1983. Carcinogenicity study with technical-grade DDT and DDE in hamsters. Cancer Res. 43: 776-781.",neoplastic nodules (hepatomas),HEq,3,4.79,mg/kg/day,ppm,4.79,30,7,Hamster,Golden Syrian,M/F,F,Oral diet,NA,128,Weeks
41,72559,"p,p'-DDE",IRIS,0.34,liver,"Rossi, L., O. Barbieri, M. Sanguineti, J.R.P. Cabral, P. Bruzzi and L. Santi. 1983. Carcinogenicity study with technical-grade DDT and DDE in hamsters. Cancer Res. 43: 776-781.",neoplastic nodules (hepatomas),HEq,3,9.57,mg/kg/day,ppm,9.57,39,8,Hamster,Golden Syrian,M/F,F,Oral diet,NA,128,Weeks
42,75014,Vinyl chloride,IRIS,0.72,liver,"Feron, VJ; Hendriksen, CFM; Speek, AJ; et al. (1981) Lifespan oral toxicity study of vinyl-chloride in rats. Food Cosmet Toxicol 19(3):317-333.","Total of liver angiosarcoma, hepatocellular carcinoma, and neoplastic nodules",HEq,4,0,mg/kg-day,mg/kg-day,0,57,2,Rat,Wistar,F,Both,Oral diet,NA,135-144,Weeks
42,75014,Vinyl chloride,IRIS,0.72,liver,"Feron, VJ; Hendriksen, CFM; Speek, AJ; et al. (1981) Lifespan oral toxicity study of vinyl-chloride in rats. Food Cosmet Toxicol 19(3):317-333.","Total of liver angiosarcoma, hepatocellular carcinoma, and neoplastic nodules",HEq,4,1.07,mg/kg-day,mg/kg-day,1.07,58,28,Rat,Wistar,F,Both,Oral diet,NA,135-144,Weeks
42,75014,Vinyl chloride,IRIS,0.72,liver,"Feron, VJ; Hendriksen, CFM; Speek, AJ; et al. (1981) Lifespan oral toxicity study of vinyl-chloride in rats. Food Cosmet Toxicol 19(3):317-333.","Total of liver angiosarcoma, hepatocellular carcinoma, and neoplastic nodules",HEq,4,3.13,mg/kg-day,mg/kg-day,3.13,59,49,Rat,Wistar,F,Both,Oral diet,NA,135-144,Weeks
42,75014,Vinyl chloride,IRIS,0.72,liver,"Feron, VJ; Hendriksen, CFM; Speek, AJ; et al. (1981) Lifespan oral toxicity study of vinyl-chloride in rats. Food Cosmet Toxicol 19(3):317-333.","Total of liver angiosarcoma, hepatocellular carcinoma, and neoplastic nodules",HEq,4,8.77,mg/kg-day,mg/kg-day,8.77,57,56,Rat,Wistar,F,Both,Oral diet,NA,135-144,Weeks
43,75252,Bromoform,IRIS,0.0079,gastrointestinal,NTP (National Toxicology Program). 1988. Technical Report on the Toxicology and Carcinogenesis Studies of Tribromomethane (Bromoform) (CAS No. 75-25-2) in F344 rats and B6C3F1 mice (gavage studies). NTP TR 350.,Neoplastic lesions in the large intestine,HEq,3,0,mg/kg/day,ppm,0,50,0,Rat,Fischer 344,M/F,F,Oral gavage,5,2,Years
43,75252,Bromoform,IRIS,0.0079,gastrointestinal,NTP (National Toxicology Program). 1988. Technical Report on the Toxicology and Carcinogenesis Studies of Tribromomethane (Bromoform) (CAS No. 75-25-2) in F344 rats and B6C3F1 mice (gavage studies). NTP TR 350.,Neoplastic lesions in the large intestine,HEq,3,10.6,mg/kg/day,ppm,10.6,50,1,Rat,Fischer 344,M/F,F,Oral gavage,5,2,Years
43,75252,Bromoform,IRIS,0.0079,gastrointestinal,NTP (National Toxicology Program). 1988. Technical Report on the Toxicology and Carcinogenesis Studies of Tribromomethane (Bromoform) (CAS No. 75-25-2) in F344 rats and B6C3F1 mice (gavage studies). NTP TR 350.,Neoplastic lesions in the large intestine,HEq,3,20.5,mg/kg/day,ppm,20.5,50,8,Rat,Fischer 344,M/F,F,Oral gavage,5,2,Years
44,75274,Bromodichloromethane,IRIS,0.062,kidneys,"NTP (National Toxicology Program). 1987. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Bromodichloromethane (CAS No. 75-27- 4) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP Tech. Report Series No. 321. U.S. Dept. Health and Human Services, Public Health Service, National Institute of Health.",Kidney (tubular cell adenoma and tubular cell adenocarcinoma),HEq,3,0,mg/kg/day,mg/kg/day,0,46,1,Mouse,B6C3F1,M/F,M,Oral gavage,5,102,Weeks
44,75274,Bromodichloromethane,IRIS,0.062,kidneys,"NTP (National Toxicology Program). 1987. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Bromodichloromethane (CAS No. 75-27- 4) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP Tech. Report Series No. 321. U.S. Dept. Health and Human Services, Public Health Service, National Institute of Health.",Kidney (tubular cell adenoma and tubular cell adenocarcinoma),HEq,3,1.5,mg/kg/day,mg/kg/day,1.5,49,2,Mouse,B6C3F1,M/F,M,Oral gavage,5,102,Weeks
44,75274,Bromodichloromethane,IRIS,0.062,kidneys,"NTP (National Toxicology Program). 1987. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Bromodichloromethane (CAS No. 75-27- 4) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP Tech. Report Series No. 321. U.S. Dept. Health and Human Services, Public Health Service, National Institute of Health.",Kidney (tubular cell adenoma and tubular cell adenocarcinoma),HEq,3,3,mg/kg/day,mg/kg/day,3,50,9,Mouse,B6C3F1,M/F,M,Oral gavage,5,102,Weeks
45,75343,"1,1-Dichloroethane",CalEPA,0.0057,mammary glands,"National Cancer Institute (NCI) 1977. Bioassay of 1,1-Dichloroethane for Possible Carcinogenicity. CAS No. 75-34-3. Carcinogenesis Technical Report Series No. 66. NCI-CG-TR-66 DHEW Publication No. (NIH) 78-1316. NTIS Publication No. PB-283 345. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",mammary gland adenocarcinomas,Dose,3,0,mg/kg/day,mg/kg/day,0,20,0,Rat,Osborne-Mendel,F,Both,Oral gavage,5,78,Weeks
45,75343,"1,1-Dichloroethane",CalEPA,0.0057,mammary glands,"National Cancer Institute (NCI) 1977. Bioassay of 1,1-Dichloroethane for Possible Carcinogenicity. CAS No. 75-34-3. Carcinogenesis Technical Report Series No. 66. NCI-CG-TR-66 DHEW Publication No. (NIH) 78-1316. NTIS Publication No. PB-283 345. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",mammary gland adenocarcinomas,Dose,3,238,mg/kg/day,mg/kg/day,170,50,1,Rat,Osborne-Mendel,F,Both,Oral gavage,5,78,Weeks
45,75343,"1,1-Dichloroethane",CalEPA,0.0057,mammary glands,"National Cancer Institute (NCI) 1977. Bioassay of 1,1-Dichloroethane for Possible Carcinogenicity. CAS No. 75-34-3. Carcinogenesis Technical Report Series No. 66. NCI-CG-TR-66 DHEW Publication No. (NIH) 78-1316. NTIS Publication No. PB-283 345. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",mammary gland adenocarcinomas,Dose,3,477,mg/kg/day,mg/kg/day,340.7142857,50,5,Rat,Osborne-Mendel,F,Both,Oral gavage,5,78,Weeks
46,75569,Propylene Oxide,IRIS,0.24,stomach/forestomach,"Dunkelberg, H. 1982. Carcinogenicity of ethylene oxide and 1,2-propylene oxide upon intragastric administration to rats. Br. J. Cancer. 46(6): 924- 933.","forestomach, squamous cell carcinoma",HEq,3,0,mg/kg-d,mg/kg-day,0,100,0,Rat,Sprague-Dawley,F,Both,Oral gavage,2,150,Weeks
46,75569,Propylene Oxide,IRIS,0.24,stomach/forestomach,"Dunkelberg, H. 1982. Carcinogenicity of ethylene oxide and 1,2-propylene oxide upon intragastric administration to rats. Br. J. Cancer. 46(6): 924- 933.","forestomach, squamous cell carcinoma",HEq,3,0.44,mg/kg-d,mg/kg-day,0.44,50,2,Rat,Sprague-Dawley,F,Both,Oral gavage,2,150,Weeks
46,75569,Propylene Oxide,IRIS,0.24,stomach/forestomach,"Dunkelberg, H. 1982. Carcinogenicity of ethylene oxide and 1,2-propylene oxide upon intragastric administration to rats. Br. J. Cancer. 46(6): 924- 933.","forestomach, squamous cell carcinoma",HEq,3,1.76,mg/kg-d,mg/kg-day,1.76,50,19,Rat,Sprague-Dawley,F,Both,Oral gavage,2,150,Weeks
47,76017,Pentachloroethane   ,PPRTV,0.09,liver,"NTP (National Toxicology Program). 1983. Carcinogenesis bioassay of pentachloroethane in F344/N rats and B6C3F1 mice (gavage studies). National Institute of Environmental Health Sciences, Public Health Service, U.S. Department of Health and Human Services, Research Triangle Park, NC; NTP TR 232. Available at: http://ntp-server.niehs.nih.gov",combined incidence of hepatocellular adenomas and hepatocarcinomas in females,HEq,3,0,mg/kg-d HED,mg/kg-day,0,44,3,Mouse,B6C3F1,M/F,F,Oral gavage,5,103,Weeks
47,76017,Pentachloroethane   ,PPRTV,0.09,liver,"NTP (National Toxicology Program). 1983. Carcinogenesis bioassay of pentachloroethane in F344/N rats and B6C3F1 mice (gavage studies). National Institute of Environmental Health Sciences, Public Health Service, U.S. Department of Health and Human Services, Research Triangle Park, NC; NTP TR 232. Available at: http://ntp-server.niehs.nih.gov",combined incidence of hepatocellular adenomas and hepatocarcinomas in females,HEq,3,25.7,mg/kg-d HED,mg/kg-day,25.7,40,36,Mouse,B6C3F1,M/F,F,Oral gavage,5,103,Weeks
47,76017,Pentachloroethane   ,PPRTV,0.09,liver,"NTP (National Toxicology Program). 1983. Carcinogenesis bioassay of pentachloroethane in F344/N rats and B6C3F1 mice (gavage studies). National Institute of Environmental Health Sciences, Public Health Service, U.S. Department of Health and Human Services, Research Triangle Park, NC; NTP TR 232. Available at: http://ntp-server.niehs.nih.gov",combined incidence of hepatocellular adenomas and hepatocarcinomas in females,HEq,3,51.4,mg/kg-d HED,mg/kg-day,51.4,34,32,Mouse,B6C3F1,M/F,F,Oral gavage,5,103,Weeks
48,76039,Trichloroacetic Acid,IRIS,0.07,liver,"DeAngelo, AB; Daniel, FB; Wong, DM; George, MH. (2008) The induction of hepatocellular neoplasia by trichloroacetic acid administered in the drinking water of the male B6C3F1 mouse. J Toxicol Environ Health A 71: 1056-1068. http://dx.doi.org/10.1080/15287390802111952.",Hepatocellular adenomas or carcinomas,HEq,3,0,mg/kg-d,TCA g/L,0,56,31,Mouse,B6C3F1,M,Both,Oral drinking water,7,104,Weeks
48,76039,Trichloroacetic Acid,IRIS,0.07,liver,"DeAngelo, AB; Daniel, FB; Wong, DM; George, MH. (2008) The induction of hepatocellular neoplasia by trichloroacetic acid administered in the drinking water of the male B6C3F1 mouse. J Toxicol Environ Health A 71: 1056-1068. http://dx.doi.org/10.1080/15287390802111952.",Hepatocellular adenomas or carcinomas,HEq,3,1,mg/kg-d,TCA g/L,1,48,21,Mouse,B6C3F1,M,Both,Oral drinking water,7,104,Weeks
48,76039,Trichloroacetic Acid,IRIS,0.07,liver,"DeAngelo, AB; Daniel, FB; Wong, DM; George, MH. (2008) The induction of hepatocellular neoplasia by trichloroacetic acid administered in the drinking water of the male B6C3F1 mouse. J Toxicol Environ Health A 71: 1056-1068. http://dx.doi.org/10.1080/15287390802111952.",Hepatocellular adenomas or carcinomas,HEq,3,12.8,mg/kg-d,TCA g/L,12.8,51,36,Mouse,B6C3F1,M,Both,Oral drinking water,7,104,Weeks
49,76448,Heptachlor,CalEPA,4.1,liver,"NCI. 1977. Bioassay of Heptachlor for Possible Carcinogenicity. NCI Carcinogenesis Tech.
Rep. Ser. No. 9 111 p. [Also publ. as DHEW Publication No. (NIH) 77-809], National Cancer
Institute, Washington, DC.",liver tumors carcinomas,HEq,3,0,mg/kg/day,ppm diet,0,19,9,Mouse,B6C3F1,M/F,M,,NA,80,Weeks
49,76448,Heptachlor,CalEPA,4.1,liver,"NCI. 1977. Bioassay of Heptachlor for Possible Carcinogenicity. NCI Carcinogenesis Tech.
Rep. Ser. No. 9 111 p. [Also publ. as DHEW Publication No. (NIH) 77-809], National Cancer
Institute, Washington, DC.",liver tumors carcinomas,HEq,3,0.063,mg/kg/day,ppm diet,0.063,46,11,Mouse,B6C3F1,M/F,M,,NA,80,Weeks
49,76448,Heptachlor,CalEPA,4.1,liver,"NCI. 1977. Bioassay of Heptachlor for Possible Carcinogenicity. NCI Carcinogenesis Tech.
Rep. Ser. No. 9 111 p. [Also publ. as DHEW Publication No. (NIH) 77-809], National Cancer
Institute, Washington, DC.",liver tumors carcinomas,HEq,3,0.14,mg/kg/day,ppm diet,0.14,47,34,Mouse,B6C3F1,M/F,M,,NA,80,Weeks
50,78422,Tris(2-ethylhexyl)phosphate   ,PPRTV,0.0032,liver,"NTP (National Toxicology Program). 1984. Toxicology and Carcinogenicity Studies of Tris(2-
Ethylhexyl)Phosphate (CAS No. 78-42-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program, National Institutes of Health. NTP TR 274.",combined hepatocellular adenoma/carcinoma,HEq,3,0,mg/kg-d (HED),mg/kg,0,48,2,Mouse,B6C3F1,,F,Oral gavage,5,104,Weeks
50,78422,Tris(2-ethylhexyl)phosphate   ,PPRTV,0.0032,liver,"NTP (National Toxicology Program). 1984. Toxicology and Carcinogenicity Studies of Tris(2-
Ethylhexyl)Phosphate (CAS No. 78-42-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program, National Institutes of Health. NTP TR 274.",combined hepatocellular adenoma/carcinoma,HEq,3,52.3,mg/kg-d (HED),mg/kg,52.3,50,8,Mouse,B6C3F1,,F,Oral gavage,5,104,Weeks
50,78422,Tris(2-ethylhexyl)phosphate   ,PPRTV,0.0032,liver,"NTP (National Toxicology Program). 1984. Toxicology and Carcinogenicity Studies of Tris(2-
Ethylhexyl)Phosphate (CAS No. 78-42-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program, National Institutes of Health. NTP TR 274.",combined hepatocellular adenoma/carcinoma,HEq,3,105,mg/kg-d (HED),mg/kg,105,50,10,Mouse,B6C3F1,,F,Oral gavage,5,104,Weeks
51,78591,Isophorone,IRIS,0.00095,other endocrine or exocrine,NTP (National Toxicology Program). 1986. Toxicology and carcinogenesis studies of isophorone (CAS No. 78-59-1) in F344/N rats and B6C3F1 mice (gavage studies). NTP TR-29l. NIH Pub. No. 86-2547.,preputial gland carcinoma,HEq,3,0,mg/kg-day,mg/kg-day,0,49,0,Rat,Fischer 344,M/F,M,Oral gavage,5,103,Weeks
51,78591,Isophorone,IRIS,0.00095,other endocrine or exocrine,NTP (National Toxicology Program). 1986. Toxicology and carcinogenesis studies of isophorone (CAS No. 78-59-1) in F344/N rats and B6C3F1 mice (gavage studies). NTP TR-29l. NIH Pub. No. 86-2547.,preputial gland carcinoma,HEq,3,32,mg/kg-day,mg/kg-day,32,46,0,Rat,Fischer 344,M/F,M,Oral gavage,5,103,Weeks
51,78591,Isophorone,IRIS,0.00095,other endocrine or exocrine,NTP (National Toxicology Program). 1986. Toxicology and carcinogenesis studies of isophorone (CAS No. 78-59-1) in F344/N rats and B6C3F1 mice (gavage studies). NTP TR-29l. NIH Pub. No. 86-2547.,preputial gland carcinoma,HEq,3,64,mg/kg-day,mg/kg-day,64,44,5,Rat,Fischer 344,M/F,M,Oral gavage,5,103,Weeks
52,78875,"1,2-Dichloropropane",CalEPA,0.036,liver,"NTP (1986). Toxicology and carcinogenesis studies of 1,2-dichloropropane (propylene dichloride) (CAS No. 78-87-5) in F344/N rats and B6C3F1 mice (gavage studies). National
Toxicology Program Technical Report Series No. 263. NIH Publication No. 86-2519.",combined hepatocellular adenoma or carcinoma,Conv,3,0,mg/kg/day,ppm/dose,0,50,18,Mouse,B6C3F1,M/F,M,Oral gavage,5,103,Weeks
52,78875,"1,2-Dichloropropane",CalEPA,0.036,liver,"NTP (1986). Toxicology and carcinogenesis studies of 1,2-dichloropropane (propylene dichloride) (CAS No. 78-87-5) in F344/N rats and B6C3F1 mice (gavage studies). National
Toxicology Program Technical Report Series No. 263. NIH Publication No. 86-2519.",combined hepatocellular adenoma or carcinoma,Conv,3,89.3,mg/kg/day,ppm/dose,89.3,47,26,Mouse,B6C3F1,M/F,M,Oral gavage,5,103,Weeks
52,78875,"1,2-Dichloropropane",CalEPA,0.036,liver,"NTP (1986). Toxicology and carcinogenesis studies of 1,2-dichloropropane (propylene dichloride) (CAS No. 78-87-5) in F344/N rats and B6C3F1 mice (gavage studies). National
Toxicology Program Technical Report Series No. 263. NIH Publication No. 86-2519.",combined hepatocellular adenoma or carcinoma,Conv,3,178.6,mg/kg/day,ppm/dose,178.6,50,33,Mouse,B6C3F1,M/F,M,Oral gavage,5,103,Weeks
53,79005,"1,1,2-Trichloroethane",IRIS,0.057,liver,"NCI (National Cancer Institute). 1978. Bioassay of 1,1,2-trichloroethane for possible carcinogenicity. U.S. DHEW Tech. Rep. Ser. 74. Publ. No. NCI-CG-TR- 74.",hepatocellular carcinoma,HEq,3,0,mg/kg/day,mg/kg/day (TWA),0,20,2,Mouse,B6C3F1,M/F,Both,Oral gavage,5,78,Weeks
53,79005,"1,1,2-Trichloroethane",IRIS,0.057,liver,"NCI (National Cancer Institute). 1978. Bioassay of 1,1,2-trichloroethane for possible carcinogenicity. U.S. DHEW Tech. Rep. Ser. 74. Publ. No. NCI-CG-TR- 74.",hepatocellular carcinoma,HEq,3,9.3,mg/kg/day,mg/kg/day (TWA),9.3,49,18,Mouse,B6C3F1,M/F,Both,Oral gavage,5,78,Weeks
53,79005,"1,1,2-Trichloroethane",IRIS,0.057,liver,"NCI (National Cancer Institute). 1978. Bioassay of 1,1,2-trichloroethane for possible carcinogenicity. U.S. DHEW Tech. Rep. Ser. 74. Publ. No. NCI-CG-TR- 74.",hepatocellular carcinoma,HEq,3,18.6,mg/kg/day,mg/kg/day (TWA),18.6,49,37,Mouse,B6C3F1,M/F,Both,Oral gavage,5,78,Weeks
54,79061,Acrylamide,CalEPA,4.5,CNS,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",Central nervous system (tumors of glial origin or glial proliferation suggestive of early tumor),HEq,5,0,mg/kg-day,mg/kg-day,0,60,1,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
54,79061,Acrylamide,CalEPA,4.5,CNS,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",Central nervous system (tumors of glial origin or glial proliferation suggestive of early tumor),HEq,5,0.001,mg/kg-day,mg/kg-day,0.001,60,2,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
54,79061,Acrylamide,CalEPA,4.5,CNS,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",Central nervous system (tumors of glial origin or glial proliferation suggestive of early tumor),HEq,5,0.015,mg/kg-day,mg/kg-day,0.015,60,1,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
54,79061,Acrylamide,CalEPA,4.5,CNS,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",Central nervous system (tumors of glial origin or glial proliferation suggestive of early tumor),HEq,5,0.076,mg/kg-day,mg/kg-day,0.076,60,1,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
54,79061,Acrylamide,CalEPA,4.5,CNS,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",Central nervous system (tumors of glial origin or glial proliferation suggestive of early tumor),HEq,5,0.305,mg/kg-day,mg/kg-day,0.305,60,9,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
55,79061,Acrylamide,CalEPA,4.5,female repro,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",uterine adenocarcinomas,HEq,5,0,mg/kg-day,mg/kg-day,0,60,1,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
55,79061,Acrylamide,CalEPA,4.5,female repro,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",uterine adenocarcinomas,HEq,5,0.001,mg/kg-day,mg/kg-day,0.001,60,2,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
55,79061,Acrylamide,CalEPA,4.5,female repro,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",uterine adenocarcinomas,HEq,5,0.015,mg/kg-day,mg/kg-day,0.015,60,1,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
55,79061,Acrylamide,CalEPA,4.5,female repro,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",uterine adenocarcinomas,HEq,5,0.076,mg/kg-day,mg/kg-day,0.076,60,0,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
55,79061,Acrylamide,CalEPA,4.5,female repro,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",uterine adenocarcinomas,HEq,5,0.305,mg/kg-day,mg/kg-day,0.305,60,5,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
56,79061,Acrylamide,CalEPA,4.5,mammary glands,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",mammary gland (adenomas and adenocarcinomas),HEq,5,0,mg/kg-day,mg/kg-day,0,60,2,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
56,79061,Acrylamide,CalEPA,4.5,mammary glands,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",mammary gland (adenomas and adenocarcinomas),HEq,5,0.001,mg/kg-day,mg/kg-day,0.001,60,2,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
56,79061,Acrylamide,CalEPA,4.5,mammary glands,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",mammary gland (adenomas and adenocarcinomas),HEq,5,0.015,mg/kg-day,mg/kg-day,0.015,60,1,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
56,79061,Acrylamide,CalEPA,4.5,mammary glands,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",mammary gland (adenomas and adenocarcinomas),HEq,5,0.076,mg/kg-day,mg/kg-day,0.076,60,5,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
56,79061,Acrylamide,CalEPA,4.5,mammary glands,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",mammary gland (adenomas and adenocarcinomas),HEq,5,0.305,mg/kg-day,mg/kg-day,0.305,60,8,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
57,79061,Acrylamide,CalEPA,4.5,oral cavity,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",Oral cavity (Squamous cell papillomas and carcinomas),HEq,5,0,mg/kg-day,mg/kg-day,0,60,0,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
57,79061,Acrylamide,CalEPA,4.5,oral cavity,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",Oral cavity (Squamous cell papillomas and carcinomas),HEq,5,0.001,mg/kg-day,mg/kg-day,0.001,60,3,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
57,79061,Acrylamide,CalEPA,4.5,oral cavity,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",Oral cavity (Squamous cell papillomas and carcinomas),HEq,5,0.015,mg/kg-day,mg/kg-day,0.015,60,2,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
57,79061,Acrylamide,CalEPA,4.5,oral cavity,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",Oral cavity (Squamous cell papillomas and carcinomas),HEq,5,0.076,mg/kg-day,mg/kg-day,0.076,60,3,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
57,79061,Acrylamide,CalEPA,4.5,oral cavity,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",Oral cavity (Squamous cell papillomas and carcinomas),HEq,5,0.305,mg/kg-day,mg/kg-day,0.305,60,8,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
58,79061,Acrylamide,CalEPA,4.5,systemic,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.","Combined incidence of tumors in the central nervous system, mammary gland, oral cavity, thyroid gland and uterus",HEq,5,0,mg/kg-day,mg/kg-day,0,60,13,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
58,79061,Acrylamide,CalEPA,4.5,systemic,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.","Combined incidence of tumors in the central nervous system, mammary gland, oral cavity, thyroid gland and uterus",HEq,5,0.001,mg/kg-day,mg/kg-day,0.001,60,18,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
58,79061,Acrylamide,CalEPA,4.5,systemic,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.","Combined incidence of tumors in the central nervous system, mammary gland, oral cavity, thyroid gland and uterus",HEq,5,0.015,mg/kg-day,mg/kg-day,0.015,60,14,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
58,79061,Acrylamide,CalEPA,4.5,systemic,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.","Combined incidence of tumors in the central nervous system, mammary gland, oral cavity, thyroid gland and uterus",HEq,5,0.076,mg/kg-day,mg/kg-day,0.076,60,21,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
58,79061,Acrylamide,CalEPA,4.5,systemic,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.","Combined incidence of tumors in the central nervous system, mammary gland, oral cavity, thyroid gland and uterus",HEq,5,0.305,mg/kg-day,mg/kg-day,0.305,60,46,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
59,79061,Acrylamide,CalEPA,4.5,thyroid,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",thyroid (follicular adenomas and adenocarcinomas),HEq,5,0,mg/kg-day,mg/kg-day,0,60,1,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
59,79061,Acrylamide,CalEPA,4.5,thyroid,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",thyroid (follicular adenomas and adenocarcinomas),HEq,5,0.001,mg/kg-day,mg/kg-day,0.001,60,0,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
59,79061,Acrylamide,CalEPA,4.5,thyroid,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",thyroid (follicular adenomas and adenocarcinomas),HEq,5,0.015,mg/kg-day,mg/kg-day,0.015,60,1,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
59,79061,Acrylamide,CalEPA,4.5,thyroid,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",thyroid (follicular adenomas and adenocarcinomas),HEq,5,0.076,mg/kg-day,mg/kg-day,0.076,60,1,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
59,79061,Acrylamide,CalEPA,4.5,thyroid,"Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CA, Friedman MA and Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.",thyroid (follicular adenomas and adenocarcinomas),HEq,5,0.305,mg/kg-day,mg/kg-day,0.305,60,5,Rat,Fischer 344,M/F,F,Oral drinking water,NA,2,Years
60,79061,Acrylamide,IRIS,0.5,male repro,"Johnson KA; Gorzinski SJ; Bodner KM; Campbell RA; Wolf CH; Friedman MA; Mast RW (1986). Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol, 85: 154-168",tunica vaginalis mesotheliomas,Dose,5,0,mg/kg-day,mg/kg-day,0,60,3,Rat,Fischer 344,M/F,M,Oral drinking water,NA,2,Years
60,79061,Acrylamide,IRIS,0.5,male repro,"Johnson KA; Gorzinski SJ; Bodner KM; Campbell RA; Wolf CH; Friedman MA; Mast RW (1986). Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol, 85: 154-168",tunica vaginalis mesotheliomas,Dose,5,0.01,mg/kg-day,mg/kg-day,0.01,60,0,Rat,Fischer 344,M/F,M,Oral drinking water,NA,2,Years
60,79061,Acrylamide,IRIS,0.5,male repro,"Johnson KA; Gorzinski SJ; Bodner KM; Campbell RA; Wolf CH; Friedman MA; Mast RW (1986). Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol, 85: 154-168",tunica vaginalis mesotheliomas,Dose,5,0.1,mg/kg-day,mg/kg-day,0.1,60,7,Rat,Fischer 344,M/F,M,Oral drinking water,NA,2,Years
60,79061,Acrylamide,IRIS,0.5,male repro,"Johnson KA; Gorzinski SJ; Bodner KM; Campbell RA; Wolf CH; Friedman MA; Mast RW (1986). Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol, 85: 154-168",tunica vaginalis mesotheliomas,Dose,5,0.5,mg/kg-day,mg/kg-day,0.5,60,11,Rat,Fischer 344,M/F,M,Oral drinking water,NA,2,Years
60,79061,Acrylamide,IRIS,0.5,male repro,"Johnson KA; Gorzinski SJ; Bodner KM; Campbell RA; Wolf CH; Friedman MA; Mast RW (1986). Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol, 85: 154-168",tunica vaginalis mesotheliomas,Dose,5,2,mg/kg-day,mg/kg-day,2,60,10,Rat,Fischer 344,M/F,M,Oral drinking water,NA,2,Years
61,79345,"1,1,2,2-Tetrachloroethane",CalEPA,0.27,liver,"National Cancer Institute 1978. Bioassay of 1,1,2,2,-Tetrachloroethane for Possible Carcinogenicity. DHEW Publication No. (NIH) 78-827. U.S. Government Printing Office, Washington, DC.",hepatocellular carcinoma,Dose,3,0,mg/kg-day,mg/kg-day,0,19,0,Mouse,B6C3F1,M/F,F,Oral gavage,5,78,Weeks
61,79345,"1,1,2,2-Tetrachloroethane",CalEPA,0.27,liver,"National Cancer Institute 1978. Bioassay of 1,1,2,2,-Tetrachloroethane for Possible Carcinogenicity. DHEW Publication No. (NIH) 78-827. U.S. Government Printing Office, Washington, DC.",hepatocellular carcinoma,Dose,3,142,mg/kg-day,mg/kg-day,101.4285714,48,30,Mouse,B6C3F1,M/F,F,Oral gavage,5,78,Weeks
61,79345,"1,1,2,2-Tetrachloroethane",CalEPA,0.27,liver,"National Cancer Institute 1978. Bioassay of 1,1,2,2,-Tetrachloroethane for Possible Carcinogenicity. DHEW Publication No. (NIH) 78-827. U.S. Government Printing Office, Washington, DC.",hepatocellular carcinoma,Dose,3,282,mg/kg-day,mg/kg-day,201.4285714,47,43,Mouse,B6C3F1,M/F,F,Oral gavage,5,78,Weeks
62,79345,"1,1,2,2-Tetrachloroethane",IRIS,0.2,liver,"NCI (National Cancer Institute). (1978) Bioassay of 1,1,2,2-tetrachloroethane for possible carcinogenicity.  Natl Cancer Inst Carcinog Tech Rep Ser No. 27; NIH Publication No. 78-827. PB2774537GA.",hepatocellular carcinomas,Dose,3,0,mg/kg/day,mg/kg/day,0,40,1,Mouse,B6C3F1,M/F,F,Oral gavage,5,78,Duration
62,79345,"1,1,2,2-Tetrachloroethane",IRIS,0.2,liver,"NCI (National Cancer Institute). (1978) Bioassay of 1,1,2,2-tetrachloroethane for possible carcinogenicity.  Natl Cancer Inst Carcinog Tech Rep Ser No. 27; NIH Publication No. 78-827. PB2774537GA.",hepatocellular carcinomas,Dose,3,142,mg/kg/day,mg/kg/day,101.4285714,48,30,Mouse,B6C3F1,M/F,F,Oral gavage,5,78,Duration
62,79345,"1,1,2,2-Tetrachloroethane",IRIS,0.2,liver,"NCI (National Cancer Institute). (1978) Bioassay of 1,1,2,2-tetrachloroethane for possible carcinogenicity.  Natl Cancer Inst Carcinog Tech Rep Ser No. 27; NIH Publication No. 78-827. PB2774537GA.",hepatocellular carcinomas,Dose,3,284,mg/kg/day,mg/kg/day,202.8571429,47,43,Mouse,B6C3F1,M/F,F,Oral gavage,5,78,Duration
63,79436,Dichloroacetic acid,IRIS,0.05,liver,"DeAngelo, AB; George, MH; House, DE. (1999) Hepatocarcinogenicity in the male B6C3F1 mouse following a life-time exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action. J Toxicol Environ Health 58:485-507.",hepatoadenoma and hepatocarcinoma,HEq,6,0,mg/kg/day,g/L,0,50,18,Mouse,B6C3F1,M,M,Oral drinking water,NA,90-100,Weeks
63,79436,Dichloroacetic acid,IRIS,0.05,liver,"DeAngelo, AB; George, MH; House, DE. (1999) Hepatocarcinogenicity in the male B6C3F1 mouse following a life-time exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action. J Toxicol Environ Health 58:485-507.",hepatoadenoma and hepatocarcinoma,HEq,6,1.3,mg/kg/day,g/L,1.3,33,11,Mouse,B6C3F1,M,M,Oral drinking water,NA,90-100,Weeks
63,79436,Dichloroacetic acid,IRIS,0.05,liver,"DeAngelo, AB; George, MH; House, DE. (1999) Hepatocarcinogenicity in the male B6C3F1 mouse following a life-time exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action. J Toxicol Environ Health 58:485-507.",hepatoadenoma and hepatocarcinoma,HEq,6,13.2,mg/kg/day,g/L,13.2,25,14,Mouse,B6C3F1,M,M,Oral drinking water,NA,90-100,Weeks
63,79436,Dichloroacetic acid,IRIS,0.05,liver,"DeAngelo, AB; George, MH; House, DE. (1999) Hepatocarcinogenicity in the male B6C3F1 mouse following a life-time exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action. J Toxicol Environ Health 58:485-507.",hepatoadenoma and hepatocarcinoma,HEq,6,26.5,mg/kg/day,g/L,26.5,35,30,Mouse,B6C3F1,M,M,Oral drinking water,NA,90-100,Weeks
63,79436,Dichloroacetic acid,IRIS,0.05,liver,"DeAngelo, AB; George, MH; House, DE. (1999) Hepatocarcinogenicity in the male B6C3F1 mouse following a life-time exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action. J Toxicol Environ Health 58:485-507.",hepatoadenoma and hepatocarcinoma,HEq,6,47.5,mg/kg/day,g/L,47.5,21,21,Mouse,B6C3F1,M,M,Oral drinking water,NA,90-100,Weeks
63,79436,Dichloroacetic acid,IRIS,0.05,liver,"DeAngelo, AB; George, MH; House, DE. (1999) Hepatocarcinogenicity in the male B6C3F1 mouse following a life-time exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action. J Toxicol Environ Health 58:485-507.",hepatoadenoma and hepatocarcinoma,HEq,6,64.6,mg/kg/day,g/L,64.6,11,11,Mouse,B6C3F1,M,M,Oral drinking water,NA,90-100,Weeks
64,82280,1-Amino-2-methylanthraquinone,CalEPA,0.15,liver,"National Cancer Institute (NCI, 1978). Bioassay of 1-Amino-2-methylanthraquinone for Possible Carcinogeniciry. Carcinogenesis Technical Report Series, Technical Report No. 111. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

National Toxicology Program (NTP, 1991). Chemical Status Report. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant liver tumors,Dose,3,0,% feed (TWA),% feed (TWA),0,48,3,Rat,Fischer 344,M/F,M,Oral diet,NA,78,Weeks
64,82280,1-Amino-2-methylanthraquinone,CalEPA,0.15,liver,"National Cancer Institute (NCI, 1978). Bioassay of 1-Amino-2-methylanthraquinone for Possible Carcinogeniciry. Carcinogenesis Technical Report Series, Technical Report No. 111. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

National Toxicology Program (NTP, 1991). Chemical Status Report. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant liver tumors,Dose,3,0.1,% feed (TWA),% feed (TWA),78.94736842,50,25,Rat,Fischer 344,M/F,M,Oral diet,NA,78,Weeks
64,82280,1-Amino-2-methylanthraquinone,CalEPA,0.15,liver,"National Cancer Institute (NCI, 1978). Bioassay of 1-Amino-2-methylanthraquinone for Possible Carcinogeniciry. Carcinogenesis Technical Report Series, Technical Report No. 111. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

National Toxicology Program (NTP, 1991). Chemical Status Report. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant liver tumors,Dose,3,0.2,% feed (TWA),% feed (TWA),157.8947368,48,24,Rat,Fischer 344,M/F,M,Oral diet,NA,78,Weeks
65,84651,"Anthraquinone, 9,10-   ",PPRTV,0.04,liver,"NTP (National Toxicology Program). (2005b) NTP technical report on the toxicology and carcinogenesis studies of anthraquinone (CAS no. 84-65-1) in F344/N rats and B6C3F1 mice (feed studies). NTP TR 494; NIH Publication No. 05-3953. U.S. Department of Health and Human Services, Public Health Service, Research Triangle Park, NC. Available online at http://ntp.niehs.nih.gov/files/TR494web1.pdf. Accessed on 4/8/2010.","Adenoma, carcinoma, or hepatoblastoma",HEq,4,0,mg/kg/day,ppm,0,50,26,Mouse,B6C3F1,M/F,M,Oral diet,NA,2,Years
65,84651,"Anthraquinone, 9,10-   ",PPRTV,0.04,liver,"NTP (National Toxicology Program). (2005b) NTP technical report on the toxicology and carcinogenesis studies of anthraquinone (CAS no. 84-65-1) in F344/N rats and B6C3F1 mice (feed studies). NTP TR 494; NIH Publication No. 05-3953. U.S. Department of Health and Human Services, Public Health Service, Research Triangle Park, NC. Available online at http://ntp.niehs.nih.gov/files/TR494web1.pdf. Accessed on 4/8/2010.","Adenoma, carcinoma, or hepatoblastoma",HEq,4,13.7,mg/kg/day,ppm,13.7,50,35,Mouse,B6C3F1,M/F,M,Oral diet,NA,2,Years
65,84651,"Anthraquinone, 9,10-   ",PPRTV,0.04,liver,"NTP (National Toxicology Program). (2005b) NTP technical report on the toxicology and carcinogenesis studies of anthraquinone (CAS no. 84-65-1) in F344/N rats and B6C3F1 mice (feed studies). NTP TR 494; NIH Publication No. 05-3953. U.S. Department of Health and Human Services, Public Health Service, Research Triangle Park, NC. Available online at http://ntp.niehs.nih.gov/files/TR494web1.pdf. Accessed on 4/8/2010.","Adenoma, carcinoma, or hepatoblastoma",HEq,4,40.3,mg/kg/day,ppm,40.3,50,43,Mouse,B6C3F1,M/F,M,Oral diet,NA,2,Years
65,84651,"Anthraquinone, 9,10-   ",PPRTV,0.04,liver,"NTP (National Toxicology Program). (2005b) NTP technical report on the toxicology and carcinogenesis studies of anthraquinone (CAS no. 84-65-1) in F344/N rats and B6C3F1 mice (feed studies). NTP TR 494; NIH Publication No. 05-3953. U.S. Department of Health and Human Services, Public Health Service, Research Triangle Park, NC. Available online at http://ntp.niehs.nih.gov/files/TR494web1.pdf. Accessed on 4/8/2010.","Adenoma, carcinoma, or hepatoblastoma",HEq,4,125.3,mg/kg/day,ppm,125.3,49,48,Mouse,B6C3F1,M/F,M,Oral diet,NA,2,Years
66,85687,Butyl Benzyl Phthalate,PPRTV,0.0019,pancreas,"NTP (National Toxicology Program). 1997a. Carcinogenesis Studies of Butyl Benzyl Phthalate
in F344/N Rats (Feed Studies). Technical Report Series No. 458. U.S. Department of Health and
Human Services, National Institute of Environmental Health Sciences, Research Triangle Park,
NC.","pancreatic adenoma, carcinoma",Conv,4,0,mg/kg-day,ppm diet,0,50,1,Rat,Fischer 344,M/F,M,Oral diet,NA,2,Years
66,85687,Butyl Benzyl Phthalate,PPRTV,0.0019,pancreas,"NTP (National Toxicology Program). 1997a. Carcinogenesis Studies of Butyl Benzyl Phthalate
in F344/N Rats (Feed Studies). Technical Report Series No. 458. U.S. Department of Health and
Human Services, National Institute of Environmental Health Sciences, Research Triangle Park,
NC.","pancreatic adenoma, carcinoma",Conv,4,120,mg/kg-day,ppm diet,120,49,2,Rat,Fischer 344,M/F,M,Oral diet,NA,2,Years
66,85687,Butyl Benzyl Phthalate,PPRTV,0.0019,pancreas,"NTP (National Toxicology Program). 1997a. Carcinogenesis Studies of Butyl Benzyl Phthalate
in F344/N Rats (Feed Studies). Technical Report Series No. 458. U.S. Department of Health and
Human Services, National Institute of Environmental Health Sciences, Research Triangle Park,
NC.","pancreatic adenoma, carcinoma",Conv,4,240,mg/kg-day,ppm diet,240,50,3,Rat,Fischer 344,M/F,M,Oral diet,NA,2,Years
66,85687,Butyl Benzyl Phthalate,PPRTV,0.0019,pancreas,"NTP (National Toxicology Program). 1997a. Carcinogenesis Studies of Butyl Benzyl Phthalate
in F344/N Rats (Feed Studies). Technical Report Series No. 458. U.S. Department of Health and
Human Services, National Institute of Environmental Health Sciences, Research Triangle Park,
NC.","pancreatic adenoma, carcinoma",Conv,4,500,mg/kg-day,ppm diet,500,50,11,Rat,Fischer 344,M/F,M,Oral diet,NA,2,Years
67,86306,Diphenylnitrosamine,CalEPA,0.009,bladder,"Cardy RH, Lijinsky W, Hildebrandt PK. 1979. Neoplastic and nonneoplastic urinary bladder lesions induced in Fischer 344 rats and B6C3F1 hybrid mice by N-nitrosodiphenylamine. Ecotoxicol Environ 3:29-35.

National Cancer Institute (NCI). 1979. Bioassay of N-Nitrosodiphenylamine for Possible Carcinogenicity, Technical Report Series No. 164, DHEW Publication No. (NIH) 79-1720), Washington DC, US Government Printing Office.",transitional-cell carcinoma of the bladder,Conv,3,0,mg/kg-day,ppm diet,0,19,0,Rat,Fischer 344,M/F,M,Oral diet,NA,100,Weeks
67,86306,Diphenylnitrosamine,CalEPA,0.009,bladder,"Cardy RH, Lijinsky W, Hildebrandt PK. 1979. Neoplastic and nonneoplastic urinary bladder lesions induced in Fischer 344 rats and B6C3F1 hybrid mice by N-nitrosodiphenylamine. Ecotoxicol Environ 3:29-35.

National Cancer Institute (NCI). 1979. Bioassay of N-Nitrosodiphenylamine for Possible Carcinogenicity, Technical Report Series No. 164, DHEW Publication No. (NIH) 79-1720), Washington DC, US Government Printing Office.",transitional-cell carcinoma of the bladder,Conv,3,79,mg/kg-day,ppm diet,79,46,0,Rat,Fischer 344,M/F,M,Oral diet,NA,100,Weeks
67,86306,Diphenylnitrosamine,CalEPA,0.009,bladder,"Cardy RH, Lijinsky W, Hildebrandt PK. 1979. Neoplastic and nonneoplastic urinary bladder lesions induced in Fischer 344 rats and B6C3F1 hybrid mice by N-nitrosodiphenylamine. Ecotoxicol Environ 3:29-35.

National Cancer Institute (NCI). 1979. Bioassay of N-Nitrosodiphenylamine for Possible Carcinogenicity, Technical Report Series No. 164, DHEW Publication No. (NIH) 79-1720), Washington DC, US Government Printing Office.",transitional-cell carcinoma of the bladder,Conv,3,316,mg/kg-day,ppm diet,316,45,16,Rat,Fischer 344,M/F,M,Oral diet,NA,100,Weeks
68,86306,Diphenylnitrosamine,CalEPA,0.009,bladder,"Cardy RH, Lijinsky W, Hildebrandt PK. 1979. Neoplastic and nonneoplastic urinary bladder lesions induced in Fischer 344 rats and B6C3F1 hybrid mice by N-nitrosodiphenylamine. Ecotoxicol Environ 3:29-35.

National Cancer Institute (NCI). 1979. Bioassay of N-Nitrosodiphenylamine for Possible Carcinogenicity, Technical Report Series No. 164, DHEW Publication No. (NIH) 79-1720), Washington DC, US Government Printing Office.",transitional-cell carcinoma of the bladder,Conv,3,0,mg/kg-day,ppm diet,0,18,0,Rat,Fischer 344,M/F,F,Oral diet,NA,100,Weeks
68,86306,Diphenylnitrosamine,CalEPA,0.009,bladder,"Cardy RH, Lijinsky W, Hildebrandt PK. 1979. Neoplastic and nonneoplastic urinary bladder lesions induced in Fischer 344 rats and B6C3F1 hybrid mice by N-nitrosodiphenylamine. Ecotoxicol Environ 3:29-35.

National Cancer Institute (NCI). 1979. Bioassay of N-Nitrosodiphenylamine for Possible Carcinogenicity, Technical Report Series No. 164, DHEW Publication No. (NIH) 79-1720), Washington DC, US Government Printing Office.",transitional-cell carcinoma of the bladder,Conv,3,92,mg/kg-day,ppm diet,92,46,0,Rat,Fischer 344,M/F,F,Oral diet,NA,100,Weeks
68,86306,Diphenylnitrosamine,CalEPA,0.009,bladder,"Cardy RH, Lijinsky W, Hildebrandt PK. 1979. Neoplastic and nonneoplastic urinary bladder lesions induced in Fischer 344 rats and B6C3F1 hybrid mice by N-nitrosodiphenylamine. Ecotoxicol Environ 3:29-35.

National Cancer Institute (NCI). 1979. Bioassay of N-Nitrosodiphenylamine for Possible Carcinogenicity, Technical Report Series No. 164, DHEW Publication No. (NIH) 79-1720), Washington DC, US Government Printing Office.",transitional-cell carcinoma of the bladder,Conv,3,368,mg/kg-day,ppm diet,368,49,40,Rat,Fischer 344,M/F,F,Oral diet,NA,100,Weeks
69,86748,Carbazole,CalEPA,0.17,liver,"Tsuda H, Hagiwara A, Shibata M, Ohshima M, Ito N (1982). Carcinogenic effect of carbazole in the liver of (C57BL/6N x C3H/HeN)F1 mice. J Natl Cancer Inst 69:1383-1387.",hepatocellular carcinoma,Dose,4,0,mg/kg-day,mg/kg-day,0,45,2,Mouse,B6C3F1,M/F,F,Oral diet,NA,22,Months
69,86748,Carbazole,CalEPA,0.17,liver,"Tsuda H, Hagiwara A, Shibata M, Ohshima M, Ito N (1982). Carcinogenic effect of carbazole in the liver of (C57BL/6N x C3H/HeN)F1 mice. J Natl Cancer Inst 69:1383-1387.",hepatocellular carcinoma,Dose,4,180,mg/kg-day,mg/kg-day,180,49,35,Mouse,B6C3F1,M/F,F,Oral diet,NA,22,Months
69,86748,Carbazole,CalEPA,0.17,liver,"Tsuda H, Hagiwara A, Shibata M, Ohshima M, Ito N (1982). Carcinogenic effect of carbazole in the liver of (C57BL/6N x C3H/HeN)F1 mice. J Natl Cancer Inst 69:1383-1387.",hepatocellular carcinoma,Dose,4,360,mg/kg-day,mg/kg-day,360,43,24,Mouse,B6C3F1,M/F,F,Oral diet,NA,22,Months
69,86748,Carbazole,CalEPA,0.17,liver,"Tsuda H, Hagiwara A, Shibata M, Ohshima M, Ito N (1982). Carcinogenic effect of carbazole in the liver of (C57BL/6N x C3H/HeN)F1 mice. J Natl Cancer Inst 69:1383-1387.",hepatocellular carcinoma,Dose,4,749,mg/kg-day,mg/kg-day,749,46,30,Mouse,B6C3F1,M/F,F,Oral diet,NA,22,Months
70,86748,Carbazole,CalEPA,0.17,stomach/forestomach,"Tsuda H, Hagiwara A, Shibata M, Ohshima M, Ito N (1982). Carcinogenic effect of carbazole in the liver of (C57BL/6N x C3H/HeN)F1 mice. J Natl Cancer Inst 69:1383-1387.",forestomach tumors,Dose,4,0,mg/kg-d,mg/kg-d,0,45,0,Mouse,B6C3F1,M/F,F,Oral diet,NA,22,Months
70,86748,Carbazole,CalEPA,0.17,stomach/forestomach,"Tsuda H, Hagiwara A, Shibata M, Ohshima M, Ito N (1982). Carcinogenic effect of carbazole in the liver of (C57BL/6N x C3H/HeN)F1 mice. J Natl Cancer Inst 69:1383-1387.",forestomach tumors,Dose,4,180,mg/kg-d,mg/kg-d,180,49,5,Mouse,B6C3F1,M/F,F,Oral diet,NA,22,Months
70,86748,Carbazole,CalEPA,0.17,stomach/forestomach,"Tsuda H, Hagiwara A, Shibata M, Ohshima M, Ito N (1982). Carcinogenic effect of carbazole in the liver of (C57BL/6N x C3H/HeN)F1 mice. J Natl Cancer Inst 69:1383-1387.",forestomach tumors,Dose,4,360,mg/kg-d,mg/kg-d,360,43,8,Mouse,B6C3F1,M/F,F,Oral diet,NA,22,Months
70,86748,Carbazole,CalEPA,0.17,stomach/forestomach,"Tsuda H, Hagiwara A, Shibata M, Ohshima M, Ito N (1982). Carcinogenic effect of carbazole in the liver of (C57BL/6N x C3H/HeN)F1 mice. J Natl Cancer Inst 69:1383-1387.",forestomach tumors,Dose,4,749,mg/kg-d,mg/kg-d,749,46,6,Mouse,B6C3F1,M/F,F,Oral diet,NA,22,Months
71,87296,Cinnamyl Anthranilate,CalEPA,0.0046,liver,"National Cancer Institute (NCI, 1979). Bioassay of Cinnamyl Anthranilate for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 196. NTIS No. PB 295835. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant liver tumors,Dose,3,0,ppm,ppm,0,50,3,Mouse,B6C3F1,M/F,F,Oral diet,NA,103,Weeks
71,87296,Cinnamyl Anthranilate,CalEPA,0.0046,liver,"National Cancer Institute (NCI, 1979). Bioassay of Cinnamyl Anthranilate for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 196. NTIS No. PB 295835. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant liver tumors,Dose,3,15000,ppm,ppm,2592.067989,49,20,Mouse,B6C3F1,M/F,F,Oral diet,NA,103,Weeks
71,87296,Cinnamyl Anthranilate,CalEPA,0.0046,liver,"National Cancer Institute (NCI, 1979). Bioassay of Cinnamyl Anthranilate for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 196. NTIS No. PB 295835. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant liver tumors,Dose,3,30000,ppm,ppm,5184.135977,49,33,Mouse,B6C3F1,M/F,F,Oral diet,NA,103,Weeks
72,87627,"2,6-Xylidine",CalEPA,0.0063,nasal passages,"NTP (1990). Toxicology and carcinogenesis studies of 2,6-xylidine in Charles River CD rats. National Toxicology Program. Technical Report Series No. 278. NIH Publication No. 90-2534. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1990.",nasal cavity tumors (adenomas/carcinomas),Conv,4,0,mg/kg/day,ppm,0,55,0,Rat,CD,M/F,F,Oral diet,NA,102,Weeks
72,87627,"2,6-Xylidine",CalEPA,0.0063,nasal passages,"NTP (1990). Toxicology and carcinogenesis studies of 2,6-xylidine in Charles River CD rats. National Toxicology Program. Technical Report Series No. 278. NIH Publication No. 90-2534. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1990.",nasal cavity tumors (adenomas/carcinomas),Conv,4,13.3,mg/kg/day,ppm,13.3,55,0,Rat,CD,M/F,F,Oral diet,NA,102,Weeks
72,87627,"2,6-Xylidine",CalEPA,0.0063,nasal passages,"NTP (1990). Toxicology and carcinogenesis studies of 2,6-xylidine in Charles River CD rats. National Toxicology Program. Technical Report Series No. 278. NIH Publication No. 90-2534. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1990.",nasal cavity tumors (adenomas/carcinomas),Conv,4,44.2,mg/kg/day,ppm,44.2,56,2,Rat,CD,M/F,F,Oral diet,NA,102,Weeks
72,87627,"2,6-Xylidine",CalEPA,0.0063,nasal passages,"NTP (1990). Toxicology and carcinogenesis studies of 2,6-xylidine in Charles River CD rats. National Toxicology Program. Technical Report Series No. 278. NIH Publication No. 90-2534. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1990.",nasal cavity tumors (adenomas/carcinomas),Conv,4,132,mg/kg/day,ppm,132,56,32,Rat,CD,M/F,F,Oral diet,NA,102,Weeks
73,87683,Hexachlorobutadiene,IRIS,0.078,kidneys,"Kociba, R.J., D.G. Keyes, G.C. Jersey, et al. 1977. Results of a two-year chronic toxicity study with hexachlorobutadiene in rats. Am. Ind. Hyg. Assoc. J. 38: 589-602.",renal tubular adenomas and adenocarcinomas,HEq,4,0,mg/kg/day,mg/kg/day,0,90,1,Rat,Sprague-Dawley,M/F,M,Oral diet,NA,22-24,Months
73,87683,Hexachlorobutadiene,IRIS,0.078,kidneys,"Kociba, R.J., D.G. Keyes, G.C. Jersey, et al. 1977. Results of a two-year chronic toxicity study with hexachlorobutadiene in rats. Am. Ind. Hyg. Assoc. J. 38: 589-602.",renal tubular adenomas and adenocarcinomas,HEq,4,0.04,mg/kg/day,mg/kg/day,0.04,40,0,Rat,Sprague-Dawley,M/F,M,Oral diet,NA,22-24,Months
73,87683,Hexachlorobutadiene,IRIS,0.078,kidneys,"Kociba, R.J., D.G. Keyes, G.C. Jersey, et al. 1977. Results of a two-year chronic toxicity study with hexachlorobutadiene in rats. Am. Ind. Hyg. Assoc. J. 38: 589-602.",renal tubular adenomas and adenocarcinomas,HEq,4,0.4,mg/kg/day,mg/kg/day,0.4,40,0,Rat,Sprague-Dawley,M/F,M,Oral diet,NA,22-24,Months
73,87683,Hexachlorobutadiene,IRIS,0.078,kidneys,"Kociba, R.J., D.G. Keyes, G.C. Jersey, et al. 1977. Results of a two-year chronic toxicity study with hexachlorobutadiene in rats. Am. Ind. Hyg. Assoc. J. 38: 589-602.",renal tubular adenomas and adenocarcinomas,HEq,4,4,mg/kg/day,mg/kg/day,4,39,9,Rat,Sprague-Dawley,M/F,M,Oral diet,NA,22-24,Months
74,87843,"Pentabromo-6-Chlorocyclohexane, 1,2,3,4,5-",HEAST,0.023,gastrointestinal,"Blair E.H. 1981. TSCA Sec 8(e) submission 8EHQ-0381-0393, 88-8100295 by Dow Chemical Co. Office of Toxic Substances, U.S. EPA, Washington, DC.","large instestine, polypoid adenoma",Dose,4,0,mg/kg/day,mg/kg/day,0,86,1,Rat,Fischer 344,M/F,F,Oral diet,NA,2,Years
74,87843,"Pentabromo-6-Chlorocyclohexane, 1,2,3,4,5-",HEAST,0.023,gastrointestinal,"Blair E.H. 1981. TSCA Sec 8(e) submission 8EHQ-0381-0393, 88-8100295 by Dow Chemical Co. Office of Toxic Substances, U.S. EPA, Washington, DC.","large instestine, polypoid adenoma",Dose,4,1,mg/kg/day,mg/kg/day,1,50,0,Rat,Fischer 344,M/F,F,Oral diet,NA,2,Years
74,87843,"Pentabromo-6-Chlorocyclohexane, 1,2,3,4,5-",HEAST,0.023,gastrointestinal,"Blair E.H. 1981. TSCA Sec 8(e) submission 8EHQ-0381-0393, 88-8100295 by Dow Chemical Co. Office of Toxic Substances, U.S. EPA, Washington, DC.","large instestine, polypoid adenoma",Dose,4,20,mg/kg/day,mg/kg/day,20,50,3,Rat,Fischer 344,M/F,F,Oral diet,NA,2,Years
74,87843,"Pentabromo-6-Chlorocyclohexane, 1,2,3,4,5-",HEAST,0.023,gastrointestinal,"Blair E.H. 1981. TSCA Sec 8(e) submission 8EHQ-0381-0393, 88-8100295 by Dow Chemical Co. Office of Toxic Substances, U.S. EPA, Washington, DC.","large instestine, polypoid adenoma",Dose,4,70,mg/kg/day,mg/kg/day,70,50,8,Rat,Fischer 344,M/F,F,Oral diet,NA,2,Years
75,87865,Pentachlorophenol,CalEPA,0.018,adrenal glands,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",Adrenal gland/medullary tumor incidence (benign and malignant pheochromocytomas),Conv,4,0,mg/kg-day diet,ppm diet,0,34,1,Mouse,B6C3F1,M/F,M,Oral diet,NA,2,Years
75,87865,Pentachlorophenol,CalEPA,0.018,adrenal glands,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",Adrenal gland/medullary tumor incidence (benign and malignant pheochromocytomas),Conv,4,18,mg/kg-day diet,ppm diet,18,48,4,Mouse,B6C3F1,M/F,M,Oral diet,NA,2,Years
75,87865,Pentachlorophenol,CalEPA,0.018,adrenal glands,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",Adrenal gland/medullary tumor incidence (benign and malignant pheochromocytomas),Conv,4,37,mg/kg-day diet,ppm diet,37,48,21,Mouse,B6C3F1,M/F,M,Oral diet,NA,2,Years
75,87865,Pentachlorophenol,CalEPA,0.018,adrenal glands,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",Adrenal gland/medullary tumor incidence (benign and malignant pheochromocytomas),Conv,4,118,mg/kg-day diet,ppm diet,118,49,45,Mouse,B6C3F1,M/F,M,Oral diet,NA,2,Years
76,87865,Pentachlorophenol,CalEPA,0.018,adrenal glands,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",Adrenal gland/medullary tumor incidence (benign and malignant pheochromocytomas),Conv,4,0,mg/kg-day diet,ppm diet,0,35,0,Mouse,B6C3F1,M/F,F,Oral diet,NA,2,Years
76,87865,Pentachlorophenol,CalEPA,0.018,adrenal glands,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",Adrenal gland/medullary tumor incidence (benign and malignant pheochromocytomas),Conv,4,17,mg/kg-day diet,ppm diet,17,49,2,Mouse,B6C3F1,M/F,F,Oral diet,NA,2,Years
76,87865,Pentachlorophenol,CalEPA,0.018,adrenal glands,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",Adrenal gland/medullary tumor incidence (benign and malignant pheochromocytomas),Conv,4,34,mg/kg-day diet,ppm diet,34,46,2,Mouse,B6C3F1,M/F,F,Oral diet,NA,2,Years
76,87865,Pentachlorophenol,CalEPA,0.018,adrenal glands,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",Adrenal gland/medullary tumor incidence (benign and malignant pheochromocytomas),Conv,4,114,mg/kg-day diet,ppm diet,114,49,38,Mouse,B6C3F1,M/F,F,Oral diet,NA,2,Years
77,87865,Pentachlorophenol,CalEPA,0.018,liver,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",hepatocellular adenomas and carcinomas,Conv,4,0,mg/kg-day,ppm diet,0,34,1,Mouse,B6C3F1,M/F,F,Oral diet,NA,2,Years
77,87865,Pentachlorophenol,CalEPA,0.018,liver,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",hepatocellular adenomas and carcinomas,Conv,4,17,mg/kg-day,ppm diet,17,50,4,Mouse,B6C3F1,M/F,F,Oral diet,NA,2,Years
77,87865,Pentachlorophenol,CalEPA,0.018,liver,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",hepatocellular adenomas and carcinomas,Conv,4,34,mg/kg-day,ppm diet,34,49,6,Mouse,B6C3F1,M/F,F,Oral diet,NA,2,Years
77,87865,Pentachlorophenol,CalEPA,0.018,liver,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",hepatocellular adenomas and carcinomas,Conv,4,114,mg/kg-day,ppm diet,114,48,31,Mouse,B6C3F1,M/F,F,Oral diet,NA,2,Years
78,87865,Pentachlorophenol,CalEPA,0.018,liver,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",hemangiosarcomas,Conv,4,0,mg/kg-day diet,ppm diet,0,35,0,Mouse,B6C3F1,M/F,F,Oral diet,NA,2,Years
78,87865,Pentachlorophenol,CalEPA,0.018,liver,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",hemangiosarcomas,Conv,4,17,mg/kg-day diet,ppm diet,17,50,1,Mouse,B6C3F1,M/F,F,Oral diet,NA,2,Years
78,87865,Pentachlorophenol,CalEPA,0.018,liver,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",hemangiosarcomas,Conv,4,34,mg/kg-day diet,ppm diet,34,50,3,Mouse,B6C3F1,M/F,F,Oral diet,NA,2,Years
78,87865,Pentachlorophenol,CalEPA,0.018,liver,"National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",hemangiosarcomas,Conv,4,114,mg/kg-day diet,ppm diet,114,49,8,Mouse,B6C3F1,M/F,F,Oral diet,NA,2,Years
79,87865,Pentachlorophenol,IRIS,0.4,adrenal glands,"NTP (National Toxicology Program). (1989) NTP toxicology and carcinogenesis studies of two pentachlorophenol technical-grade mixtures (CAS No. 87-86-5) in B6C3F1 mice (feed studies).  Public Health Service, U.S. Department of Health and Human Services; NTP TR 349. Available from the National Institute of Environmental Health Sciences, Research Triangle Park, NC.",Adrenal benign or malignant pheochromocytomas,Conv,3,0,mg/kg/day,ppm,0,31,0,Mouse,B6C3F1,M/F,M,Oral diet,NA,2,Years
79,87865,Pentachlorophenol,IRIS,0.4,adrenal glands,"NTP (National Toxicology Program). (1989) NTP toxicology and carcinogenesis studies of two pentachlorophenol technical-grade mixtures (CAS No. 87-86-5) in B6C3F1 mice (feed studies).  Public Health Service, U.S. Department of Health and Human Services; NTP TR 349. Available from the National Institute of Environmental Health Sciences, Research Triangle Park, NC.",Adrenal benign or malignant pheochromocytomas,Conv,3,18,mg/kg/day,ppm,18,45,10,Mouse,B6C3F1,M/F,M,Oral diet,NA,2,Years
79,87865,Pentachlorophenol,IRIS,0.4,adrenal glands,"NTP (National Toxicology Program). (1989) NTP toxicology and carcinogenesis studies of two pentachlorophenol technical-grade mixtures (CAS No. 87-86-5) in B6C3F1 mice (feed studies).  Public Health Service, U.S. Department of Health and Human Services; NTP TR 349. Available from the National Institute of Environmental Health Sciences, Research Triangle Park, NC.",Adrenal benign or malignant pheochromocytomas,Conv,3,35,mg/kg/day,ppm,35,45,23,Mouse,B6C3F1,M/F,M,Oral diet,NA,2,Years
80,87865,Pentachlorophenol,IRIS,0.4,liver,"NTP (National Toxicology Program). (1989) NTP toxicology and carcinogenesis studies of two pentachlorophenol technical-grade mixtures (CAS No. 87-86-5) in B6C3F1 mice (feed studies).  Public Health Service, U.S. Department of Health and Human Services; NTP TR 349. Available from the National Institute of Environmental Health Sciences, Research Triangle Park, NC.",Hepatocellular adenomas or carcinomas,Conv,3,0,mg/kg/day,ppm,0,32,7,Mouse,B6C3F1,M/F,M,Oral diet,NA,2,Years
80,87865,Pentachlorophenol,IRIS,0.4,liver,"NTP (National Toxicology Program). (1989) NTP toxicology and carcinogenesis studies of two pentachlorophenol technical-grade mixtures (CAS No. 87-86-5) in B6C3F1 mice (feed studies).  Public Health Service, U.S. Department of Health and Human Services; NTP TR 349. Available from the National Institute of Environmental Health Sciences, Research Triangle Park, NC.",Hepatocellular adenomas or carcinomas,Conv,3,18,mg/kg/day,ppm,18,47,26,Mouse,B6C3F1,M/F,M,Oral diet,NA,2,Years
80,87865,Pentachlorophenol,IRIS,0.4,liver,"NTP (National Toxicology Program). (1989) NTP toxicology and carcinogenesis studies of two pentachlorophenol technical-grade mixtures (CAS No. 87-86-5) in B6C3F1 mice (feed studies).  Public Health Service, U.S. Department of Health and Human Services; NTP TR 349. Available from the National Institute of Environmental Health Sciences, Research Triangle Park, NC.",Hepatocellular adenomas or carcinomas,Conv,3,35,mg/kg/day,ppm,35,48,37,Mouse,B6C3F1,M/F,M,Oral diet,NA,2,Years
81,88062,"2,4,6-Trichlorophenol",CalEPA,0.07,liver,"National Cancer Institute (NCI). 1979. Bioassay of 2,4,6-Trichlorophenol for Possible Carcinogenicity. National Cancer Institute, National Institutes of Health, Bethesda, MD.",hepatoma,Conv,3,0,mg/kg/day,ppm,0,20,4,Mouse,B6C3F1,M/F,M,Oral diet,NA,105,Weeks
81,88062,"2,4,6-Trichlorophenol",CalEPA,0.07,liver,"National Cancer Institute (NCI). 1979. Bioassay of 2,4,6-Trichlorophenol for Possible Carcinogenicity. National Cancer Institute, National Institutes of Health, Bethesda, MD.",hepatoma,Conv,3,678,mg/kg/day,ppm,678,49,32,Mouse,B6C3F1,M/F,M,Oral diet,NA,105,Weeks
81,88062,"2,4,6-Trichlorophenol",CalEPA,0.07,liver,"National Cancer Institute (NCI). 1979. Bioassay of 2,4,6-Trichlorophenol for Possible Carcinogenicity. National Cancer Institute, National Institutes of Health, Bethesda, MD.",hepatoma,Conv,3,1356,mg/kg/day,ppm,1356,47,39,Mouse,B6C3F1,M/F,M,Oral diet,NA,105,Weeks
82,88062,"2,4,6-Trichlorophenol",CalEPA,0.07,liver,"National Cancer Institute (NCI). 1979. Bioassay of 2,4,6-Trichlorophenol for Possible Carcinogenicity. National Cancer Institute, National Institutes of Health, Bethesda, MD.",hepatoma,Conv,3,0,mg/kg/day,ppm,0,20,1,Mouse,B6C3F1,M/F,F,Oral diet,NA,105,Weeks
82,88062,"2,4,6-Trichlorophenol",CalEPA,0.07,liver,"National Cancer Institute (NCI). 1979. Bioassay of 2,4,6-Trichlorophenol for Possible Carcinogenicity. National Cancer Institute, National Institutes of Health, Bethesda, MD.",hepatoma,Conv,3,600,mg/kg/day,ppm,600,50,12,Mouse,B6C3F1,M/F,F,Oral diet,NA,105,Weeks
82,88062,"2,4,6-Trichlorophenol",CalEPA,0.07,liver,"National Cancer Institute (NCI). 1979. Bioassay of 2,4,6-Trichlorophenol for Possible Carcinogenicity. National Cancer Institute, National Institutes of Health, Bethesda, MD.",hepatoma,Conv,3,1200,mg/kg/day,ppm,1200,48,24,Mouse,B6C3F1,M/F,F,Oral diet,NA,105,Weeks
83,88062,"2,4,6-Trichlorophenol",IRIS,0.011,blood,"NCI (National Cancer Institute). 1979. Bioassay of 2,4,6-Trichlorophenol for Possible Carcinogenicity. U.S. DHEW Publ. No. NCI-CG-TR-155.",leukemia,HEq,3,0,mg/kg/day,ppm,0,20,3,Rat,Fischer 344,M/F,M,Oral diet,NA,106-107,Weeks
83,88062,"2,4,6-Trichlorophenol",IRIS,0.011,blood,"NCI (National Cancer Institute). 1979. Bioassay of 2,4,6-Trichlorophenol for Possible Carcinogenicity. U.S. DHEW Publ. No. NCI-CG-TR-155.",leukemia,HEq,3,44.6,mg/kg/day,ppm,44.6,50,23,Rat,Fischer 344,M/F,M,Oral diet,NA,106-107,Weeks
83,88062,"2,4,6-Trichlorophenol",IRIS,0.011,blood,"NCI (National Cancer Institute). 1979. Bioassay of 2,4,6-Trichlorophenol for Possible Carcinogenicity. U.S. DHEW Publ. No. NCI-CG-TR-155.",leukemia,HEq,3,94.4,mg/kg/day,ppm,94.4,50,29,Rat,Fischer 344,M/F,M,Oral diet,NA,106-107,Weeks
84,88722,"Nitrotoluene, o-   ",PPRTV,0.22,skin,NTP (National Toxicology Program). 2002a. Toxicology and carcinogenesis studies of o-nitrotoluene (CAS No. 88-72-2) in F344/N rats and B6C3F1 mice (feed studies). NTP TR 504. NIH Publication No. 01-4438. Online. Http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr504.pdf.,Skin Fibroma or Fibrosarcoma,Conv,6,0,mg/kg-day,ppm,0,60,5,Rat,Fischer 344,M/F,M,Oral diet,NA,24,Months
84,88722,"Nitrotoluene, o-   ",PPRTV,0.22,skin,NTP (National Toxicology Program). 2002a. Toxicology and carcinogenesis studies of o-nitrotoluene (CAS No. 88-72-2) in F344/N rats and B6C3F1 mice (feed studies). NTP TR 504. NIH Publication No. 01-4438. Online. Http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr504.pdf.,Skin Fibroma or Fibrosarcoma,Conv,6,25,mg/kg-day,ppm,25,60,47,Rat,Fischer 344,M/F,M,Oral diet,NA,24,Months
84,88722,"Nitrotoluene, o-   ",PPRTV,0.22,skin,NTP (National Toxicology Program). 2002a. Toxicology and carcinogenesis studies of o-nitrotoluene (CAS No. 88-72-2) in F344/N rats and B6C3F1 mice (feed studies). NTP TR 504. NIH Publication No. 01-4438. Online. Http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr504.pdf.,Skin Fibroma or Fibrosarcoma,Conv,6,50,mg/kg-day,ppm,50,60,55,Rat,Fischer 344,M/F,M,Oral diet,NA,24,Months
84,88722,"Nitrotoluene, o-   ",PPRTV,0.22,skin,NTP (National Toxicology Program). 2002a. Toxicology and carcinogenesis studies of o-nitrotoluene (CAS No. 88-72-2) in F344/N rats and B6C3F1 mice (feed studies). NTP TR 504. NIH Publication No. 01-4438. Online. Http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr504.pdf.,Skin Fibroma or Fibrosarcoma,Conv,6,90,mg/kg-day,ppm,90,60,59,Rat,Fischer 344,M/F,M,Oral diet,NA,24,Months
84,88722,"Nitrotoluene, o-   ",PPRTV,0.22,skin,NTP (National Toxicology Program). 2002a. Toxicology and carcinogenesis studies of o-nitrotoluene (CAS No. 88-72-2) in F344/N rats and B6C3F1 mice (feed studies). NTP TR 504. NIH Publication No. 01-4438. Online. Http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr504.pdf.,Skin Fibroma or Fibrosarcoma,Conv,6,125,mg/kg-day,ppm,125,60,47,Rat,Fischer 344,M/F,M,Oral diet,NA,24,Months
84,88722,"Nitrotoluene, o-   ",PPRTV,0.22,skin,NTP (National Toxicology Program). 2002a. Toxicology and carcinogenesis studies of o-nitrotoluene (CAS No. 88-72-2) in F344/N rats and B6C3F1 mice (feed studies). NTP TR 504. NIH Publication No. 01-4438. Online. Http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr504.pdf.,Skin Fibroma or Fibrosarcoma,Conv,6,315,mg/kg-day,ppm,315,60,53,Rat,Fischer 344,M/F,M,Oral diet,NA,24,Months
85,88733,"Chloronitrobenzene, o-   ",PPRTV,0.3,liver,"Matsumoto, M., Y. Umeda, H. Senoh et al. 2006b. Two-year feed study of carcinogenicity and chronic toxicity of ortho-chloronitrobenzene in rats and mice. J. Toxicol. Sci. 31(3):247-267. Online. http://www.jstage.jst.go.jp/article/jts/31/3/247/_pdf.",liver adenoma or carcinoma,Dose,4,0,mg/kg-d,mg/kg-d,0,50,8,Mouse,BDF1,M/F,F,Oral diet,NA,2,Years
85,88733,"Chloronitrobenzene, o-   ",PPRTV,0.3,liver,"Matsumoto, M., Y. Umeda, H. Senoh et al. 2006b. Two-year feed study of carcinogenicity and chronic toxicity of ortho-chloronitrobenzene in rats and mice. J. Toxicol. Sci. 31(3):247-267. Online. http://www.jstage.jst.go.jp/article/jts/31/3/247/_pdf.",liver adenoma or carcinoma,Dose,4,14,mg/kg-d,mg/kg-d,14,50,22,Mouse,BDF1,M/F,F,Oral diet,NA,2,Years
85,88733,"Chloronitrobenzene, o-   ",PPRTV,0.3,liver,"Matsumoto, M., Y. Umeda, H. Senoh et al. 2006b. Two-year feed study of carcinogenicity and chronic toxicity of ortho-chloronitrobenzene in rats and mice. J. Toxicol. Sci. 31(3):247-267. Online. http://www.jstage.jst.go.jp/article/jts/31/3/247/_pdf.",liver adenoma or carcinoma,Dose,4,69,mg/kg-d,mg/kg-d,69,50,48,Mouse,BDF1,M/F,F,Oral diet,NA,2,Years
85,88733,"Chloronitrobenzene, o-   ",PPRTV,0.3,liver,"Matsumoto, M., Y. Umeda, H. Senoh et al. 2006b. Two-year feed study of carcinogenicity and chronic toxicity of ortho-chloronitrobenzene in rats and mice. J. Toxicol. Sci. 31(3):247-267. Online. http://www.jstage.jst.go.jp/article/jts/31/3/247/_pdf.",liver adenoma or carcinoma,Dose,4,369,mg/kg-d,mg/kg-d,369,50,48,Mouse,BDF1,M/F,F,Oral diet,NA,2,Years
86,90040,o-Anisidine,CalEPA,0.14,bladder,"National Cancer Institute (NCI, 1978). Bioassay of ortho-Anisidine for Possible Carcinogenicity. Carcinogenesis Technical Report Series, Technical Report No. 89.
US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",Transitional-cell carcinomas or papillomas of the urinary bladder,Dose,3,0,ppm diet,ppm diet,0,51,0,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
86,90040,o-Anisidine,CalEPA,0.14,bladder,"National Cancer Institute (NCI, 1978). Bioassay of ortho-Anisidine for Possible Carcinogenicity. Carcinogenesis Technical Report Series, Technical Report No. 89.
US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",Transitional-cell carcinomas or papillomas of the urinary bladder,Dose,3,5000,ppm diet,ppm diet,394.7368421,54,52,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
86,90040,o-Anisidine,CalEPA,0.14,bladder,"National Cancer Institute (NCI, 1978). Bioassay of ortho-Anisidine for Possible Carcinogenicity. Carcinogenesis Technical Report Series, Technical Report No. 89.
US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",Transitional-cell carcinomas or papillomas of the urinary bladder,Dose,3,10000,ppm diet,ppm diet,789.4736842,52,52,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
87,90948,Michlers Ketone,CalEPA,0.86,liver,"National Cancer Institute (NCI, 1979). Bioassay of Michler's Ketone for Possible Carcinogenicity. Carcinogenesis echnica1 Report Series No. 181. NTIS Publication No. PB 299855. US Department f Health, Education and Welfare (DHEW), NCI Carcinogenesis Testing Program, Bethesda, MD.",liver tumors,Dose,3,0,ppm,ppm,0,20,0,Rat,Fischer 344,M/F,F,Oral diet,NA,109,Weeks
87,90948,Michlers Ketone,CalEPA,0.86,liver,"National Cancer Institute (NCI, 1979). Bioassay of Michler's Ketone for Possible Carcinogenicity. Carcinogenesis echnica1 Report Series No. 181. NTIS Publication No. PB 299855. US Department f Health, Education and Welfare (DHEW), NCI Carcinogenesis Testing Program, Bethesda, MD.",liver tumors,Dose,3,500,ppm,ppm,45.85152838,47,41,Rat,Fischer 344,M/F,F,Oral diet,NA,109,Weeks
87,90948,Michlers Ketone,CalEPA,0.86,liver,"National Cancer Institute (NCI, 1979). Bioassay of Michler's Ketone for Possible Carcinogenicity. Carcinogenesis echnica1 Report Series No. 181. NTIS Publication No. PB 299855. US Department f Health, Education and Welfare (DHEW), NCI Carcinogenesis Testing Program, Bethesda, MD.",liver tumors,Dose,3,1000,ppm,ppm,91.70305677,49,44,Rat,Fischer 344,M/F,F,Oral diet,NA,109,Weeks
88,91225,Quinoline,IRIS,3,liver,"Hirao, K; Shinohara,Y; Tsuda, H; et al. (1976) Carcinogenic activity of quinoline on rat liver. Cancer Res 36(1):329.",hepatic hemangioendotheliomas or hemangiosarcomas,Conv,4,0,mg/kg/day,ppm,0,6,0,Rat,Sprague-Dawley,M,Both,Oral diet,NA,16-40,Weeks
88,91225,Quinoline,IRIS,3,liver,"Hirao, K; Shinohara,Y; Tsuda, H; et al. (1976) Carcinogenic activity of quinoline on rat liver. Cancer Res 36(1):329.",hepatic hemangioendotheliomas or hemangiosarcomas,Conv,4,25,mg/kg/day,ppm,25,11,6,Rat,Sprague-Dawley,M,Both,Oral diet,NA,16-40,Weeks
88,91225,Quinoline,IRIS,3,liver,"Hirao, K; Shinohara,Y; Tsuda, H; et al. (1976) Carcinogenic activity of quinoline on rat liver. Cancer Res 36(1):329.",hepatic hemangioendotheliomas or hemangiosarcomas,Conv,4,50,mg/kg/day,ppm,50,16,12,Rat,Sprague-Dawley,M,Both,Oral diet,NA,16-40,Weeks
88,91225,Quinoline,IRIS,3,liver,"Hirao, K; Shinohara,Y; Tsuda, H; et al. (1976) Carcinogenic activity of quinoline on rat liver. Cancer Res 36(1):329.",hepatic hemangioendotheliomas or hemangiosarcomas,Conv,4,125,mg/kg/day,ppm,125,19,18,Rat,Sprague-Dawley,M,Both,Oral diet,NA,16-40,Weeks
89,91598,2-Naphthylamine,CalEPA,1.8,bladder,"Conzelman GM, Moulton JE, Flanders LE, Springer K and Crout DW (1969). Induction of transitional cell carcinoma of the urinary bladder in monkeys fed 2-naphthylamine. J. Nat. Cancer Inst. 42: 825-831.",benign and malignant bladder tumors,Dose,13,0,mg/kg/day (TWA),mg/kg/day (TWA),0,3,0,Non-human primate,Rhesus Monkey,M/F,F,Oral - other,6,260,Weeks
89,91598,2-Naphthylamine,CalEPA,1.8,bladder,"Conzelman GM, Moulton JE, Flanders LE, Springer K and Crout DW (1969). Induction of transitional cell carcinoma of the urinary bladder in monkeys fed 2-naphthylamine. J. Nat. Cancer Inst. 42: 825-831.",benign and malignant bladder tumors,Dose,13,11.9,mg/kg/day (TWA),mg/kg/day (TWA),10.2,1,1,Non-human primate,Rhesus Monkey,M/F,F,Oral - other,6,260,Weeks
89,91598,2-Naphthylamine,CalEPA,1.8,bladder,"Conzelman GM, Moulton JE, Flanders LE, Springer K and Crout DW (1969). Induction of transitional cell carcinoma of the urinary bladder in monkeys fed 2-naphthylamine. J. Nat. Cancer Inst. 42: 825-831.",benign and malignant bladder tumors,Dose,13,12.5,mg/kg/day (TWA),mg/kg/day (TWA),10.71428571,1,0,Non-human primate,Rhesus Monkey,M/F,F,Oral - other,6,260,Weeks
89,91598,2-Naphthylamine,CalEPA,1.8,bladder,"Conzelman GM, Moulton JE, Flanders LE, Springer K and Crout DW (1969). Induction of transitional cell carcinoma of the urinary bladder in monkeys fed 2-naphthylamine. J. Nat. Cancer Inst. 42: 825-831.",benign and malignant bladder tumors,Dose,13,23.8,mg/kg/day (TWA),mg/kg/day (TWA),20.4,1,0,Non-human primate,Rhesus Monkey,M/F,F,Oral - other,6,260,Weeks
89,91598,2-Naphthylamine,CalEPA,1.8,bladder,"Conzelman GM, Moulton JE, Flanders LE, Springer K and Crout DW (1969). Induction of transitional cell carcinoma of the urinary bladder in monkeys fed 2-naphthylamine. J. Nat. Cancer Inst. 42: 825-831.",benign and malignant bladder tumors,Dose,13,25,mg/kg/day (TWA),mg/kg/day (TWA),21.42857143,2,0,Non-human primate,Rhesus Monkey,M/F,F,Oral - other,6,260,Weeks
89,91598,2-Naphthylamine,CalEPA,1.8,bladder,"Conzelman GM, Moulton JE, Flanders LE, Springer K and Crout DW (1969). Induction of transitional cell carcinoma of the urinary bladder in monkeys fed 2-naphthylamine. J. Nat. Cancer Inst. 42: 825-831.",benign and malignant bladder tumors,Dose,13,47.5,mg/kg/day (TWA),mg/kg/day (TWA),40.71428571,2,0,Non-human primate,Rhesus Monkey,M/F,F,Oral - other,6,260,Weeks
89,91598,2-Naphthylamine,CalEPA,1.8,bladder,"Conzelman GM, Moulton JE, Flanders LE, Springer K and Crout DW (1969). Induction of transitional cell carcinoma of the urinary bladder in monkeys fed 2-naphthylamine. J. Nat. Cancer Inst. 42: 825-831.",benign and malignant bladder tumors,Dose,13,50,mg/kg/day (TWA),mg/kg/day (TWA),42.85714286,2,2,Non-human primate,Rhesus Monkey,M/F,F,Oral - other,6,260,Weeks
89,91598,2-Naphthylamine,CalEPA,1.8,bladder,"Conzelman GM, Moulton JE, Flanders LE, Springer K and Crout DW (1969). Induction of transitional cell carcinoma of the urinary bladder in monkeys fed 2-naphthylamine. J. Nat. Cancer Inst. 42: 825-831.",benign and malignant bladder tumors,Dose,13,100,mg/kg/day (TWA),mg/kg/day (TWA),85.71428571,1,0,Non-human primate,Rhesus Monkey,M/F,F,Oral - other,6,260,Weeks
89,91598,2-Naphthylamine,CalEPA,1.8,bladder,"Conzelman GM, Moulton JE, Flanders LE, Springer K and Crout DW (1969). Induction of transitional cell carcinoma of the urinary bladder in monkeys fed 2-naphthylamine. J. Nat. Cancer Inst. 42: 825-831.",benign and malignant bladder tumors,Dose,13,155,mg/kg/day (TWA),mg/kg/day (TWA),132.8571429,1,1,Non-human primate,Rhesus Monkey,M/F,F,Oral - other,6,260,Weeks
89,91598,2-Naphthylamine,CalEPA,1.8,bladder,"Conzelman GM, Moulton JE, Flanders LE, Springer K and Crout DW (1969). Induction of transitional cell carcinoma of the urinary bladder in monkeys fed 2-naphthylamine. J. Nat. Cancer Inst. 42: 825-831.",benign and malignant bladder tumors,Dose,13,170,mg/kg/day (TWA),mg/kg/day (TWA),145.7142857,1,1,Non-human primate,Rhesus Monkey,M/F,F,Oral - other,6,260,Weeks
89,91598,2-Naphthylamine,CalEPA,1.8,bladder,"Conzelman GM, Moulton JE, Flanders LE, Springer K and Crout DW (1969). Induction of transitional cell carcinoma of the urinary bladder in monkeys fed 2-naphthylamine. J. Nat. Cancer Inst. 42: 825-831.",benign and malignant bladder tumors,Dose,13,173,mg/kg/day (TWA),mg/kg/day (TWA),148.2857143,2,1,Non-human primate,Rhesus Monkey,M/F,F,Oral - other,6,260,Weeks
89,91598,2-Naphthylamine,CalEPA,1.8,bladder,"Conzelman GM, Moulton JE, Flanders LE, Springer K and Crout DW (1969). Induction of transitional cell carcinoma of the urinary bladder in monkeys fed 2-naphthylamine. J. Nat. Cancer Inst. 42: 825-831.",benign and malignant bladder tumors,Dose,13,174,mg/kg/day (TWA),mg/kg/day (TWA),149.1428571,1,1,Non-human primate,Rhesus Monkey,M/F,F,Oral - other,6,260,Weeks
89,91598,2-Naphthylamine,CalEPA,1.8,bladder,"Conzelman GM, Moulton JE, Flanders LE, Springer K and Crout DW (1969). Induction of transitional cell carcinoma of the urinary bladder in monkeys fed 2-naphthylamine. J. Nat. Cancer Inst. 42: 825-831.",benign and malignant bladder tumors,Dose,13,176,mg/kg/day (TWA),mg/kg/day (TWA),150.8571429,1,1,Non-human primate,Rhesus Monkey,M/F,F,Oral - other,6,260,Weeks
90,94780,Phenazopyridine,CalEPA,0.17,liver,"National Cancer Institute (NCI, 1978). Bioassay of Phenazopyridine Hydrochloride for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 99. NTIS Publication No. PB 286207. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular adenoma or carcinoma,Dose,3,0,ppm diet,ppm diet,0,15,5,Mouse,B6C3F1,M/F,F,Oral diet,NA,80,Weeks
90,94780,Phenazopyridine,CalEPA,0.17,liver,"National Cancer Institute (NCI, 1978). Bioassay of Phenazopyridine Hydrochloride for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 99. NTIS Publication No. PB 286207. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular adenoma or carcinoma,Dose,3,600,ppm diet,ppm diet,103.6827195,35,15,Mouse,B6C3F1,M/F,F,Oral diet,NA,80,Weeks
90,94780,Phenazopyridine,CalEPA,0.17,liver,"National Cancer Institute (NCI, 1978). Bioassay of Phenazopyridine Hydrochloride for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 99. NTIS Publication No. PB 286207. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular adenoma or carcinoma,Dose,3,1200,ppm diet,ppm diet,207.3654391,33,15,Mouse,B6C3F1,M/F,F,Oral diet,NA,80,Weeks
91,95067,Sulfallate,CalEPA,0.19,mammary glands,"National Cancer Institute (NCI, 1978). Bioassay of Sulfallate for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. lIS. NTIS Publication
No. PB 286386. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",adenocarcinomas of the mammary gland,Dose,3,0,ppm,ppm,0,50,0,Rat,Osborne-Mendel,M/F,F,Oral diet,NA,78,Weeks
91,95067,Sulfallate,CalEPA,0.19,mammary glands,"National Cancer Institute (NCI, 1978). Bioassay of Sulfallate for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. lIS. NTIS Publication
No. PB 286386. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",adenocarcinomas of the mammary gland,Dose,3,250,ppm,ppm,19.28020566,50,7,Rat,Osborne-Mendel,M/F,F,Oral diet,NA,78,Weeks
91,95067,Sulfallate,CalEPA,0.19,mammary glands,"National Cancer Institute (NCI, 1978). Bioassay of Sulfallate for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. lIS. NTIS Publication
No. PB 286386. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",adenocarcinomas of the mammary gland,Dose,3,404,ppm,ppm,31.15681234,48,11,Rat,Osborne-Mendel,M/F,F,Oral diet,NA,78,Weeks
92,95681,"Dimethylaniline, 2,4-   ",PPRTV,0.2,lung,"Weisburger, EK; et al. (1978) Testing of twenty-one environmental aromatic amines or derivates for long-term toxicity or carcinogenicity. J Environ Path Tox 2(2):325?356. 064640",lung tumors,HEq,3,0,mg/kg-day,mg/kg-day,0,22,5,Mouse,CD-1,M/F,F,Oral diet,NA,21,Months
92,95681,"Dimethylaniline, 2,4-   ",PPRTV,0.2,lung,"Weisburger, EK; et al. (1978) Testing of twenty-one environmental aromatic amines or derivates for long-term toxicity or carcinogenicity. J Environ Path Tox 2(2):325?356. 064640",lung tumors,HEq,3,2.9,mg/kg-day,mg/kg-day,2.9,18,5,Mouse,CD-1,M/F,F,Oral diet,NA,21,Months
92,95681,"Dimethylaniline, 2,4-   ",PPRTV,0.2,lung,"Weisburger, EK; et al. (1978) Testing of twenty-one environmental aromatic amines or derivates for long-term toxicity or carcinogenicity. J Environ Path Tox 2(2):325?356. 064640",lung tumors,HEq,3,5.8,mg/kg-day,mg/kg-day,5.8,19,11,Mouse,CD-1,M/F,F,Oral diet,NA,21,Months
93,95692,p-Chloro-o-toluidine,CalEPA,0.27,vascular system,"National Cancer Institute (NCI) 1979. Bioassay of 4-Chloro-o-Toluidine Hydrochloride for Possible Carcinogenicity. CAS No. 3165-93-3. Carcinogenesis Technical Report Series No. 165. NCI-CG-TR-165 DHEW Publication No. (NIH) 79-1721. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

Gold L, Sawyer C, Magaw R, Backman G, de Veciana M, Levinson R, Hooper N, Havender W, Bernstein L, Peto R, Pike M and Ames B. 1984. A Carcinogenic Potency Database of the standardized results of animal bioassays. Environ Health Perspect 58:9-319.",hemangiomas and hemangiosarcomas,Conv,3,0,mg/kg/day,mg/kg-diet,0,20,0,Mouse,B6C3F1,M/F,M,Oral diet,NA,99,Weeks
93,95692,p-Chloro-o-toluidine,CalEPA,0.27,vascular system,"National Cancer Institute (NCI) 1979. Bioassay of 4-Chloro-o-Toluidine Hydrochloride for Possible Carcinogenicity. CAS No. 3165-93-3. Carcinogenesis Technical Report Series No. 165. NCI-CG-TR-165 DHEW Publication No. (NIH) 79-1721. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

Gold L, Sawyer C, Magaw R, Backman G, de Veciana M, Levinson R, Hooper N, Havender W, Bernstein L, Peto R, Pike M and Ames B. 1984. A Carcinogenic Potency Database of the standardized results of animal bioassays. Environ Health Perspect 58:9-319.",hemangiomas and hemangiosarcomas,Conv,3,450,mg/kg/day,mg/kg-diet,450,50,6,Mouse,B6C3F1,M/F,M,Oral diet,NA,99,Weeks
93,95692,p-Chloro-o-toluidine,CalEPA,0.27,vascular system,"National Cancer Institute (NCI) 1979. Bioassay of 4-Chloro-o-Toluidine Hydrochloride for Possible Carcinogenicity. CAS No. 3165-93-3. Carcinogenesis Technical Report Series No. 165. NCI-CG-TR-165 DHEW Publication No. (NIH) 79-1721. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

Gold L, Sawyer C, Magaw R, Backman G, de Veciana M, Levinson R, Hooper N, Havender W, Bernstein L, Peto R, Pike M and Ames B. 1984. A Carcinogenic Potency Database of the standardized results of animal bioassays. Environ Health Perspect 58:9-319.",hemangiomas and hemangiosarcomas,Conv,3,1800,mg/kg/day,mg/kg-diet,1800,50,41,Mouse,B6C3F1,M/F,M,Oral diet,NA,99,Weeks
94,95692,p-Chloro-o-toluidine,CalEPA,0.27,vascular system,"Weisburger EK, Russfield AB, Homburger F, Weisburger JH, Boger E, Van Dongen CG and Chu KC. 1978. Testing of twenty-one environmental aromatic amines or derivatives for long-term toxicity or carcinogenicity. J Environ Pathol Toxicol 2:325-356.",hemangiomas and hemangiosarcomas,Conv,3,0,mg/kg-day,mg/kg-diet,0,14,0,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
94,95692,p-Chloro-o-toluidine,CalEPA,0.27,vascular system,"Weisburger EK, Russfield AB, Homburger F, Weisburger JH, Boger E, Van Dongen CG and Chu KC. 1978. Testing of twenty-one environmental aromatic amines or derivatives for long-term toxicity or carcinogenicity. J Environ Pathol Toxicol 2:325-356.",hemangiomas and hemangiosarcomas,Conv,3,90,mg/kg-day,mg/kg-diet,90,20,12,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
94,95692,p-Chloro-o-toluidine,CalEPA,0.27,vascular system,"Weisburger EK, Russfield AB, Homburger F, Weisburger JH, Boger E, Van Dongen CG and Chu KC. 1978. Testing of twenty-one environmental aromatic amines or derivatives for long-term toxicity or carcinogenicity. J Environ Pathol Toxicol 2:325-356.",hemangiomas and hemangiosarcomas,Conv,3,180,mg/kg-day,mg/kg-diet,180,20,13,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
95,95692,p-Chloro-o-toluidine,PPRTV,0.1,vascular system,"Weisburger EK; Russfield AB; Homburger F; Weisburger JH; Boger E; Van Dongen CG; Chu KC. (1978) Testing of twenty-one environmental aromatic amines or derivatives for long-term
toxicity or carcinogenicity. J Environ Pathol Toxicol, 2:325?356. 064640","vascular tumors (hemangiosarcoma or hemangioma, all sites)",HEq,3,0,mg/kg-day (salt),mg/kg diet (salt),0,15,0,Mouse,Unspecified,M/F,F,Oral diet,7,18,Months
95,95692,p-Chloro-o-toluidine,PPRTV,0.1,vascular system,"Weisburger EK; Russfield AB; Homburger F; Weisburger JH; Boger E; Van Dongen CG; Chu KC. (1978) Testing of twenty-one environmental aromatic amines or derivatives for long-term
toxicity or carcinogenicity. J Environ Pathol Toxicol, 2:325?356. 064640","vascular tumors (hemangiosarcoma or hemangioma, all sites)",HEq,3,52.5,mg/kg-day (salt),mg/kg diet (salt),52.5,19,18,Mouse,Unspecified,M/F,F,Oral diet,7,18,Months
95,95692,p-Chloro-o-toluidine,PPRTV,0.1,vascular system,"Weisburger EK; Russfield AB; Homburger F; Weisburger JH; Boger E; Van Dongen CG; Chu KC. (1978) Testing of twenty-one environmental aromatic amines or derivatives for long-term
toxicity or carcinogenicity. J Environ Pathol Toxicol, 2:325?356. 064640","vascular tumors (hemangiosarcoma or hemangioma, all sites)",HEq,3,105,mg/kg-day (salt),mg/kg diet (salt),105,16,12,Mouse,Unspecified,M/F,F,Oral diet,7,18,Months
96,95807,"2,4-Diaminotoluene",CalEPA,4,mammary glands,"National Cancer Institute (NCI) 1979. Bioassay of 2,4-Diaminotoluene for Possible Carcinogenicity. CAS No. 95-80-7. Carcinogenesis Technical Report Series No. 162. NCI-CG-TR-162 DHEW Publication No. (NIH) 79-1718. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",mammary gland tumors in the female rat,Dose,3,0,mg/kg/day (TWA),mg/kg/day (TWA),0,20,0,Rat,Fischer 344,M/F,F,Oral diet,NA,103,Weeks
96,95807,"2,4-Diaminotoluene",CalEPA,4,mammary glands,"National Cancer Institute (NCI) 1979. Bioassay of 2,4-Diaminotoluene for Possible Carcinogenicity. CAS No. 95-80-7. Carcinogenesis Technical Report Series No. 162. NCI-CG-TR-162 DHEW Publication No. (NIH) 79-1718. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",mammary gland tumors in the female rat,Dose,3,79,mg/kg/day (TWA),mg/kg/day (TWA),79,50,11,Rat,Fischer 344,M/F,F,Oral diet,NA,103,Weeks
96,95807,"2,4-Diaminotoluene",CalEPA,4,mammary glands,"National Cancer Institute (NCI) 1979. Bioassay of 2,4-Diaminotoluene for Possible Carcinogenicity. CAS No. 95-80-7. Carcinogenesis Technical Report Series No. 162. NCI-CG-TR-162 DHEW Publication No. (NIH) 79-1718. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",mammary gland tumors in the female rat,Dose,3,171,mg/kg/day (TWA),mg/kg/day (TWA),171,50,14,Rat,Fischer 344,M/F,F,Oral diet,NA,103,Weeks
97,95830,4-Chloro-ortho-phenylenediamine,CalEPA,0.016,bladder,"National Cancer Institute (NCI) 1978. Bioassay of 4-Chloro-o-Phenylenediamine for Possible Carcinogenicity. CAS No. 95-83-0. Carcinogenesis Technical Report Series No. 165. NCI-CG-TR-63. DHEW Publication No. (NIH) 78-1313. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

Gold L, Sawyer C, Magaw R, Backman G, de Veciana M, Levinson R, Hooper N, Havender W, Bernstein L, Peto R, Pike M, and Ames B (1984). A Carcinogenic Potency Database of the standardized results of animal bioassays. Environmental Health Perspectives 58: 9-319.",urinary bladder tumor,Conv,3,0,mg/kg/day,ppm,0,50,0,Rat,Fischer 344,M/F,M,Oral diet,NA,78,Weeks
97,95830,4-Chloro-ortho-phenylenediamine,CalEPA,0.016,bladder,"National Cancer Institute (NCI) 1978. Bioassay of 4-Chloro-o-Phenylenediamine for Possible Carcinogenicity. CAS No. 95-83-0. Carcinogenesis Technical Report Series No. 165. NCI-CG-TR-63. DHEW Publication No. (NIH) 78-1313. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

Gold L, Sawyer C, Magaw R, Backman G, de Veciana M, Levinson R, Hooper N, Havender W, Bernstein L, Peto R, Pike M, and Ames B (1984). A Carcinogenic Potency Database of the standardized results of animal bioassays. Environmental Health Perspectives 58: 9-319.",urinary bladder tumor,Conv,3,149,mg/kg/day,ppm,149,49,15,Rat,Fischer 344,M/F,M,Oral diet,NA,78,Weeks
97,95830,4-Chloro-ortho-phenylenediamine,CalEPA,0.016,bladder,"National Cancer Institute (NCI) 1978. Bioassay of 4-Chloro-o-Phenylenediamine for Possible Carcinogenicity. CAS No. 95-83-0. Carcinogenesis Technical Report Series No. 165. NCI-CG-TR-63. DHEW Publication No. (NIH) 78-1313. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

Gold L, Sawyer C, Magaw R, Backman G, de Veciana M, Levinson R, Hooper N, Havender W, Bernstein L, Peto R, Pike M, and Ames B (1984). A Carcinogenic Potency Database of the standardized results of animal bioassays. Environmental Health Perspectives 58: 9-319.",urinary bladder tumor,Conv,3,294,mg/kg/day,ppm,294,50,25,Rat,Fischer 344,M/F,M,Oral diet,NA,78,Weeks
98,96093,Styrene oxide,CalEPA,0.16,stomach/forestomach,Lijinsky W (1986). Rat and mouse forestomach tumors induced by chronic oral administration of styrene oxide. J. Nat. Cancer Inst. 77: 471-476.,benign and malignant tumors of the forestomach,Dose,3,0,mg/kg/dose,mg/kg/dose,0,52,1,Rat,Fischer 344,M/F,M,Oral gavage,3,2,Years
98,96093,Styrene oxide,CalEPA,0.16,stomach/forestomach,Lijinsky W (1986). Rat and mouse forestomach tumors induced by chronic oral administration of styrene oxide. J. Nat. Cancer Inst. 77: 471-476.,benign and malignant tumors of the forestomach,Dose,3,375,mg/kg/dose,mg/kg/dose,160.7142857,52,50,Rat,Fischer 344,M/F,M,Oral gavage,3,2,Years
98,96093,Styrene oxide,CalEPA,0.16,stomach/forestomach,Lijinsky W (1986). Rat and mouse forestomach tumors induced by chronic oral administration of styrene oxide. J. Nat. Cancer Inst. 77: 471-476.,benign and malignant tumors of the forestomach,Dose,3,750,mg/kg/dose,mg/kg/dose,321.4285714,51,50,Rat,Fischer 344,M/F,M,Oral gavage,3,2,Years
99,96128,"1,2-Dibromo-3-Chloropropane",PPRTV,0.8,kidneys,"Hazelton Laboratories. 1977. 104-Week dietary study in rats, 1,2-dibromo-3-chloropropane (DBCP). Final Report. Unpublished report submitted to Dow Chemical Co., Midland, MI. October 29, 1977. (Cited in U.S. EPA, 1979, 1988a, 1989a)",Renal tubular cell adenoma or carcinoma,Dose,4,0,mg/kg/day,mg/kg/day,0,48,0,Rat,CD,M/F,M,Oral diet,NA,104,Weeks
99,96128,"1,2-Dibromo-3-Chloropropane",PPRTV,0.8,kidneys,"Hazelton Laboratories. 1977. 104-Week dietary study in rats, 1,2-dibromo-3-chloropropane (DBCP). Final Report. Unpublished report submitted to Dow Chemical Co., Midland, MI. October 29, 1977. (Cited in U.S. EPA, 1979, 1988a, 1989a)",Renal tubular cell adenoma or carcinoma,Dose,4,0.24,mg/kg/day,mg/kg/day,0.24,46,1,Rat,CD,M/F,M,Oral diet,NA,104,Weeks
99,96128,"1,2-Dibromo-3-Chloropropane",PPRTV,0.8,kidneys,"Hazelton Laboratories. 1977. 104-Week dietary study in rats, 1,2-dibromo-3-chloropropane (DBCP). Final Report. Unpublished report submitted to Dow Chemical Co., Midland, MI. October 29, 1977. (Cited in U.S. EPA, 1979, 1988a, 1989a)",Renal tubular cell adenoma or carcinoma,Dose,4,0.8,mg/kg/day,mg/kg/day,0.8,46,4,Rat,CD,M/F,M,Oral diet,NA,104,Weeks
99,96128,"1,2-Dibromo-3-Chloropropane",PPRTV,0.8,kidneys,"Hazelton Laboratories. 1977. 104-Week dietary study in rats, 1,2-dibromo-3-chloropropane (DBCP). Final Report. Unpublished report submitted to Dow Chemical Co., Midland, MI. October 29, 1977. (Cited in U.S. EPA, 1979, 1988a, 1989a)",Renal tubular cell adenoma or carcinoma,Dose,4,2.39,mg/kg/day,mg/kg/day,2.39,41,15,Rat,CD,M/F,M,Oral diet,NA,104,Weeks
100,96184,"1,2,3-Trichloropropane",IRIS,30,alimentary canal,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",alimentary system squamous cell neoplasms,Dose,4,0,mg/kg/day,mg/kg/day,0,59,0,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
100,96184,"1,2,3-Trichloropropane",IRIS,30,alimentary canal,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",alimentary system squamous cell neoplasms,Dose,4,6,mg/kg/day,mg/kg/day,6,60,54,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
100,96184,"1,2,3-Trichloropropane",IRIS,30,alimentary canal,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",alimentary system squamous cell neoplasms,Dose,4,20,mg/kg/day,mg/kg/day,20,60,59,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
100,96184,"1,2,3-Trichloropropane",IRIS,30,alimentary canal,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",alimentary system squamous cell neoplasms,Dose,4,60,mg/kg/day,mg/kg/day,60,60,59,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
101,96184,"1,2,3-Trichloropropane",IRIS,30,eyes/ocular,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",Harderian gland adenomas,Dose,4,0,mg/kg/day,mg/kg/day,0,59,3,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
101,96184,"1,2,3-Trichloropropane",IRIS,30,eyes/ocular,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",Harderian gland adenomas,Dose,4,6,mg/kg/day,mg/kg/day,6,59,6,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
101,96184,"1,2,3-Trichloropropane",IRIS,30,eyes/ocular,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",Harderian gland adenomas,Dose,4,20,mg/kg/day,mg/kg/day,20,60,7,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
101,96184,"1,2,3-Trichloropropane",IRIS,30,eyes/ocular,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",Harderian gland adenomas,Dose,4,60,mg/kg/day,mg/kg/day,60,60,10,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
102,96184,"1,2,3-Trichloropropane",IRIS,30,female repro,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",uterine/cervix adenomas or carcinomas,Dose,4,0,mg/kg/day,mg/kg/day,0,59,0,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
102,96184,"1,2,3-Trichloropropane",IRIS,30,female repro,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",uterine/cervix adenomas or carcinomas,Dose,4,6,mg/kg/day,mg/kg/day,6,59,5,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
102,96184,"1,2,3-Trichloropropane",IRIS,30,female repro,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",uterine/cervix adenomas or carcinomas,Dose,4,20,mg/kg/day,mg/kg/day,20,59,3,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
102,96184,"1,2,3-Trichloropropane",IRIS,30,female repro,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",uterine/cervix adenomas or carcinomas,Dose,4,60,mg/kg/day,mg/kg/day,60,57,11,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
103,96184,"1,2,3-Trichloropropane",IRIS,30,liver,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",liver hepatocellular adenomas or carcinomas,Dose,4,0,mg/kg/day,mg/kg/day,0,59,8,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
103,96184,"1,2,3-Trichloropropane",IRIS,30,liver,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",liver hepatocellular adenomas or carcinomas,Dose,4,6,mg/kg/day,mg/kg/day,6,60,11,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
103,96184,"1,2,3-Trichloropropane",IRIS,30,liver,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",liver hepatocellular adenomas or carcinomas,Dose,4,20,mg/kg/day,mg/kg/day,20,60,9,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
103,96184,"1,2,3-Trichloropropane",IRIS,30,liver,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",liver hepatocellular adenomas or carcinomas,Dose,4,60,mg/kg/day,mg/kg/day,60,58,36,Mouse,B6C3F1,M/F,F,Oral gavage,NA,73-79,Weeks
104,96457,Ethylenethiourea,CalEPA,0.045,thyroid,"Graham SL, Davis KJ, Hansen WH and Graham CH. 1975. Effects of prolonged ethylene thiourea ingestion on the thyroid of the rat. Food Cosmet Toxicol 13:493-499.

Graham SL, Hansen WH, Davis KJ and Perry CH. 1973. Effects of one-year administration of ethylenethiourea upon the thyroid of the rat. J Agr Food Chem 21:324-329.

Gold L, Sawyer C, Magaw R, Backman G, de Veciana M, Levinson R, Hooper N, Havender W, Bernstein L, Peto R, Pike M and Ames B. 1984. A Carcinogenic Potency Database of the standardized results of animal bioassays. Environ Health Perspect 58:9-319.",thyroid tumor,Conv,6,0,mg/kg/day,mg/kg diet,0,72,2,Rat,CD,M/F,Both,Oral diet,NA,24,Months
104,96457,Ethylenethiourea,CalEPA,0.045,thyroid,"Graham SL, Davis KJ, Hansen WH and Graham CH. 1975. Effects of prolonged ethylene thiourea ingestion on the thyroid of the rat. Food Cosmet Toxicol 13:493-499.

Graham SL, Hansen WH, Davis KJ and Perry CH. 1973. Effects of one-year administration of ethylenethiourea upon the thyroid of the rat. J Agr Food Chem 21:324-329.

Gold L, Sawyer C, Magaw R, Backman G, de Veciana M, Levinson R, Hooper N, Havender W, Bernstein L, Peto R, Pike M and Ames B. 1984. A Carcinogenic Potency Database of the standardized results of animal bioassays. Environ Health Perspect 58:9-319.",thyroid tumor,Conv,6,0.225,mg/kg/day,mg/kg diet,0.225,75,2,Rat,CD,M/F,Both,Oral diet,NA,24,Months
104,96457,Ethylenethiourea,CalEPA,0.045,thyroid,"Graham SL, Davis KJ, Hansen WH and Graham CH. 1975. Effects of prolonged ethylene thiourea ingestion on the thyroid of the rat. Food Cosmet Toxicol 13:493-499.

Graham SL, Hansen WH, Davis KJ and Perry CH. 1973. Effects of one-year administration of ethylenethiourea upon the thyroid of the rat. J Agr Food Chem 21:324-329.

Gold L, Sawyer C, Magaw R, Backman G, de Veciana M, Levinson R, Hooper N, Havender W, Bernstein L, Peto R, Pike M and Ames B. 1984. A Carcinogenic Potency Database of the standardized results of animal bioassays. Environ Health Perspect 58:9-319.",thyroid tumor,Conv,6,1.13,mg/kg/day,mg/kg diet,1.13,73,1,Rat,CD,M/F,Both,Oral diet,NA,24,Months
104,96457,Ethylenethiourea,CalEPA,0.045,thyroid,"Graham SL, Davis KJ, Hansen WH and Graham CH. 1975. Effects of prolonged ethylene thiourea ingestion on the thyroid of the rat. Food Cosmet Toxicol 13:493-499.

Graham SL, Hansen WH, Davis KJ and Perry CH. 1973. Effects of one-year administration of ethylenethiourea upon the thyroid of the rat. J Agr Food Chem 21:324-329.

Gold L, Sawyer C, Magaw R, Backman G, de Veciana M, Levinson R, Hooper N, Havender W, Bernstein L, Peto R, Pike M and Ames B. 1984. A Carcinogenic Potency Database of the standardized results of animal bioassays. Environ Health Perspect 58:9-319.",thyroid tumor,Conv,6,5.63,mg/kg/day,mg/kg diet,5.63,73,2,Rat,CD,M/F,Both,Oral diet,NA,24,Months
104,96457,Ethylenethiourea,CalEPA,0.045,thyroid,"Graham SL, Davis KJ, Hansen WH and Graham CH. 1975. Effects of prolonged ethylene thiourea ingestion on the thyroid of the rat. Food Cosmet Toxicol 13:493-499.

Graham SL, Hansen WH, Davis KJ and Perry CH. 1973. Effects of one-year administration of ethylenethiourea upon the thyroid of the rat. J Agr Food Chem 21:324-329.

Gold L, Sawyer C, Magaw R, Backman G, de Veciana M, Levinson R, Hooper N, Havender W, Bernstein L, Peto R, Pike M and Ames B. 1984. A Carcinogenic Potency Database of the standardized results of animal bioassays. Environ Health Perspect 58:9-319.",thyroid tumor,Conv,6,11.3,mg/kg/day,mg/kg diet,11.3,69,16,Rat,CD,M/F,Both,Oral diet,NA,24,Months
104,96457,Ethylenethiourea,CalEPA,0.045,thyroid,"Graham SL, Davis KJ, Hansen WH and Graham CH. 1975. Effects of prolonged ethylene thiourea ingestion on the thyroid of the rat. Food Cosmet Toxicol 13:493-499.

Graham SL, Hansen WH, Davis KJ and Perry CH. 1973. Effects of one-year administration of ethylenethiourea upon the thyroid of the rat. J Agr Food Chem 21:324-329.

Gold L, Sawyer C, Magaw R, Backman G, de Veciana M, Levinson R, Hooper N, Havender W, Bernstein L, Peto R, Pike M and Ames B. 1984. A Carcinogenic Potency Database of the standardized results of animal bioassays. Environ Health Perspect 58:9-319.",thyroid tumor,Conv,6,22.5,mg/kg/day,mg/kg diet,22.5,70,62,Rat,CD,M/F,Both,Oral diet,NA,24,Months
105,99558,"Methyl-5-Nitroaniline, 2-   ",PPRTV,0.009,liver,"NCI (National Cancer Institute). (1978) Report on bioassay of 5-nitro-o-toluidine for possible carcinogenicity (CAS No. 99-55-8). National Cancer Institute, Bethesda, MD; Report No. 107.",hepatocellular carcinomas,HEq,3,0,"mg/kg-d (AJD, HED)",mg/kg-day,0,47,2,Mouse,B6C3F1,M/F,F,Oral diet,NA,78,Weeks
105,99558,"Methyl-5-Nitroaniline, 2-   ",PPRTV,0.009,liver,"NCI (National Cancer Institute). (1978) Report on bioassay of 5-nitro-o-toluidine for possible carcinogenicity (CAS No. 99-55-8). National Cancer Institute, Bethesda, MD; Report No. 107.",hepatocellular carcinomas,HEq,3,25,"mg/kg-d (AJD, HED)",mg/kg-day,25,46,7,Mouse,B6C3F1,M/F,F,Oral diet,NA,78,Weeks
105,99558,"Methyl-5-Nitroaniline, 2-   ",PPRTV,0.009,liver,"NCI (National Cancer Institute). (1978) Report on bioassay of 5-nitro-o-toluidine for possible carcinogenicity (CAS No. 99-55-8). National Cancer Institute, Bethesda, MD; Report No. 107.",hepatocellular carcinomas,HEq,3,47,"mg/kg-d (AJD, HED)",mg/kg-day,47,45,20,Mouse,B6C3F1,M/F,F,Oral diet,NA,78,Weeks
106,99990,"Nitrotoluene, p-   ",PPRTV,0.016,female repro,NTP (National Toxicology Program). 2002. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS No. 99-99-0) in F344/N rats and B6C3F1 mice (feed studies). NTP TR 498. NIH Publication No. 02-4432. http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr498.pdf,Adenoma or carcinoma (Clitoris),Conv,4,0,mg/kg-day,ppm,0,50,8,Rat,Fischer 344,M/F,F,Oral diet,NA,2,Years
106,99990,"Nitrotoluene, p-   ",PPRTV,0.016,female repro,NTP (National Toxicology Program). 2002. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS No. 99-99-0) in F344/N rats and B6C3F1 mice (feed studies). NTP TR 498. NIH Publication No. 02-4432. http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr498.pdf,Adenoma or carcinoma (Clitoris),Conv,4,60,mg/kg-day,ppm,60,50,12,Rat,Fischer 344,M/F,F,Oral diet,NA,2,Years
106,99990,"Nitrotoluene, p-   ",PPRTV,0.016,female repro,NTP (National Toxicology Program). 2002. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS No. 99-99-0) in F344/N rats and B6C3F1 mice (feed studies). NTP TR 498. NIH Publication No. 02-4432. http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr498.pdf,Adenoma or carcinoma (Clitoris),Conv,4,125,mg/kg-day,ppm,125,50,20,Rat,Fischer 344,M/F,F,Oral diet,NA,2,Years
106,99990,"Nitrotoluene, p-   ",PPRTV,0.016,female repro,NTP (National Toxicology Program). 2002. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS No. 99-99-0) in F344/N rats and B6C3F1 mice (feed studies). NTP TR 498. NIH Publication No. 02-4432. http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr498.pdf,Adenoma or carcinoma (Clitoris),Conv,4,265,mg/kg-day,ppm,265,49,8,Rat,Fischer 344,M/F,F,Oral diet,NA,2,Years
107,100005,"Chloronitrobenzene, p-   ",PPRTV,0.0063,vascular system,"Weisburger, E.K., A.B. Russfield, F. Homburger et al. 1978. Testing of twenty-one environmental aromatic amines or derivatives for long-term toxicity of carcinogenicity. J. Environ. Pathol. Toxicol. 2: 325-356.",vascular tumors,Dose,3,0,mg/kg-day,mg/kg-day,0,14,0,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
107,100005,"Chloronitrobenzene, p-   ",PPRTV,0.0063,vascular system,"Weisburger, E.K., A.B. Russfield, F. Homburger et al. 1978. Testing of twenty-one environmental aromatic amines or derivatives for long-term toxicity of carcinogenicity. J. Environ. Pathol. Toxicol. 2: 325-356.",vascular tumors,Dose,3,441,mg/kg-day,mg/kg-day,441,14,2,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
107,100005,"Chloronitrobenzene, p-   ",PPRTV,0.0063,vascular system,"Weisburger, E.K., A.B. Russfield, F. Homburger et al. 1978. Testing of twenty-one environmental aromatic amines or derivatives for long-term toxicity of carcinogenicity. J. Environ. Pathol. Toxicol. 2: 325-356.",vascular tumors,Dose,3,882,mg/kg-day,mg/kg-day,882,14,4,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
108,100016,"Nitroaniline, 4-   ",PPRTV,0.02,systemic,NTP (National Toxicology Program). 1993. Toxicology and carcinogenesis studies of p-nitroaniline (CAS No. 100-01-6) in B6C3F1 mice (gavage studies). NTP TR 418. NIH Publication No. 93-3149.,hemangiomas or hemangiosarcomas (all sites),Conv,4,0,mg/kg-day (daily average),mg/kg-day,0,50,5,Mouse,B6C3F1,M/F,M,Oral gavage,5,2,Years
108,100016,"Nitroaniline, 4-   ",PPRTV,0.02,systemic,NTP (National Toxicology Program). 1993. Toxicology and carcinogenesis studies of p-nitroaniline (CAS No. 100-01-6) in B6C3F1 mice (gavage studies). NTP TR 418. NIH Publication No. 93-3149.,hemangiomas or hemangiosarcomas (all sites),Conv,4,2.1,mg/kg-day (daily average),mg/kg-day,2.1,50,3,Mouse,B6C3F1,M/F,M,Oral gavage,5,2,Years
108,100016,"Nitroaniline, 4-   ",PPRTV,0.02,systemic,NTP (National Toxicology Program). 1993. Toxicology and carcinogenesis studies of p-nitroaniline (CAS No. 100-01-6) in B6C3F1 mice (gavage studies). NTP TR 418. NIH Publication No. 93-3149.,hemangiomas or hemangiosarcomas (all sites),Conv,4,21,mg/kg-day (daily average),mg/kg-day,21,50,4,Mouse,B6C3F1,M/F,M,Oral gavage,5,2,Years
108,100016,"Nitroaniline, 4-   ",PPRTV,0.02,systemic,NTP (National Toxicology Program). 1993. Toxicology and carcinogenesis studies of p-nitroaniline (CAS No. 100-01-6) in B6C3F1 mice (gavage studies). NTP TR 418. NIH Publication No. 93-3149.,hemangiomas or hemangiosarcomas (all sites),Conv,4,71,mg/kg-day (daily average),mg/kg-day,71,50,10,Mouse,B6C3F1,M/F,M,Oral gavage,5,2,Years
109,100447,alpha-Chlorotoluene,CalEPA,0.17,thyroid,Lijinsky W. 1986. Chronic bioassay of benzyl chloride in F344 rats and (C57BL/6J × BALB/c) F1 mice. J Natl Cancer Inst 76:1231-1236.,C-cell adenoma/carcinoma of the thyroid,HEq,3,0,mg/kg-day,mg/kg-day,0,52,4,Rat,Fischer 344,M/F,F,Oral gavage,3,2,Years
109,100447,alpha-Chlorotoluene,CalEPA,0.17,thyroid,Lijinsky W. 1986. Chronic bioassay of benzyl chloride in F344 rats and (C57BL/6J × BALB/c) F1 mice. J Natl Cancer Inst 76:1231-1236.,C-cell adenoma/carcinoma of the thyroid,HEq,3,1.06,mg/kg-day,mg/kg-day,1.06,51,8,Rat,Fischer 344,M/F,F,Oral gavage,3,2,Years
109,100447,alpha-Chlorotoluene,CalEPA,0.17,thyroid,Lijinsky W. 1986. Chronic bioassay of benzyl chloride in F344 rats and (C57BL/6J × BALB/c) F1 mice. J Natl Cancer Inst 76:1231-1236.,C-cell adenoma/carcinoma of the thyroid,HEq,3,2.12,mg/kg-day,mg/kg-day,2.12,52,14,Rat,Fischer 344,M/F,F,Oral gavage,3,2,Years
110,100447,alpha-Chlorotoluene,IRIS,0.17,thyroid,"Lijinsky, W. 1986. Chronic bioassay of benzyl chloride in F344 rats and (C57BL/6J x BALB/c)F1 mice. J. Natl. Cancer Inst. 76(6): 1231-1236.",C-cell adenoma/carcinoma,HEq,3,0,mg/kg-day,mg/kg,0,52,4,Rat,Fischer 344,M/F,F,Oral gavage,3,104,Weeks
110,100447,alpha-Chlorotoluene,IRIS,0.17,thyroid,"Lijinsky, W. 1986. Chronic bioassay of benzyl chloride in F344 rats and (C57BL/6J x BALB/c)F1 mice. J. Natl. Cancer Inst. 76(6): 1231-1236.",C-cell adenoma/carcinoma,HEq,3,1.06,mg/kg-day,mg/kg,1.06,51,8,Rat,Fischer 344,M/F,F,Oral gavage,3,104,Weeks
110,100447,alpha-Chlorotoluene,IRIS,0.17,thyroid,"Lijinsky, W. 1986. Chronic bioassay of benzyl chloride in F344 rats and (C57BL/6J x BALB/c)F1 mice. J. Natl. Cancer Inst. 76(6): 1231-1236.",C-cell adenoma/carcinoma,HEq,3,2.12,mg/kg-day,mg/kg,2.12,52,14,Rat,Fischer 344,M/F,F,Oral gavage,3,104,Weeks
111,101611,Bis(4-Dimethylaminophenyl)Methane,CalEPA,0.046,thyroid,"NCI (National Cancer Institute). 1979a. Bioassay of 4,4'-methylenebis(N,Ndimethyl) benzenamine for possible carcinogenicity. NCI Carcinogenesis Technical Report Series No. 186. CAS 101-61-1, NCI-CG-TR-186, U.S. DHEW, NIH.","thyroid, follicular cell carcinoma/adenoma",HEq,3,0,mg/kg/day,,0,20,0,Rat,Fischer 344,M/F,F,Oral diet,NA,59,Weeks
111,101611,Bis(4-Dimethylaminophenyl)Methane,CalEPA,0.046,thyroid,"NCI (National Cancer Institute). 1979a. Bioassay of 4,4'-methylenebis(N,Ndimethyl) benzenamine for possible carcinogenicity. NCI Carcinogenesis Technical Report Series No. 186. CAS 101-61-1, NCI-CG-TR-186, U.S. DHEW, NIH.","thyroid, follicular cell carcinoma/adenoma",HEq,3,1.63,mg/kg/day,,1.63,46,4,Rat,Fischer 344,M/F,F,Oral diet,NA,59,Weeks
111,101611,Bis(4-Dimethylaminophenyl)Methane,CalEPA,0.046,thyroid,"NCI (National Cancer Institute). 1979a. Bioassay of 4,4'-methylenebis(N,Ndimethyl) benzenamine for possible carcinogenicity. NCI Carcinogenesis Technical Report Series No. 186. CAS 101-61-1, NCI-CG-TR-186, U.S. DHEW, NIH.","thyroid, follicular cell carcinoma/adenoma",HEq,3,3.25,mg/kg/day,,3.25,45,36,Rat,Fischer 344,M/F,F,Oral diet,NA,59,Weeks
112,101611,Bis(4-Dimethylaminophenyl)Methane,IRIS,0.046,thyroid,"NCI (National Cancer Institute). 1979a. Bioassay of 4,4'-methylenebis(N,N- dimethyl)benzenamine for possible carcinogenicity. NCI Carcinogenesis Technical Report Series No. 186. CAS 101-61-1, NCI-CG-TR-186, U.S. DHEW, NIH.","thyroid, follicular cell carcinoma/adenoma",HEq,3,0,mg/kg/day,ppm,0,20,0,Rat,Fischer 344,M/F,F,Oral diet,NA,59,Weeks
112,101611,Bis(4-Dimethylaminophenyl)Methane,IRIS,0.046,thyroid,"NCI (National Cancer Institute). 1979a. Bioassay of 4,4'-methylenebis(N,N- dimethyl)benzenamine for possible carcinogenicity. NCI Carcinogenesis Technical Report Series No. 186. CAS 101-61-1, NCI-CG-TR-186, U.S. DHEW, NIH.","thyroid, follicular cell carcinoma/adenoma",HEq,3,1.63,mg/kg/day,ppm,1.63,46,4,Rat,Fischer 344,M/F,F,Oral diet,NA,59,Weeks
112,101611,Bis(4-Dimethylaminophenyl)Methane,IRIS,0.046,thyroid,"NCI (National Cancer Institute). 1979a. Bioassay of 4,4'-methylenebis(N,N- dimethyl)benzenamine for possible carcinogenicity. NCI Carcinogenesis Technical Report Series No. 186. CAS 101-61-1, NCI-CG-TR-186, U.S. DHEW, NIH.","thyroid, follicular cell carcinoma/adenoma",HEq,3,3.25,mg/kg/day,ppm,3.25,45,36,Rat,Fischer 344,M/F,F,Oral diet,NA,59,Weeks
113,101779,"4,4-Methylenedianiline",CalEPA,1.6,liver,"Nationial Toxicology Program (NTP, 1983). Toxicology and Carcinogenesis Studies of 4,4'-Methylenedianiline Dihydrochloride in F344IN Rats and B6C3F1 Mice (Drinking Water Studies). NTP Technical Report Series No. 248. NTIS Publication No. PB 83238824. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant liver tumors (hepatocellular adenoma and carcinomas),Conv,3,0,mg dihydrocholoride/kg/day,ppm (dihydrochloride),0,49,17,Mouse,B6C3F1,M/F,M,Oral drinking water,NA,103,Weeks
113,101779,"4,4-Methylenedianiline",CalEPA,1.6,liver,"Nationial Toxicology Program (NTP, 1983). Toxicology and Carcinogenesis Studies of 4,4'-Methylenedianiline Dihydrochloride in F344IN Rats and B6C3F1 Mice (Drinking Water Studies). NTP Technical Report Series No. 248. NTIS Publication No. PB 83238824. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant liver tumors (hepatocellular adenoma and carcinomas),Conv,3,25,mg dihydrocholoride/kg/day,ppm (dihydrochloride),25,50,43,Mouse,B6C3F1,M/F,M,Oral drinking water,NA,103,Weeks
113,101779,"4,4-Methylenedianiline",CalEPA,1.6,liver,"Nationial Toxicology Program (NTP, 1983). Toxicology and Carcinogenesis Studies of 4,4'-Methylenedianiline Dihydrochloride in F344IN Rats and B6C3F1 Mice (Drinking Water Studies). NTP Technical Report Series No. 248. NTIS Publication No. PB 83238824. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant liver tumors (hepatocellular adenoma and carcinomas),Conv,3,57,mg dihydrocholoride/kg/day,ppm (dihydrochloride),57,50,37,Mouse,B6C3F1,M/F,M,Oral drinking water,NA,103,Weeks
114,101804,"4,4-Diaminodiphenyl ether",CalEPA,0.14,liver,"National Cancer Institute (NCI, 1980). Bioassay of 4,4'-Oxydianiline/or Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 205. NIH Publication No. 80-1761. US Department of Health and Human Services, NCI Carcinogenesis Testing Program, and National Toxicology Program.",benign and malignant liver tumors,Dose,4,0,ppm,ppm,0,50,1,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
114,101804,"4,4-Diaminodiphenyl ether",CalEPA,0.14,liver,"National Cancer Institute (NCI, 1980). Bioassay of 4,4'-Oxydianiline/or Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 205. NIH Publication No. 80-1761. US Department of Health and Human Services, NCI Carcinogenesis Testing Program, and National Toxicology Program.",benign and malignant liver tumors,Dose,4,200,ppm,ppm,15.78947368,50,13,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
114,101804,"4,4-Diaminodiphenyl ether",CalEPA,0.14,liver,"National Cancer Institute (NCI, 1980). Bioassay of 4,4'-Oxydianiline/or Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 205. NIH Publication No. 80-1761. US Department of Health and Human Services, NCI Carcinogenesis Testing Program, and National Toxicology Program.",benign and malignant liver tumors,Dose,4,400,ppm,ppm,31.57894737,50,41,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
114,101804,"4,4-Diaminodiphenyl ether",CalEPA,0.14,liver,"National Cancer Institute (NCI, 1980). Bioassay of 4,4'-Oxydianiline/or Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 205. NIH Publication No. 80-1761. US Department of Health and Human Services, NCI Carcinogenesis Testing Program, and National Toxicology Program.",benign and malignant liver tumors,Dose,4,500,ppm,ppm,39.47368421,50,39,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
115,101906,Diglycidyl Resorcinol Ether,CalEPA,1.7,stomach/forestomach,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Diglycidyl Resorcinol Ether in F344IN Rats and B6C3F] Mice (Gavage Studies). NTP Technical Report Series No. 257. NIH Publication No. 87-2513. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",forestomach squamous cell papillomas,Dose,4,0,mg/kg-day,mg/kg-day,0,100,0,Rat,Fischer 344,M/F,M,Oral gavage,NA,104,Weeks
115,101906,Diglycidyl Resorcinol Ether,CalEPA,1.7,stomach/forestomach,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Diglycidyl Resorcinol Ether in F344IN Rats and B6C3F] Mice (Gavage Studies). NTP Technical Report Series No. 257. NIH Publication No. 87-2513. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",forestomach squamous cell papillomas,Dose,4,12,mg/kg-day,mg/kg-day,12,50,16,Rat,Fischer 344,M/F,M,Oral gavage,NA,104,Weeks
115,101906,Diglycidyl Resorcinol Ether,CalEPA,1.7,stomach/forestomach,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Diglycidyl Resorcinol Ether in F344IN Rats and B6C3F] Mice (Gavage Studies). NTP Technical Report Series No. 257. NIH Publication No. 87-2513. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",forestomach squamous cell papillomas,Dose,4,25,mg/kg-day,mg/kg-day,25,50,17,Rat,Fischer 344,M/F,M,Oral gavage,NA,104,Weeks
115,101906,Diglycidyl Resorcinol Ether,CalEPA,1.7,stomach/forestomach,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Diglycidyl Resorcinol Ether in F344IN Rats and B6C3F] Mice (Gavage Studies). NTP Technical Report Series No. 257. NIH Publication No. 87-2513. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",forestomach squamous cell papillomas,Dose,4,50,mg/kg-day,mg/kg-day,50,49,6,Rat,Fischer 344,M/F,M,Oral gavage,NA,104,Weeks
116,101906,Diglycidyl Resorcinol Ether,CalEPA,1.7,stomach/forestomach,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Diglycidyl Resorcinol Ether in F344IN Rats and B6C3F] Mice (Gavage Studies). NTP Technical Report Series No. 257. NIH Publication No. 87-2513. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",forestomach squamous cell carcinoma,Dose,4,0,mg/kg-day,mg/kg-day,0,100,0,Rat,Fischer 344,M/F,M,Oral gavage,NA,104,Weeks
116,101906,Diglycidyl Resorcinol Ether,CalEPA,1.7,stomach/forestomach,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Diglycidyl Resorcinol Ether in F344IN Rats and B6C3F] Mice (Gavage Studies). NTP Technical Report Series No. 257. NIH Publication No. 87-2513. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",forestomach squamous cell carcinoma,Dose,4,12,mg/kg-day,mg/kg-day,12,50,39,Rat,Fischer 344,M/F,M,Oral gavage,NA,104,Weeks
116,101906,Diglycidyl Resorcinol Ether,CalEPA,1.7,stomach/forestomach,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Diglycidyl Resorcinol Ether in F344IN Rats and B6C3F] Mice (Gavage Studies). NTP Technical Report Series No. 257. NIH Publication No. 87-2513. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",forestomach squamous cell carcinoma,Dose,4,25,mg/kg-day,mg/kg-day,25,50,38,Rat,Fischer 344,M/F,M,Oral gavage,NA,104,Weeks
116,101906,Diglycidyl Resorcinol Ether,CalEPA,1.7,stomach/forestomach,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Diglycidyl Resorcinol Ether in F344IN Rats and B6C3F] Mice (Gavage Studies). NTP Technical Report Series No. 257. NIH Publication No. 87-2513. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",forestomach squamous cell carcinoma,Dose,4,50,mg/kg-day,mg/kg-day,50,49,4,Rat,Fischer 344,M/F,M,Oral gavage,NA,104,Weeks
117,103231,Di-2-Ethylhexyl Adipate,IRIS,0.0012,liver,"NTP (National Toxicology Program). 1982. Carcinogenesis bioassay of di(2-ethylhexyl)adipate (CAS No. 103-23-1) in F344 rats and B6C3F1 mice (Feed Study). U.S. Department of Health and Human Services, National Toxicology Program, Technical Report Series, No. 212.",Combined hepatocellular adenomas and carcinomas,HEq,3,0,mg/kg/day,ppm,0,50,3,Mouse,B6C3F1,F,Both,Oral diet,NA,103,Weeks
117,103231,Di-2-Ethylhexyl Adipate,IRIS,0.0012,liver,"NTP (National Toxicology Program). 1982. Carcinogenesis bioassay of di(2-ethylhexyl)adipate (CAS No. 103-23-1) in F344 rats and B6C3F1 mice (Feed Study). U.S. Department of Health and Human Services, National Toxicology Program, Technical Report Series, No. 212.",Combined hepatocellular adenomas and carcinomas,HEq,3,255,mg/kg/day,ppm,255,50,19,Mouse,B6C3F1,F,Both,Oral diet,NA,103,Weeks
117,103231,Di-2-Ethylhexyl Adipate,IRIS,0.0012,liver,"NTP (National Toxicology Program). 1982. Carcinogenesis bioassay of di(2-ethylhexyl)adipate (CAS No. 103-23-1) in F344 rats and B6C3F1 mice (Feed Study). U.S. Department of Health and Human Services, National Toxicology Program, Technical Report Series, No. 212.",Combined hepatocellular adenomas and carcinomas,HEq,3,625,mg/kg/day,ppm,625,49,18,Mouse,B6C3F1,F,Both,Oral diet,NA,103,Weeks
118,103333,Azobenzene,IRIS,0.11,systemic,NCI (National Cancer institute). 1979. Bioassay of azobenzene for possible carcinogenicity. NCI Carcinogenesis Technical Report Series. No. 154. p. 112.,"abdominal cavity sarcomas: combined incidence of fibrosarcomas, hemangiosarcomas and osteosarcomas in the spleen and other abdominal organs",HEq,3,0,mg/kg-day,ppm,0,20,0,Rat,Fischer 344,M/F,F,Oral diet,7,106,Weeks
118,103333,Azobenzene,IRIS,0.11,systemic,NCI (National Cancer institute). 1979. Bioassay of azobenzene for possible carcinogenicity. NCI Carcinogenesis Technical Report Series. No. 154. p. 112.,"abdominal cavity sarcomas: combined incidence of fibrosarcomas, hemangiosarcomas and osteosarcomas in the spleen and other abdominal organs",HEq,3,1.53,mg/kg-day,ppm,1.53,50,5,Rat,Fischer 344,M/F,F,Oral diet,7,106,Weeks
118,103333,Azobenzene,IRIS,0.11,systemic,NCI (National Cancer institute). 1979. Bioassay of azobenzene for possible carcinogenicity. NCI Carcinogenesis Technical Report Series. No. 154. p. 112.,"abdominal cavity sarcomas: combined incidence of fibrosarcomas, hemangiosarcomas and osteosarcomas in the spleen and other abdominal organs",HEq,3,3.06,mg/kg-day,ppm,3.06,50,21,Rat,Fischer 344,M/F,F,Oral diet,7,106,Weeks
119,106467,"1,4-Dichlorobenzene",CalEPA,0.0054,liver,"National Toxicology Program (NTP) 1987. Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene in F344/N Rats and B6C3F1 Mice. U.S. Department of Health and Human Services, NIH Publication No. 87-2575. Research Triangle Park, NC.",liver hepatocarcinoma and adenoma,Conv,3,0,mg/kg-day (ADJ),mg/kg-day,0,50,17,Mouse,B6C3F1,M/F,M,Oral gavage,5,104,Weeks
119,106467,"1,4-Dichlorobenzene",CalEPA,0.0054,liver,"National Toxicology Program (NTP) 1987. Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene in F344/N Rats and B6C3F1 Mice. U.S. Department of Health and Human Services, NIH Publication No. 87-2575. Research Triangle Park, NC.",liver hepatocarcinoma and adenoma,Conv,3,214,mg/kg-day (ADJ),mg/kg-day,214,49,22,Mouse,B6C3F1,M/F,M,Oral gavage,5,104,Weeks
119,106467,"1,4-Dichlorobenzene",CalEPA,0.0054,liver,"National Toxicology Program (NTP) 1987. Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene in F344/N Rats and B6C3F1 Mice. U.S. Department of Health and Human Services, NIH Publication No. 87-2575. Research Triangle Park, NC.",liver hepatocarcinoma and adenoma,Conv,3,428,mg/kg-day (ADJ),mg/kg-day,428,50,40,Mouse,B6C3F1,M/F,M,Oral gavage,5,104,Weeks
120,106478,4-Chloroaniline,PPRTV,0.2,adrenal glands,NTP (National Toxicology Program). 1989. Toxicology and carcinogenesis studies of parachloroaniline hydrochloride (CAS No. 20265-96-7) in F344/N rats and B6C3F1 mice (gavage studies). NTP-TR-351. NIH Pub. No. 89-2806.,Adrenal medulla pheochromocytoma or malignant pheochromocytoma,Conv,4,0,mg/kg-day (ADJ),mg/kg-day,0,49,13,Rat,Fischer 344,M/F,M,Oral gavage,5,103,Weeks
120,106478,4-Chloroaniline,PPRTV,0.2,adrenal glands,NTP (National Toxicology Program). 1989. Toxicology and carcinogenesis studies of parachloroaniline hydrochloride (CAS No. 20265-96-7) in F344/N rats and B6C3F1 mice (gavage studies). NTP-TR-351. NIH Pub. No. 89-2806.,Adrenal medulla pheochromocytoma or malignant pheochromocytoma,Conv,4,1.4,mg/kg-day (ADJ),mg/kg-day,1.4,48,14,Rat,Fischer 344,M/F,M,Oral gavage,5,103,Weeks
120,106478,4-Chloroaniline,PPRTV,0.2,adrenal glands,NTP (National Toxicology Program). 1989. Toxicology and carcinogenesis studies of parachloroaniline hydrochloride (CAS No. 20265-96-7) in F344/N rats and B6C3F1 mice (gavage studies). NTP-TR-351. NIH Pub. No. 89-2806.,Adrenal medulla pheochromocytoma or malignant pheochromocytoma,Conv,4,4.3,mg/kg-day (ADJ),mg/kg-day,4.3,48,15,Rat,Fischer 344,M/F,M,Oral gavage,5,103,Weeks
120,106478,4-Chloroaniline,PPRTV,0.2,adrenal glands,NTP (National Toxicology Program). 1989. Toxicology and carcinogenesis studies of parachloroaniline hydrochloride (CAS No. 20265-96-7) in F344/N rats and B6C3F1 mice (gavage studies). NTP-TR-351. NIH Pub. No. 89-2806.,Adrenal medulla pheochromocytoma or malignant pheochromocytoma,Conv,4,13,mg/kg-day (ADJ),mg/kg-day,13,49,26,Rat,Fischer 344,M/F,M,Oral gavage,5,103,Weeks
121,106490,"Toluidine, p-",HEAST,0.19,liver,"Weisburger E.K., A.B. Russfield and F. Homburger, et al. 1978. Testing of twenty-one environmental aromatic Amines or derivatives for long-term toxicity or carcinogenicity. J Environ Pathol Toxicol.2(2): 325-356.",liver hepatomas,Conv,3,0,mg p-toludine/kg/day,mg p-toluidine HCl/kg/day (TWA),0,18,3,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
121,106490,"Toluidine, p-",HEAST,0.19,liver,"Weisburger E.K., A.B. Russfield and F. Homburger, et al. 1978. Testing of twenty-one environmental aromatic Amines or derivatives for long-term toxicity or carcinogenicity. J Environ Pathol Toxicol.2(2): 325-356.",liver hepatomas,Conv,3,55.5,mg p-toludine/kg/day,mg p-toluidine HCl/kg/day (TWA),55.5,17,8,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
121,106490,"Toluidine, p-",HEAST,0.19,liver,"Weisburger E.K., A.B. Russfield and F. Homburger, et al. 1978. Testing of twenty-one environmental aromatic Amines or derivatives for long-term toxicity or carcinogenicity. J Environ Pathol Toxicol.2(2): 325-356.",liver hepatomas,Conv,3,111,mg p-toludine/kg/day,mg p-toluidine HCl/kg/day (TWA),111,18,9,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
122,106898,"1-Chloro-2,3-Epoxypropane",CalEPA,0.08,stomach/forestomach,"Konishi Y, Kawabata A, Denda A, Ikeda T, Katada H, Maruyama H and Higashiguchi R. 1980. Forestomach tumors induced by orally administered epichlorohydrin in male Wistar rats. Gann 71:922-923.",benign squamous cell papillomas of the forestomach,Conv,4,0,mg/kg/day,ppm,0,10,0,Rat,Wistar,M,Both,Oral drinking water,NA,81,Weeks
122,106898,"1-Chloro-2,3-Epoxypropane",CalEPA,0.08,stomach/forestomach,"Konishi Y, Kawabata A, Denda A, Ikeda T, Katada H, Maruyama H and Higashiguchi R. 1980. Forestomach tumors induced by orally administered epichlorohydrin in male Wistar rats. Gann 71:922-923.",benign squamous cell papillomas of the forestomach,Conv,4,15.1,mg/kg/day,ppm,15.1,9,0,Rat,Wistar,M,Both,Oral drinking water,NA,81,Weeks
122,106898,"1-Chloro-2,3-Epoxypropane",CalEPA,0.08,stomach/forestomach,"Konishi Y, Kawabata A, Denda A, Ikeda T, Katada H, Maruyama H and Higashiguchi R. 1980. Forestomach tumors induced by orally administered epichlorohydrin in male Wistar rats. Gann 71:922-923.",benign squamous cell papillomas of the forestomach,Conv,4,31.9,mg/kg/day,ppm,31.9,10,1,Rat,Wistar,M,Both,Oral drinking water,NA,81,Weeks
122,106898,"1-Chloro-2,3-Epoxypropane",CalEPA,0.08,stomach/forestomach,"Konishi Y, Kawabata A, Denda A, Ikeda T, Katada H, Maruyama H and Higashiguchi R. 1980. Forestomach tumors induced by orally administered epichlorohydrin in male Wistar rats. Gann 71:922-923.",benign squamous cell papillomas of the forestomach,Conv,4,76.1,mg/kg/day,ppm,76.1,12,7,Rat,Wistar,M,Both,Oral drinking water,NA,81,Weeks
123,106898,"1-Chloro-2,3-Epoxypropane",IRIS,0.0099,stomach/forestomach,"Konishi, T., A. Kawabata, A. Denda, et al. 1980. Forestomach tumors induced by orally administered epichlorohydrin in male Wistar rats. Gann. 71: 922-923.",,HEq,4,0,mg/kg/day (HED),ppm,0,10,0,Rat,Wistar,M,M,Oral drinking water,NA,81,Weeks
123,106898,"1-Chloro-2,3-Epoxypropane",IRIS,0.0099,stomach/forestomach,"Konishi, T., A. Kawabata, A. Denda, et al. 1980. Forestomach tumors induced by orally administered epichlorohydrin in male Wistar rats. Gann. 71: 922-923.",,HEq,4,27.1,mg/kg/day (HED),ppm,27.1,9,0,Rat,Wistar,M,M,Oral drinking water,NA,81,Weeks
123,106898,"1-Chloro-2,3-Epoxypropane",IRIS,0.0099,stomach/forestomach,"Konishi, T., A. Kawabata, A. Denda, et al. 1980. Forestomach tumors induced by orally administered epichlorohydrin in male Wistar rats. Gann. 71: 922-923.",,HEq,4,55.7,mg/kg/day (HED),ppm,55.7,10,2,Rat,Wistar,M,M,Oral drinking water,NA,81,Weeks
123,106898,"1-Chloro-2,3-Epoxypropane",IRIS,0.0099,stomach/forestomach,"Konishi, T., A. Kawabata, A. Denda, et al. 1980. Forestomach tumors induced by orally administered epichlorohydrin in male Wistar rats. Gann. 71: 922-923.",,HEq,4,108.6,mg/kg/day (HED),ppm,108.6,12,9,Rat,Wistar,M,M,Oral drinking water,NA,81,Weeks
124,106934,"1,2-Dibromoethane",CalEPA,3.6,stomach/forestomach,"National Cancer Institute (NCI) 1978. Bioassay of 1,2-Dibromoethane for Possible Carcinogenicity. Technical Report Series No. 86, DHEW Pub. No. (NIH) 78-1336.",forestomach squamous cell carcinoma,Dose,3,0,mg/kg/day,mg/kg/day,0,40,0,Rat,Osborne-Mendel,M/F,M,Oral gavage,5,lifetime,Duration
124,106934,"1,2-Dibromoethane",CalEPA,3.6,stomach/forestomach,"National Cancer Institute (NCI) 1978. Bioassay of 1,2-Dibromoethane for Possible Carcinogenicity. Technical Report Series No. 86, DHEW Pub. No. (NIH) 78-1336.",forestomach squamous cell carcinoma,Dose,3,38,mg/kg/day,mg/kg/day,27.14285714,50,45,Rat,Osborne-Mendel,M/F,M,Oral gavage,5,lifetime,Duration
124,106934,"1,2-Dibromoethane",CalEPA,3.6,stomach/forestomach,"National Cancer Institute (NCI) 1978. Bioassay of 1,2-Dibromoethane for Possible Carcinogenicity. Technical Report Series No. 86, DHEW Pub. No. (NIH) 78-1336.",forestomach squamous cell carcinoma,Dose,3,41,mg/kg/day,mg/kg/day,29.28571429,50,33,Rat,Osborne-Mendel,M/F,M,Oral gavage,5,lifetime,Duration
125,106934,"1,2-Dibromoethane",IRIS,2,stomach/forestomach,"National Cancer Institute (NCI). (1978) Bioassay of 1,2-dibromoethane for possible carcinogenicity. Bethesda, MD: National Cancer Institute. NTIS no. PB 288428.",forestomach tumors,HEq,3,0,mg/kg/day,mg/kg/day,0,13,0,Rat,Osborne-Mendel,M,M,Oral gavage,5,49,Weeks
125,106934,"1,2-Dibromoethane",IRIS,2,stomach/forestomach,"National Cancer Institute (NCI). (1978) Bioassay of 1,2-dibromoethane for possible carcinogenicity. Bethesda, MD: National Cancer Institute. NTIS no. PB 288428.",forestomach tumors,HEq,3,7.8,mg/kg/day,mg/kg/day,7.8,50,45,Rat,Osborne-Mendel,M,M,Oral gavage,5,49,Weeks
125,106934,"1,2-Dibromoethane",IRIS,2,stomach/forestomach,"National Cancer Institute (NCI). (1978) Bioassay of 1,2-dibromoethane for possible carcinogenicity. Bethesda, MD: National Cancer Institute. NTIS no. PB 288428.",forestomach tumors,HEq,3,8.4,mg/kg/day,mg/kg/day,8.4,34,33,Rat,Osborne-Mendel,M,M,Oral gavage,5,49,Weeks
126,106934,"1,2-Dibromoethane",IRIS,2,thyroid,"National Cancer Institute (NCI). (1978) Bioassay of 1,2-dibromoethane for possible carcinogenicity. Bethesda, MD: National Cancer Institute. NTIS no. PB 288428.",thyroid follicular cell adenomas or carcinomas,HEq,3,0,mg/kg/day,mg/kg/day,0,13,0,Rat,Osborne-Mendel,M,Both,Oral gavage,5,49,Weeks
126,106934,"1,2-Dibromoethane",IRIS,2,thyroid,"National Cancer Institute (NCI). (1978) Bioassay of 1,2-dibromoethane for possible carcinogenicity. Bethesda, MD: National Cancer Institute. NTIS no. PB 288428.",thyroid follicular cell adenomas or carcinomas,HEq,3,7.8,mg/kg/day,mg/kg/day,7.8,29,5,Rat,Osborne-Mendel,M,Both,Oral gavage,5,49,Weeks
126,106934,"1,2-Dibromoethane",IRIS,2,thyroid,"National Cancer Institute (NCI). (1978) Bioassay of 1,2-dibromoethane for possible carcinogenicity. Bethesda, MD: National Cancer Institute. NTIS no. PB 288428.",thyroid follicular cell adenomas or carcinomas,HEq,3,8.4,mg/kg/day,mg/kg/day,8.4,23,8,Rat,Osborne-Mendel,M,Both,Oral gavage,5,49,Weeks
127,106934,"1,2-Dibromoethane",IRIS,2,vascular system,"National Cancer Institute (NCI). (1978) Bioassay of 1,2-dibromoethane for possible carcinogenicity. Bethesda, MD: National Cancer Institute. NTIS no. PB 288428.",hemangiosarcomas (incidence),HEq,3,0,mg/kg/day,mg/kg/day,0,13,0,Rat,Osborne-Mendel,M,Both,Oral gavage,5,49,Weeks
127,106934,"1,2-Dibromoethane",IRIS,2,vascular system,"National Cancer Institute (NCI). (1978) Bioassay of 1,2-dibromoethane for possible carcinogenicity. Bethesda, MD: National Cancer Institute. NTIS no. PB 288428.",hemangiosarcomas (incidence),HEq,3,7.8,mg/kg/day,mg/kg/day,7.8,42,11,Rat,Osborne-Mendel,M,Both,Oral gavage,5,49,Weeks
127,106934,"1,2-Dibromoethane",IRIS,2,vascular system,"National Cancer Institute (NCI). (1978) Bioassay of 1,2-dibromoethane for possible carcinogenicity. Bethesda, MD: National Cancer Institute. NTIS no. PB 288428.",hemangiosarcomas (incidence),HEq,3,8.4,mg/kg/day,mg/kg/day,8.4,23,4,Rat,Osborne-Mendel,M,Both,Oral gavage,5,49,Weeks
128,107062,"1,2-Dichloroethane",CalEPA,0.047,liver,"National Cancer Institute (NCI) 1978. Bioassay of 1,2-Dichloroethane for Possible Carcinogenicity. NCI Carcinogenesis Technical Report Series No. 55. DHEW Pub. No. (NIH) 78-1361.Government Printing Office, Washington, DC.",hemangiosarcomas,Dose,3,0,mg/kg/day,mg/kg/day,0,60,1,Rat,Osborne-Mendel,M/F,M,Oral gavage,5,78,Weeks
128,107062,"1,2-Dichloroethane",CalEPA,0.047,liver,"National Cancer Institute (NCI) 1978. Bioassay of 1,2-Dichloroethane for Possible Carcinogenicity. NCI Carcinogenesis Technical Report Series No. 55. DHEW Pub. No. (NIH) 78-1361.Government Printing Office, Washington, DC.",hemangiosarcomas,Dose,3,47,mg/kg/day,mg/kg/day,33.57142857,50,9,Rat,Osborne-Mendel,M/F,M,Oral gavage,5,78,Weeks
128,107062,"1,2-Dichloroethane",CalEPA,0.047,liver,"National Cancer Institute (NCI) 1978. Bioassay of 1,2-Dichloroethane for Possible Carcinogenicity. NCI Carcinogenesis Technical Report Series No. 55. DHEW Pub. No. (NIH) 78-1361.Government Printing Office, Washington, DC.",hemangiosarcomas,Dose,3,95,mg/kg/day,mg/kg/day,67.85714286,50,7,Rat,Osborne-Mendel,M/F,M,Oral gavage,5,78,Weeks
129,107062,"1,2-Dichloroethane",IRIS,0.091,vascular system,"NCI (National Cancer Institute). 1978. Bioassay of 1,2-Dichloroethane for Possible Carcinogenicity. NCI Carcinogenesis Technical Report Series No. 55. DHEW Publ. No. (NIH) 78-1361, Washington DC.",hemangiosarcomas,HEq,3,0,mg/kg/day,mg/kg/day,0,40,0,Rat,Osborne-Mendel,M,Both,Oral gavage,NA,104,Weeks
129,107062,"1,2-Dichloroethane",IRIS,0.091,vascular system,"NCI (National Cancer Institute). 1978. Bioassay of 1,2-Dichloroethane for Possible Carcinogenicity. NCI Carcinogenesis Technical Report Series No. 55. DHEW Publ. No. (NIH) 78-1361, Washington DC.",hemangiosarcomas,HEq,3,4.46,mg/kg/day,mg/kg/day,4.46,48,9,Rat,Osborne-Mendel,M,Both,Oral gavage,NA,104,Weeks
129,107062,"1,2-Dichloroethane",IRIS,0.091,vascular system,"NCI (National Cancer Institute). 1978. Bioassay of 1,2-Dichloroethane for Possible Carcinogenicity. NCI Carcinogenesis Technical Report Series No. 55. DHEW Publ. No. (NIH) 78-1361, Washington DC.",hemangiosarcomas,HEq,3,8.23,mg/kg/day,mg/kg/day,8.23,27,7,Rat,Osborne-Mendel,M,Both,Oral gavage,NA,104,Weeks
130,107131,Acrylonitrile,IRIS,0.54,systemic,"Biodynamics, Inc. 1980a. A twenty-four month oral toxicity/carcinogenicity study of acrylonitrile administered to Spartan rats in the drinking water, Vol. 1-2. Prepared by
Biodynamics Inc., Division of Biology and Safety Evaluation, East Millstone, NJ, for Monsanto
Company, St. Louis, MO.","brain and spinal cord astrocytomas, Zymbal gland carcinomas and stomach papillomas/carcinomas",HEq,3,0,mg/kg-day,ppm,0,100,6,Rat,Sprague-Dawley,M,Both,Oral drinking water,7,18,Months
130,107131,Acrylonitrile,IRIS,0.54,systemic,"Biodynamics, Inc. 1980a. A twenty-four month oral toxicity/carcinogenicity study of acrylonitrile administered to Spartan rats in the drinking water, Vol. 1-2. Prepared by
Biodynamics Inc., Division of Biology and Safety Evaluation, East Millstone, NJ, for Monsanto
Company, St. Louis, MO.","brain and spinal cord astrocytomas, Zymbal gland carcinomas and stomach papillomas/carcinomas",HEq,3,0.02,mg/kg-day,ppm,0.02,98,6,Rat,Sprague-Dawley,M,Both,Oral drinking water,7,18,Months
130,107131,Acrylonitrile,IRIS,0.54,systemic,"Biodynamics, Inc. 1980a. A twenty-four month oral toxicity/carcinogenicity study of acrylonitrile administered to Spartan rats in the drinking water, Vol. 1-2. Prepared by
Biodynamics Inc., Division of Biology and Safety Evaluation, East Millstone, NJ, for Monsanto
Company, St. Louis, MO.","brain and spinal cord astrocytomas, Zymbal gland carcinomas and stomach papillomas/carcinomas",HEq,3,1.36,mg/kg-day,ppm,1.36,98,36,Rat,Sprague-Dawley,M,Both,Oral drinking water,7,18,Months
131,107131,Acrylonitrile,IRIS,0.54,systemic,"Biodynamics, Inc. 1980b. A twenty-four month oral toxicity/carcinogenicity study of acrylonitrile administered in the drinking water to Fischer 344 rats, Vol. 1-4. Prepared by
Biodynamics Inc., Division of Biology and Safety Evaluation, East Millstone, NJ, for Monsanto Company, St. Louis, MO.","brain and spinal cord astrocytomas, Zymbal gland carcinomas and stomach papillomas/carcinomas",HEq,6,0,mg/kg-day,ppm,0,200,5,Rat,Fischer 344,M,Both,Oral drinking water,7,18,Months
131,107131,Acrylonitrile,IRIS,0.54,systemic,"Biodynamics, Inc. 1980b. A twenty-four month oral toxicity/carcinogenicity study of acrylonitrile administered in the drinking water to Fischer 344 rats, Vol. 1-4. Prepared by
Biodynamics Inc., Division of Biology and Safety Evaluation, East Millstone, NJ, for Monsanto Company, St. Louis, MO.","brain and spinal cord astrocytomas, Zymbal gland carcinomas and stomach papillomas/carcinomas",HEq,6,0.02,mg/kg-day,ppm,0.02,100,4,Rat,Fischer 344,M,Both,Oral drinking water,7,18,Months
131,107131,Acrylonitrile,IRIS,0.54,systemic,"Biodynamics, Inc. 1980b. A twenty-four month oral toxicity/carcinogenicity study of acrylonitrile administered in the drinking water to Fischer 344 rats, Vol. 1-4. Prepared by
Biodynamics Inc., Division of Biology and Safety Evaluation, East Millstone, NJ, for Monsanto Company, St. Louis, MO.","brain and spinal cord astrocytomas, Zymbal gland carcinomas and stomach papillomas/carcinomas",HEq,6,0.04,mg/kg-day,ppm,0.04,100,5,Rat,Fischer 344,M,Both,Oral drinking water,7,18,Months
131,107131,Acrylonitrile,IRIS,0.54,systemic,"Biodynamics, Inc. 1980b. A twenty-four month oral toxicity/carcinogenicity study of acrylonitrile administered in the drinking water to Fischer 344 rats, Vol. 1-4. Prepared by
Biodynamics Inc., Division of Biology and Safety Evaluation, East Millstone, NJ, for Monsanto Company, St. Louis, MO.","brain and spinal cord astrocytomas, Zymbal gland carcinomas and stomach papillomas/carcinomas",HEq,6,0.14,mg/kg-day,ppm,0.14,100,7,Rat,Fischer 344,M,Both,Oral drinking water,7,18,Months
131,107131,Acrylonitrile,IRIS,0.54,systemic,"Biodynamics, Inc. 1980b. A twenty-four month oral toxicity/carcinogenicity study of acrylonitrile administered in the drinking water to Fischer 344 rats, Vol. 1-4. Prepared by
Biodynamics Inc., Division of Biology and Safety Evaluation, East Millstone, NJ, for Monsanto Company, St. Louis, MO.","brain and spinal cord astrocytomas, Zymbal gland carcinomas and stomach papillomas/carcinomas",HEq,6,0.43,mg/kg-day,ppm,0.43,100,20,Rat,Fischer 344,M,Both,Oral drinking water,7,18,Months
131,107131,Acrylonitrile,IRIS,0.54,systemic,"Biodynamics, Inc. 1980b. A twenty-four month oral toxicity/carcinogenicity study of acrylonitrile administered in the drinking water to Fischer 344 rats, Vol. 1-4. Prepared by
Biodynamics Inc., Division of Biology and Safety Evaluation, East Millstone, NJ, for Monsanto Company, St. Louis, MO.","brain and spinal cord astrocytomas, Zymbal gland carcinomas and stomach papillomas/carcinomas",HEq,6,1.39,mg/kg-day,ppm,1.39,100,36,Rat,Fischer 344,M,Both,Oral drinking water,7,18,Months
132,107131,Acrylonitrile,IRIS,0.54,systemic,"Quast, J.F., C.E. Wade, C.G. Humiston, R.M. Carreon, E.A. Hermann, C.N. Park and B.A. Schwetz. 1980a. A two-year toxicity and oncogenicity study with acrylonitrile incorporated in the drinking water of rats. Prepared by the Toxicology Research Laboratory, Health and Environmental Sciences, Dow Chemical USA, Midland, MI, for the Chemical Manufacturers Association, Washington, DC. Available from: CMA, Washington DC","brain and spinal cord astrocytomas, Zymbal gland carcinomas and stomach papillomas/carcinomas",HEq,4,0,mg/kg-day,ppm,0,80,4,Rat,Sprague-Dawley,M,Both,Oral drinking water,7,2,Years
132,107131,Acrylonitrile,IRIS,0.54,systemic,"Quast, J.F., C.E. Wade, C.G. Humiston, R.M. Carreon, E.A. Hermann, C.N. Park and B.A. Schwetz. 1980a. A two-year toxicity and oncogenicity study with acrylonitrile incorporated in the drinking water of rats. Prepared by the Toxicology Research Laboratory, Health and Environmental Sciences, Dow Chemical USA, Midland, MI, for the Chemical Manufacturers Association, Washington, DC. Available from: CMA, Washington DC","brain and spinal cord astrocytomas, Zymbal gland carcinomas and stomach papillomas/carcinomas",HEq,4,0.58,mg/kg-day,ppm,0.58,47,18,Rat,Sprague-Dawley,M,Both,Oral drinking water,7,2,Years
132,107131,Acrylonitrile,IRIS,0.54,systemic,"Quast, J.F., C.E. Wade, C.G. Humiston, R.M. Carreon, E.A. Hermann, C.N. Park and B.A. Schwetz. 1980a. A two-year toxicity and oncogenicity study with acrylonitrile incorporated in the drinking water of rats. Prepared by the Toxicology Research Laboratory, Health and Environmental Sciences, Dow Chemical USA, Midland, MI, for the Chemical Manufacturers Association, Washington, DC. Available from: CMA, Washington DC","brain and spinal cord astrocytomas, Zymbal gland carcinomas and stomach papillomas/carcinomas",HEq,4,1.46,mg/kg-day,ppm,1.46,48,36,Rat,Sprague-Dawley,M,Both,Oral drinking water,7,2,Years
132,107131,Acrylonitrile,IRIS,0.54,systemic,"Quast, J.F., C.E. Wade, C.G. Humiston, R.M. Carreon, E.A. Hermann, C.N. Park and B.A. Schwetz. 1980a. A two-year toxicity and oncogenicity study with acrylonitrile incorporated in the drinking water of rats. Prepared by the Toxicology Research Laboratory, Health and Environmental Sciences, Dow Chemical USA, Midland, MI, for the Chemical Manufacturers Association, Washington, DC. Available from: CMA, Washington DC","brain and spinal cord astrocytomas, Zymbal gland carcinomas and stomach papillomas/carcinomas",HEq,4,3.62,mg/kg-day,ppm,3.62,48,45,Rat,Sprague-Dawley,M,Both,Oral drinking water,7,2,Years
133,108601,Bis(2-chloro-1-methylethyl) ether,HEAST,0.07,liver,NTP (National Toxicology Program). 1982. Carcinogenic bioassay of Bis(2-chloro-1-methylethyl) Ether (70%) containing 2-Chloro-1-ethylethyl-(2-chloropropyl) Ether (30%) in B6C3F1 mice (gavage study). NCI Carcinogen Tech Rep Ser No. 239. 105 p. Also publ as DHHS (NIH) 83-1795.,liver tumors (hepatocellular adenomas or carcinomas),Conv,3,0,mg/kg/day,mg/kg/dose,0,50,13,Mouse,B6C3F1,M/F,M,Oral gavage,5,103,Weeks
133,108601,Bis(2-chloro-1-methylethyl) ether,HEAST,0.07,liver,NTP (National Toxicology Program). 1982. Carcinogenic bioassay of Bis(2-chloro-1-methylethyl) Ether (70%) containing 2-Chloro-1-ethylethyl-(2-chloropropyl) Ether (30%) in B6C3F1 mice (gavage study). NCI Carcinogen Tech Rep Ser No. 239. 105 p. Also publ as DHHS (NIH) 83-1795.,liver tumors (hepatocellular adenomas or carcinomas),Conv,3,68.8,mg/kg/day,mg/kg/dose,68.8,50,23,Mouse,B6C3F1,M/F,M,Oral gavage,5,103,Weeks
133,108601,Bis(2-chloro-1-methylethyl) ether,HEAST,0.07,liver,NTP (National Toxicology Program). 1982. Carcinogenic bioassay of Bis(2-chloro-1-methylethyl) Ether (70%) containing 2-Chloro-1-ethylethyl-(2-chloropropyl) Ether (30%) in B6C3F1 mice (gavage study). NCI Carcinogen Tech Rep Ser No. 239. 105 p. Also publ as DHHS (NIH) 83-1795.,liver tumors (hepatocellular adenomas or carcinomas),Conv,3,137.5,mg/kg/day,mg/kg/dose,137.5,50,27,Mouse,B6C3F1,M/F,M,Oral gavage,5,103,Weeks
134,115286,Chlorendic Acid,CalEPA,0.091,liver,"National Toxicology Program (NTP, 1987). Toxicology and Carcinogenesis Studies of Chlorendic Acid in F344 Rats and B6C3F1 Mice (Feed Studies). NTP Technical
Report Series No. 304. NIH Publication No. 87-2560. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",Liver hepatocellular carcinomas or neoplastic nodules,Dose,3,0,,,0,50,5,Rat,Fischer 344,M/F,M,Oral diet,NA,104,Weeks
134,115286,Chlorendic Acid,CalEPA,0.091,liver,"National Toxicology Program (NTP, 1987). Toxicology and Carcinogenesis Studies of Chlorendic Acid in F344 Rats and B6C3F1 Mice (Feed Studies). NTP Technical
Report Series No. 304. NIH Publication No. 87-2560. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",Liver hepatocellular carcinomas or neoplastic nodules,Dose,3,24.5,,,27,50,22,Rat,Fischer 344,M/F,M,Oral diet,NA,104,Weeks
134,115286,Chlorendic Acid,CalEPA,0.091,liver,"National Toxicology Program (NTP, 1987). Toxicology and Carcinogenesis Studies of Chlorendic Acid in F344 Rats and B6C3F1 Mice (Feed Studies). NTP Technical
Report Series No. 304. NIH Publication No. 87-2560. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",Liver hepatocellular carcinomas or neoplastic nodules,Dose,3,49.5,,,56,50,23,Rat,Fischer 344,M/F,M,Oral diet,NA,104,Weeks
135,115968,Tris(2-chloroethyl)phosphate   ,PPRTV,0.02,kidneys,"Matthews, H.B., S.L. Eustis and J. Haseman. 1993. Toxicity and carcinogenicity of chronic exposure to tris(2-chloroethyl)phosphate. Fundam. Appl. Toxicol. 20(4):477485.

NTP (National Toxicology Program). 1991. NTP Toxicology and Carcinogenesis Studies of
Tris(2-chloroethyl) Phosphate (CAS No. 115-96-8) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser. 391:1233",combined incidence of renal tubular cell adenomas and carcinomas,HEq,3,0,mg/kg-day,mg/kg-day,0,50,2,Rat,Fischer 344,M/F,M,Oral gavage,5,104,Weeks
135,115968,Tris(2-chloroethyl)phosphate   ,PPRTV,0.02,kidneys,"Matthews, H.B., S.L. Eustis and J. Haseman. 1993. Toxicity and carcinogenicity of chronic exposure to tris(2-chloroethyl)phosphate. Fundam. Appl. Toxicol. 20(4):477485.

NTP (National Toxicology Program). 1991. NTP Toxicology and Carcinogenesis Studies of
Tris(2-chloroethyl) Phosphate (CAS No. 115-96-8) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser. 391:1233",combined incidence of renal tubular cell adenomas and carcinomas,HEq,3,8.8,mg/kg-day,mg/kg-day,8.8,50,5,Rat,Fischer 344,M/F,M,Oral gavage,5,104,Weeks
135,115968,Tris(2-chloroethyl)phosphate   ,PPRTV,0.02,kidneys,"Matthews, H.B., S.L. Eustis and J. Haseman. 1993. Toxicity and carcinogenicity of chronic exposure to tris(2-chloroethyl)phosphate. Fundam. Appl. Toxicol. 20(4):477485.

NTP (National Toxicology Program). 1991. NTP Toxicology and Carcinogenesis Studies of
Tris(2-chloroethyl) Phosphate (CAS No. 115-96-8) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser. 391:1233",combined incidence of renal tubular cell adenomas and carcinomas,HEq,3,17.7,mg/kg-day,mg/kg-day,17.7,50,25,Rat,Fischer 344,M/F,M,Oral gavage,5,104,Weeks
136,117793,2-Aminoanthraquinone,CalEPA,0.033,liver,"National Cancer Institute (NCI, 1978). Bioassay of 2-Aminoanthraquinone for Possible Carcinogenicity Carcinogenesis. Technical Report Series, Technical Report No. 144. NTIS PB-287 739. US Department of Health, Education, and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant hepatocellular tumors,Dose,3,0,% diet (TWA,% diet (TWA,0,36,0,Rat,Fischer 344,M/F,M,Oral diet,NA,78,Weeks
136,117793,2-Aminoanthraquinone,CalEPA,0.033,liver,"National Cancer Institute (NCI, 1978). Bioassay of 2-Aminoanthraquinone for Possible Carcinogenicity Carcinogenesis. Technical Report Series, Technical Report No. 144. NTIS PB-287 739. US Department of Health, Education, and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant hepatocellular tumors,Dose,3,0.35,% diet (TWA,% diet (TWA,276.3157895,41,18,Rat,Fischer 344,M/F,M,Oral diet,NA,78,Weeks
136,117793,2-Aminoanthraquinone,CalEPA,0.033,liver,"National Cancer Institute (NCI, 1978). Bioassay of 2-Aminoanthraquinone for Possible Carcinogenicity Carcinogenesis. Technical Report Series, Technical Report No. 144. NTIS PB-287 739. US Department of Health, Education, and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant hepatocellular tumors,Dose,3,0.69,% diet (TWA,% diet (TWA,544.7368421,45,18,Rat,Fischer 344,M/F,M,Oral diet,NA,78,Weeks
137,117817,Bis(2-Ethylhexyl)Phthalate,CalEPA,0.0084,liver,"National Toxicology Program (NTP). 1982. Carcinogenesis bioassay of di-(2-ethylhexyl)phthalate (CAS No. 117-81-7) in F344 rats and B6C3F1 mice (feed study). NTP Tech Rep Ser TR No. 217, NTP, Research Triangle Park, NC.

US Environmental Protection Agency (US EPA). 1987. Health and environmental effects profile for phthalilc acid alkyl, aryl and alkyl/aryl esters. Draft document dated September 1987. ECAO/OHEA, US EPA, Cincinnati, OH.",hepatocellular carcinoma,Conv,3,0,mg/kg/day,ppm diet,0,50,9,Mouse,B6C3F1,M/F,M,Oral diet,NA,103,Weeks
137,117817,Bis(2-Ethylhexyl)Phthalate,CalEPA,0.0084,liver,"National Toxicology Program (NTP). 1982. Carcinogenesis bioassay of di-(2-ethylhexyl)phthalate (CAS No. 117-81-7) in F344 rats and B6C3F1 mice (feed study). NTP Tech Rep Ser TR No. 217, NTP, Research Triangle Park, NC.

US Environmental Protection Agency (US EPA). 1987. Health and environmental effects profile for phthalilc acid alkyl, aryl and alkyl/aryl esters. Draft document dated September 1987. ECAO/OHEA, US EPA, Cincinnati, OH.",hepatocellular carcinoma,Conv,3,672,mg/kg/day,ppm diet,672,48,14,Mouse,B6C3F1,M/F,M,Oral diet,NA,103,Weeks
137,117817,Bis(2-Ethylhexyl)Phthalate,CalEPA,0.0084,liver,"National Toxicology Program (NTP). 1982. Carcinogenesis bioassay of di-(2-ethylhexyl)phthalate (CAS No. 117-81-7) in F344 rats and B6C3F1 mice (feed study). NTP Tech Rep Ser TR No. 217, NTP, Research Triangle Park, NC.

US Environmental Protection Agency (US EPA). 1987. Health and environmental effects profile for phthalilc acid alkyl, aryl and alkyl/aryl esters. Draft document dated September 1987. ECAO/OHEA, US EPA, Cincinnati, OH.",hepatocellular carcinoma,Conv,3,1325,mg/kg/day,ppm diet,1325,50,19,Mouse,B6C3F1,M/F,M,Oral diet,NA,103,Weeks
138,118741,Hexachlorobenzene,CalEPA,1.8,adrenal glands,"Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Hepatocarcinogenicity of chronically administered hexachlorobenzene in rats. Fed Proc 42:786.
Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Renal tumors in rats chronically exposed to hexachlorobenzene. Proc. Am Assoc Cancer Res 24:59.
Arnold DL, Moodie CA, Charbonneau SM, Grice HC, McGuire PF, Bryce FR, Collins BT, Zawidzka ZZ, Krewski DR, Nera EA and Munro IC. 1985. Long-term toxicity of hexachlorobenzene in the rat and the effect of dietary Vitamin A. Food Chem Toxicol 23:779-793.",adrenal pheochromocytomas,Dose,5,0,mg/kg diet,mg/kg diet,0,49,2,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,130,Weeks
138,118741,Hexachlorobenzene,CalEPA,1.8,adrenal glands,"Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Hepatocarcinogenicity of chronically administered hexachlorobenzene in rats. Fed Proc 42:786.
Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Renal tumors in rats chronically exposed to hexachlorobenzene. Proc. Am Assoc Cancer Res 24:59.
Arnold DL, Moodie CA, Charbonneau SM, Grice HC, McGuire PF, Bryce FR, Collins BT, Zawidzka ZZ, Krewski DR, Nera EA and Munro IC. 1985. Long-term toxicity of hexachlorobenzene in the rat and the effect of dietary Vitamin A. Food Chem Toxicol 23:779-793.",adrenal pheochromocytomas,Dose,5,0.32,mg/kg diet,mg/kg diet,0.02556213,49,4,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,130,Weeks
138,118741,Hexachlorobenzene,CalEPA,1.8,adrenal glands,"Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Hepatocarcinogenicity of chronically administered hexachlorobenzene in rats. Fed Proc 42:786.
Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Renal tumors in rats chronically exposed to hexachlorobenzene. Proc. Am Assoc Cancer Res 24:59.
Arnold DL, Moodie CA, Charbonneau SM, Grice HC, McGuire PF, Bryce FR, Collins BT, Zawidzka ZZ, Krewski DR, Nera EA and Munro IC. 1985. Long-term toxicity of hexachlorobenzene in the rat and the effect of dietary Vitamin A. Food Chem Toxicol 23:779-793.",adrenal pheochromocytomas,Dose,5,1.6,mg/kg diet,mg/kg diet,0.127810651,50,4,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,130,Weeks
138,118741,Hexachlorobenzene,CalEPA,1.8,adrenal glands,"Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Hepatocarcinogenicity of chronically administered hexachlorobenzene in rats. Fed Proc 42:786.
Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Renal tumors in rats chronically exposed to hexachlorobenzene. Proc. Am Assoc Cancer Res 24:59.
Arnold DL, Moodie CA, Charbonneau SM, Grice HC, McGuire PF, Bryce FR, Collins BT, Zawidzka ZZ, Krewski DR, Nera EA and Munro IC. 1985. Long-term toxicity of hexachlorobenzene in the rat and the effect of dietary Vitamin A. Food Chem Toxicol 23:779-793.",adrenal pheochromocytomas,Dose,5,8,mg/kg diet,mg/kg diet,0.639053254,49,5,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,130,Weeks
138,118741,Hexachlorobenzene,CalEPA,1.8,adrenal glands,"Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Hepatocarcinogenicity of chronically administered hexachlorobenzene in rats. Fed Proc 42:786.
Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Renal tumors in rats chronically exposed to hexachlorobenzene. Proc. Am Assoc Cancer Res 24:59.
Arnold DL, Moodie CA, Charbonneau SM, Grice HC, McGuire PF, Bryce FR, Collins BT, Zawidzka ZZ, Krewski DR, Nera EA and Munro IC. 1985. Long-term toxicity of hexachlorobenzene in the rat and the effect of dietary Vitamin A. Food Chem Toxicol 23:779-793.",adrenal pheochromocytomas,Dose,5,40,mg/kg diet,mg/kg diet,3.195266272,49,17,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,130,Weeks
139,118741,Hexachlorobenzene,CalEPA,1.8,liver,"Cabral JRP, Shubik P, Mollner T and Raitano F. 1977. Carcinogenic activity of hexachlorobenzene in hamsters. Nature 269:510-511.",hepatoma,Conv,4,0,mg/kg-day,mg/kg diet,0,40,0,Hamster,Golden Syrian,M/F,M,Oral diet,NA,lifetime,Duration
139,118741,Hexachlorobenzene,CalEPA,1.8,liver,"Cabral JRP, Shubik P, Mollner T and Raitano F. 1977. Carcinogenic activity of hexachlorobenzene in hamsters. Nature 269:510-511.",hepatoma,Conv,4,4,mg/kg-day,mg/kg diet,4,30,14,Hamster,Golden Syrian,M/F,M,Oral diet,NA,lifetime,Duration
139,118741,Hexachlorobenzene,CalEPA,1.8,liver,"Cabral JRP, Shubik P, Mollner T and Raitano F. 1977. Carcinogenic activity of hexachlorobenzene in hamsters. Nature 269:510-511.",hepatoma,Conv,4,8,mg/kg-day,mg/kg diet,8,30,26,Hamster,Golden Syrian,M/F,M,Oral diet,NA,lifetime,Duration
139,118741,Hexachlorobenzene,CalEPA,1.8,liver,"Cabral JRP, Shubik P, Mollner T and Raitano F. 1977. Carcinogenic activity of hexachlorobenzene in hamsters. Nature 269:510-511.",hepatoma,Conv,4,16,mg/kg-day,mg/kg diet,16,57,49,Hamster,Golden Syrian,M/F,M,Oral diet,NA,lifetime,Duration
140,118741,Hexachlorobenzene,CalEPA,1.8,liver,"Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Hepatocarcinogenicity of chronically administered hexachlorobenzene in rats. Fed Proc 42:786.
Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Renal tumors in rats chronically exposed to hexachlorobenzene. Proc. Am Assoc Cancer Res 24:59.",hepatocarcinoma,Dose,3,0,mg/kg diet,mg/kg diet,0,52,0,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,2,Years
140,118741,Hexachlorobenzene,CalEPA,1.8,liver,"Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Hepatocarcinogenicity of chronically administered hexachlorobenzene in rats. Fed Proc 42:786.
Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Renal tumors in rats chronically exposed to hexachlorobenzene. Proc. Am Assoc Cancer Res 24:59.",hepatocarcinoma,Dose,3,75,mg/kg diet,mg/kg diet,5.99112426,56,36,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,2,Years
140,118741,Hexachlorobenzene,CalEPA,1.8,liver,"Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Hepatocarcinogenicity of chronically administered hexachlorobenzene in rats. Fed Proc 42:786.
Lambrecht RW, Ertürk E, Grunden EE, Peters HA, Morris CR and Bryan GT. 1983. Renal tumors in rats chronically exposed to hexachlorobenzene. Proc. Am Assoc Cancer Res 24:59.",hepatocarcinoma,Dose,3,150,mg/kg diet,mg/kg diet,11.98224852,55,48,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,2,Years
141,118741,Hexachlorobenzene,IRIS,1.6,liver,"Erturk, E., R.W. Lambrecht, H.A. Peters, D.J. Cripps, A. Gocmen, C.R. Morris and G.T. Bryan. 1986. Oncogenicity of hexachlorobenzene. In: Hexachlorobenzene: Proc. Int. Symp., C.R. Morris and J.R.P. Cabral, Ed. IARC Scientific Publ. No. 77, Oxford University Press, Oxford. p. 417-423.",hepatocellular carcinoma,HEq,3,0,mg/kg/day,ppm diet,0,52,0,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,2,Years
141,118741,Hexachlorobenzene,IRIS,1.6,liver,"Erturk, E., R.W. Lambrecht, H.A. Peters, D.J. Cripps, A. Gocmen, C.R. Morris and G.T. Bryan. 1986. Oncogenicity of hexachlorobenzene. In: Hexachlorobenzene: Proc. Int. Symp., C.R. Morris and J.R.P. Cabral, Ed. IARC Scientific Publ. No. 77, Oxford University Press, Oxford. p. 417-423.",hepatocellular carcinoma,HEq,3,0.73,mg/kg/day,ppm diet,0.73,56,36,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,2,Years
141,118741,Hexachlorobenzene,IRIS,1.6,liver,"Erturk, E., R.W. Lambrecht, H.A. Peters, D.J. Cripps, A. Gocmen, C.R. Morris and G.T. Bryan. 1986. Oncogenicity of hexachlorobenzene. In: Hexachlorobenzene: Proc. Int. Symp., C.R. Morris and J.R.P. Cabral, Ed. IARC Scientific Publ. No. 77, Oxford University Press, Oxford. p. 417-423.",hepatocellular carcinoma,HEq,3,1.46,mg/kg/day,ppm diet,1.46,55,48,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,2,Years
142,118967,"2,4,6-Trinitrotoluene",IRIS,0.03,bladder,"U.S. Department of Defense. 1984a. AD-A168 637. Available from Defense Technical Center. Write to Documents, Cameron Station, Alexandria, VA 22314, or call (703)274-7633.","urinary bladder, transitional cell papilloma and transitional squamous cell carcinomas",HEq,5,0,mg/kg/day,ppm,0,54,0,Rat,Fischer 344,M/F,F,Oral diet,NA,24,Months
142,118967,"2,4,6-Trinitrotoluene",IRIS,0.03,bladder,"U.S. Department of Defense. 1984a. AD-A168 637. Available from Defense Technical Center. Write to Documents, Cameron Station, Alexandria, VA 22314, or call (703)274-7633.","urinary bladder, transitional cell papilloma and transitional squamous cell carcinomas",HEq,5,0.065,mg/kg/day,ppm,0.065,54,0,Rat,Fischer 344,M/F,F,Oral diet,NA,24,Months
142,118967,"2,4,6-Trinitrotoluene",IRIS,0.03,bladder,"U.S. Department of Defense. 1984a. AD-A168 637. Available from Defense Technical Center. Write to Documents, Cameron Station, Alexandria, VA 22314, or call (703)274-7633.","urinary bladder, transitional cell papilloma and transitional squamous cell carcinomas",HEq,5,0.325,mg/kg/day,ppm,0.325,55,0,Rat,Fischer 344,M/F,F,Oral diet,NA,24,Months
142,118967,"2,4,6-Trinitrotoluene",IRIS,0.03,bladder,"U.S. Department of Defense. 1984a. AD-A168 637. Available from Defense Technical Center. Write to Documents, Cameron Station, Alexandria, VA 22314, or call (703)274-7633.","urinary bladder, transitional cell papilloma and transitional squamous cell carcinomas",HEq,5,1.623,mg/kg/day,ppm,1.623,55,1,Rat,Fischer 344,M/F,F,Oral diet,NA,24,Months
142,118967,"2,4,6-Trinitrotoluene",IRIS,0.03,bladder,"U.S. Department of Defense. 1984a. AD-A168 637. Available from Defense Technical Center. Write to Documents, Cameron Station, Alexandria, VA 22314, or call (703)274-7633.","urinary bladder, transitional cell papilloma and transitional squamous cell carcinomas",HEq,5,8.117,mg/kg/day,ppm,8.117,55,17,Rat,Fischer 344,M/F,F,Oral diet,NA,24,Months
143,119937,"Dimethylbenzidine, 3,3'-   ",PPRTV,11,systemic,"NTP (National Toxicology Program). 1991a. NTP Technical Report on Toxicology and Carcinogenesis Studies of 3,3'-dimethylbenzidine dihydrochloride (CAS No. 612-82-8) in F344/N Rats (Drinking Water Studies). National Toxicology Program, Research Triangle Park, N.C. Toxicity Report No. 390.","Combined incidence of skin tumors, zymbal gland tumors, and clitoral gland tumors",Dose,4,0,mg/kg-day,mg/kg-day,0,60,1,Rat,Fischer 344,M/F,F,Oral drinking water,NA,14,Months
143,119937,"Dimethylbenzidine, 3,3'-   ",PPRTV,11,systemic,"NTP (National Toxicology Program). 1991a. NTP Technical Report on Toxicology and Carcinogenesis Studies of 3,3'-dimethylbenzidine dihydrochloride (CAS No. 612-82-8) in F344/N Rats (Drinking Water Studies). National Toxicology Program, Research Triangle Park, N.C. Toxicity Report No. 390.","Combined incidence of skin tumors, zymbal gland tumors, and clitoral gland tumors",Dose,4,2,mg/kg-day,mg/kg-day,2,45,25,Rat,Fischer 344,M/F,F,Oral drinking water,NA,14,Months
143,119937,"Dimethylbenzidine, 3,3'-   ",PPRTV,11,systemic,"NTP (National Toxicology Program). 1991a. NTP Technical Report on Toxicology and Carcinogenesis Studies of 3,3'-dimethylbenzidine dihydrochloride (CAS No. 612-82-8) in F344/N Rats (Drinking Water Studies). National Toxicology Program, Research Triangle Park, N.C. Toxicity Report No. 390.","Combined incidence of skin tumors, zymbal gland tumors, and clitoral gland tumors",Dose,4,5.1,mg/kg-day,mg/kg-day,5.1,74,70,Rat,Fischer 344,M/F,F,Oral drinking water,NA,14,Months
143,119937,"Dimethylbenzidine, 3,3'-   ",PPRTV,11,systemic,"NTP (National Toxicology Program). 1991a. NTP Technical Report on Toxicology and Carcinogenesis Studies of 3,3'-dimethylbenzidine dihydrochloride (CAS No. 612-82-8) in F344/N Rats (Drinking Water Studies). National Toxicology Program, Research Triangle Park, N.C. Toxicity Report No. 390.","Combined incidence of skin tumors, zymbal gland tumors, and clitoral gland tumors",Dose,4,9.6,mg/kg-day,mg/kg-day,9.6,59,58,Rat,Fischer 344,M/F,F,Oral drinking water,NA,14,Months
144,120718,para-Cresidine,CalEPA,0.15,bladder,"National Cancer Institute (NCI) 1979. Bioassay of p-Cresidine for Possible Carcinogenicity. CAS No. 120-71-8. Carcinogenesis Technical Report Series No. 142. NCI-CG-TR-142 DHEW Publication No. (NIH) 78-1355. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant urinary bladder tumors,Dose,3,0,mg/kg/day (TWA),mg/kg/day (TWA),0,50,0,Mouse,B6C3F1,M/F,F,Oral diet,NA,104,Weeks
144,120718,para-Cresidine,CalEPA,0.15,bladder,"National Cancer Institute (NCI) 1979. Bioassay of p-Cresidine for Possible Carcinogenicity. CAS No. 120-71-8. Carcinogenesis Technical Report Series No. 142. NCI-CG-TR-142 DHEW Publication No. (NIH) 78-1355. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant urinary bladder tumors,Dose,3,281,mg/kg/day (TWA),mg/kg/day (TWA),281,50,42,Mouse,B6C3F1,M/F,F,Oral diet,NA,104,Weeks
144,120718,para-Cresidine,CalEPA,0.15,bladder,"National Cancer Institute (NCI) 1979. Bioassay of p-Cresidine for Possible Carcinogenicity. CAS No. 120-71-8. Carcinogenesis Technical Report Series No. 142. NCI-CG-TR-142 DHEW Publication No. (NIH) 78-1355. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant urinary bladder tumors,Dose,3,563,mg/kg/day (TWA),mg/kg/day (TWA),563,50,42,Mouse,B6C3F1,M/F,F,Oral diet,NA,104,Weeks
145,120821,"1,2,4-Trichlorobenzene",PPRTV,0.029,liver,"CMA (Chemical Manufacturers Association). 1994b. Final report: 104-week dietary carcinogenicity study with 1,2,4-trichlorobenzene in mice, with cover letter dated 6/15/94. Produced 6/06/94 by Hazelton Washington Inc. Submitted 6/16/94. TSCATS 444833. EPA Doc. #OPPTS-44612. OTS #0558831. Section 4.",hepatocellular carcinomas,HEq,4,0,mg/kg-day,mg/kg-day,0,49,8,Mouse,B6C3F1,M/F,M,Oral diet,NA,104,Weeks
145,120821,"1,2,4-Trichlorobenzene",PPRTV,0.029,liver,"CMA (Chemical Manufacturers Association). 1994b. Final report: 104-week dietary carcinogenicity study with 1,2,4-trichlorobenzene in mice, with cover letter dated 6/15/94. Produced 6/06/94 by Hazelton Washington Inc. Submitted 6/16/94. TSCATS 444833. EPA Doc. #OPPTS-44612. OTS #0558831. Section 4.",hepatocellular carcinomas,HEq,4,3.19,mg/kg-day,mg/kg-day,3.19,50,5,Mouse,B6C3F1,M/F,M,Oral diet,NA,104,Weeks
145,120821,"1,2,4-Trichlorobenzene",PPRTV,0.029,liver,"CMA (Chemical Manufacturers Association). 1994b. Final report: 104-week dietary carcinogenicity study with 1,2,4-trichlorobenzene in mice, with cover letter dated 6/15/94. Produced 6/06/94 by Hazelton Washington Inc. Submitted 6/16/94. TSCATS 444833. EPA Doc. #OPPTS-44612. OTS #0558831. Section 4.",hepatocellular carcinomas,HEq,4,15.2,mg/kg-day,mg/kg-day,15.2,50,27,Mouse,B6C3F1,M/F,M,Oral diet,NA,104,Weeks
145,120821,"1,2,4-Trichlorobenzene",PPRTV,0.029,liver,"CMA (Chemical Manufacturers Association). 1994b. Final report: 104-week dietary carcinogenicity study with 1,2,4-trichlorobenzene in mice, with cover letter dated 6/15/94. Produced 6/06/94 by Hazelton Washington Inc. Submitted 6/16/94. TSCATS 444833. EPA Doc. #OPPTS-44612. OTS #0558831. Section 4.",hepatocellular carcinomas,HEq,4,74.9,mg/kg-day,mg/kg-day,74.9,50,50,Mouse,B6C3F1,M/F,M,Oral diet,NA,104,Weeks
146,121142,"2,4-Dinitrotoluene",CalEPA,0.31,combined,"Lee CC, Ellis HV, Kowalski JJ, Hodgson JR, Short RD, Jagdis BC, Reddig TW and Minor JL. 1978. Mammalian toxicity of munition compounds. Phase II. Effects of multiple doses and Phase III. Effects of lifetime exposure. Part II. 2,4-Dinitrotoluene. US Army Medical Bioengineering Research and Development Laboratory. Contract No. DAMD-17-74-C-4073. Midwest Research Institute, Kansas City, MO. NTIS ADA 061715.

US Environmental Protection Agency (US EPA). May, 1987. Health Effects Assessment for 2,4- and 2,6-Dinitrotoluene. Prepared by the Environmental Criteria and Assessment Office. Office of Health and Environmental Assessment. Office of Research and Development. Cincinnati, OH 45268. EPA/600/8-88/032.",combined liver and mamary gland tumors,Conv,4,0,mg/kg/day,ppm,0,31,11,Rat,CD,M/F,F,Oral diet,NA,720,Days
146,121142,"2,4-Dinitrotoluene",CalEPA,0.31,combined,"Lee CC, Ellis HV, Kowalski JJ, Hodgson JR, Short RD, Jagdis BC, Reddig TW and Minor JL. 1978. Mammalian toxicity of munition compounds. Phase II. Effects of multiple doses and Phase III. Effects of lifetime exposure. Part II. 2,4-Dinitrotoluene. US Army Medical Bioengineering Research and Development Laboratory. Contract No. DAMD-17-74-C-4073. Midwest Research Institute, Kansas City, MO. NTIS ADA 061715.

US Environmental Protection Agency (US EPA). May, 1987. Health Effects Assessment for 2,4- and 2,6-Dinitrotoluene. Prepared by the Environmental Criteria and Assessment Office. Office of Health and Environmental Assessment. Office of Research and Development. Cincinnati, OH 45268. EPA/600/8-88/032.",combined liver and mamary gland tumors,Conv,4,0.71,mg/kg/day,ppm,0.71,43,13,Rat,CD,M/F,F,Oral diet,NA,720,Days
146,121142,"2,4-Dinitrotoluene",CalEPA,0.31,combined,"Lee CC, Ellis HV, Kowalski JJ, Hodgson JR, Short RD, Jagdis BC, Reddig TW and Minor JL. 1978. Mammalian toxicity of munition compounds. Phase II. Effects of multiple doses and Phase III. Effects of lifetime exposure. Part II. 2,4-Dinitrotoluene. US Army Medical Bioengineering Research and Development Laboratory. Contract No. DAMD-17-74-C-4073. Midwest Research Institute, Kansas City, MO. NTIS ADA 061715.

US Environmental Protection Agency (US EPA). May, 1987. Health Effects Assessment for 2,4- and 2,6-Dinitrotoluene. Prepared by the Environmental Criteria and Assessment Office. Office of Health and Environmental Assessment. Office of Research and Development. Cincinnati, OH 45268. EPA/600/8-88/032.",combined liver and mamary gland tumors,Conv,4,3.9,mg/kg/day,ppm,3.9,35,18,Rat,CD,M/F,F,Oral diet,NA,720,Days
146,121142,"2,4-Dinitrotoluene",CalEPA,0.31,combined,"Lee CC, Ellis HV, Kowalski JJ, Hodgson JR, Short RD, Jagdis BC, Reddig TW and Minor JL. 1978. Mammalian toxicity of munition compounds. Phase II. Effects of multiple doses and Phase III. Effects of lifetime exposure. Part II. 2,4-Dinitrotoluene. US Army Medical Bioengineering Research and Development Laboratory. Contract No. DAMD-17-74-C-4073. Midwest Research Institute, Kansas City, MO. NTIS ADA 061715.

US Environmental Protection Agency (US EPA). May, 1987. Health Effects Assessment for 2,4- and 2,6-Dinitrotoluene. Prepared by the Environmental Criteria and Assessment Office. Office of Health and Environmental Assessment. Office of Research and Development. Cincinnati, OH 45268. EPA/600/8-88/032.",combined liver and mamary gland tumors,Conv,4,34,mg/kg/day,ppm,34,43,34,Rat,CD,M/F,F,Oral diet,NA,720,Days
147,121824,RDX,IRIS,0.11,liver,"U.S. Department of Defense. 1984. Available from U.S. Army Medical Research and Development Command. DAMD17-79-C-9161. Ft. Detrick, Frederick, MD 20701.","liver, hepatocellular carcinoma, and adenomas (combined)",HEq,5,0,mg/kg/day,mg/kg/day,0,65,1,Mouse,B6C3F1,M/F,F,Oral diet,NA,24,Months
147,121824,RDX,IRIS,0.11,liver,"U.S. Department of Defense. 1984. Available from U.S. Army Medical Research and Development Command. DAMD17-79-C-9161. Ft. Detrick, Frederick, MD 20701.","liver, hepatocellular carcinoma, and adenomas (combined)",HEq,5,0.13,mg/kg/day,mg/kg/day,0.13,62,5,Mouse,B6C3F1,M/F,F,Oral diet,NA,24,Months
147,121824,RDX,IRIS,0.11,liver,"U.S. Department of Defense. 1984. Available from U.S. Army Medical Research and Development Command. DAMD17-79-C-9161. Ft. Detrick, Frederick, MD 20701.","liver, hepatocellular carcinoma, and adenomas (combined)",HEq,5,0.58,mg/kg/day,mg/kg/day,0.58,64,9,Mouse,B6C3F1,M/F,F,Oral diet,NA,24,Months
147,121824,RDX,IRIS,0.11,liver,"U.S. Department of Defense. 1984. Available from U.S. Army Medical Research and Development Command. DAMD17-79-C-9161. Ft. Detrick, Frederick, MD 20701.","liver, hepatocellular carcinoma, and adenomas (combined)",HEq,5,2.9,mg/kg/day,mg/kg/day,2.9,64,12,Mouse,B6C3F1,M/F,F,Oral diet,NA,24,Months
147,121824,RDX,IRIS,0.11,liver,"U.S. Department of Defense. 1984. Available from U.S. Army Medical Research and Development Command. DAMD17-79-C-9161. Ft. Detrick, Frederick, MD 20701.","liver, hepatocellular carcinoma, and adenomas (combined)",HEq,5,8.3,mg/kg/day,mg/kg/day,8.3,31,6,Mouse,B6C3F1,M/F,F,Oral diet,NA,24,Months
148,122667,Hydrazobenzene,IRIS,0.8,liver,NCI (National Cancer Institute). 1979. Bioassay of Hydrazobenzene for Possible Carcinogenicity. U.S. DHEW Publ. No. NIH 78-1342.,hepatocellular carcinomas and neoplastic liver nodules,HEq,3,0,mg/kg/day,% of diet,0,95,6,Rat,Fischer 344,M/F,M,Oral diet,NA,78,Weeks
148,122667,Hydrazobenzene,IRIS,0.8,liver,NCI (National Cancer Institute). 1979. Bioassay of Hydrazobenzene for Possible Carcinogenicity. U.S. DHEW Publ. No. NIH 78-1342.,hepatocellular carcinomas and neoplastic liver nodules,HEq,3,4,mg/kg/day,% of diet,4,49,13,Rat,Fischer 344,M/F,M,Oral diet,NA,78,Weeks
148,122667,Hydrazobenzene,IRIS,0.8,liver,NCI (National Cancer Institute). 1979. Bioassay of Hydrazobenzene for Possible Carcinogenicity. U.S. DHEW Publ. No. NIH 78-1342.,hepatocellular carcinomas and neoplastic liver nodules,HEq,3,15,mg/kg/day,% of diet,15,49,37,Rat,Fischer 344,M/F,M,Oral diet,NA,78,Weeks
149,123319,Hydroquinone   ,PPRTV,0.06,blood,NTP (National Toxicology Program). 1989. Toxicology and carcinogenesis studies of hydroquinone (CAS No. 123-31-9) in F344/N rats and B6C3F1 mice (gavage studies). NTP TR 366. NIH Publication No. 90-2821.,mononuclear cell leukemia,Dose,3,0,mg/kg-d,mg/kg-d,0,55,9,Rat,Fischer 344,M/F,F,Oral gavage,5,103,Weeks
149,123319,Hydroquinone   ,PPRTV,0.06,blood,NTP (National Toxicology Program). 1989. Toxicology and carcinogenesis studies of hydroquinone (CAS No. 123-31-9) in F344/N rats and B6C3F1 mice (gavage studies). NTP TR 366. NIH Publication No. 90-2821.,mononuclear cell leukemia,Dose,3,25,mg/kg-d,mg/kg-d,17.85714286,55,15,Rat,Fischer 344,M/F,F,Oral gavage,5,103,Weeks
149,123319,Hydroquinone   ,PPRTV,0.06,blood,NTP (National Toxicology Program). 1989. Toxicology and carcinogenesis studies of hydroquinone (CAS No. 123-31-9) in F344/N rats and B6C3F1 mice (gavage studies). NTP TR 366. NIH Publication No. 90-2821.,mononuclear cell leukemia,Dose,3,50,mg/kg-d,mg/kg-d,35.71428571,55,22,Rat,Fischer 344,M/F,F,Oral gavage,5,103,Weeks
150,123739,trans-Crotonaldehyde,HEAST,1.9,liver,"Chung, F.L., T. Tamaka, S.S. Hecht. 1986. Induction of liver tumors in F344 rats by Crotonaldehyde. Cancer Res. 46: 1285-1289.",liver neoplastic nodules and hepatocellular carcinomas,HEq,3,0,mg/kg/day,mg/L,0,23,0,Rat,Fischer 344,M,Both,Oral drinking water,NA,113,Weeks
150,123739,trans-Crotonaldehyde,HEAST,1.9,liver,"Chung, F.L., T. Tamaka, S.S. Hecht. 1986. Induction of liver tumors in F344 rats by Crotonaldehyde. Cancer Res. 46: 1285-1289.",liver neoplastic nodules and hepatocellular carcinomas,HEq,3,0.36,mg/kg/day,mg/L,0.36,27,9,Rat,Fischer 344,M,Both,Oral drinking water,NA,113,Weeks
150,123739,trans-Crotonaldehyde,HEAST,1.9,liver,"Chung, F.L., T. Tamaka, S.S. Hecht. 1986. Induction of liver tumors in F344 rats by Crotonaldehyde. Cancer Res. 46: 1285-1289.",liver neoplastic nodules and hepatocellular carcinomas,HEq,3,3,mg/kg/day,mg/L,3,23,1,Rat,Fischer 344,M,Both,Oral drinking water,NA,113,Weeks
151,123911,"1,4-Dioxane",CalEPA,0.027,liver,"National Cancer Institute (NCI). 1978. Bioassay of 1,4-Dioxane for Possible Carcinogenicity. DHEW Pb. No. 78-1330. Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD.",combined hepatocellular carcinoma and adenoma,Dose,3,0,mg/kg/day,mg/kg/day,0,50,0,Mouse,B6C3F1,M/F,F,Oral drinking water,NA,90,Weeks
151,123911,"1,4-Dioxane",CalEPA,0.027,liver,"National Cancer Institute (NCI). 1978. Bioassay of 1,4-Dioxane for Possible Carcinogenicity. DHEW Pb. No. 78-1330. Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD.",combined hepatocellular carcinoma and adenoma,Dose,3,380,mg/kg/day,mg/kg/day,380,48,21,Mouse,B6C3F1,M/F,F,Oral drinking water,NA,90,Weeks
151,123911,"1,4-Dioxane",CalEPA,0.027,liver,"National Cancer Institute (NCI). 1978. Bioassay of 1,4-Dioxane for Possible Carcinogenicity. DHEW Pb. No. 78-1330. Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD.",combined hepatocellular carcinoma and adenoma,Dose,3,860,mg/kg/day,mg/kg/day,860,37,35,Mouse,B6C3F1,M/F,F,Oral drinking water,NA,90,Weeks
152,123911,"1,4-Dioxane",IRIS,0.1,liver,"Kano H; Umeda Y; Kasai T; Sasaki T; Matsumoto M; Yamazaki K; Nagano K; Arito H; Fukushima S (2009). Carcinogenicity studies of 1,4-dioxane administered in drinking-water to rats and mice for 2 years. Food Chem Toxicol, 47: 2776-2784.",hepatocellular adenomas and carcinomas in female mice,Dose,4,0,mg/kg/day,mg/kg/day,0,50,5,Mouse,BDF1,F,F,Oral drinking water,NA,2,Years
152,123911,"1,4-Dioxane",IRIS,0.1,liver,"Kano H; Umeda Y; Kasai T; Sasaki T; Matsumoto M; Yamazaki K; Nagano K; Arito H; Fukushima S (2009). Carcinogenicity studies of 1,4-dioxane administered in drinking-water to rats and mice for 2 years. Food Chem Toxicol, 47: 2776-2784.",hepatocellular adenomas and carcinomas in female mice,Dose,4,66,mg/kg/day,mg/kg/day,66,50,35,Mouse,BDF1,F,F,Oral drinking water,NA,2,Years
152,123911,"1,4-Dioxane",IRIS,0.1,liver,"Kano H; Umeda Y; Kasai T; Sasaki T; Matsumoto M; Yamazaki K; Nagano K; Arito H; Fukushima S (2009). Carcinogenicity studies of 1,4-dioxane administered in drinking-water to rats and mice for 2 years. Food Chem Toxicol, 47: 2776-2784.",hepatocellular adenomas and carcinomas in female mice,Dose,4,278,mg/kg/day,mg/kg/day,278,50,41,Mouse,BDF1,F,F,Oral drinking water,NA,2,Years
152,123911,"1,4-Dioxane",IRIS,0.1,liver,"Kano H; Umeda Y; Kasai T; Sasaki T; Matsumoto M; Yamazaki K; Nagano K; Arito H; Fukushima S (2009). Carcinogenicity studies of 1,4-dioxane administered in drinking-water to rats and mice for 2 years. Food Chem Toxicol, 47: 2776-2784.",hepatocellular adenomas and carcinomas in female mice,Dose,4,964,mg/kg/day,mg/kg/day,964,50,46,Mouse,BDF1,F,F,Oral drinking water,NA,2,Years
153,124481,Dibromochloromethane,CalEPA,0.094,liver,"National Toxicology Program (NTP, 1985). Toxicology and Carcinogenesis Studies of Chlorodibromomethane in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP Technical Report Series No. 282. NIH Publication No. 85-2538. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",Combined hepatocellular adenomas and carcinomas,Conv,3,0,mg/kg-day (ADJ),mg/kg-day,0,50,6,Mouse,B6C3F1,M/F,F,Oral gavage,5,105,Weeks
153,124481,Dibromochloromethane,CalEPA,0.094,liver,"National Toxicology Program (NTP, 1985). Toxicology and Carcinogenesis Studies of Chlorodibromomethane in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP Technical Report Series No. 282. NIH Publication No. 85-2538. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",Combined hepatocellular adenomas and carcinomas,Conv,3,36,mg/kg-day (ADJ),mg/kg-day,36,49,10,Mouse,B6C3F1,M/F,F,Oral gavage,5,105,Weeks
153,124481,Dibromochloromethane,CalEPA,0.094,liver,"National Toxicology Program (NTP, 1985). Toxicology and Carcinogenesis Studies of Chlorodibromomethane in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP Technical Report Series No. 282. NIH Publication No. 85-2538. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",Combined hepatocellular adenomas and carcinomas,Conv,3,71,mg/kg-day (ADJ),mg/kg-day,71,50,19,Mouse,B6C3F1,M/F,F,Oral gavage,5,105,Weeks
154,124481,Dibromochloromethane,IRIS,0.084,liver,NTP (National Toxicology Program). 1985. Toxicology and carcinogenesis studies of chlorodibromomethane (CAS No. 124-48-1) in F344/N rats and B6C3F1 mice (gavage studies). NTP Tech. Report Series No. 282. NTIS PB 86-166675.,hepatocellular adenoma or carcinoma,HEq,3,0,mg/kg-day,mg/kg-day,0,50,6,Mouse,B6C3F1,M/F,F,Oral gavage,5,105,Weeks
154,124481,Dibromochloromethane,IRIS,0.084,liver,NTP (National Toxicology Program). 1985. Toxicology and carcinogenesis studies of chlorodibromomethane (CAS No. 124-48-1) in F344/N rats and B6C3F1 mice (gavage studies). NTP Tech. Report Series No. 282. NTIS PB 86-166675.,hepatocellular adenoma or carcinoma,HEq,3,35.71,mg/kg-day,mg/kg-day,35.71,49,10,Mouse,B6C3F1,M/F,F,Oral gavage,5,105,Weeks
154,124481,Dibromochloromethane,IRIS,0.084,liver,NTP (National Toxicology Program). 1985. Toxicology and carcinogenesis studies of chlorodibromomethane (CAS No. 124-48-1) in F344/N rats and B6C3F1 mice (gavage studies). NTP Tech. Report Series No. 282. NTIS PB 86-166675.,hepatocellular adenoma or carcinoma,HEq,3,71.43,mg/kg-day,mg/kg-day,71.43,50,19,Mouse,B6C3F1,M/F,F,Oral gavage,5,105,Weeks
155,126727,Tris(2-3-dibromopropyl)phosphate,CalEPA,2.3,kidneys,"National Cancer Institute (NCI, 1978). Bioassay of Tris(2,3-dibromopropyl)phosphate for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 76. NTIS Publication No. PB 280271. US Department of Health, Education and Welfare, NCI Carcinclgenesis Testing Program, Bethesda, MD.",kidney tumors - tubular cell adenoma or adenocarcinoma,Dose,3,0,ppm diet,ppm diet,0,53,0,Rat,Fischer 344,M/F,M,Oral diet,NA,104,Weeks
155,126727,Tris(2-3-dibromopropyl)phosphate,CalEPA,2.3,kidneys,"National Cancer Institute (NCI, 1978). Bioassay of Tris(2,3-dibromopropyl)phosphate for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 76. NTIS Publication No. PB 280271. US Department of Health, Education and Welfare, NCI Carcinclgenesis Testing Program, Bethesda, MD.",kidney tumors - tubular cell adenoma or adenocarcinoma,Dose,3,50,ppm diet,ppm diet,3.947368421,54,26,Rat,Fischer 344,M/F,M,Oral diet,NA,104,Weeks
155,126727,Tris(2-3-dibromopropyl)phosphate,CalEPA,2.3,kidneys,"National Cancer Institute (NCI, 1978). Bioassay of Tris(2,3-dibromopropyl)phosphate for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 76. NTIS Publication No. PB 280271. US Department of Health, Education and Welfare, NCI Carcinclgenesis Testing Program, Bethesda, MD.",kidney tumors - tubular cell adenoma or adenocarcinoma,Dose,3,100,ppm diet,ppm diet,7.894736842,54,29,Rat,Fischer 344,M/F,M,Oral diet,NA,104,Weeks
156,126738,Tributyl Phosphate   ,PPRTV,0.009,bladder,"Auletta, C.S., M. L. Weiner and W.R. Richter. 1998a. A dietary toxicity/oncogenicity study of tributyl phosphate in the rat. Toxicology. 128:125134.",urinary bladder tumor,HEq,4,0,mg/kg-day,mg/kg-day,0,50,0,Rat,Sprague-Dawley,M/F,M,Oral diet,NA,2,Years
156,126738,Tributyl Phosphate   ,PPRTV,0.009,bladder,"Auletta, C.S., M. L. Weiner and W.R. Richter. 1998a. A dietary toxicity/oncogenicity study of tributyl phosphate in the rat. Toxicology. 128:125134.",urinary bladder tumor,HEq,4,2.62,mg/kg-day,mg/kg-day,2.62,50,0,Rat,Sprague-Dawley,M/F,M,Oral diet,NA,2,Years
156,126738,Tributyl Phosphate   ,PPRTV,0.009,bladder,"Auletta, C.S., M. L. Weiner and W.R. Richter. 1998a. A dietary toxicity/oncogenicity study of tributyl phosphate in the rat. Toxicology. 128:125134.",urinary bladder tumor,HEq,4,9.56,mg/kg-day,mg/kg-day,9.56,49,2,Rat,Sprague-Dawley,M/F,M,Oral diet,NA,2,Years
156,126738,Tributyl Phosphate   ,PPRTV,0.009,bladder,"Auletta, C.S., M. L. Weiner and W.R. Richter. 1998a. A dietary toxicity/oncogenicity study of tributyl phosphate in the rat. Toxicology. 128:125134.",urinary bladder tumor,HEq,4,42.13,mg/kg-day,mg/kg-day,42.13,49,30,Rat,Sprague-Dawley,M/F,M,Oral diet,NA,2,Years
157,129157,2-Methyl-1-nitroanthraquinone (of uncertain purity),CalEPA,4.3,systemic,"National Cancer Institute (NCI, 1978). Bioassay of 2-Methyl-l-Nitroanthraquinone for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 29. NTIS Publication No. PB 277439. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",subcutaneous tissue (fibroma),Dose,3,0,% diet,% diet,0,48,3,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
157,129157,2-Methyl-1-nitroanthraquinone (of uncertain purity),CalEPA,4.3,systemic,"National Cancer Institute (NCI, 1978). Bioassay of 2-Methyl-l-Nitroanthraquinone for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 29. NTIS Publication No. PB 277439. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",subcutaneous tissue (fibroma),Dose,3,0.06,% diet,% diet,102.9490617,49,10,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
157,129157,2-Methyl-1-nitroanthraquinone (of uncertain purity),CalEPA,4.3,systemic,"National Cancer Institute (NCI, 1978). Bioassay of 2-Methyl-l-Nitroanthraquinone for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 29. NTIS Publication No. PB 277439. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",subcutaneous tissue (fibroma),Dose,3,0.12,% diet,% diet,205.8981233,49,34,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
158,129157,2-Methyl-1-nitroanthraquinone (of uncertain purity),CalEPA,4.3,vascular system,"National Cancer Institute (NCI, 1978). Bioassay of 2-Methyl-l-Nitroanthraquinone for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 29. NTIS Publication No. PB 277439. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hemangiosarcomas,Dose,3,0,% diet,% diet,0,48,0,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
158,129157,2-Methyl-1-nitroanthraquinone (of uncertain purity),CalEPA,4.3,vascular system,"National Cancer Institute (NCI, 1978). Bioassay of 2-Methyl-l-Nitroanthraquinone for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 29. NTIS Publication No. PB 277439. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hemangiosarcomas,Dose,3,0.06,% diet,% diet,102.9490617,49,1,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
158,129157,2-Methyl-1-nitroanthraquinone (of uncertain purity),CalEPA,4.3,vascular system,"National Cancer Institute (NCI, 1978). Bioassay of 2-Methyl-l-Nitroanthraquinone for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 29. NTIS Publication No. PB 277439. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hemangiosarcomas,Dose,3,0.12,% diet,% diet,205.8981233,49,3,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
159,132274,"o-Phenylphenate, sodium",CalEPA,0.003,urinary tract,"Hiraga K and Fujii T (1981). Induction of tumors of the urinary system in the F344 rats by dietary administration of sodium o-phenylphenate. Food Cosmet. Toxicol. 19:
303-310.",Tumors of urinary tract system,Dose,7,0,% diet,% diet,0,20,0,Rat,Fischer 344,M,Both,Oral diet,NA,91,Weeks
159,132274,"o-Phenylphenate, sodium",CalEPA,0.003,urinary tract,"Hiraga K and Fujii T (1981). Induction of tumors of the urinary system in the F344 rats by dietary administration of sodium o-phenylphenate. Food Cosmet. Toxicol. 19:
303-310.",Tumors of urinary tract system,Dose,7,0.125,% diet,% diet,98.68421053,20,0,Rat,Fischer 344,M,Both,Oral diet,NA,91,Weeks
159,132274,"o-Phenylphenate, sodium",CalEPA,0.003,urinary tract,"Hiraga K and Fujii T (1981). Induction of tumors of the urinary system in the F344 rats by dietary administration of sodium o-phenylphenate. Food Cosmet. Toxicol. 19:
303-310.",Tumors of urinary tract system,Dose,7,0.25,% diet,% diet,197.3684211,20,0,Rat,Fischer 344,M,Both,Oral diet,NA,91,Weeks
159,132274,"o-Phenylphenate, sodium",CalEPA,0.003,urinary tract,"Hiraga K and Fujii T (1981). Induction of tumors of the urinary system in the F344 rats by dietary administration of sodium o-phenylphenate. Food Cosmet. Toxicol. 19:
303-310.",Tumors of urinary tract system,Dose,7,0.5,% diet,% diet,394.7368421,21,1,Rat,Fischer 344,M,Both,Oral diet,NA,91,Weeks
159,132274,"o-Phenylphenate, sodium",CalEPA,0.003,urinary tract,"Hiraga K and Fujii T (1981). Induction of tumors of the urinary system in the F344 rats by dietary administration of sodium o-phenylphenate. Food Cosmet. Toxicol. 19:
303-310.",Tumors of urinary tract system,Dose,7,1,% diet,% diet,789.4736842,21,7,Rat,Fischer 344,M,Both,Oral diet,NA,91,Weeks
159,132274,"o-Phenylphenate, sodium",CalEPA,0.003,urinary tract,"Hiraga K and Fujii T (1981). Induction of tumors of the urinary system in the F344 rats by dietary administration of sodium o-phenylphenate. Food Cosmet. Toxicol. 19:
303-310.",Tumors of urinary tract system,Dose,7,2,% diet,% diet,1578.947368,21,20,Rat,Fischer 344,M,Both,Oral diet,NA,91,Weeks
159,132274,"o-Phenylphenate, sodium",CalEPA,0.003,urinary tract,"Hiraga K and Fujii T (1981). Induction of tumors of the urinary system in the F344 rats by dietary administration of sodium o-phenylphenate. Food Cosmet. Toxicol. 19:
303-310.",Tumors of urinary tract system,Dose,7,4,% diet,% diet,3157.894737,20,17,Rat,Fischer 344,M,Both,Oral diet,NA,91,Weeks
160,133073,Folpet,IRIS,0.0035,gastrointestinal,"Chevron Chemical Corporation. 1982. Chevron study: Lifetime oncogenicity feeding study of pholton technical (SX-946; folpet) in CD-1 (ICR derived) mice. August 24. Social Study No. 1331. (Cited in U.S. EPA, 1986)",digestive tract tumors (adenoma and/or adenocarcinoma),HEq,4,0,mg/kg/day,ppm,0,104,1,Mouse,CD-1,M/F,M,Oral diet,NA,112-113,Weeks
160,133073,Folpet,IRIS,0.0035,gastrointestinal,"Chevron Chemical Corporation. 1982. Chevron study: Lifetime oncogenicity feeding study of pholton technical (SX-946; folpet) in CD-1 (ICR derived) mice. August 24. Social Study No. 1331. (Cited in U.S. EPA, 1986)",digestive tract tumors (adenoma and/or adenocarcinoma),HEq,4,7.4,mg/kg/day,ppm,7.4,80,2,Mouse,CD-1,M/F,M,Oral diet,NA,112-113,Weeks
160,133073,Folpet,IRIS,0.0035,gastrointestinal,"Chevron Chemical Corporation. 1982. Chevron study: Lifetime oncogenicity feeding study of pholton technical (SX-946; folpet) in CD-1 (ICR derived) mice. August 24. Social Study No. 1331. (Cited in U.S. EPA, 1986)",digestive tract tumors (adenoma and/or adenocarcinoma),HEq,4,40.2,mg/kg/day,ppm,40.2,80,8,Mouse,CD-1,M/F,M,Oral diet,NA,112-113,Weeks
160,133073,Folpet,IRIS,0.0035,gastrointestinal,"Chevron Chemical Corporation. 1982. Chevron study: Lifetime oncogenicity feeding study of pholton technical (SX-946; folpet) in CD-1 (ICR derived) mice. August 24. Social Study No. 1331. (Cited in U.S. EPA, 1986)",digestive tract tumors (adenoma and/or adenocarcinoma),HEq,4,102.6,mg/kg/day,ppm,102.6,80,41,Mouse,CD-1,M/F,M,Oral diet,NA,112-113,Weeks
161,133073,Folpet,IRIS,0.0035,gastrointestinal,"Chevron Chemical Corporation. 1982. Chevron study: Lifetime oncogenicity feeding study of pholton technical (SX-946; folpet) in CD-1 (ICR derived) mice. August 24. Social Study No. 1331. (Cited in U.S. EPA, 1986)",digestive tract tumors (adenoma and/or adenocarcinoma),HEq,4,0,mg/kg/day,ppm,0,104,0,Mouse,CD-1,M/F,F,Oral diet,NA,112-113,Weeks
161,133073,Folpet,IRIS,0.0035,gastrointestinal,"Chevron Chemical Corporation. 1982. Chevron study: Lifetime oncogenicity feeding study of pholton technical (SX-946; folpet) in CD-1 (ICR derived) mice. August 24. Social Study No. 1331. (Cited in U.S. EPA, 1986)",digestive tract tumors (adenoma and/or adenocarcinoma),HEq,4,7.6,mg/kg/day,ppm,7.6,80,1,Mouse,CD-1,M/F,F,Oral diet,NA,112-113,Weeks
161,133073,Folpet,IRIS,0.0035,gastrointestinal,"Chevron Chemical Corporation. 1982. Chevron study: Lifetime oncogenicity feeding study of pholton technical (SX-946; folpet) in CD-1 (ICR derived) mice. August 24. Social Study No. 1331. (Cited in U.S. EPA, 1986)",digestive tract tumors (adenoma and/or adenocarcinoma),HEq,4,41.2,mg/kg/day,ppm,41.2,80,8,Mouse,CD-1,M/F,F,Oral diet,NA,112-113,Weeks
161,133073,Folpet,IRIS,0.0035,gastrointestinal,"Chevron Chemical Corporation. 1982. Chevron study: Lifetime oncogenicity feeding study of pholton technical (SX-946; folpet) in CD-1 (ICR derived) mice. August 24. Social Study No. 1331. (Cited in U.S. EPA, 1986)",digestive tract tumors (adenoma and/or adenocarcinoma),HEq,4,102.7,mg/kg/day,ppm,102.7,80,41,Mouse,CD-1,M/F,F,Oral diet,NA,112-113,Weeks
162,139139,Nitrilotriacetic Acid,CalEPA,0.0053,liver,"National Cancer Institute (NCI, 1977). Bioassay of Nitrilotriacetic Acid (NTA) for Possible Carcinogenicity. Carcinogenesis Technical Report Series No.6. NTIS .
Publication No. PB 266177. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

National Toxicology Program (NTP, 1991). Chemical Status Report. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant liver tumors,Dose,3,0,ppm diet,ppm diet,0,15,2,Rat,Fischer 344,M/F,F,Oral diet,NA,99,Weeks
162,139139,Nitrilotriacetic Acid,CalEPA,0.0053,liver,"National Cancer Institute (NCI, 1977). Bioassay of Nitrilotriacetic Acid (NTA) for Possible Carcinogenicity. Carcinogenesis Technical Report Series No.6. NTIS .
Publication No. PB 266177. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

National Toxicology Program (NTP, 1991). Chemical Status Report. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant liver tumors,Dose,3,7500,ppm diet,ppm diet,687.7729258,49,8,Rat,Fischer 344,M/F,F,Oral diet,NA,99,Weeks
162,139139,Nitrilotriacetic Acid,CalEPA,0.0053,liver,"National Cancer Institute (NCI, 1977). Bioassay of Nitrilotriacetic Acid (NTA) for Possible Carcinogenicity. Carcinogenesis Technical Report Series No.6. NTIS .
Publication No. PB 266177. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

National Toxicology Program (NTP, 1991). Chemical Status Report. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant liver tumors,Dose,3,15000,ppm diet,ppm diet,1375.545852,46,22,Rat,Fischer 344,M/F,F,Oral diet,NA,99,Weeks
163,139651,"4,4-Thiodianiline",CalEPA,15,female repro,"NCI 1978 as cited in Gold 1984

Nancer Institute (NCI, 1978). Bioassay of 4,4'-Thiodianilinefor Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 47. NTIS Publication No. PB 280360. US Department of Health, Education and Welfare, NCI CarcilrlOgenesis Testing Program, Bethesda, MD.",carcinomas of the uterus,Dose,3,0,ppm diet,ppm diet,0,15,0,Rat,Fischer 344,M/F,F,Oral diet,5,69-72,Weeks
163,139651,"4,4-Thiodianiline",CalEPA,15,female repro,"NCI 1978 as cited in Gold 1984

Nancer Institute (NCI, 1978). Bioassay of 4,4'-Thiodianilinefor Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 47. NTIS Publication No. PB 280360. US Department of Health, Education and Welfare, NCI CarcilrlOgenesis Testing Program, Bethesda, MD.",carcinomas of the uterus,Dose,3,1500,ppm diet,ppm diet,98.25327511,33,31,Rat,Fischer 344,M/F,F,Oral diet,5,69-72,Weeks
163,139651,"4,4-Thiodianiline",CalEPA,15,female repro,"NCI 1978 as cited in Gold 1984

Nancer Institute (NCI, 1978). Bioassay of 4,4'-Thiodianilinefor Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 47. NTIS Publication No. PB 280360. US Department of Health, Education and Welfare, NCI CarcilrlOgenesis Testing Program, Bethesda, MD.",carcinomas of the uterus,Dose,3,3000,ppm diet,ppm diet,196.5065502,32,23,Rat,Fischer 344,M/F,F,Oral diet,5,69-72,Weeks
164,140578,Aramite,CalEPA,0.03,liver,"Oser BL and Oser M (1960). 2-(p-Tert-butylphenoxy) isopropyl2-chloroethyl sulfite (aramiite). 1. Acute, subacute, and chronic oral toxicity. Toxicol. Appl. Pharmacol. 2:441·457.",liver tumors,Dose,4,0,ppm diet,ppm diet,0,22,0,Rat,Albino,M/F,Both,Oral diet,NA,104,Weeks
164,140578,Aramite,CalEPA,0.03,liver,"Oser BL and Oser M (1960). 2-(p-Tert-butylphenoxy) isopropyl2-chloroethyl sulfite (aramiite). 1. Acute, subacute, and chronic oral toxicity. Toxicol. Appl. Pharmacol. 2:441·457.",liver tumors,Dose,4,500,ppm diet,ppm diet,38.72282609,20,0,Rat,Albino,M/F,Both,Oral diet,NA,104,Weeks
164,140578,Aramite,CalEPA,0.03,liver,"Oser BL and Oser M (1960). 2-(p-Tert-butylphenoxy) isopropyl2-chloroethyl sulfite (aramiite). 1. Acute, subacute, and chronic oral toxicity. Toxicol. Appl. Pharmacol. 2:441·457.",liver tumors,Dose,4,1500,ppm diet,ppm diet,116.1684783,21,2,Rat,Albino,M/F,Both,Oral diet,NA,104,Weeks
164,140578,Aramite,CalEPA,0.03,liver,"Oser BL and Oser M (1960). 2-(p-Tert-butylphenoxy) isopropyl2-chloroethyl sulfite (aramiite). 1. Acute, subacute, and chronic oral toxicity. Toxicol. Appl. Pharmacol. 2:441·457.",liver tumors,Dose,4,5000,ppm diet,ppm diet,387.2282609,20,6,Rat,Albino,M/F,Both,Oral diet,NA,104,Weeks
165,140578,Aramite,CalEPA,0.03,liver,"Popper H, Sternberg SS, Oser BL and Oser M (1960). The carcinogenic effect of aramite in rats. A study of hepatic nodules. Cancer 13: 1035-1046.",liver tumors (adenoma and carcinoma combined),Dose,4,0,ppm diet,ppm diet,0,193,0,Rat,Wistar,M/F,Both,Oral diet,NA,104,Weeks
165,140578,Aramite,CalEPA,0.03,liver,"Popper H, Sternberg SS, Oser BL and Oser M (1960). The carcinogenic effect of aramite in rats. A study of hepatic nodules. Cancer 13: 1035-1046.",liver tumors (adenoma and carcinoma combined),Dose,4,100,ppm diet,ppm diet,7.763157895,93,0,Rat,Wistar,M/F,Both,Oral diet,NA,104,Weeks
165,140578,Aramite,CalEPA,0.03,liver,"Popper H, Sternberg SS, Oser BL and Oser M (1960). The carcinogenic effect of aramite in rats. A study of hepatic nodules. Cancer 13: 1035-1046.",liver tumors (adenoma and carcinoma combined),Dose,4,200,ppm diet,ppm diet,15.52631579,100,0,Rat,Wistar,M/F,Both,Oral diet,NA,104,Weeks
165,140578,Aramite,CalEPA,0.03,liver,"Popper H, Sternberg SS, Oser BL and Oser M (1960). The carcinogenic effect of aramite in rats. A study of hepatic nodules. Cancer 13: 1035-1046.",liver tumors (adenoma and carcinoma combined),Dose,4,400,ppm diet,ppm diet,31.05263158,90,7,Rat,Wistar,M/F,Both,Oral diet,NA,104,Weeks
166,140578,Aramite,CalEPA,0.03,liver,"Popper H, Sternberg SS, Oser BL and Oser M (1960). The carcinogenic effect of aramite in rats. A study of hepatic nodules. Cancer 13: 1035-1046.",liver tumors (adenoma and carcinoma combined) FDRL,Dose,4,0,ppm diet,ppm diet,0,180,0,Rat,CF-N,M/F,Both,Oral diet,NA,104,Weeks
166,140578,Aramite,CalEPA,0.03,liver,"Popper H, Sternberg SS, Oser BL and Oser M (1960). The carcinogenic effect of aramite in rats. A study of hepatic nodules. Cancer 13: 1035-1046.",liver tumors (adenoma and carcinoma combined) FDRL,Dose,4,100,ppm diet,ppm diet,7.744565217,93,0,Rat,CF-N,M/F,Both,Oral diet,NA,104,Weeks
166,140578,Aramite,CalEPA,0.03,liver,"Popper H, Sternberg SS, Oser BL and Oser M (1960). The carcinogenic effect of aramite in rats. A study of hepatic nodules. Cancer 13: 1035-1046.",liver tumors (adenoma and carcinoma combined) FDRL,Dose,4,200,ppm diet,ppm diet,15.48913043,90,0,Rat,CF-N,M/F,Both,Oral diet,NA,104,Weeks
166,140578,Aramite,CalEPA,0.03,liver,"Popper H, Sternberg SS, Oser BL and Oser M (1960). The carcinogenic effect of aramite in rats. A study of hepatic nodules. Cancer 13: 1035-1046.",liver tumors (adenoma and carcinoma combined) FDRL,Dose,4,400,ppm diet,ppm diet,30.97826087,96,2,Rat,CF-N,M/F,Both,Oral diet,NA,104,Weeks
167,140578,Aramite,IRIS,0.025,liver,"Oser, B.L. and M. Oser. 1962. 2-(p-tert-Butylphenoxy)isopropyl 2-chloroethyl sulfite (aramite). II. Carcinogenicity. Toxicol. Appl. Pharmacol. 4: 70-88. 

Popper, H., S.S. Sternberg, B.L. Oser and M. Oser. 1960. The carcinogenic effect of aramite in rats: A study of hepatic nodules. Cancer. 13(5): 1035- 1046.",neoplastic liver nodules and carcinomas,HEq,4,0,mg/kg-day,ppm diet,0,193,2,Rat,,M/F,Both,Oral diet,7,104,Weeks
167,140578,Aramite,IRIS,0.025,liver,"Oser, B.L. and M. Oser. 1962. 2-(p-tert-Butylphenoxy)isopropyl 2-chloroethyl sulfite (aramite). II. Carcinogenicity. Toxicol. Appl. Pharmacol. 4: 70-88. 

Popper, H., S.S. Sternberg, B.L. Oser and M. Oser. 1960. The carcinogenic effect of aramite in rats: A study of hepatic nodules. Cancer. 13(5): 1035- 1046.",neoplastic liver nodules and carcinomas,HEq,4,0.78,mg/kg-day,ppm diet,0.78,93,2,Rat,,M/F,Both,Oral diet,7,104,Weeks
167,140578,Aramite,IRIS,0.025,liver,"Oser, B.L. and M. Oser. 1962. 2-(p-tert-Butylphenoxy)isopropyl 2-chloroethyl sulfite (aramite). II. Carcinogenicity. Toxicol. Appl. Pharmacol. 4: 70-88. 

Popper, H., S.S. Sternberg, B.L. Oser and M. Oser. 1960. The carcinogenic effect of aramite in rats: A study of hepatic nodules. Cancer. 13(5): 1035- 1046.",neoplastic liver nodules and carcinomas,HEq,4,1.57,mg/kg-day,ppm diet,1.57,100,3,Rat,,M/F,Both,Oral diet,7,104,Weeks
167,140578,Aramite,IRIS,0.025,liver,"Oser, B.L. and M. Oser. 1962. 2-(p-tert-Butylphenoxy)isopropyl 2-chloroethyl sulfite (aramite). II. Carcinogenicity. Toxicol. Appl. Pharmacol. 4: 70-88. 

Popper, H., S.S. Sternberg, B.L. Oser and M. Oser. 1960. The carcinogenic effect of aramite in rats: A study of hepatic nodules. Cancer. 13(5): 1035- 1046.",neoplastic liver nodules and carcinomas,HEq,4,3.14,mg/kg-day,ppm diet,3.14,90,20,Rat,,M/F,Both,Oral diet,7,104,Weeks
168,140885,Ethyl Acrylate,HEAST,0.048,stomach/forestomach,NTP (National Toxicology Program). 1986. Carcinogenesis studies of Ethyl Acrylate in F344/N rats and B6C3F1 mice (gavage studies).,forestomach (combined papilloma/carcinoma),Conv,3,0,mg/kg/day,mg/kg/dose,0,50,1,Rat,Fischer 344,M/F,M,Oral gavage,5,104,Weeks
168,140885,Ethyl Acrylate,HEAST,0.048,stomach/forestomach,NTP (National Toxicology Program). 1986. Carcinogenesis studies of Ethyl Acrylate in F344/N rats and B6C3F1 mice (gavage studies).,forestomach (combined papilloma/carcinoma),Conv,3,70.7,mg/kg/day,mg/kg/dose,70.7,50,18,Rat,Fischer 344,M/F,M,Oral gavage,5,104,Weeks
168,140885,Ethyl Acrylate,HEAST,0.048,stomach/forestomach,NTP (National Toxicology Program). 1986. Carcinogenesis studies of Ethyl Acrylate in F344/N rats and B6C3F1 mice (gavage studies).,forestomach (combined papilloma/carcinoma),Conv,3,141.5,mg/kg/day,mg/kg/dose,141.5,50,36,Rat,Fischer 344,M/F,M,Oral gavage,5,104,Weeks
169,143500,Kepone,CalEPA,16,liver,"National Cancer Institute (NCI, 1976). Report on the Carcinogenesis Bioassay of Kepone. NTIS Publication No. PB 264018. ·US Department of Health, Education and
Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant liver tumors,Dose,3,0,ppm diet (TWA),ppm diet (TWA),0,19,6,Mouse,B6C3F1,M/F,M,Oral diet,NA,80,Weeks
169,143500,Kepone,CalEPA,16,liver,"National Cancer Institute (NCI, 1976). Report on the Carcinogenesis Bioassay of Kepone. NTIS Publication No. PB 264018. ·US Department of Health, Education and
Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant liver tumors,Dose,3,20,ppm diet (TWA),ppm diet (TWA),3.431635389,48,39,Mouse,B6C3F1,M/F,M,Oral diet,NA,80,Weeks
169,143500,Kepone,CalEPA,16,liver,"National Cancer Institute (NCI, 1976). Report on the Carcinogenesis Bioassay of Kepone. NTIS Publication No. PB 264018. ·US Department of Health, Education and
Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant liver tumors,Dose,3,23,ppm diet (TWA),ppm diet (TWA),3.946380697,49,43,Mouse,B6C3F1,M/F,M,Oral diet,NA,80,Weeks
170,156105,p-Nitrosodiphenylamine,CalEPA,0.022,liver,"National Cancer Institute (NCI) 1979. Bioassay of p-Nitrosodiphenylamine for Possible Carcinogenicity. CAS No. 156-10-5. Carcinogenesis Technical Report Series No. 190. NCI-CG-TR-190 DHEW Publication No. (NIH) 79-1746. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",liver tumors,Dose,3,0,mg/kg-day,mg/kg-day,0,20,0,Rat,Fischer 344,M/F,M,Oral diet,NA,105,Weeks
170,156105,p-Nitrosodiphenylamine,CalEPA,0.022,liver,"National Cancer Institute (NCI) 1979. Bioassay of p-Nitrosodiphenylamine for Possible Carcinogenicity. CAS No. 156-10-5. Carcinogenesis Technical Report Series No. 190. NCI-CG-TR-190 DHEW Publication No. (NIH) 79-1746. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",liver tumors,Dose,3,74.3,mg/kg-day,mg/kg-day,74.3,50,10,Rat,Fischer 344,M/F,M,Oral diet,NA,105,Weeks
170,156105,p-Nitrosodiphenylamine,CalEPA,0.022,liver,"National Cancer Institute (NCI) 1979. Bioassay of p-Nitrosodiphenylamine for Possible Carcinogenicity. CAS No. 156-10-5. Carcinogenesis Technical Report Series No. 190. NCI-CG-TR-190 DHEW Publication No. (NIH) 79-1746. U.S. Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",liver tumors,Dose,3,149,mg/kg-day,mg/kg-day,149,50,19,Rat,Fischer 344,M/F,M,Oral diet,NA,105,Weeks
171,271896,Benzofuran,CalEPA,0.63,liver,"National Toxicology Program (NTP, 1989). Toxicology and Carcinogenicity Studies of Benzofuran (CAS No. 271-89-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP, U.S. Department of Health and Human Services, Research Triangle Park, North Carolina, Technical Report 370.","Hepatocellular adenoma, carcinoma, or hepatoblastoma",Conv,3,0,mg/kg/day (ADJ),mg/kg/day,0,48,12,Mouse,B6C3F1,M/F,M,Oral gavage,5,104,Weeks
171,271896,Benzofuran,CalEPA,0.63,liver,"National Toxicology Program (NTP, 1989). Toxicology and Carcinogenicity Studies of Benzofuran (CAS No. 271-89-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP, U.S. Department of Health and Human Services, Research Triangle Park, North Carolina, Technical Report 370.","Hepatocellular adenoma, carcinoma, or hepatoblastoma",Conv,3,42.9,mg/kg/day (ADJ),mg/kg/day,42.9,35,31,Mouse,B6C3F1,M/F,M,Oral gavage,5,104,Weeks
171,271896,Benzofuran,CalEPA,0.63,liver,"National Toxicology Program (NTP, 1989). Toxicology and Carcinogenicity Studies of Benzofuran (CAS No. 271-89-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP, U.S. Department of Health and Human Services, Research Triangle Park, North Carolina, Technical Report 370.","Hepatocellular adenoma, carcinoma, or hepatoblastoma",Conv,3,85.7,mg/kg/day (ADJ),mg/kg/day,85.7,43,40,Mouse,B6C3F1,M/F,M,Oral gavage,5,104,Weeks
172,271896,Benzofuran,CalEPA,0.63,lung,"National Toxicology Program (NTP, 1989). Toxicology and Carcinogenicity Studies of Benzofuran (CAS No. 271-89-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP, U.S. Department of Health and Human Services, Research Triangle Park, North Carolina, Technical Report 370.",Alveolar/bronchiolar adenoma or carcinoma,Conv,3,0,mg/kg/day,mg/kg/day,0,48,10,Mouse,B6C3F1,M/F,M,Oral gavage,5,104,Weeks
172,271896,Benzofuran,CalEPA,0.63,lung,"National Toxicology Program (NTP, 1989). Toxicology and Carcinogenicity Studies of Benzofuran (CAS No. 271-89-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP, U.S. Department of Health and Human Services, Research Triangle Park, North Carolina, Technical Report 370.",Alveolar/bronchiolar adenoma or carcinoma,Conv,3,42.9,mg/kg/day,mg/kg/day,42.9,35,9,Mouse,B6C3F1,M/F,M,Oral gavage,5,104,Weeks
172,271896,Benzofuran,CalEPA,0.63,lung,"National Toxicology Program (NTP, 1989). Toxicology and Carcinogenicity Studies of Benzofuran (CAS No. 271-89-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP, U.S. Department of Health and Human Services, Research Triangle Park, North Carolina, Technical Report 370.",Alveolar/bronchiolar adenoma or carcinoma,Conv,3,85.7,mg/kg/day,mg/kg/day,85.7,35,19,Mouse,B6C3F1,M/F,M,Oral gavage,5,104,Weeks
173,271896,Benzofuran,CalEPA,0.63,stomach/forestomach,"National Toxicology Program (NTP, 1989). Toxicology and Carcinogenicity Studies of Benzofuran (CAS No. 271-89-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP, U.S. Department of Health and Human Services, Research Triangle Park, North Carolina, Technical Report 370.",Squamous-cell papilloma or carcinoma,Conv,3,0,mg/kg/day (ADJ),mg/kg/day,0,49,2,Mouse,B6C3F1,M/F,M,Oral gavage,5,104,Weeks
173,271896,Benzofuran,CalEPA,0.63,stomach/forestomach,"National Toxicology Program (NTP, 1989). Toxicology and Carcinogenicity Studies of Benzofuran (CAS No. 271-89-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP, U.S. Department of Health and Human Services, Research Triangle Park, North Carolina, Technical Report 370.",Squamous-cell papilloma or carcinoma,Conv,3,42.9,mg/kg/day (ADJ),mg/kg/day,42.9,39,11,Mouse,B6C3F1,M/F,M,Oral gavage,5,104,Weeks
173,271896,Benzofuran,CalEPA,0.63,stomach/forestomach,"National Toxicology Program (NTP, 1989). Toxicology and Carcinogenicity Studies of Benzofuran (CAS No. 271-89-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP, U.S. Department of Health and Human Services, Research Triangle Park, North Carolina, Technical Report 370.",Squamous-cell papilloma or carcinoma,Conv,3,85.7,mg/kg/day (ADJ),mg/kg/day,85.7,48,13,Mouse,B6C3F1,M/F,M,Oral gavage,5,104,Weeks
174,303344,Lasiocarpine,CalEPA,7.8,liver,"National Cancer Institute (NCI, 1978). Bioassay of Lasiocarpine for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 39. NTIS Publication No. PB 278641. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant liver tumors (combined incidence),Dose,4,0,ppm,ppm,0,24,0,Rat,Fischer 344,M/F,M,Oral diet,NA,104,Weeks
174,303344,Lasiocarpine,CalEPA,7.8,liver,"National Cancer Institute (NCI, 1978). Bioassay of Lasiocarpine for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 39. NTIS Publication No. PB 278641. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant liver tumors (combined incidence),Dose,4,7,ppm,ppm,0.552631579,24,0,Rat,Fischer 344,M/F,M,Oral diet,NA,104,Weeks
174,303344,Lasiocarpine,CalEPA,7.8,liver,"National Cancer Institute (NCI, 1978). Bioassay of Lasiocarpine for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 39. NTIS Publication No. PB 278641. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant liver tumors (combined incidence),Dose,4,15,ppm,ppm,1.184210526,24,3,Rat,Fischer 344,M/F,M,Oral diet,NA,104,Weeks
174,303344,Lasiocarpine,CalEPA,7.8,liver,"National Cancer Institute (NCI, 1978). Bioassay of Lasiocarpine for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 39. NTIS Publication No. PB 278641. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant liver tumors (combined incidence),Dose,4,30,ppm,ppm,2.368421053,24,5,Rat,Fischer 344,M/F,M,Oral diet,NA,104,Weeks
175,309002,Aldrin,CalEPA,17,liver,NCI (National Cancer Institute). 1978. Bioassays of aldrin and dieldrin for possible carcinogenicity. DHE,liver carcinoma,HEq,3,0,mg/kg-day,ppm,0,20,3,Mouse,B6C3F1,M/F,M,Oral diet,NA,80,Weeks
175,309002,Aldrin,CalEPA,17,liver,NCI (National Cancer Institute). 1978. Bioassays of aldrin and dieldrin for possible carcinogenicity. DHE,liver carcinoma,HEq,3,0.04,mg/kg-day,ppm,0.04,49,16,Mouse,B6C3F1,M/F,M,Oral diet,NA,80,Weeks
175,309002,Aldrin,CalEPA,17,liver,NCI (National Cancer Institute). 1978. Bioassays of aldrin and dieldrin for possible carcinogenicity. DHE,liver carcinoma,HEq,3,0.08,mg/kg-day,ppm,0.08,45,25,Mouse,B6C3F1,M/F,M,Oral diet,NA,80,Weeks
176,309002,Aldrin,IRIS,17,liver,"Davis, K.J. 1965. Pathology report on mice fed dieldrin, aldrin, heptachlor, or heptachlor epoxide for two years. Internal FDA memorandum to Dr. A.J. Lehrman, July 19.",liver carcinoma: incidence in NCI 1978,HEq,3,0,mg/kg-day,ppm,0,20,3,Mouse,C3H,M/F,M,Oral diet,NA,2,Years
176,309002,Aldrin,IRIS,17,liver,"Davis, K.J. 1965. Pathology report on mice fed dieldrin, aldrin, heptachlor, or heptachlor epoxide for two years. Internal FDA memorandum to Dr. A.J. Lehrman, July 19.",liver carcinoma: incidence in NCI 1978,HEq,3,0.04,mg/kg-day,ppm,0.04,49,16,Mouse,C3H,M/F,M,Oral diet,NA,2,Years
176,309002,Aldrin,IRIS,17,liver,"Davis, K.J. 1965. Pathology report on mice fed dieldrin, aldrin, heptachlor, or heptachlor epoxide for two years. Internal FDA memorandum to Dr. A.J. Lehrman, July 19.",liver carcinoma: incidence in NCI 1978,HEq,3,0.08,mg/kg-day,ppm,0.08,45,25,Mouse,C3H,M/F,M,Oral diet,NA,2,Years
177,309002,Aldrin,IRIS,17,liver,NCI (National Cancer Institute). 1978. Bioassays of aldrin and dieldrin for possible carcinogenicity. DHEW Publication No. (NIH) 78-821. NCI Carcinogenesis Tech. Rep. Ser. No. 21. NCI-C6-TR-21.,liver carcinoma,HEq,3,0,mg/kg-day,ppm,0,20,3,Mouse,B6C3F1,M/F,M,Oral diet,NA,80,Weeks
177,309002,Aldrin,IRIS,17,liver,NCI (National Cancer Institute). 1978. Bioassays of aldrin and dieldrin for possible carcinogenicity. DHEW Publication No. (NIH) 78-821. NCI Carcinogenesis Tech. Rep. Ser. No. 21. NCI-C6-TR-21.,liver carcinoma,HEq,3,0.04,mg/kg-day,ppm,0.04,49,16,Mouse,B6C3F1,M/F,M,Oral diet,NA,80,Weeks
177,309002,Aldrin,IRIS,17,liver,NCI (National Cancer Institute). 1978. Bioassays of aldrin and dieldrin for possible carcinogenicity. DHEW Publication No. (NIH) 78-821. NCI Carcinogenesis Tech. Rep. Ser. No. 21. NCI-C6-TR-21.,liver carcinoma,HEq,3,0.08,mg/kg-day,ppm,0.08,45,25,Mouse,B6C3F1,M/F,M,Oral diet,NA,80,Weeks
178,319846,alpha-Hexachlorocyclohexane,IRIS,6.3,liver,"Ito, N., H. Nagasaki, M. Arai, S. Sugihara and S. Makiura. 1973a. Histologic and ultrastructural studies on the hepatocarcinogenicity of benzene hexachloride in mice. J. Natl. Cancer Inst. 51(3): 817-826.",hepatic nodules and hepatocellular carcinomas,HEq,4,0,mg/kg-day,ppm,0,20,0,Mouse,,M,Both,Oral diet,NA,24,Weeks
178,319846,alpha-Hexachlorocyclohexane,IRIS,6.3,liver,"Ito, N., H. Nagasaki, M. Arai, S. Sugihara and S. Makiura. 1973a. Histologic and ultrastructural studies on the hepatocarcinogenicity of benzene hexachloride in mice. J. Natl. Cancer Inst. 51(3): 817-826.",hepatic nodules and hepatocellular carcinomas,HEq,4,0.012,mg/kg-day,ppm,0.012,20,0,Mouse,,M,Both,Oral diet,NA,24,Weeks
178,319846,alpha-Hexachlorocyclohexane,IRIS,6.3,liver,"Ito, N., H. Nagasaki, M. Arai, S. Sugihara and S. Makiura. 1973a. Histologic and ultrastructural studies on the hepatocarcinogenicity of benzene hexachloride in mice. J. Natl. Cancer Inst. 51(3): 817-826.",hepatic nodules and hepatocellular carcinomas,HEq,4,0.035,mg/kg-day,ppm,0.035,38,30,Mouse,,M,Both,Oral diet,NA,24,Weeks
178,319846,alpha-Hexachlorocyclohexane,IRIS,6.3,liver,"Ito, N., H. Nagasaki, M. Arai, S. Sugihara and S. Makiura. 1973a. Histologic and ultrastructural studies on the hepatocarcinogenicity of benzene hexachloride in mice. J. Natl. Cancer Inst. 51(3): 817-826.",hepatic nodules and hepatocellular carcinomas,HEq,4,0.06,mg/kg-day,ppm,0.06,20,20,Mouse,,M,Both,Oral diet,NA,24,Weeks
179,389082,Nalidixic Acid,CalEPA,0.025,other endocrine or exocrine,"National Toxicology Program (NTP, 1989). Toxicology and Carcinogenesis Studies of Nalidixic Acid (CAS No. 389-08-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 368. NIH Publication No. 90-2823. U.S. Department of Health and Human Services, NTP, Research Triangle Park, NC.",preputial gland tumors in male rats,Dose,3,0,mg/kg day,mg/kg day,0,50,3,Rat,Fischer 344,M/F,M,Oral diet,NA,24,Months
179,389082,Nalidixic Acid,CalEPA,0.025,other endocrine or exocrine,"National Toxicology Program (NTP, 1989). Toxicology and Carcinogenesis Studies of Nalidixic Acid (CAS No. 389-08-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 368. NIH Publication No. 90-2823. U.S. Department of Health and Human Services, NTP, Research Triangle Park, NC.",preputial gland tumors in male rats,Dose,3,79.2,mg/kg day,mg/kg day,79.2,50,19,Rat,Fischer 344,M/F,M,Oral diet,NA,24,Months
179,389082,Nalidixic Acid,CalEPA,0.025,other endocrine or exocrine,"National Toxicology Program (NTP, 1989). Toxicology and Carcinogenesis Studies of Nalidixic Acid (CAS No. 389-08-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 368. NIH Publication No. 90-2823. U.S. Department of Health and Human Services, NTP, Research Triangle Park, NC.",preputial gland tumors in male rats,Dose,3,159,mg/kg day,mg/kg day,159,50,20,Rat,Fischer 344,M/F,M,Oral diet,NA,24,Months
180,510156,Chlorobenzilate,CalEPA,0.11,liver,"National Cancer Institute (NCI, 1978). Bioassay of Chlorobenzilate for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 75. NTIS Publication No. PB 287123. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinoma,Dose,3,0,ppm (TWA),ppm (TWA),0,19,4,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
180,510156,Chlorobenzilate,CalEPA,0.11,liver,"National Cancer Institute (NCI, 1978). Bioassay of Chlorobenzilate for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 75. NTIS Publication No. PB 287123. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinoma,Dose,3,4231,ppm (TWA),ppm (TWA),725.9624665,48,32,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
180,510156,Chlorobenzilate,CalEPA,0.11,liver,"National Cancer Institute (NCI, 1978). Bioassay of Chlorobenzilate for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 75. NTIS Publication No. PB 287123. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinoma,Dose,3,7846,ppm (TWA),ppm (TWA),1346.230563,45,22,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
181,510156,Chlorobenzilate,CalEPA,0.11,liver,"National Cancer Institute (NCI, 1978). Bioassay of Chlorobenzilate for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 75. NTIS Publication No. PB 287123. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinoma,Dose,3,0,ppm (TWA),ppm (TWA),0,20,0,Mouse,B6C3F1,M/F,F,Oral diet,NA,78,Weeks
181,510156,Chlorobenzilate,CalEPA,0.11,liver,"National Cancer Institute (NCI, 1978). Bioassay of Chlorobenzilate for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 75. NTIS Publication No. PB 287123. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinoma,Dose,3,3200,ppm (TWA),ppm (TWA),552.9745042,49,11,Mouse,B6C3F1,M/F,F,Oral diet,NA,78,Weeks
181,510156,Chlorobenzilate,CalEPA,0.11,liver,"National Cancer Institute (NCI, 1978). Bioassay of Chlorobenzilate for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 75. NTIS Publication No. PB 287123. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinoma,Dose,3,5908,ppm (TWA),ppm (TWA),1020.929178,50,13,Mouse,B6C3F1,M/F,F,Oral diet,NA,78,Weeks
182,512561,Trimethyl phospahte,CalEPA,0.029,female repro,"National Cancer Institute (NCI, 1978). Bioassay of Trimethylphosphate for Possible Carcinogenicity (CAS No. 512-56-1). NIH Technical Reports Series No. 81. NIH
Expedited NSRLs for -15- May 2001 Six Proposition 65 Carcinogens OEHHA Publication No. 78-1331. U.S. Department of Health, Education and Welfare, Public Health Service, National Institutes of Health.",uterus endometrium adenocarcinoma,Dose,3,0,mg/kg-day,mg/kg-day,0,20,0,Mouse,B6C3F1,M/F,F,Oral gavage,7,24,Months
182,512561,Trimethyl phospahte,CalEPA,0.029,female repro,"National Cancer Institute (NCI, 1978). Bioassay of Trimethylphosphate for Possible Carcinogenicity (CAS No. 512-56-1). NIH Technical Reports Series No. 81. NIH
Expedited NSRLs for -15- May 2001 Six Proposition 65 Carcinogens OEHHA Publication No. 78-1331. U.S. Department of Health, Education and Welfare, Public Health Service, National Institutes of Health.",uterus endometrium adenocarcinoma,Dose,3,107,mg/kg-day,mg/kg-day,107,50,7,Mouse,B6C3F1,M/F,F,Oral gavage,7,24,Months
182,512561,Trimethyl phospahte,CalEPA,0.029,female repro,"National Cancer Institute (NCI, 1978). Bioassay of Trimethylphosphate for Possible Carcinogenicity (CAS No. 512-56-1). NIH Technical Reports Series No. 81. NIH
Expedited NSRLs for -15- May 2001 Six Proposition 65 Carcinogens OEHHA Publication No. 78-1331. U.S. Department of Health, Education and Welfare, Public Health Service, National Institutes of Health.",uterus endometrium adenocarcinoma,Dose,3,214,mg/kg-day,mg/kg-day,214,49,13,Mouse,B6C3F1,M/F,F,Oral gavage,7,24,Months
183,512561,Trimethyl phospahte,PPRTV,0.02,female repro,"NCI (National Cancer Institute). (1978) Bioassay of trimethyl phosphate for possible carcinogenicity. NCI Carcinogenesis Tech. Rep. Ser. No. 81. Available online at
http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr081.pdf (accessed September 15, 2009).",uterine endometrial adenocarcinoma,HEq,3,0,mg/kg-day,mg/kg-day,0,16,0,Mouse,B6C3F1,M/F,F,Oral gavage,3,103,Weeks
183,512561,Trimethyl phospahte,PPRTV,0.02,female repro,"NCI (National Cancer Institute). (1978) Bioassay of trimethyl phosphate for possible carcinogenicity. NCI Carcinogenesis Tech. Rep. Ser. No. 81. Available online at
http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr081.pdf (accessed September 15, 2009).",uterine endometrial adenocarcinoma,HEq,3,16,mg/kg-day,mg/kg-day,16,40,7,Mouse,B6C3F1,M/F,F,Oral gavage,3,103,Weeks
183,512561,Trimethyl phospahte,PPRTV,0.02,female repro,"NCI (National Cancer Institute). (1978) Bioassay of trimethyl phosphate for possible carcinogenicity. NCI Carcinogenesis Tech. Rep. Ser. No. 81. Available online at
http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr081.pdf (accessed September 15, 2009).",uterine endometrial adenocarcinoma,HEq,3,32,mg/kg-day,mg/kg-day,32,37,13,Mouse,B6C3F1,M/F,F,Oral gavage,3,103,Weeks
184,513371,Dimethylvinylchloride,CalEPA,0.045,stomach/forestomach,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Dimethylvinyl Chloride (l-chloro-2-methyl-propene) in F344IN Rats and B6C3F1 Mice (Gavage Studies). NTP Technical Report Series No. 316. NIH Publication No. 86-2572. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant forestomach tumors (squamous cell carcinoma),Conv,3,0,mg/kg-day (ADJ),mg/kg-day,0,50,0,Mouse,B6C3F1,M/F,Both,Oral gavage,5,102,Weeks
184,513371,Dimethylvinylchloride,CalEPA,0.045,stomach/forestomach,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Dimethylvinyl Chloride (l-chloro-2-methyl-propene) in F344IN Rats and B6C3F1 Mice (Gavage Studies). NTP Technical Report Series No. 316. NIH Publication No. 86-2572. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant forestomach tumors (squamous cell carcinoma),Conv,3,71,mg/kg-day (ADJ),mg/kg-day,71,47,40,Mouse,B6C3F1,M/F,Both,Oral gavage,5,102,Weeks
184,513371,Dimethylvinylchloride,CalEPA,0.045,stomach/forestomach,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Dimethylvinyl Chloride (l-chloro-2-methyl-propene) in F344IN Rats and B6C3F1 Mice (Gavage Studies). NTP Technical Report Series No. 316. NIH Publication No. 86-2572. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant forestomach tumors (squamous cell carcinoma),Conv,3,143,mg/kg-day (ADJ),mg/kg-day,143,43,36,Mouse,B6C3F1,M/F,Both,Oral gavage,5,102,Weeks
185,513371,Dimethylvinylchloride,CalEPA,0.045,stomach/forestomach,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Dimethylvinyl Chloride (l-chloro-2-methyl-propene) in F344IN Rats and B6C3F1 Mice (Gavage Studies). NTP Technical Report Series No. 316. NIH Publication No. 86-2572. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant forestomach tumors (squamous cell papilloma),Conv,3,0,mg/kg-day (ADJ),mg/kg-day,0,50,0,Mouse,B6C3F1,M/F,F,Oral gavage,5,102,Weeks
185,513371,Dimethylvinylchloride,CalEPA,0.045,stomach/forestomach,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Dimethylvinyl Chloride (l-chloro-2-methyl-propene) in F344IN Rats and B6C3F1 Mice (Gavage Studies). NTP Technical Report Series No. 316. NIH Publication No. 86-2572. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant forestomach tumors (squamous cell papilloma),Conv,3,71,mg/kg-day (ADJ),mg/kg-day,71,47,1,Mouse,B6C3F1,M/F,F,Oral gavage,5,102,Weeks
185,513371,Dimethylvinylchloride,CalEPA,0.045,stomach/forestomach,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Dimethylvinyl Chloride (l-chloro-2-methyl-propene) in F344IN Rats and B6C3F1 Mice (Gavage Studies). NTP Technical Report Series No. 316. NIH Publication No. 86-2572. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant forestomach tumors (squamous cell papilloma),Conv,3,143,mg/kg-day (ADJ),mg/kg-day,143,43,3,Mouse,B6C3F1,M/F,F,Oral gavage,5,102,Weeks
186,542756,"1,3-Dichloropropene, mixed isomer",IRIS,0.1,liver,"Stott, WT; Johnson, KA; Jeffries, TK; et al. (1995) Telone II soil fumigant: two-year chronic toxicity/oncogenicity study in Fischer 344 rats. Dow Chemical Company, Midland, MI. Study # M-003993-031l",hepatocellular adenoma/carcinoma,HEq,4,0,mg/kg-day,mg/kg-day,0,49,2,Rat,Fischer 344,M/F,M,Oral diet,NA,24,Months
186,542756,"1,3-Dichloropropene, mixed isomer",IRIS,0.1,liver,"Stott, WT; Johnson, KA; Jeffries, TK; et al. (1995) Telone II soil fumigant: two-year chronic toxicity/oncogenicity study in Fischer 344 rats. Dow Chemical Company, Midland, MI. Study # M-003993-031l",hepatocellular adenoma/carcinoma,HEq,4,0.65,mg/kg-day,mg/kg-day,0.65,50,4,Rat,Fischer 344,M/F,M,Oral diet,NA,24,Months
186,542756,"1,3-Dichloropropene, mixed isomer",IRIS,0.1,liver,"Stott, WT; Johnson, KA; Jeffries, TK; et al. (1995) Telone II soil fumigant: two-year chronic toxicity/oncogenicity study in Fischer 344 rats. Dow Chemical Company, Midland, MI. Study # M-003993-031l",hepatocellular adenoma/carcinoma,HEq,4,3.22,mg/kg-day,mg/kg-day,3.22,50,6,Rat,Fischer 344,M/F,M,Oral diet,NA,24,Months
186,542756,"1,3-Dichloropropene, mixed isomer",IRIS,0.1,liver,"Stott, WT; Johnson, KA; Jeffries, TK; et al. (1995) Telone II soil fumigant: two-year chronic toxicity/oncogenicity study in Fischer 344 rats. Dow Chemical Company, Midland, MI. Study # M-003993-031l",hepatocellular adenoma/carcinoma,HEq,4,6.31,mg/kg-day,mg/kg-day,6.31,49,10,Rat,Fischer 344,M/F,M,Oral diet,NA,24,Months
187,542756,"1,3-Dichloropropene, mixed isomer",IRIS,0.1,bladder,"NTP (National Toxicology Program). (1985) Toxicology and carcinogenesis studies of Telone II (technical grade 1,3-dichloropropene containing 1% epichlorohydrin as a stabilizer) in F344/N rats and B6C3F1 mice (gavage studies). U.S. Dept. of Health and Human Services, Technical Report Series No. 269.",urinary bladder carcinoma,HEq,3,0,mg/kg-day,mg/kg-day,0,50,0,Mouse,B6C3F1,M/F,F,Oral gavage,3,104,Weeks
187,542756,"1,3-Dichloropropene, mixed isomer",IRIS,0.1,bladder,"NTP (National Toxicology Program). (1985) Toxicology and carcinogenesis studies of Telone II (technical grade 1,3-dichloropropene containing 1% epichlorohydrin as a stabilizer) in F344/N rats and B6C3F1 mice (gavage studies). U.S. Dept. of Health and Human Services, Technical Report Series No. 269.",urinary bladder carcinoma,HEq,3,2.88,mg/kg-day,mg/kg-day,2.88,50,8,Mouse,B6C3F1,M/F,F,Oral gavage,3,104,Weeks
187,542756,"1,3-Dichloropropene, mixed isomer",IRIS,0.1,bladder,"NTP (National Toxicology Program). (1985) Toxicology and carcinogenesis studies of Telone II (technical grade 1,3-dichloropropene containing 1% epichlorohydrin as a stabilizer) in F344/N rats and B6C3F1 mice (gavage studies). U.S. Dept. of Health and Human Services, Technical Report Series No. 269.",urinary bladder carcinoma,HEq,3,5.81,mg/kg-day,mg/kg-day,5.81,47,21,Mouse,B6C3F1,M/F,F,Oral gavage,3,104,Weeks
188,542756,"1,3-Dichloropropene, mixed isomer",IRIS,0.1,kidneys,"NTP (National Toxicology Program). (1985) Toxicology and carcinogenesis studies of Telone II (technical grade 1,3-dichloropropene containing 1% epichlorohydrin as a stabilizer) in F344/N rats and B6C3F1 mice (gavage studies). U.S. Dept. of Health and Human Services, Technical Report Series No. 269.",hepatocellular adenoma/carcinoma,HEq,3,0,mg/kg-day,mg/kg-day,0,49,1,Rat,Fischer 344,M/F,M,Oral gavage,3,104,Weeks
188,542756,"1,3-Dichloropropene, mixed isomer",IRIS,0.1,kidneys,"NTP (National Toxicology Program). (1985) Toxicology and carcinogenesis studies of Telone II (technical grade 1,3-dichloropropene containing 1% epichlorohydrin as a stabilizer) in F344/N rats and B6C3F1 mice (gavage studies). U.S. Dept. of Health and Human Services, Technical Report Series No. 269.",hepatocellular adenoma/carcinoma,HEq,3,2.74,mg/kg-day,mg/kg-day,2.74,48,6,Rat,Fischer 344,M/F,M,Oral gavage,3,104,Weeks
188,542756,"1,3-Dichloropropene, mixed isomer",IRIS,0.1,kidneys,"NTP (National Toxicology Program). (1985) Toxicology and carcinogenesis studies of Telone II (technical grade 1,3-dichloropropene containing 1% epichlorohydrin as a stabilizer) in F344/N rats and B6C3F1 mice (gavage studies). U.S. Dept. of Health and Human Services, Technical Report Series No. 269.",hepatocellular adenoma/carcinoma,HEq,3,5.4,mg/kg-day,mg/kg-day,5.4,50,8,Rat,Fischer 344,M/F,M,Oral gavage,3,104,Weeks
189,563473,3-Chloro-2-methylpropene,CalEPA,0.14,stomach/forestomach,"National Toxicology Program (NrP, 1986). Toxicology and Carcinogenesis Studies of 3-Chloro-2-methylpropene in F344IN Rats and B6C3F1 Mice (Gavage Studies). NTP
Technical Report Series No. 300. NIH Publication No. 86-2556. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant forestomach tumors,Dose,3,0,mg/kg/day,mg/kg/day,0,49,3,Mouse,B6C3F1,M/F,M,Oral gavage,5,103,Weeks
189,563473,3-Chloro-2-methylpropene,CalEPA,0.14,stomach/forestomach,"National Toxicology Program (NrP, 1986). Toxicology and Carcinogenesis Studies of 3-Chloro-2-methylpropene in F344IN Rats and B6C3F1 Mice (Gavage Studies). NTP
Technical Report Series No. 300. NIH Publication No. 86-2556. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant forestomach tumors,Dose,3,100,mg/kg/day,mg/kg/day,71.42857143,49,24,Mouse,B6C3F1,M/F,M,Oral gavage,5,103,Weeks
189,563473,3-Chloro-2-methylpropene,CalEPA,0.14,stomach/forestomach,"National Toxicology Program (NrP, 1986). Toxicology and Carcinogenesis Studies of 3-Chloro-2-methylpropene in F344IN Rats and B6C3F1 Mice (Gavage Studies). NTP
Technical Report Series No. 300. NIH Publication No. 86-2556. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant forestomach tumors,Dose,3,200,mg/kg/day,mg/kg/day,142.8571429,49,36,Mouse,B6C3F1,M/F,M,Oral gavage,5,103,Weeks
190,569619,C.I. Basic Red 9 Monohydrochloride,CalEPA,240,liver,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of C.l. Basic Red 9 Monohydrochloride in F344/N Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 196. NIH Publication No. 86-2541. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",hepatocellular carcinoma,Conv,3,0,mg/kg-day,ppm diet,0,49,3,Mouse,B6C3F1,M/F,F,Oral diet,NA,104,Weeks
190,569619,C.I. Basic Red 9 Monohydrochloride,CalEPA,240,liver,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of C.l. Basic Red 9 Monohydrochloride in F344/N Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 196. NIH Publication No. 86-2541. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",hepatocellular carcinoma,Conv,3,149,mg/kg-day,ppm diet,149,50,19,Mouse,B6C3F1,M/F,F,Oral diet,NA,104,Weeks
190,569619,C.I. Basic Red 9 Monohydrochloride,CalEPA,240,liver,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of C.l. Basic Red 9 Monohydrochloride in F344/N Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 196. NIH Publication No. 86-2541. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",hepatocellular carcinoma,Conv,3,407,mg/kg-day,ppm diet,407,49,37,Mouse,B6C3F1,M/F,F,Oral diet,NA,104,Weeks
191,598550,Methyl Carbamate,CalEPA,0.0044,liver,"National Toxicology Program (NTP, 1987). Toxicology and Carcinogenesis Studies of Methyl Carbamate (CAS No. 598-55-0) in F344/N Rats and B6C3F1 Mice (Gavage
Studies). NTP Technical Report Series No. 328. NIH Publication No. 88-2584. U.S. Department of Health and Human Services, NTP, Research Triangle Park, NC.",liver tumors,Dose,3,0,mg/kg/day,mg/kg/day,0,50,0,Rat,Fischer 344,M/F,F,Oral gavage,NA,24,Months
191,598550,Methyl Carbamate,CalEPA,0.0044,liver,"National Toxicology Program (NTP, 1987). Toxicology and Carcinogenesis Studies of Methyl Carbamate (CAS No. 598-55-0) in F344/N Rats and B6C3F1 Mice (Gavage
Studies). NTP Technical Report Series No. 328. NIH Publication No. 88-2584. U.S. Department of Health and Human Services, NTP, Research Triangle Park, NC.",liver tumors,Dose,3,70.7,mg/kg/day,mg/kg/day,70.7,50,0,Rat,Fischer 344,M/F,F,Oral gavage,NA,24,Months
191,598550,Methyl Carbamate,CalEPA,0.0044,liver,"National Toxicology Program (NTP, 1987). Toxicology and Carcinogenesis Studies of Methyl Carbamate (CAS No. 598-55-0) in F344/N Rats and B6C3F1 Mice (Gavage
Studies). NTP Technical Report Series No. 328. NIH Publication No. 88-2584. U.S. Department of Health and Human Services, NTP, Research Triangle Park, NC.",liver tumors,Dose,3,142,mg/kg/day,mg/kg/day,142,50,6,Rat,Fischer 344,M/F,F,Oral gavage,NA,24,Months
192,602879,5-Nitroacenaphthene,CalEPA,0.13,auditory system,"National Cancer Institute (NCI, 1978). Bioassay of 5-Nuroacenaphthene for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 118. NTIS Publication No. PB 287347. US Department of Health, Education and Welfare (DHEW), NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant tumors of the ear canal,Dose,3,0,% diet,% diet,0,99,0,Rat,Fischer 344,M/F,F,Oral diet,NA,78,Weeks
192,602879,5-Nitroacenaphthene,CalEPA,0.13,auditory system,"National Cancer Institute (NCI, 1978). Bioassay of 5-Nuroacenaphthene for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 118. NTIS Publication No. PB 287347. US Department of Health, Education and Welfare (DHEW), NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant tumors of the ear canal,Dose,3,0.12,% diet,% diet,110.0436681,49,27,Rat,Fischer 344,M/F,F,Oral diet,NA,78,Weeks
192,602879,5-Nitroacenaphthene,CalEPA,0.13,auditory system,"National Cancer Institute (NCI, 1978). Bioassay of 5-Nuroacenaphthene for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 118. NTIS Publication No. PB 287347. US Department of Health, Education and Welfare (DHEW), NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant tumors of the ear canal,Dose,3,0.24,% diet,% diet,220.0873362,47,35,Rat,Fischer 344,M/F,F,Oral diet,NA,78,Weeks
193,621647,N-Nitrosodipropylamine,CalEPA,7,liver,"Druckrey H, Preussmann R, Ivankovic S, and Schmähl D. 1967. Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten. Z Krebsforsch 69:103-201.",hepatocellular carcinoma,Dose,4,4,mg/kg-day,mg/kg/day,4,16,14,Rat,BD,Unspecified,Both,Oral drinking water,NA,lifetime,Duration
193,621647,N-Nitrosodipropylamine,CalEPA,7,liver,"Druckrey H, Preussmann R, Ivankovic S, and Schmähl D. 1967. Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten. Z Krebsforsch 69:103-201.",hepatocellular carcinoma,Dose,4,8,mg/kg-day,mg/kg/day,8,16,15,Rat,BD,Unspecified,Both,Oral drinking water,NA,lifetime,Duration
193,621647,N-Nitrosodipropylamine,CalEPA,7,liver,"Druckrey H, Preussmann R, Ivankovic S, and Schmähl D. 1967. Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten. Z Krebsforsch 69:103-201.",hepatocellular carcinoma,Dose,4,15,mg/kg-day,mg/kg/day,15,15,15,Rat,BD,Unspecified,Both,Oral drinking water,NA,lifetime,Duration
193,621647,N-Nitrosodipropylamine,CalEPA,7,liver,"Druckrey H, Preussmann R, Ivankovic S, and Schmähl D. 1967. Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten. Z Krebsforsch 69:103-201.",hepatocellular carcinoma,Dose,4,30,mg/kg-day,mg/kg/day,30,1,1,Rat,BD,Unspecified,Both,Oral drinking water,NA,lifetime,Duration
194,630206,"1,1,1,2-Tetrachloroethane",IRIS,0.026,liver,"NTP (National Toxicology Program). 1983. Carcinogenesis studies of 1,1,1,2- tetrachloroethane in F344/N rats and B6C3F1 mice (gavage studies). NTP-81-53; NIH Publ.
No. 83-1793; NTP Technical Report Series No. 237. NTIS, Springfield, VA.",hepatocellular adenoma or carcinoma,HEq,3,0,mg/kg/day,mg/kg/day,0,49,5,Mouse,B6C3F1,M/F,F,Oral gavage,5,103,Weeks
194,630206,"1,1,1,2-Tetrachloroethane",IRIS,0.026,liver,"NTP (National Toxicology Program). 1983. Carcinogenesis studies of 1,1,1,2- tetrachloroethane in F344/N rats and B6C3F1 mice (gavage studies). NTP-81-53; NIH Publ.
No. 83-1793; NTP Technical Report Series No. 237. NTIS, Springfield, VA.",hepatocellular adenoma or carcinoma,HEq,3,14.8,mg/kg/day,mg/kg/day,14.8,46,13,Mouse,B6C3F1,M/F,F,Oral gavage,5,103,Weeks
194,630206,"1,1,1,2-Tetrachloroethane",IRIS,0.026,liver,"NTP (National Toxicology Program). 1983. Carcinogenesis studies of 1,1,1,2- tetrachloroethane in F344/N rats and B6C3F1 mice (gavage studies). NTP-81-53; NIH Publ.
No. 83-1793; NTP Technical Report Series No. 237. NTIS, Springfield, VA.",hepatocellular adenoma or carcinoma,HEq,3,27.6,mg/kg/day,mg/kg/day,27.6,48,30,Mouse,B6C3F1,M/F,F,Oral gavage,5,103,Weeks
195,634935,"Trichloroaniline, 2,4,6-",HEAST,0.034,vascular system,"Weisburger, E.L., A.B. Russfield, F. Homburger, et al. 1978. Testing of 21 environmental aromatic Amines or derivatives for long term toxicity or carcinogenicity. J Environ Pathol Toxicol. 2: 325-356.",vascular system tumors,Conv,3,0,"mg 2,4,6-Trichloroaniline HCl/kg/day (ADJ)","ppm 2,4,6-Trichloroaniline HCl (TWA)",0,16,2,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
195,634935,"Trichloroaniline, 2,4,6-",HEAST,0.034,vascular system,"Weisburger, E.L., A.B. Russfield, F. Homburger, et al. 1978. Testing of 21 environmental aromatic Amines or derivatives for long term toxicity or carcinogenicity. J Environ Pathol Toxicol. 2: 325-356.",vascular system tumors,Conv,3,669,"mg 2,4,6-Trichloroaniline HCl/kg/day (ADJ)","ppm 2,4,6-Trichloroaniline HCl (TWA)",669,18,10,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
195,634935,"Trichloroaniline, 2,4,6-",HEAST,0.034,vascular system,"Weisburger, E.L., A.B. Russfield, F. Homburger, et al. 1978. Testing of 21 environmental aromatic Amines or derivatives for long term toxicity or carcinogenicity. J Environ Pathol Toxicol. 2: 325-356.",vascular system tumors,Conv,3,1337,"mg 2,4,6-Trichloroaniline HCl/kg/day (ADJ)","ppm 2,4,6-Trichloroaniline HCl (TWA)",1337,16,12,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
196,756796,Dimethyl methylphosphonate   ,PPRTV,0.0017,blood,NTP (National Toxicology Program). 1987. Toxicology and carcinogenesis studies of dimethyl methylphosphonate (CAS No. 756-79-6) in F344/N rats and B6C3F1 mice (gavage studies). NTP TR-323. November. NIH Pub. No. 88-2579.,mononuclear cell leukemia,Conv,3,0,mg/kg-day (ADJ),mg/kg-day,0,50,10,Rat,Fischer 344,M/F,M,Oral gavage,5,103,Weeks
196,756796,Dimethyl methylphosphonate   ,PPRTV,0.0017,blood,NTP (National Toxicology Program). 1987. Toxicology and carcinogenesis studies of dimethyl methylphosphonate (CAS No. 756-79-6) in F344/N rats and B6C3F1 mice (gavage studies). NTP TR-323. November. NIH Pub. No. 88-2579.,mononuclear cell leukemia,Conv,3,357,mg/kg-day (ADJ),mg/kg-day,357,50,11,Rat,Fischer 344,M/F,M,Oral gavage,5,103,Weeks
196,756796,Dimethyl methylphosphonate   ,PPRTV,0.0017,blood,NTP (National Toxicology Program). 1987. Toxicology and carcinogenesis studies of dimethyl methylphosphonate (CAS No. 756-79-6) in F344/N rats and B6C3F1 mice (gavage studies). NTP TR-323. November. NIH Pub. No. 88-2579.,mononuclear cell leukemia,Conv,3,714,mg/kg-day (ADJ),mg/kg-day,714,50,17,Rat,Fischer 344,M/F,M,Oral gavage,5,103,Weeks
197,930552,N-Nitrosopyrrolidine,CalEPA,2.1,liver,"Preussmann R, Schmähl D and Eisenbrand G. 1977. Carcinogenicity of N-nitrosopyrrolidine: dose-response study in rats. Z Krebsforsch 90:161-166.

U.S. Environmental Protection Agency (US EPA) 1994. Integrated Risk Information System: N-Nitrosopyrrolidine. Office of Health and Environmental Assessment.",hepatocellular carcinomas and adenomas,HEq,5,0,mg/kg-day,mg/kg-day,0,61,0,Rat,Sprague-Dawley,M/F,Both,Oral drinking water,NA,lifetime,Duration
197,930552,N-Nitrosopyrrolidine,CalEPA,2.1,liver,"Preussmann R, Schmähl D and Eisenbrand G. 1977. Carcinogenicity of N-nitrosopyrrolidine: dose-response study in rats. Z Krebsforsch 90:161-166.

U.S. Environmental Protection Agency (US EPA) 1994. Integrated Risk Information System: N-Nitrosopyrrolidine. Office of Health and Environmental Assessment.",hepatocellular carcinomas and adenomas,HEq,5,0.051,mg/kg-day,mg/kg-day,0.051,60,3,Rat,Sprague-Dawley,M/F,Both,Oral drinking water,NA,lifetime,Duration
197,930552,N-Nitrosopyrrolidine,CalEPA,2.1,liver,"Preussmann R, Schmähl D and Eisenbrand G. 1977. Carcinogenicity of N-nitrosopyrrolidine: dose-response study in rats. Z Krebsforsch 90:161-166.

U.S. Environmental Protection Agency (US EPA) 1994. Integrated Risk Information System: N-Nitrosopyrrolidine. Office of Health and Environmental Assessment.",hepatocellular carcinomas and adenomas,HEq,5,0.17,mg/kg-day,mg/kg-day,0.17,62,17,Rat,Sprague-Dawley,M/F,Both,Oral drinking water,NA,lifetime,Duration
197,930552,N-Nitrosopyrrolidine,CalEPA,2.1,liver,"Preussmann R, Schmähl D and Eisenbrand G. 1977. Carcinogenicity of N-nitrosopyrrolidine: dose-response study in rats. Z Krebsforsch 90:161-166.

U.S. Environmental Protection Agency (US EPA) 1994. Integrated Risk Information System: N-Nitrosopyrrolidine. Office of Health and Environmental Assessment.",hepatocellular carcinomas and adenomas,HEq,5,0.51,mg/kg-day,mg/kg-day,0.51,38,31,Rat,Sprague-Dawley,M/F,Both,Oral drinking water,NA,lifetime,Duration
197,930552,N-Nitrosopyrrolidine,CalEPA,2.1,liver,"Preussmann R, Schmähl D and Eisenbrand G. 1977. Carcinogenicity of N-nitrosopyrrolidine: dose-response study in rats. Z Krebsforsch 90:161-166.

U.S. Environmental Protection Agency (US EPA) 1994. Integrated Risk Information System: N-Nitrosopyrrolidine. Office of Health and Environmental Assessment.",hepatocellular carcinomas and adenomas,HEq,5,1.7,mg/kg-day,mg/kg-day,1.7,24,14,Rat,Sprague-Dawley,M/F,Both,Oral drinking water,NA,lifetime,Duration
198,930552,N-Nitrosopyrrolidine,IRIS,2.1,liver,"Preussmann, R., D. Schmahl and G. Eisenbrand. 1977. Carcinogenicity of N-nitrosopyrrolidine: Dose-response study in rats. Z. Krebsforsch. 90: 161-166.",hepatocellular carcinoma and adenoma,HEq,5,0,mg/kg/day,mg/kg/day,0,61,0,Rat,Sprague-Dawley,M/F,Both,Oral drinking water,NA,lifetime,Duration
198,930552,N-Nitrosopyrrolidine,IRIS,2.1,liver,"Preussmann, R., D. Schmahl and G. Eisenbrand. 1977. Carcinogenicity of N-nitrosopyrrolidine: Dose-response study in rats. Z. Krebsforsch. 90: 161-166.",hepatocellular carcinoma and adenoma,HEq,5,0.051,mg/kg/day,mg/kg/day,0.051,60,3,Rat,Sprague-Dawley,M/F,Both,Oral drinking water,NA,lifetime,Duration
198,930552,N-Nitrosopyrrolidine,IRIS,2.1,liver,"Preussmann, R., D. Schmahl and G. Eisenbrand. 1977. Carcinogenicity of N-nitrosopyrrolidine: Dose-response study in rats. Z. Krebsforsch. 90: 161-166.",hepatocellular carcinoma and adenoma,HEq,5,0.17,mg/kg/day,mg/kg/day,0.17,62,17,Rat,Sprague-Dawley,M/F,Both,Oral drinking water,NA,lifetime,Duration
198,930552,N-Nitrosopyrrolidine,IRIS,2.1,liver,"Preussmann, R., D. Schmahl and G. Eisenbrand. 1977. Carcinogenicity of N-nitrosopyrrolidine: Dose-response study in rats. Z. Krebsforsch. 90: 161-166.",hepatocellular carcinoma and adenoma,HEq,5,0.51,mg/kg/day,mg/kg/day,0.51,38,31,Rat,Sprague-Dawley,M/F,Both,Oral drinking water,NA,lifetime,Duration
198,930552,N-Nitrosopyrrolidine,IRIS,2.1,liver,"Preussmann, R., D. Schmahl and G. Eisenbrand. 1977. Carcinogenicity of N-nitrosopyrrolidine: Dose-response study in rats. Z. Krebsforsch. 90: 161-166.",hepatocellular carcinoma and adenoma,HEq,5,1.7,mg/kg/day,mg/kg/day,1.7,24,14,Rat,Sprague-Dawley,M/F,Both,Oral drinking water,NA,lifetime,Duration
199,1024573,Heptachlor Epoxide,CalEPA,5.5,liver,"IRDC. 1973. Unpublished report to Velsicol Chemical corporation, Eighteen Month Oral Carcinogenic Study in Mice, December 14. (Cited in Epstein, 1976), International Research and Development Corporation, Mattawan, MI.",liver tumors,HEq,4,0,mg/kg/day,ppm diet,0,62,0,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
199,1024573,Heptachlor Epoxide,CalEPA,5.5,liver,"IRDC. 1973. Unpublished report to Velsicol Chemical corporation, Eighteen Month Oral Carcinogenic Study in Mice, December 14. (Cited in Epstein, 1976), International Research and Development Corporation, Mattawan, MI.",liver tumors,HEq,4,0.01,mg/kg/day,ppm diet,0.01,68,2,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
199,1024573,Heptachlor Epoxide,CalEPA,5.5,liver,"IRDC. 1973. Unpublished report to Velsicol Chemical corporation, Eighteen Month Oral Carcinogenic Study in Mice, December 14. (Cited in Epstein, 1976), International Research and Development Corporation, Mattawan, MI.",liver tumors,HEq,4,0.052,mg/kg/day,ppm diet,0.052,68,18,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
199,1024573,Heptachlor Epoxide,CalEPA,5.5,liver,"IRDC. 1973. Unpublished report to Velsicol Chemical corporation, Eighteen Month Oral Carcinogenic Study in Mice, December 14. (Cited in Epstein, 1976), International Research and Development Corporation, Mattawan, MI.",liver tumors,HEq,4,0.1,mg/kg/day,ppm diet,0.1,80,52,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
200,1024573,Heptachlor Epoxide,CalEPA,5.5,liver,"IRDC. 1973. Unpublished report to Velsicol Chemical corporation, Eighteen Month Oral Carcinogenic Study in Mice, December 14. (Cited in Epstein, 1976), International Research and Development Corporation, Mattawan, MI.",liver tumors,HEq,4,0,mg/kg/day,ppm diet,0,76,6,Mouse,CD-1,M/F,F,Oral diet,NA,18,Months
200,1024573,Heptachlor Epoxide,CalEPA,5.5,liver,"IRDC. 1973. Unpublished report to Velsicol Chemical corporation, Eighteen Month Oral Carcinogenic Study in Mice, December 14. (Cited in Epstein, 1976), International Research and Development Corporation, Mattawan, MI.",liver tumors,HEq,4,0.01,mg/kg/day,ppm diet,0.01,70,1,Mouse,CD-1,M/F,F,Oral diet,NA,18,Months
200,1024573,Heptachlor Epoxide,CalEPA,5.5,liver,"IRDC. 1973. Unpublished report to Velsicol Chemical corporation, Eighteen Month Oral Carcinogenic Study in Mice, December 14. (Cited in Epstein, 1976), International Research and Development Corporation, Mattawan, MI.",liver tumors,HEq,4,0.052,mg/kg/day,ppm diet,0.052,65,6,Mouse,CD-1,M/F,F,Oral diet,NA,18,Months
200,1024573,Heptachlor Epoxide,CalEPA,5.5,liver,"IRDC. 1973. Unpublished report to Velsicol Chemical corporation, Eighteen Month Oral Carcinogenic Study in Mice, December 14. (Cited in Epstein, 1976), International Research and Development Corporation, Mattawan, MI.",liver tumors,HEq,4,0.1,mg/kg/day,ppm diet,0.1,57,30,Mouse,CD-1,M/F,F,Oral diet,NA,18,Months
201,1024573,Heptachlor Epoxide,IRIS,9.1,liver,"Velsicol Chemical Corporation. 1973. MRID No. 00062678. Available from EPA. Write to FOI, EPA, Washington, D.C. 20460.
Reuber, M.D. 1977. Histopathology of carcinomas of the liver in mice ingesting heptachlor or heptachlor epoxide. Exp. Cell Biol. 45: 147-157.",hepatocelluar carcinomas (incidence),HEq,4,0,mg/kg/day,ppm,0,62,0,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
201,1024573,Heptachlor Epoxide,IRIS,9.1,liver,"Velsicol Chemical Corporation. 1973. MRID No. 00062678. Available from EPA. Write to FOI, EPA, Washington, D.C. 20460.
Reuber, M.D. 1977. Histopathology of carcinomas of the liver in mice ingesting heptachlor or heptachlor epoxide. Exp. Cell Biol. 45: 147-157.",hepatocelluar carcinomas (incidence),HEq,4,0.01,mg/kg/day,ppm,0.01,68,2,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
201,1024573,Heptachlor Epoxide,IRIS,9.1,liver,"Velsicol Chemical Corporation. 1973. MRID No. 00062678. Available from EPA. Write to FOI, EPA, Washington, D.C. 20460.
Reuber, M.D. 1977. Histopathology of carcinomas of the liver in mice ingesting heptachlor or heptachlor epoxide. Exp. Cell Biol. 45: 147-157.",hepatocelluar carcinomas (incidence),HEq,4,0.052,mg/kg/day,ppm,0.052,68,18,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
201,1024573,Heptachlor Epoxide,IRIS,9.1,liver,"Velsicol Chemical Corporation. 1973. MRID No. 00062678. Available from EPA. Write to FOI, EPA, Washington, D.C. 20460.
Reuber, M.D. 1977. Histopathology of carcinomas of the liver in mice ingesting heptachlor or heptachlor epoxide. Exp. Cell Biol. 45: 147-157.",hepatocelluar carcinomas (incidence),HEq,4,0.1,mg/kg/day,ppm,0.1,80,52,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
202,1024573,Heptachlor Epoxide,IRIS,9.1,liver,"Velsicol Chemical Corporation. 1973. MRID No. 00062678. Available from EPA. Write to FOI, EPA, Washington, D.C. 20460.
Reuber, M.D. 1977. Histopathology of carcinomas of the liver in mice ingesting heptachlor or heptachlor epoxide. Exp. Cell Biol. 45: 147-157.",hepatocelluar carcinomas (mg/kg/day),HEq,4,0,mg/kg/day,ppm,0,76,6,Mouse,CD-1,M/F,F,Oral diet,NA,18,Months
202,1024573,Heptachlor Epoxide,IRIS,9.1,liver,"Velsicol Chemical Corporation. 1973. MRID No. 00062678. Available from EPA. Write to FOI, EPA, Washington, D.C. 20460.
Reuber, M.D. 1977. Histopathology of carcinomas of the liver in mice ingesting heptachlor or heptachlor epoxide. Exp. Cell Biol. 45: 147-157.",hepatocelluar carcinomas (mg/kg/day),HEq,4,0.01,mg/kg/day,ppm,0.01,70,1,Mouse,CD-1,M/F,F,Oral diet,NA,18,Months
202,1024573,Heptachlor Epoxide,IRIS,9.1,liver,"Velsicol Chemical Corporation. 1973. MRID No. 00062678. Available from EPA. Write to FOI, EPA, Washington, D.C. 20460.
Reuber, M.D. 1977. Histopathology of carcinomas of the liver in mice ingesting heptachlor or heptachlor epoxide. Exp. Cell Biol. 45: 147-157.",hepatocelluar carcinomas (mg/kg/day),HEq,4,0.052,mg/kg/day,ppm,0.052,65,6,Mouse,CD-1,M/F,F,Oral diet,NA,18,Months
202,1024573,Heptachlor Epoxide,IRIS,9.1,liver,"Velsicol Chemical Corporation. 1973. MRID No. 00062678. Available from EPA. Write to FOI, EPA, Washington, D.C. 20460.
Reuber, M.D. 1977. Histopathology of carcinomas of the liver in mice ingesting heptachlor or heptachlor epoxide. Exp. Cell Biol. 45: 147-157.",hepatocelluar carcinomas (mg/kg/day),HEq,4,0.1,mg/kg/day,ppm,0.1,57,30,Mouse,CD-1,M/F,F,Oral diet,NA,18,Months
203,1116547,N-Nitrosodiethanolamine,CalEPA,2.8,liver,"Lijinsky, W. and R.M. Kovatch. 1985. Induction of liver tumors in rats by nitrosodiethanolamine at low doses. Carcinogenesis. 6(12): 1679-1681.","hepatocellular carcinoma, cholangiocellular carcinoma and adenoma and neoplastic nodules",HEq,3,0,mg/kg-day,mg/kg-day,0,20,1,Rat,Fischer 344,M/F,F,Oral drinking water,NA,100,Weeks
203,1116547,N-Nitrosodiethanolamine,CalEPA,2.8,liver,"Lijinsky, W. and R.M. Kovatch. 1985. Induction of liver tumors in rats by nitrosodiethanolamine at low doses. Carcinogenesis. 6(12): 1679-1681.","hepatocellular carcinoma, cholangiocellular carcinoma and adenoma and neoplastic nodules",HEq,3,0.15,mg/kg-day,mg/kg-day,0.15,39,10,Rat,Fischer 344,M/F,F,Oral drinking water,NA,100,Weeks
203,1116547,N-Nitrosodiethanolamine,CalEPA,2.8,liver,"Lijinsky, W. and R.M. Kovatch. 1985. Induction of liver tumors in rats by nitrosodiethanolamine at low doses. Carcinogenesis. 6(12): 1679-1681.","hepatocellular carcinoma, cholangiocellular carcinoma and adenoma and neoplastic nodules",HEq,3,0.34,mg/kg-day,mg/kg-day,0.34,20,14,Rat,Fischer 344,M/F,F,Oral drinking water,NA,100,Weeks
204,1116547,N-Nitrosodiethanolamine,IRIS,2.8,liver,"Lijinsky, W. and R.M. Kovatch. 1985. Induction of liver tumors in rats by nitrosodiethanolamine at low doses. Carcinogenesis. 6(12): 1679-1681.","hepatocellular carcinoma, cholangiocellular carcinoma and adenoma and neoplastic nodules",HEq,3,0,mg/kg/day,mg/kg/day,0,20,1,Rat,Fischer 344,M/F,F,Oral drinking water,NA,100,Weeks
204,1116547,N-Nitrosodiethanolamine,IRIS,2.8,liver,"Lijinsky, W. and R.M. Kovatch. 1985. Induction of liver tumors in rats by nitrosodiethanolamine at low doses. Carcinogenesis. 6(12): 1679-1681.","hepatocellular carcinoma, cholangiocellular carcinoma and adenoma and neoplastic nodules",HEq,3,0.15,mg/kg/day,mg/kg/day,0.15,39,10,Rat,Fischer 344,M/F,F,Oral drinking water,NA,100,Weeks
204,1116547,N-Nitrosodiethanolamine,IRIS,2.8,liver,"Lijinsky, W. and R.M. Kovatch. 1985. Induction of liver tumors in rats by nitrosodiethanolamine at low doses. Carcinogenesis. 6(12): 1679-1681.","hepatocellular carcinoma, cholangiocellular carcinoma and adenoma and neoplastic nodules",HEq,3,0.34,mg/kg/day,mg/kg/day,0.34,20,14,Rat,Fischer 344,M/F,F,Oral drinking water,NA,100,Weeks
205,1120714,"1,3-Propane sultone",CalEPA,2.4,brain,"Ulland B, Finkelstein M, Weisburger EK, Rice JM and Weisburger J.H. 1971. Carcinogenicity of industrial chemicals propylene imine and propane sultone. Nature 230:460-461.

Weisburger EK, Ulland BM, Nam J, Gart JJ and Weisburger JH. 1981. Carcinogenicity tests of certain environmental and industrial chemicals. J Natl Cancer Inst 67:75-88.",Male rat cerebellar malignant glioma tumor,Dose,3,0,mg/kg dose,mg/kg dose,0,6,0,Rat,CD,M/F,M,Oral gavage,2,32-60,Weeks
205,1120714,"1,3-Propane sultone",CalEPA,2.4,brain,"Ulland B, Finkelstein M, Weisburger EK, Rice JM and Weisburger J.H. 1971. Carcinogenicity of industrial chemicals propylene imine and propane sultone. Nature 230:460-461.

Weisburger EK, Ulland BM, Nam J, Gart JJ and Weisburger JH. 1981. Carcinogenicity tests of certain environmental and industrial chemicals. J Natl Cancer Inst 67:75-88.",Male rat cerebellar malignant glioma tumor,Dose,3,28,mg/kg dose,mg/kg dose,8,26,12,Rat,CD,M/F,M,Oral gavage,2,32-60,Weeks
205,1120714,"1,3-Propane sultone",CalEPA,2.4,brain,"Ulland B, Finkelstein M, Weisburger EK, Rice JM and Weisburger J.H. 1971. Carcinogenicity of industrial chemicals propylene imine and propane sultone. Nature 230:460-461.

Weisburger EK, Ulland BM, Nam J, Gart JJ and Weisburger JH. 1981. Carcinogenicity tests of certain environmental and industrial chemicals. J Natl Cancer Inst 67:75-88.",Male rat cerebellar malignant glioma tumor,Dose,3,56,mg/kg dose,mg/kg dose,16,26,16,Rat,CD,M/F,M,Oral gavage,2,32-60,Weeks
206,1163195,Decabromodiphenyl Ether,IRIS,7.00E-04,liver,"NTP (National Toxicology Program). (1986) Toxicology and carcinogenesis studies of
decabromodiphenyl oxide (CAS No. 1163-19-5) in F344/N rats and B6C3F1 mice (feed
studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 309.
Available from the National Institute of Environmental Health Sciences, Research Triangle Park,
NC, and online at http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr309.pdf.",Liver neoplastic nodules or carcinoma (combined),HEq,3,0,mg/kg/day,mg/kg/day,0,50,2,Rat,Fischer 344,M/F,M,Oral diet,NA,2,Years
206,1163195,Decabromodiphenyl Ether,IRIS,7.00E-04,liver,"NTP (National Toxicology Program). (1986) Toxicology and carcinogenesis studies of
decabromodiphenyl oxide (CAS No. 1163-19-5) in F344/N rats and B6C3F1 mice (feed
studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 309.
Available from the National Institute of Environmental Health Sciences, Research Triangle Park,
NC, and online at http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr309.pdf.",Liver neoplastic nodules or carcinoma (combined),HEq,3,305,mg/kg/day,mg/kg/day,305,50,8,Rat,Fischer 344,M/F,M,Oral diet,NA,2,Years
206,1163195,Decabromodiphenyl Ether,IRIS,7.00E-04,liver,"NTP (National Toxicology Program). (1986) Toxicology and carcinogenesis studies of
decabromodiphenyl oxide (CAS No. 1163-19-5) in F344/N rats and B6C3F1 mice (feed
studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 309.
Available from the National Institute of Environmental Health Sciences, Research Triangle Park,
NC, and online at http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr309.pdf.",Liver neoplastic nodules or carcinoma (combined),HEq,3,608,mg/kg/day,mg/kg/day,608,49,15,Rat,Fischer 344,M/F,M,Oral diet,NA,2,Years
207,1336363,PCBs- high risk and persistence,IRIS,2,liver,"Brunner, M.J., T.M. Sullivan, A.W. Singer, et. al. 1996. An assessment of the chronic toxicity and oncogenicity of Aroclor-1016, Aroclor-1242, Aroclor- 1254, and Aroclor-1260 administered in diet to rats. Study No. SC920192. Chronic toxicity and oncogenicity report. Battelle, Columbus OH. 
Norback, D.H. and R.H. Weltman. 1985. Polychlorinated biphenyl induction of hepatocellular carcinoma in the Sprague-Dawley rat. Environ. Health Perspect. 60: 97-105.",liver tumors,HEq,4,0,mg/kg-d,ppm diet,0,84,1,Rat,Sprague-Dawley,F,F,Oral diet,NA,104,Weeks
207,1336363,PCBs- high risk and persistence,IRIS,2,liver,"Brunner, M.J., T.M. Sullivan, A.W. Singer, et. al. 1996. An assessment of the chronic toxicity and oncogenicity of Aroclor-1016, Aroclor-1242, Aroclor- 1254, and Aroclor-1260 administered in diet to rats. Study No. SC920192. Chronic toxicity and oncogenicity report. Battelle, Columbus OH. 
Norback, D.H. and R.H. Weltman. 1985. Polychlorinated biphenyl induction of hepatocellular carcinoma in the Sprague-Dawley rat. Environ. Health Perspect. 60: 97-105.",liver tumors,HEq,4,0.35,mg/kg-d,ppm diet,0.35,45,19,Rat,Sprague-Dawley,F,F,Oral diet,NA,104,Weeks
207,1336363,PCBs- high risk and persistence,IRIS,2,liver,"Brunner, M.J., T.M. Sullivan, A.W. Singer, et. al. 1996. An assessment of the chronic toxicity and oncogenicity of Aroclor-1016, Aroclor-1242, Aroclor- 1254, and Aroclor-1260 administered in diet to rats. Study No. SC920192. Chronic toxicity and oncogenicity report. Battelle, Columbus OH. 
Norback, D.H. and R.H. Weltman. 1985. Polychlorinated biphenyl induction of hepatocellular carcinoma in the Sprague-Dawley rat. Environ. Health Perspect. 60: 97-105.",liver tumors,HEq,4,0.76,mg/kg-d,ppm diet,0.76,49,28,Rat,Sprague-Dawley,F,F,Oral diet,NA,104,Weeks
207,1336363,PCBs- high risk and persistence,IRIS,2,liver,"Brunner, M.J., T.M. Sullivan, A.W. Singer, et. al. 1996. An assessment of the chronic toxicity and oncogenicity of Aroclor-1016, Aroclor-1242, Aroclor- 1254, and Aroclor-1260 administered in diet to rats. Study No. SC920192. Chronic toxicity and oncogenicity report. Battelle, Columbus OH. 
Norback, D.H. and R.H. Weltman. 1985. Polychlorinated biphenyl induction of hepatocellular carcinoma in the Sprague-Dawley rat. Environ. Health Perspect. 60: 97-105.",liver tumors,HEq,4,1.59,mg/kg-d,ppm diet,1.59,49,28,Rat,Sprague-Dawley,F,F,Oral diet,NA,104,Weeks
208,1336363,PCBs- high risk and persistence,IRIS,2,liver,"Brunner, M.J., T.M. Sullivan, A.W. Singer, et. al. 1996. An assessment of the chronic toxicity and oncogenicity of Aroclor-1016, Aroclor-1242, Aroclor- 1254, and Aroclor-1260 administered in diet to rats. Study No. SC920192. Chronic toxicity and oncogenicity report. Battelle, Columbus OH. 
Norback, D.H. and R.H. Weltman. 1985. Polychlorinated biphenyl induction of hepatocellular carcinoma in the Sprague-Dawley rat. Environ. Health Perspect. 60: 97-105.",liver tumors,HEq,3,0,mg/kg-d,ppm,0,85,1,Rat,Sprague-Dawley,F,F,Oral diet,NA,104,Weeks
208,1336363,PCBs- high risk and persistence,IRIS,2,liver,"Brunner, M.J., T.M. Sullivan, A.W. Singer, et. al. 1996. An assessment of the chronic toxicity and oncogenicity of Aroclor-1016, Aroclor-1242, Aroclor- 1254, and Aroclor-1260 administered in diet to rats. Study No. SC920192. Chronic toxicity and oncogenicity report. Battelle, Columbus OH. 
Norback, D.H. and R.H. Weltman. 1985. Polychlorinated biphenyl induction of hepatocellular carcinoma in the Sprague-Dawley rat. Environ. Health Perspect. 60: 97-105.",liver tumors,HEq,3,0.75,mg/kg-d,ppm,0.75,49,11,Rat,Sprague-Dawley,F,F,Oral diet,NA,104,Weeks
208,1336363,PCBs- high risk and persistence,IRIS,2,liver,"Brunner, M.J., T.M. Sullivan, A.W. Singer, et. al. 1996. An assessment of the chronic toxicity and oncogenicity of Aroclor-1016, Aroclor-1242, Aroclor- 1254, and Aroclor-1260 administered in diet to rats. Study No. SC920192. Chronic toxicity and oncogenicity report. Battelle, Columbus OH. 
Norback, D.H. and R.H. Weltman. 1985. Polychlorinated biphenyl induction of hepatocellular carcinoma in the Sprague-Dawley rat. Environ. Health Perspect. 60: 97-105.",liver tumors,HEq,3,1.53,mg/kg-d,ppm,1.53,45,15,Rat,Sprague-Dawley,F,F,Oral diet,NA,104,Weeks
209,1336363,PCBs- high risk and persistence,IRIS,2,liver,"Brunner, M.J., T.M. Sullivan, A.W. Singer, et. al. 1996. An assessment of the chronic toxicity and oncogenicity of Aroclor-1016, Aroclor-1242, Aroclor- 1254, and Aroclor-1260 administered in diet to rats. Study No. SC920192. Chronic toxicity and oncogenicity report. Battelle, Columbus OH. 
Norback, D.H. and R.H. Weltman. 1985. Polychlorinated biphenyl induction of hepatocellular carcinoma in the Sprague-Dawley rat. Environ. Health Perspect. 60: 97-105.",liver tumors,HEq,4,0,mg/kg-d,ppm,0,85,1,Rat,Sprague-Dawley,F,F,Oral diet,NA,104,Weeks
209,1336363,PCBs- high risk and persistence,IRIS,2,liver,"Brunner, M.J., T.M. Sullivan, A.W. Singer, et. al. 1996. An assessment of the chronic toxicity and oncogenicity of Aroclor-1016, Aroclor-1242, Aroclor- 1254, and Aroclor-1260 administered in diet to rats. Study No. SC920192. Chronic toxicity and oncogenicity report. Battelle, Columbus OH. 
Norback, D.H. and R.H. Weltman. 1985. Polychlorinated biphenyl induction of hepatocellular carcinoma in the Sprague-Dawley rat. Environ. Health Perspect. 60: 97-105.",liver tumors,HEq,4,0.72,mg/kg-d,ppm,0.72,48,1,Rat,Sprague-Dawley,F,F,Oral diet,NA,104,Weeks
209,1336363,PCBs- high risk and persistence,IRIS,2,liver,"Brunner, M.J., T.M. Sullivan, A.W. Singer, et. al. 1996. An assessment of the chronic toxicity and oncogenicity of Aroclor-1016, Aroclor-1242, Aroclor- 1254, and Aroclor-1260 administered in diet to rats. Study No. SC920192. Chronic toxicity and oncogenicity report. Battelle, Columbus OH. 
Norback, D.H. and R.H. Weltman. 1985. Polychlorinated biphenyl induction of hepatocellular carcinoma in the Sprague-Dawley rat. Environ. Health Perspect. 60: 97-105.",liver tumors,HEq,4,1.43,mg/kg-d,ppm,1.43,45,7,Rat,Sprague-Dawley,F,F,Oral diet,NA,104,Weeks
209,1336363,PCBs- high risk and persistence,IRIS,2,liver,"Brunner, M.J., T.M. Sullivan, A.W. Singer, et. al. 1996. An assessment of the chronic toxicity and oncogenicity of Aroclor-1016, Aroclor-1242, Aroclor- 1254, and Aroclor-1260 administered in diet to rats. Study No. SC920192. Chronic toxicity and oncogenicity report. Battelle, Columbus OH. 
Norback, D.H. and R.H. Weltman. 1985. Polychlorinated biphenyl induction of hepatocellular carcinoma in the Sprague-Dawley rat. Environ. Health Perspect. 60: 97-105.",liver tumors,HEq,4,2.99,mg/kg-d,ppm,2.99,50,6,Rat,Sprague-Dawley,F,F,Oral diet,NA,104,Weeks
210,1582098,Trifluralin,IRIS,0.0077,combined,"Emmerson, J.L., E.C. Pierce, J.P. McGrath, et al. 1980. The chronic toxicity of compound 36352 (trifluralin) given as a compound of the diet to the Fischer 344 rats for two years. Studies R-87 and R-97 (unpublished study received September 18, 1980 under 1471-35; submitted by Elanco Products Co., Division of Eli Lilly and Co., Indianapolis, IN).","combined renal pelvis carcinomas, urinary bladder papillomas and/or thyroid adenomas and carcinomas",HEq,4,0,mg/kg/day,ppm,0,60,5,Rat,Fischer 344,M/F,M,Oral diet,NA,2,Years
210,1582098,Trifluralin,IRIS,0.0077,combined,"Emmerson, J.L., E.C. Pierce, J.P. McGrath, et al. 1980. The chronic toxicity of compound 36352 (trifluralin) given as a compound of the diet to the Fischer 344 rats for two years. Studies R-87 and R-97 (unpublished study received September 18, 1980 under 1471-35; submitted by Elanco Products Co., Division of Eli Lilly and Co., Indianapolis, IN).","combined renal pelvis carcinomas, urinary bladder papillomas and/or thyroid adenomas and carcinomas",HEq,4,5.1,mg/kg/day,ppm,5.1,60,5,Rat,Fischer 344,M/F,M,Oral diet,NA,2,Years
210,1582098,Trifluralin,IRIS,0.0077,combined,"Emmerson, J.L., E.C. Pierce, J.P. McGrath, et al. 1980. The chronic toxicity of compound 36352 (trifluralin) given as a compound of the diet to the Fischer 344 rats for two years. Studies R-87 and R-97 (unpublished study received September 18, 1980 under 1471-35; submitted by Elanco Products Co., Division of Eli Lilly and Co., Indianapolis, IN).","combined renal pelvis carcinomas, urinary bladder papillomas and/or thyroid adenomas and carcinomas",HEq,4,21.9,mg/kg/day,ppm,21.9,60,9,Rat,Fischer 344,M/F,M,Oral diet,NA,2,Years
210,1582098,Trifluralin,IRIS,0.0077,combined,"Emmerson, J.L., E.C. Pierce, J.P. McGrath, et al. 1980. The chronic toxicity of compound 36352 (trifluralin) given as a compound of the diet to the Fischer 344 rats for two years. Studies R-87 and R-97 (unpublished study received September 18, 1980 under 1471-35; submitted by Elanco Products Co., Division of Eli Lilly and Co., Indianapolis, IN).","combined renal pelvis carcinomas, urinary bladder papillomas and/or thyroid adenomas and carcinomas",HEq,4,46.5,mg/kg/day,ppm,46.5,60,17,Rat,Fischer 344,M/F,M,Oral diet,NA,2,Years
211,1634044,Methyl T-Butyl Ether,CalEPA,0.0018,lymphatic system,"Belpoggi F, Soffritti M and Maltoni C. 1995. Methyl tertiary-butyl ether (MtBE) - a gasoline additive - causes testicular and lymphohaematopoietic cancers in rats. Toxicol Ind Hlth 11:119-149.",leukemia and lymphomas of lymphoid origin,Dose,3,0,mg/kg-day,mg/kg-day,0,58,2,Rat,Sprague-Dawley,M/F,F,Oral gavage,4,104,Weeks
211,1634044,Methyl T-Butyl Ether,CalEPA,0.0018,lymphatic system,"Belpoggi F, Soffritti M and Maltoni C. 1995. Methyl tertiary-butyl ether (MtBE) - a gasoline additive - causes testicular and lymphohaematopoietic cancers in rats. Toxicol Ind Hlth 11:119-149.",leukemia and lymphomas of lymphoid origin,Dose,3,250,mg/kg-day,mg/kg-day,142.8571429,51,7,Rat,Sprague-Dawley,M/F,F,Oral gavage,4,104,Weeks
211,1634044,Methyl T-Butyl Ether,CalEPA,0.0018,lymphatic system,"Belpoggi F, Soffritti M and Maltoni C. 1995. Methyl tertiary-butyl ether (MtBE) - a gasoline additive - causes testicular and lymphohaematopoietic cancers in rats. Toxicol Ind Hlth 11:119-149.",leukemia and lymphomas of lymphoid origin,Dose,3,1000,mg/kg-day,mg/kg-day,571.4285714,47,12,Rat,Sprague-Dawley,M/F,F,Oral gavage,4,104,Weeks
212,1634044,Methyl T-Butyl Ether,CalEPA,0.0018,male repro,"Belpoggi F, Soffritti M and Maltoni C. 1995. Methyl tertiary-butyl ether (MtBE) - a gasoline additive - causes testicular and lymphohaematopoietic cancers in rats. Toxicol Ind Hlth 11:119-149.",Leydig interstitial cell adenomas,Dose,3,0,mg/kg-day,mg/kg-day,0,26,3,Rat,Sprague-Dawley,M/F,M,Oral gavage,4,104,Weeks
212,1634044,Methyl T-Butyl Ether,CalEPA,0.0018,male repro,"Belpoggi F, Soffritti M and Maltoni C. 1995. Methyl tertiary-butyl ether (MtBE) - a gasoline additive - causes testicular and lymphohaematopoietic cancers in rats. Toxicol Ind Hlth 11:119-149.",Leydig interstitial cell adenomas,Dose,3,250,mg/kg-day,mg/kg-day,142.8571429,25,5,Rat,Sprague-Dawley,M/F,M,Oral gavage,4,104,Weeks
212,1634044,Methyl T-Butyl Ether,CalEPA,0.0018,male repro,"Belpoggi F, Soffritti M and Maltoni C. 1995. Methyl tertiary-butyl ether (MtBE) - a gasoline additive - causes testicular and lymphohaematopoietic cancers in rats. Toxicol Ind Hlth 11:119-149.",Leydig interstitial cell adenomas,Dose,3,1000,mg/kg-day,mg/kg-day,571.4285714,32,11,Rat,Sprague-Dawley,M/F,M,Oral gavage,4,104,Weeks
213,1746016,"2,3,7,8-Tetrachlorodibenzo-p-Dioxin",CalEPA,130000,liver,"National Toxicology Program (NTP) 1982. Bioassay of 2,3,7,8-tetrachlorodibenzo-p-dioxin for possible carcinogenicity (gavage study). DHHS Publ No. (NIH) 82-1765. Carcinogenesis Testing Program, National Cancer Institute, Bethesda, MD, and National Toxicology Program, Research Triangle Park, NC.",hepatocellular adenoma or carcinoma,Dose,4,0,ng/m3,ug/kg/wk,0,73,15,Mouse,B6C3F1,M/F,M,Oral gavage,2,104,Weeks
213,1746016,"2,3,7,8-Tetrachlorodibenzo-p-Dioxin",CalEPA,130000,liver,"National Toxicology Program (NTP) 1982. Bioassay of 2,3,7,8-tetrachlorodibenzo-p-dioxin for possible carcinogenicity (gavage study). DHHS Publ No. (NIH) 82-1765. Carcinogenesis Testing Program, National Cancer Institute, Bethesda, MD, and National Toxicology Program, Research Triangle Park, NC.",hepatocellular adenoma or carcinoma,Dose,4,0.44,ng/m3,ug/kg/wk,1.43E-06,49,12,Mouse,B6C3F1,M/F,M,Oral gavage,2,104,Weeks
213,1746016,"2,3,7,8-Tetrachlorodibenzo-p-Dioxin",CalEPA,130000,liver,"National Toxicology Program (NTP) 1982. Bioassay of 2,3,7,8-tetrachlorodibenzo-p-dioxin for possible carcinogenicity (gavage study). DHHS Publ No. (NIH) 82-1765. Carcinogenesis Testing Program, National Cancer Institute, Bethesda, MD, and National Toxicology Program, Research Triangle Park, NC.",hepatocellular adenoma or carcinoma,Dose,4,2.2,ng/m3,ug/kg/wk,7.14E-06,49,13,Mouse,B6C3F1,M/F,M,Oral gavage,2,104,Weeks
213,1746016,"2,3,7,8-Tetrachlorodibenzo-p-Dioxin",CalEPA,130000,liver,"National Toxicology Program (NTP) 1982. Bioassay of 2,3,7,8-tetrachlorodibenzo-p-dioxin for possible carcinogenicity (gavage study). DHHS Publ No. (NIH) 82-1765. Carcinogenesis Testing Program, National Cancer Institute, Bethesda, MD, and National Toxicology Program, Research Triangle Park, NC.",hepatocellular adenoma or carcinoma,Dose,4,22,ng/m3,ug/kg/wk,7.14E-05,50,27,Mouse,B6C3F1,M/F,M,Oral gavage,2,104,Weeks
214,1836755,Nitrofen (technical grade),CalEPA,2.30E-05,liver,"National Cancer Institute (NCI, 1979). Bioassay of Nitrofenfor Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 184. NTIS Publication
No. PB 296038. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

National Cancer Institute (NCI, 1978). Bioassay of Nitrofen for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 26. NTIS Publication
No. PB 277440. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinoma,Dose,3,0,ppm diet,ppm diet,0,20,0,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
214,1836755,Nitrofen (technical grade),CalEPA,2.30E-05,liver,"National Cancer Institute (NCI, 1979). Bioassay of Nitrofenfor Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 184. NTIS Publication
No. PB 296038. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

National Cancer Institute (NCI, 1978). Bioassay of Nitrofen for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 26. NTIS Publication
No. PB 277440. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinoma,Dose,3,3000,ppm diet,ppm diet,514.7453083,49,13,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
214,1836755,Nitrofen (technical grade),CalEPA,2.30E-05,liver,"National Cancer Institute (NCI, 1979). Bioassay of Nitrofenfor Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 184. NTIS Publication
No. PB 296038. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

National Cancer Institute (NCI, 1978). Bioassay of Nitrofen for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 26. NTIS Publication
No. PB 277440. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinoma,Dose,3,6000,ppm diet,ppm diet,1029.490617,48,20,Mouse,B6C3F1,M/F,M,Oral diet,NA,78,Weeks
215,1836755,Nitrofen (technical grade),CalEPA,2.30E-05,liver,"National Cancer Institute (NCI, 1979). Bioassay of Nitrofenfor Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 184. NTIS Publication
No. PB 296038. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

National Cancer Institute (NCI, 1978). Bioassay of Nitrofen for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 26. NTIS Publication
No. PB 277440. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinoma,Dose,3,0,ppm diet,ppm diet,0,18,0,Mouse,B6C3F1,M/F,F,Oral diet,NA,78,Weeks
215,1836755,Nitrofen (technical grade),CalEPA,2.30E-05,liver,"National Cancer Institute (NCI, 1979). Bioassay of Nitrofenfor Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 184. NTIS Publication
No. PB 296038. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

National Cancer Institute (NCI, 1978). Bioassay of Nitrofen for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 26. NTIS Publication
No. PB 277440. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinoma,Dose,3,3000,ppm diet,ppm diet,518.4135977,48,5,Mouse,B6C3F1,M/F,F,Oral diet,NA,78,Weeks
215,1836755,Nitrofen (technical grade),CalEPA,2.30E-05,liver,"National Cancer Institute (NCI, 1979). Bioassay of Nitrofenfor Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 184. NTIS Publication
No. PB 296038. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.

National Cancer Institute (NCI, 1978). Bioassay of Nitrofen for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 26. NTIS Publication
No. PB 277440. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinoma,Dose,3,6000,ppm diet,ppm diet,1036.827195,50,13,Mouse,B6C3F1,M/F,F,Oral diet,NA,78,Weeks
216,1897456,Chlorothalonil,CalEPA,0.0031,kidneys,"National Cancer Institute (1978). Bioassay of Chlorothalonil for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 41. US Department of Health, Education and Welfare Publication No. (NIH) 79-1716. NCI Carcinogenesis
Testing Program, Bethesda, MD.

National Toxicology Program (NTP, 1991). Chemical Status Report. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant kidney tumors,Dose,3,0,ppm (TWA),ppm (TWA),0,10,0,Rat,Osborne-Mendel,M/F,M,Oral diet,NA,80,Weeks
216,1897456,Chlorothalonil,CalEPA,0.0031,kidneys,"National Cancer Institute (1978). Bioassay of Chlorothalonil for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 41. US Department of Health, Education and Welfare Publication No. (NIH) 79-1716. NCI Carcinogenesis
Testing Program, Bethesda, MD.

National Toxicology Program (NTP, 1991). Chemical Status Report. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant kidney tumors,Dose,3,5063,ppm (TWA),ppm (TWA),354.6070039,46,3,Rat,Osborne-Mendel,M/F,M,Oral diet,NA,80,Weeks
216,1897456,Chlorothalonil,CalEPA,0.0031,kidneys,"National Cancer Institute (1978). Bioassay of Chlorothalonil for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 41. US Department of Health, Education and Welfare Publication No. (NIH) 79-1716. NCI Carcinogenesis
Testing Program, Bethesda, MD.

National Toxicology Program (NTP, 1991). Chemical Status Report. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant kidney tumors,Dose,3,10126,ppm (TWA),ppm (TWA),709.2140078,49,4,Rat,Osborne-Mendel,M/F,M,Oral diet,NA,80,Weeks
217,1937377,Direct Black 38 (Technical Grade),CalEPA,7.4,liver,"National Cancer Institute (NCI, 1978). 13-Week Subchronic Toxicity Studies of Direct Blue 6, Direct Black 38, and Direct Brown 95 Dyes. Carcinogenesis Technical Report Seric:s No. 108. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinomas,Dose,5,190,ppm,ppm,15,10,0,Rat,Fischer 344,M/F,M,Oral diet,NA,91,Days
217,1937377,Direct Black 38 (Technical Grade),CalEPA,7.4,liver,"National Cancer Institute (NCI, 1978). 13-Week Subchronic Toxicity Studies of Direct Blue 6, Direct Black 38, and Direct Brown 95 Dyes. Carcinogenesis Technical Report Seric:s No. 108. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinomas,Dose,5,375,ppm,ppm,29.60526316,10,0,Rat,Fischer 344,M/F,M,Oral diet,NA,91,Days
217,1937377,Direct Black 38 (Technical Grade),CalEPA,7.4,liver,"National Cancer Institute (NCI, 1978). 13-Week Subchronic Toxicity Studies of Direct Blue 6, Direct Black 38, and Direct Brown 95 Dyes. Carcinogenesis Technical Report Seric:s No. 108. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinomas,Dose,5,750,ppm,ppm,59.21052632,10,0,Rat,Fischer 344,M/F,M,Oral diet,NA,91,Days
217,1937377,Direct Black 38 (Technical Grade),CalEPA,7.4,liver,"National Cancer Institute (NCI, 1978). 13-Week Subchronic Toxicity Studies of Direct Blue 6, Direct Black 38, and Direct Brown 95 Dyes. Carcinogenesis Technical Report Seric:s No. 108. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinomas,Dose,5,1500,ppm,ppm,118.4210526,9,9,Rat,Fischer 344,M/F,M,Oral diet,NA,91,Days
217,1937377,Direct Black 38 (Technical Grade),CalEPA,7.4,liver,"National Cancer Institute (NCI, 1978). 13-Week Subchronic Toxicity Studies of Direct Blue 6, Direct Black 38, and Direct Brown 95 Dyes. Carcinogenesis Technical Report Seric:s No. 108. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinomas,Dose,5,3000,ppm,ppm,236.8421053,9,0,Rat,Fischer 344,M/F,M,Oral diet,NA,91,Days
218,2475458,Disperse Blue 1 (Technical Grade),CalEPA,0.0045,bladder,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Disperse Blue 1 (a commercial dye containing approximately 50% I.4.5.8-tetra amino
anthraquinone. 30% other compounds structurally related to I.4,5.8-tetra amino anthraquinone and 20% water in F344IN Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 299. NIH Publication No. 86-2555. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",squamous cell papilloma or carcinoma,Dose,4,0,ppm,ppm,0,49,0,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
218,2475458,Disperse Blue 1 (Technical Grade),CalEPA,0.0045,bladder,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Disperse Blue 1 (a commercial dye containing approximately 50% I.4.5.8-tetra amino
anthraquinone. 30% other compounds structurally related to I.4,5.8-tetra amino anthraquinone and 20% water in F344IN Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 299. NIH Publication No. 86-2555. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",squamous cell papilloma or carcinoma,Dose,4,1250,ppm,ppm,98.68421053,50,0,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
218,2475458,Disperse Blue 1 (Technical Grade),CalEPA,0.0045,bladder,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Disperse Blue 1 (a commercial dye containing approximately 50% I.4.5.8-tetra amino
anthraquinone. 30% other compounds structurally related to I.4,5.8-tetra amino anthraquinone and 20% water in F344IN Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 299. NIH Publication No. 86-2555. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",squamous cell papilloma or carcinoma,Dose,4,2500,ppm,ppm,197.3684211,50,2,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
218,2475458,Disperse Blue 1 (Technical Grade),CalEPA,0.0045,bladder,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Disperse Blue 1 (a commercial dye containing approximately 50% I.4.5.8-tetra amino
anthraquinone. 30% other compounds structurally related to I.4,5.8-tetra amino anthraquinone and 20% water in F344IN Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 299. NIH Publication No. 86-2555. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",squamous cell papilloma or carcinoma,Dose,4,5000,ppm,ppm,394.7368421,49,4,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
219,2475458,Disperse Blue 1 (Technical Grade),CalEPA,0.0045,bladder,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Disperse Blue 1 (a commercial dye containing approximately 50% I.4.5.8-tetra amino
anthraquinone. 30% other compounds structurally related to I.4,5.8-tetra amino anthraquinone and 20% water in F344IN Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 299. NIH Publication No. 86-2555. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",transitional cell papilloma or carcinoma,Dose,4,0,ppm,ppm,0,49,0,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
219,2475458,Disperse Blue 1 (Technical Grade),CalEPA,0.0045,bladder,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Disperse Blue 1 (a commercial dye containing approximately 50% I.4.5.8-tetra amino
anthraquinone. 30% other compounds structurally related to I.4,5.8-tetra amino anthraquinone and 20% water in F344IN Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 299. NIH Publication No. 86-2555. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",transitional cell papilloma or carcinoma,Dose,4,1250,ppm,ppm,98.68421053,50,0,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
219,2475458,Disperse Blue 1 (Technical Grade),CalEPA,0.0045,bladder,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Disperse Blue 1 (a commercial dye containing approximately 50% I.4.5.8-tetra amino
anthraquinone. 30% other compounds structurally related to I.4,5.8-tetra amino anthraquinone and 20% water in F344IN Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 299. NIH Publication No. 86-2555. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",transitional cell papilloma or carcinoma,Dose,4,2500,ppm,ppm,197.3684211,50,10,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
219,2475458,Disperse Blue 1 (Technical Grade),CalEPA,0.0045,bladder,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Disperse Blue 1 (a commercial dye containing approximately 50% I.4.5.8-tetra amino
anthraquinone. 30% other compounds structurally related to I.4,5.8-tetra amino anthraquinone and 20% water in F344IN Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 299. NIH Publication No. 86-2555. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",transitional cell papilloma or carcinoma,Dose,4,5000,ppm,ppm,394.7368421,49,11,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
220,2475458,Disperse Blue 1 (Technical Grade),CalEPA,0.0045,bladder,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Disperse Blue 1 (a commercial dye containing approximately 50% I.4.5.8-tetra amino
anthraquinone. 30% other compounds structurally related to I.4,5.8-tetra amino anthraquinone and 20% water in F344IN Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 299. NIH Publication No. 86-2555. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",Leiomyoma or Leiomyosarcoma,Dose,4,0,ppm,ppm,0,49,0,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
220,2475458,Disperse Blue 1 (Technical Grade),CalEPA,0.0045,bladder,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Disperse Blue 1 (a commercial dye containing approximately 50% I.4.5.8-tetra amino
anthraquinone. 30% other compounds structurally related to I.4,5.8-tetra amino anthraquinone and 20% water in F344IN Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 299. NIH Publication No. 86-2555. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",Leiomyoma or Leiomyosarcoma,Dose,4,1250,ppm,ppm,98.68421053,50,0,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
220,2475458,Disperse Blue 1 (Technical Grade),CalEPA,0.0045,bladder,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Disperse Blue 1 (a commercial dye containing approximately 50% I.4.5.8-tetra amino
anthraquinone. 30% other compounds structurally related to I.4,5.8-tetra amino anthraquinone and 20% water in F344IN Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 299. NIH Publication No. 86-2555. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",Leiomyoma or Leiomyosarcoma,Dose,4,2500,ppm,ppm,197.3684211,50,7,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
220,2475458,Disperse Blue 1 (Technical Grade),CalEPA,0.0045,bladder,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of Disperse Blue 1 (a commercial dye containing approximately 50% I.4.5.8-tetra amino
anthraquinone. 30% other compounds structurally related to I.4,5.8-tetra amino anthraquinone and 20% water in F344IN Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series No. 299. NIH Publication No. 86-2555. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",Leiomyoma or Leiomyosarcoma,Dose,4,5000,ppm,ppm,394.7368421,49,41,Rat,Fischer 344,M/F,M,Oral diet,NA,103,Weeks
221,2602462,Direct Blue 6 (Technical Grade),CalEPA,7.4,liver,"National Cancer Institute (NCI, 1978). 13-Week Subchronic Toxicity Studies of Direct Blue 6. Direct Black 38, and Direct Brown 95 Dyes. Carcinogenesis Technical Report Series No. 108. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinomas,Dose,5,190,ppm,ppm,15,10,0,Rat,Fischer 344,M/F,M,Oral diet,NA,91,Days
221,2602462,Direct Blue 6 (Technical Grade),CalEPA,7.4,liver,"National Cancer Institute (NCI, 1978). 13-Week Subchronic Toxicity Studies of Direct Blue 6. Direct Black 38, and Direct Brown 95 Dyes. Carcinogenesis Technical Report Series No. 108. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinomas,Dose,5,375,ppm,ppm,29.60526316,10,0,Rat,Fischer 344,M/F,M,Oral diet,NA,91,Days
221,2602462,Direct Blue 6 (Technical Grade),CalEPA,7.4,liver,"National Cancer Institute (NCI, 1978). 13-Week Subchronic Toxicity Studies of Direct Blue 6. Direct Black 38, and Direct Brown 95 Dyes. Carcinogenesis Technical Report Series No. 108. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinomas,Dose,5,750,ppm,ppm,59.21052632,10,0,Rat,Fischer 344,M/F,M,Oral diet,NA,91,Days
221,2602462,Direct Blue 6 (Technical Grade),CalEPA,7.4,liver,"National Cancer Institute (NCI, 1978). 13-Week Subchronic Toxicity Studies of Direct Blue 6. Direct Black 38, and Direct Brown 95 Dyes. Carcinogenesis Technical Report Series No. 108. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinomas,Dose,5,1500,ppm,ppm,118.4210526,10,8,Rat,Fischer 344,M/F,M,Oral diet,NA,91,Days
221,2602462,Direct Blue 6 (Technical Grade),CalEPA,7.4,liver,"National Cancer Institute (NCI, 1978). 13-Week Subchronic Toxicity Studies of Direct Blue 6. Direct Black 38, and Direct Brown 95 Dyes. Carcinogenesis Technical Report Series No. 108. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",hepatocellular carcinomas,Dose,5,3000,ppm,ppm,236.8421053,9,1,Rat,Fischer 344,M/F,M,Oral diet,NA,91,Days
222,2784943,HC Blue 1,CalEPA,0.051,liver,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of HC Blue 1 in F344/N Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series; No. 271. NTIS Publication No. PB 86-114683. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",liver tumor (hepatocellular adenoma or carcinoma),Dose,3,0,ppm diet,ppm diet,0,50,3,Mouse,B6C3F1,M/F,F,Oral diet,NA,104,Weeks
222,2784943,HC Blue 1,CalEPA,0.051,liver,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of HC Blue 1 in F344/N Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series; No. 271. NTIS Publication No. PB 86-114683. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",liver tumor (hepatocellular adenoma or carcinoma),Dose,3,1500,ppm diet,ppm diet,259.2067989,48,33,Mouse,B6C3F1,M/F,F,Oral diet,NA,104,Weeks
222,2784943,HC Blue 1,CalEPA,0.051,liver,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies of HC Blue 1 in F344/N Rats and B6C3F1 Mice (Feed Studies). NTP Technical Report Series; No. 271. NTIS Publication No. PB 86-114683. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",liver tumor (hepatocellular adenoma or carcinoma),Dose,3,3000,ppm diet,ppm diet,518.4135977,49,47,Mouse,B6C3F1,M/F,F,Oral diet,NA,104,Weeks
223,3546109,Phenesterin,CalEPA,150,lung,"National Cancer Institute (NCI, 1978). Bioassay of Phenesterin for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 60. NTIS Publication No. PH 283361. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",lung tumors (alveolar/broncholar  carcinomas),Conv,4,0,mg/kg-day (ADJ),mg/kg-day,0,70,1,Mouse,B6C3F1,M/F,F,Oral gavage,3,83,Weeks
223,3546109,Phenesterin,CalEPA,150,lung,"National Cancer Institute (NCI, 1978). Bioassay of Phenesterin for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 60. NTIS Publication No. PH 283361. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",lung tumors (alveolar/broncholar  carcinomas),Conv,4,3,mg/kg-day (ADJ),mg/kg-day,3,38,8,Mouse,B6C3F1,M/F,F,Oral gavage,3,83,Weeks
223,3546109,Phenesterin,CalEPA,150,lung,"National Cancer Institute (NCI, 1978). Bioassay of Phenesterin for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 60. NTIS Publication No. PH 283361. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",lung tumors (alveolar/broncholar  carcinomas),Conv,4,6.4,mg/kg-day (ADJ),mg/kg-day,6.4,27,0,Mouse,B6C3F1,M/F,F,Oral gavage,3,83,Weeks
223,3546109,Phenesterin,CalEPA,150,lung,"National Cancer Institute (NCI, 1978). Bioassay of Phenesterin for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 60. NTIS Publication No. PH 283361. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",lung tumors (alveolar/broncholar  carcinomas),Conv,4,12.8,mg/kg-day (ADJ),mg/kg-day,12.8,31,0,Mouse,B6C3F1,M/F,F,Oral gavage,3,83,Weeks
224,3546109,Phenesterin,CalEPA,150,lung,"National Cancer Institute (NCI, 1978). Bioassay of Phenesterin for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 60. NTIS Publication No. PH 283361. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",lung tumors (alveolar/broncholar  adenomas),Conv,4,0,mg/kg-day (ADJ),mg/kg-day,0,70,1,Mouse,B6C3F1,M/F,Both,Oral gavage,3,83,Weeks
224,3546109,Phenesterin,CalEPA,150,lung,"National Cancer Institute (NCI, 1978). Bioassay of Phenesterin for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 60. NTIS Publication No. PH 283361. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",lung tumors (alveolar/broncholar  adenomas),Conv,4,3,mg/kg-day (ADJ),mg/kg-day,3,38,7,Mouse,B6C3F1,M/F,Both,Oral gavage,3,83,Weeks
224,3546109,Phenesterin,CalEPA,150,lung,"National Cancer Institute (NCI, 1978). Bioassay of Phenesterin for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 60. NTIS Publication No. PH 283361. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",lung tumors (alveolar/broncholar  adenomas),Conv,4,6.4,mg/kg-day (ADJ),mg/kg-day,6.4,27,1,Mouse,B6C3F1,M/F,Both,Oral gavage,3,83,Weeks
224,3546109,Phenesterin,CalEPA,150,lung,"National Cancer Institute (NCI, 1978). Bioassay of Phenesterin for Possible Carcinogenicity. Carcinogenesis Technical Report Series No. 60. NTIS Publication No. PH 283361. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",lung tumors (alveolar/broncholar  adenomas),Conv,4,12.8,mg/kg-day (ADJ),mg/kg-day,12.8,31,1,Mouse,B6C3F1,M/F,Both,Oral gavage,3,83,Weeks
225,3761533,Ponceau MX,CalEPA,0.0045,liver,"Grasso P, Lansdown ABG, Kiss IS, Gaunt IF and Gangolli SD (1969). Nodular hyperplasia in the rat liver following prolonged feeding of ponceau MX. Food Cosmet.
Toxicol. 7: 425-442.",nodular hyperplasia with fibrosis,Dose,5,0,% diet,% diet,0,30,0,Rat,CFE,M/F,F,Oral diet,NA,104,Weeks
225,3761533,Ponceau MX,CalEPA,0.0045,liver,"Grasso P, Lansdown ABG, Kiss IS, Gaunt IF and Gangolli SD (1969). Nodular hyperplasia in the rat liver following prolonged feeding of ponceau MX. Food Cosmet.
Toxicol. 7: 425-442.",nodular hyperplasia with fibrosis,Dose,5,0.125,% diet,% diet,105.6338028,30,1,Rat,CFE,M/F,F,Oral diet,NA,104,Weeks
225,3761533,Ponceau MX,CalEPA,0.0045,liver,"Grasso P, Lansdown ABG, Kiss IS, Gaunt IF and Gangolli SD (1969). Nodular hyperplasia in the rat liver following prolonged feeding of ponceau MX. Food Cosmet.
Toxicol. 7: 425-442.",nodular hyperplasia with fibrosis,Dose,5,0.25,% diet,% diet,211.2676056,29,0,Rat,CFE,M/F,F,Oral diet,NA,104,Weeks
225,3761533,Ponceau MX,CalEPA,0.0045,liver,"Grasso P, Lansdown ABG, Kiss IS, Gaunt IF and Gangolli SD (1969). Nodular hyperplasia in the rat liver following prolonged feeding of ponceau MX. Food Cosmet.
Toxicol. 7: 425-442.",nodular hyperplasia with fibrosis,Dose,5,0.5,% diet,% diet,422.5352113,28,5,Rat,CFE,M/F,F,Oral diet,NA,104,Weeks
225,3761533,Ponceau MX,CalEPA,0.0045,liver,"Grasso P, Lansdown ABG, Kiss IS, Gaunt IF and Gangolli SD (1969). Nodular hyperplasia in the rat liver following prolonged feeding of ponceau MX. Food Cosmet.
Toxicol. 7: 425-442.",nodular hyperplasia with fibrosis,Dose,5,1,% diet,% diet,845.0704225,25,14,Rat,CFE,M/F,F,Oral diet,NA,104,Weeks
226,5216251,"Tetrachlorotoluene, Para, Alpha, Alpha, Alpha-",HEAST,20,lung,"Fukada, K.S., Matsashita and K. Takemoto. 1979. Carcinogenicity of p-Chlorobenzotrichloride. Proc of Japan Assoc of Ind Health, p. 330-331.",Adenocarcinoma in the lung,Conv,6,0,mg/kg-day,uL,0,26,0,Mouse,ICR,F,Both,Oral gavage,2,17.5,Weeks
226,5216251,"Tetrachlorotoluene, Para, Alpha, Alpha, Alpha-",HEAST,20,lung,"Fukada, K.S., Matsashita and K. Takemoto. 1979. Carcinogenicity of p-Chlorobenzotrichloride. Proc of Japan Assoc of Ind Health, p. 330-331.",Adenocarcinoma in the lung,Conv,6,0.17,mg/kg-day,uL,0.17,22,3,Mouse,ICR,F,Both,Oral gavage,2,17.5,Weeks
226,5216251,"Tetrachlorotoluene, Para, Alpha, Alpha, Alpha-",HEAST,20,lung,"Fukada, K.S., Matsashita and K. Takemoto. 1979. Carcinogenicity of p-Chlorobenzotrichloride. Proc of Japan Assoc of Ind Health, p. 330-331.",Adenocarcinoma in the lung,Conv,6,0.45,mg/kg-day,uL,0.45,28,7,Mouse,ICR,F,Both,Oral gavage,2,17.5,Weeks
226,5216251,"Tetrachlorotoluene, Para, Alpha, Alpha, Alpha-",HEAST,20,lung,"Fukada, K.S., Matsashita and K. Takemoto. 1979. Carcinogenicity of p-Chlorobenzotrichloride. Proc of Japan Assoc of Ind Health, p. 330-331.",Adenocarcinoma in the lung,Conv,6,1.1,mg/kg-day,uL,1.1,22,10,Mouse,ICR,F,Both,Oral gavage,2,17.5,Weeks
226,5216251,"Tetrachlorotoluene, Para, Alpha, Alpha, Alpha-",HEAST,20,lung,"Fukada, K.S., Matsashita and K. Takemoto. 1979. Carcinogenicity of p-Chlorobenzotrichloride. Proc of Japan Assoc of Ind Health, p. 330-331.",Adenocarcinoma in the lung,Conv,6,2.75,mg/kg-day,uL,2.75,29,15,Mouse,ICR,F,Both,Oral gavage,2,17.5,Weeks
226,5216251,"Tetrachlorotoluene, Para, Alpha, Alpha, Alpha-",HEAST,20,lung,"Fukada, K.S., Matsashita and K. Takemoto. 1979. Carcinogenicity of p-Chlorobenzotrichloride. Proc of Japan Assoc of Ind Health, p. 330-331.",Adenocarcinoma in the lung,Conv,6,6.88,mg/kg-day,uL,6.88,29,2,Mouse,ICR,F,Both,Oral gavage,2,17.5,Weeks
227,6109973,3-Amino-9-ethylcarbazolehydrochloride,CalEPA,0.078,liver,"National Cancer Institute (NCI, 1978). Bioassay of 3-Amino-9-Ethylcarbazole Hydrochloride for Possible Carcinogenicity. Carcinogenesis Technical Report Series,
Technical Report No. 93. DHEW Publication No. (NIH) 78-1337. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant liver tumors,Dose,3,0,ppm,ppm,0,94,1,Rat,Fischer 344,M/F,M,Oral diet,NA,78,Weeks
227,6109973,3-Amino-9-ethylcarbazolehydrochloride,CalEPA,0.078,liver,"National Cancer Institute (NCI, 1978). Bioassay of 3-Amino-9-Ethylcarbazole Hydrochloride for Possible Carcinogenicity. Carcinogenesis Technical Report Series,
Technical Report No. 93. DHEW Publication No. (NIH) 78-1337. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant liver tumors,Dose,3,800,ppm,ppm,63.15789474,42,12,Rat,Fischer 344,M/F,M,Oral diet,NA,78,Weeks
227,6109973,3-Amino-9-ethylcarbazolehydrochloride,CalEPA,0.078,liver,"National Cancer Institute (NCI, 1978). Bioassay of 3-Amino-9-Ethylcarbazole Hydrochloride for Possible Carcinogenicity. Carcinogenesis Technical Report Series,
Technical Report No. 93. DHEW Publication No. (NIH) 78-1337. US Department of Health, Education and Welfare, NCI Carcinogenesis Testing Program, Bethesda, MD.",benign and malignant liver tumors,Dose,3,2000,ppm,ppm,157.8947368,48,22,Rat,Fischer 344,M/F,M,Oral diet,NA,78,Weeks
228,8001352,Toxaphene,IRIS,1.1,liver,"Litton Bionetics. 1978. Carcinogenic evaluation in mice: Toxaphene. Final report. Prepared by Litton Bionetics, Inc., Kensington, MD for Hercules, Inc., Wilmington, DE. LBI Project No. 20602.",hepatocellular carcinomas and neoplastic nodules,HEq,4,0,mg/kg/day,ppm,0,53,10,Mouse,B6C3F1,M/F,M,Oral diet,NA,18,Months
228,8001352,Toxaphene,IRIS,1.1,liver,"Litton Bionetics. 1978. Carcinogenic evaluation in mice: Toxaphene. Final report. Prepared by Litton Bionetics, Inc., Kensington, MD for Hercules, Inc., Wilmington, DE. LBI Project No. 20602.",hepatocellular carcinomas and neoplastic nodules,HEq,4,0.051,mg/kg/day,ppm,0.051,54,10,Mouse,B6C3F1,M/F,M,Oral diet,NA,18,Months
228,8001352,Toxaphene,IRIS,1.1,liver,"Litton Bionetics. 1978. Carcinogenic evaluation in mice: Toxaphene. Final report. Prepared by Litton Bionetics, Inc., Kensington, MD for Hercules, Inc., Wilmington, DE. LBI Project No. 20602.",hepatocellular carcinomas and neoplastic nodules,HEq,4,0.144,mg/kg/day,ppm,0.144,53,12,Mouse,B6C3F1,M/F,M,Oral diet,NA,18,Months
228,8001352,Toxaphene,IRIS,1.1,liver,"Litton Bionetics. 1978. Carcinogenic evaluation in mice: Toxaphene. Final report. Prepared by Litton Bionetics, Inc., Kensington, MD for Hercules, Inc., Wilmington, DE. LBI Project No. 20602.",hepatocellular carcinomas and neoplastic nodules,HEq,4,0.361,mg/kg/day,ppm,0.361,51,18,Mouse,B6C3F1,M/F,M,Oral diet,NA,18,Months
229,10048132,Sterigmatocystin,CalEPA,35,liver,"Maekawa A, Kajiwara T, Odashima Sand Kurata H (1979). Hepatic changes in male ACI/N rats on low dietary levels of sterigmatocystin. Gann 70: 777-781.",liver tumors,Dose,4,0,ppm,ppm,0,11,0,Rat,ACI/N,M,Both,Oral diet,NA,lifespan,
229,10048132,Sterigmatocystin,CalEPA,35,liver,"Maekawa A, Kajiwara T, Odashima Sand Kurata H (1979). Hepatic changes in male ACI/N rats on low dietary levels of sterigmatocystin. Gann 70: 777-781.",liver tumors,Dose,4,0.1,ppm,ppm,0.007300885,27,0,Rat,ACI/N,M,Both,Oral diet,NA,lifespan,
229,10048132,Sterigmatocystin,CalEPA,35,liver,"Maekawa A, Kajiwara T, Odashima Sand Kurata H (1979). Hepatic changes in male ACI/N rats on low dietary levels of sterigmatocystin. Gann 70: 777-781.",liver tumors,Dose,4,1,ppm,ppm,0.07300885,29,1,Rat,ACI/N,M,Both,Oral diet,NA,lifespan,
229,10048132,Sterigmatocystin,CalEPA,35,liver,"Maekawa A, Kajiwara T, Odashima Sand Kurata H (1979). Hepatic changes in male ACI/N rats on low dietary levels of sterigmatocystin. Gann 70: 777-781.",liver tumors,Dose,4,10,ppm,ppm,0.730088496,26,5,Rat,ACI/N,M,Both,Oral diet,NA,lifespan,
230,10048132,Sterigmatocystin,CalEPA,35,liver,"Ohtsubo K, Saito M, Kimura H and Tsuruta O(1978). High incidence of hepatic tumours in rats fed mouldy rice contaminated with Aspergillus versicolor containing
sterigmatocystin. Food Cosmet. Toxicol. 16: 143-149.",liver tumors,Dose,3,0,ppm,ppm,0,17,0,Rat,Donryu,M,Both,Oral diet,NA,709,Days
230,10048132,Sterigmatocystin,CalEPA,35,liver,"Ohtsubo K, Saito M, Kimura H and Tsuruta O(1978). High incidence of hepatic tumours in rats fed mouldy rice contaminated with Aspergillus versicolor containing
sterigmatocystin. Food Cosmet. Toxicol. 16: 143-149.",liver tumors,Dose,3,5,ppm,ppm,0.365044248,13,11,Rat,Donryu,M,Both,Oral diet,NA,709,Days
230,10048132,Sterigmatocystin,CalEPA,35,liver,"Ohtsubo K, Saito M, Kimura H and Tsuruta O(1978). High incidence of hepatic tumours in rats fed mouldy rice contaminated with Aspergillus versicolor containing
sterigmatocystin. Food Cosmet. Toxicol. 16: 143-149.",liver tumors,Dose,3,10,ppm,ppm,0.730088496,13,12,Rat,Donryu,M,Both,Oral diet,NA,709,Days
231,10048132,Sterigmatocystin,CalEPA,35,liver,Purchase IFH and van der Watt JJ (1970). Carcinogenicity of sterigmatocystin. Food Cosmet. Toxicol. 8: 289-295.,hepatocellular carcinomas,Dose,4,0,mg/rat/day (TWA),ppm (TWA),0,9,0,Rat,Wistar,M,M,Oral diet,NA,1,Years
231,10048132,Sterigmatocystin,CalEPA,35,liver,Purchase IFH and van der Watt JJ (1970). Carcinogenicity of sterigmatocystin. Food Cosmet. Toxicol. 8: 289-295.,hepatocellular carcinomas,Dose,4,0.19,mg/rat/day (TWA),ppm (TWA),0.411255411,9,8,Rat,Wistar,M,M,Oral diet,NA,1,Years
231,10048132,Sterigmatocystin,CalEPA,35,liver,Purchase IFH and van der Watt JJ (1970). Carcinogenicity of sterigmatocystin. Food Cosmet. Toxicol. 8: 289-295.,hepatocellular carcinomas,Dose,4,0.38,mg/rat/day (TWA),ppm (TWA),0.822510823,10,10,Rat,Wistar,M,M,Oral diet,NA,1,Years
231,10048132,Sterigmatocystin,CalEPA,35,liver,Purchase IFH and van der Watt JJ (1970). Carcinogenicity of sterigmatocystin. Food Cosmet. Toxicol. 8: 289-295.,hepatocellular carcinomas,Dose,4,1.9,mg/rat/day (TWA),ppm (TWA),4.112554113,3,3,Rat,Wistar,M,M,Oral diet,NA,1,Years
232,10048132,Sterigmatocystin,CalEPA,35,liver,Purchase IFH and van der Watt JJ (1970). Carcinogenicity of sterigmatocystin. Food Cosmet. Toxicol. 8: 289-295.,hepatocellular carcinomas,Dose,4,0,mg/rat/day,mg/rat/day,0,10,0,Rat,Wistar,M,Both,Oral gavage,5,1,Years
232,10048132,Sterigmatocystin,CalEPA,35,liver,Purchase IFH and van der Watt JJ (1970). Carcinogenicity of sterigmatocystin. Food Cosmet. Toxicol. 8: 289-295.,hepatocellular carcinomas,Dose,4,0.15,mg/rat/day,mg/rat/day,0.231910946,10,4,Rat,Wistar,M,Both,Oral gavage,5,1,Years
232,10048132,Sterigmatocystin,CalEPA,35,liver,Purchase IFH and van der Watt JJ (1970). Carcinogenicity of sterigmatocystin. Food Cosmet. Toxicol. 8: 289-295.,hepatocellular carcinomas,Dose,4,0.3,mg/rat/day,mg/rat/day,0.463821892,9,5,Rat,Wistar,M,Both,Oral gavage,5,1,Years
232,10048132,Sterigmatocystin,CalEPA,35,liver,Purchase IFH and van der Watt JJ (1970). Carcinogenicity of sterigmatocystin. Food Cosmet. Toxicol. 8: 289-295.,hepatocellular carcinomas,Dose,4,1.5,mg/rat/day,mg/rat/day,2.319109462,9,9,Rat,Wistar,M,Both,Oral gavage,5,1,Years
233,12789036,"Chlordane, technical grade",IRIS,0.35,liver,IRDC (International Research and Development Corporation). 1973. Eighteen-month oral carcinogenic study of chlordane in mice. Unpublished report to Velsicol Chemical Corporation. MRID No. 00067568. Available from U.S. Environmental Protection Agency.,hepatocellular carcinoma,HEq,4,0,mg/kg/day,ppm,0,33,3,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
233,12789036,"Chlordane, technical grade",IRIS,0.35,liver,IRDC (International Research and Development Corporation). 1973. Eighteen-month oral carcinogenic study of chlordane in mice. Unpublished report to Velsicol Chemical Corporation. MRID No. 00067568. Available from U.S. Environmental Protection Agency.,hepatocellular carcinoma,HEq,4,0.1022,mg/kg/day,ppm,0.1022,55,5,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
233,12789036,"Chlordane, technical grade",IRIS,0.35,liver,IRDC (International Research and Development Corporation). 1973. Eighteen-month oral carcinogenic study of chlordane in mice. Unpublished report to Velsicol Chemical Corporation. MRID No. 00067568. Available from U.S. Environmental Protection Agency.,hepatocellular carcinoma,HEq,4,0.5137,mg/kg/day,ppm,0.5137,52,41,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
233,12789036,"Chlordane, technical grade",IRIS,0.35,liver,IRDC (International Research and Development Corporation). 1973. Eighteen-month oral carcinogenic study of chlordane in mice. Unpublished report to Velsicol Chemical Corporation. MRID No. 00067568. Available from U.S. Environmental Protection Agency.,hepatocellular carcinoma,HEq,4,1.0273,mg/kg/day,ppm,1.0273,39,32,Mouse,CD-1,M/F,M,Oral diet,NA,18,Months
234,12789036,"Chlordane, technical grade",IRIS,0.35,liver,IRDC (International Research and Development Corporation). 1973. Eighteen-month oral carcinogenic study of chlordane in mice. Unpublished report to Velsicol Chemical Corporation. MRID No. 00067568. Available from U.S. Environmental Protection Agency.,hepatocellular carcinoma,HEq,4,0,mg/kg/day,ppm,0,45,0,Mouse,CD-1,M/F,F,Oral diet,NA,18,Months
234,12789036,"Chlordane, technical grade",IRIS,0.35,liver,IRDC (International Research and Development Corporation). 1973. Eighteen-month oral carcinogenic study of chlordane in mice. Unpublished report to Velsicol Chemical Corporation. MRID No. 00067568. Available from U.S. Environmental Protection Agency.,hepatocellular carcinoma,HEq,4,0.1022,mg/kg/day,ppm,0.1022,61,0,Mouse,CD-1,M/F,F,Oral diet,NA,18,Months
234,12789036,"Chlordane, technical grade",IRIS,0.35,liver,IRDC (International Research and Development Corporation). 1973. Eighteen-month oral carcinogenic study of chlordane in mice. Unpublished report to Velsicol Chemical Corporation. MRID No. 00067568. Available from U.S. Environmental Protection Agency.,hepatocellular carcinoma,HEq,4,0.5137,mg/kg/day,ppm,0.5137,50,32,Mouse,CD-1,M/F,F,Oral diet,NA,18,Months
234,12789036,"Chlordane, technical grade",IRIS,0.35,liver,IRDC (International Research and Development Corporation). 1973. Eighteen-month oral carcinogenic study of chlordane in mice. Unpublished report to Velsicol Chemical Corporation. MRID No. 00067568. Available from U.S. Environmental Protection Agency.,hepatocellular carcinoma,HEq,4,1.0273,mg/kg/day,ppm,1.0273,37,26,Mouse,CD-1,M/F,F,Oral diet,NA,18,Months
235,12789036,"Chlordane, technical grade",IRIS,0.35,liver,"Khasawinah, A.M. and J.F. Grutsch. 1989. Chlordane: thirty-month tumorigenicity and chronic toxicity test in mice. Regul. Toxicol. Pharmacol. 10(2): 95-109.",hepatocellular carcinoma,HEq,4,0,mg/kg/day,ppm,0,71,3,Mouse,ICR,M/F,M,Oral diet,NA,104,Weeks
235,12789036,"Chlordane, technical grade",IRIS,0.35,liver,"Khasawinah, A.M. and J.F. Grutsch. 1989. Chlordane: thirty-month tumorigenicity and chronic toxicity test in mice. Regul. Toxicol. Pharmacol. 10(2): 95-109.",hepatocellular carcinoma,HEq,4,0.0216,mg/kg/day,ppm,0.0216,71,3,Mouse,ICR,M/F,M,Oral diet,NA,104,Weeks
235,12789036,"Chlordane, technical grade",IRIS,0.35,liver,"Khasawinah, A.M. and J.F. Grutsch. 1989. Chlordane: thirty-month tumorigenicity and chronic toxicity test in mice. Regul. Toxicol. Pharmacol. 10(2): 95-109.",hepatocellular carcinoma,HEq,4,0.1079,mg/kg/day,ppm,0.1079,72,7,Mouse,ICR,M/F,M,Oral diet,NA,104,Weeks
235,12789036,"Chlordane, technical grade",IRIS,0.35,liver,"Khasawinah, A.M. and J.F. Grutsch. 1989. Chlordane: thirty-month tumorigenicity and chronic toxicity test in mice. Regul. Toxicol. Pharmacol. 10(2): 95-109.",hepatocellular carcinoma,HEq,4,0.2698,mg/kg/day,ppm,0.2698,72,9,Mouse,ICR,M/F,M,Oral diet,NA,104,Weeks
236,12789036,"Chlordane, technical grade",IRIS,0.35,liver,"NCI (National Cancer Institute). 1977. Bioassay of chlordane for possible carcinogenicity. Technical Report Series No. 8. U.S. Department of Health, Education and Welfare; National Institutes of Health. PB 271 977.",hepatocellular carcinoma,HEq,3,0,mg/kg/day,ppm,0,92,17,Mouse,B6C3F1,M/F,M,Oral diet,NA,80,Weeks
236,12789036,"Chlordane, technical grade",IRIS,0.35,liver,"NCI (National Cancer Institute). 1977. Bioassay of chlordane for possible carcinogenicity. Technical Report Series No. 8. U.S. Department of Health, Education and Welfare; National Institutes of Health. PB 271 977.",hepatocellular carcinoma,HEq,3,0.65187,mg/kg/day,ppm,0.65187,48,16,Mouse,B6C3F1,M/F,M,Oral diet,NA,80,Weeks
236,12789036,"Chlordane, technical grade",IRIS,0.35,liver,"NCI (National Cancer Institute). 1977. Bioassay of chlordane for possible carcinogenicity. Technical Report Series No. 8. U.S. Department of Health, Education and Welfare; National Institutes of Health. PB 271 977.",hepatocellular carcinoma,HEq,3,1.1511,mg/kg/day,ppm,1.1511,49,43,Mouse,B6C3F1,M/F,M,Oral diet,NA,80,Weeks
237,12789036,"Chlordane, technical grade",IRIS,0.35,liver,"NCI (National Cancer Institute). 1977. Bioassay of chlordane for possible carcinogenicity. Technical Report Series No. 8. U.S. Department of Health, Education and Welfare; National Institutes of Health. PB 271 977.",hepatocellular carcinoma,HEq,3,0,mg/kg/day,ppm,0,78,3,Mouse,B6C3F1,M/F,F,Oral diet,NA,80,Weeks
237,12789036,"Chlordane, technical grade",IRIS,0.35,liver,"NCI (National Cancer Institute). 1977. Bioassay of chlordane for possible carcinogenicity. Technical Report Series No. 8. U.S. Department of Health, Education and Welfare; National Institutes of Health. PB 271 977.",hepatocellular carcinoma,HEq,3,0.6187,mg/kg/day,ppm,0.6187,47,3,Mouse,B6C3F1,M/F,F,Oral diet,NA,80,Weeks
237,12789036,"Chlordane, technical grade",IRIS,0.35,liver,"NCI (National Cancer Institute). 1977. Bioassay of chlordane for possible carcinogenicity. Technical Report Series No. 8. U.S. Department of Health, Education and Welfare; National Institutes of Health. PB 271 977.",hepatocellular carcinoma,HEq,3,1.3093,mg/kg/day,ppm,1.3093,49,33,Mouse,B6C3F1,M/F,F,Oral diet,NA,80,Weeks
238,25013165,Butylated Hydroxyanisole,CalEPA,2.00E-04,stomach/forestomach,"Ito N, Fukushima S, Tamano S, Hirose M, and Hagiwara A (1986a)  Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.  JNCI 77:1261-1265",Forestomach papillomas,Dose,6,0,mg/kg-day,mg/kg-day,0,50,0,Rat,Fischer 344,,M,Oral diet,NA,104,Weeks
238,25013165,Butylated Hydroxyanisole,CalEPA,2.00E-04,stomach/forestomach,"Ito N, Fukushima S, Tamano S, Hirose M, and Hagiwara A (1986a)  Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.  JNCI 77:1261-1265",Forestomach papillomas,Dose,6,54.8,mg/kg-day,mg/kg-day,54.8,50,0,Rat,Fischer 344,,M,Oral diet,NA,104,Weeks
238,25013165,Butylated Hydroxyanisole,CalEPA,2.00E-04,stomach/forestomach,"Ito N, Fukushima S, Tamano S, Hirose M, and Hagiwara A (1986a)  Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.  JNCI 77:1261-1265",Forestomach papillomas,Dose,6,109.6,mg/kg-day,mg/kg-day,109.6,50,0,Rat,Fischer 344,,M,Oral diet,NA,104,Weeks
238,25013165,Butylated Hydroxyanisole,CalEPA,2.00E-04,stomach/forestomach,"Ito N, Fukushima S, Tamano S, Hirose M, and Hagiwara A (1986a)  Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.  JNCI 77:1261-1265",Forestomach papillomas,Dose,6,230.4,mg/kg-day,mg/kg-day,230.4,50,0,Rat,Fischer 344,,M,Oral diet,NA,104,Weeks
238,25013165,Butylated Hydroxyanisole,CalEPA,2.00E-04,stomach/forestomach,"Ito N, Fukushima S, Tamano S, Hirose M, and Hagiwara A (1986a)  Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.  JNCI 77:1261-1265",Forestomach papillomas,Dose,6,427.6,mg/kg-day,mg/kg-day,427.6,50,10,Rat,Fischer 344,,M,Oral diet,NA,104,Weeks
238,25013165,Butylated Hydroxyanisole,CalEPA,2.00E-04,stomach/forestomach,"Ito N, Fukushima S, Tamano S, Hirose M, and Hagiwara A (1986a)  Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.  JNCI 77:1261-1265",Forestomach papillomas,Dose,6,1322.6,mg/kg-day,mg/kg-day,1322.6,50,50,Rat,Fischer 344,,M,Oral diet,NA,104,Weeks
239,25013165,Butylated Hydroxyanisole,CalEPA,2.00E-04,stomach/forestomach,"Ito N, Fukushima S, Tamano S, Hirose M, and Hagiwara A (1986a)  Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.  JNCI 77:1261-1265",forestomach carcinomas,Dose,6,0,mg/kg-day,mg/kg-day,0,50,0,Rat,Fischer 344,,Both,Oral diet,NA,104,Weeks
239,25013165,Butylated Hydroxyanisole,CalEPA,2.00E-04,stomach/forestomach,"Ito N, Fukushima S, Tamano S, Hirose M, and Hagiwara A (1986a)  Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.  JNCI 77:1261-1265",forestomach carcinomas,Dose,6,54.8,mg/kg-day,mg/kg-day,54.8,50,0,Rat,Fischer 344,,Both,Oral diet,NA,104,Weeks
239,25013165,Butylated Hydroxyanisole,CalEPA,2.00E-04,stomach/forestomach,"Ito N, Fukushima S, Tamano S, Hirose M, and Hagiwara A (1986a)  Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.  JNCI 77:1261-1265",forestomach carcinomas,Dose,6,109.6,mg/kg-day,mg/kg-day,109.6,50,0,Rat,Fischer 344,,Both,Oral diet,NA,104,Weeks
239,25013165,Butylated Hydroxyanisole,CalEPA,2.00E-04,stomach/forestomach,"Ito N, Fukushima S, Tamano S, Hirose M, and Hagiwara A (1986a)  Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.  JNCI 77:1261-1265",forestomach carcinomas,Dose,6,230.4,mg/kg-day,mg/kg-day,230.4,50,0,Rat,Fischer 344,,Both,Oral diet,NA,104,Weeks
239,25013165,Butylated Hydroxyanisole,CalEPA,2.00E-04,stomach/forestomach,"Ito N, Fukushima S, Tamano S, Hirose M, and Hagiwara A (1986a)  Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.  JNCI 77:1261-1265",forestomach carcinomas,Dose,6,427.6,mg/kg-day,mg/kg-day,427.6,50,0,Rat,Fischer 344,,Both,Oral diet,NA,104,Weeks
239,25013165,Butylated Hydroxyanisole,CalEPA,2.00E-04,stomach/forestomach,"Ito N, Fukushima S, Tamano S, Hirose M, and Hagiwara A (1986a)  Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.  JNCI 77:1261-1265",forestomach carcinomas,Dose,6,1322.6,mg/kg-day,mg/kg-day,1322.6,50,11,Rat,Fischer 344,,Both,Oral diet,NA,104,Weeks
240,26471625,"2,4/2,6-Toluene diisocyanate",CalEPA,0.039,systemic,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies Toluen Diisocyanate in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP
Technical Report Series No. 251. NTIS Publicatlon No. 87115176. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",fibromas and fibrosarcomas of the subcutaneous tissue,Dose,3,0,mg/kg/dose,mg/kg/dose,0,50,3,Rat,Fischer 344,M/F,M,Oral gavage,5,106,Weeks
240,26471625,"2,4/2,6-Toluene diisocyanate",CalEPA,0.039,systemic,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies Toluen Diisocyanate in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP
Technical Report Series No. 251. NTIS Publicatlon No. 87115176. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",fibromas and fibrosarcomas of the subcutaneous tissue,Dose,3,30,mg/kg/dose,mg/kg/dose,21.42857143,50,6,Rat,Fischer 344,M/F,M,Oral gavage,5,106,Weeks
240,26471625,"2,4/2,6-Toluene diisocyanate",CalEPA,0.039,systemic,"National Toxicology Program (NTP, 1986). Toxicology and Carcinogenesis Studies Toluen Diisocyanate in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP
Technical Report Series No. 251. NTIS Publicatlon No. 87115176. US Department of Health and Human Services, NTP, Research Triangle Park, NC.",fibromas and fibrosarcomas of the subcutaneous tissue,Dose,3,60,mg/kg/dose,mg/kg/dose,42.85714286,50,12,Rat,Fischer 344,M/F,M,Oral gavage,5,106,Weeks
241,30560191,Acephate,IRIS,0.0087,liver,"Chevron Chemical Corporation. 1982a. MRID No. 00105197. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",liver adenomas and carcinomas,HEq,4,0,mg/kg-day,ppm,0,62,1,Mouse,CD-1,M/F,F,Oral diet,7,105,Weeks
241,30560191,Acephate,IRIS,0.0087,liver,"Chevron Chemical Corporation. 1982a. MRID No. 00105197. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",liver adenomas and carcinomas,HEq,4,0.63,mg/kg-day,ppm,0.63,61,3,Mouse,CD-1,M/F,F,Oral diet,7,105,Weeks
241,30560191,Acephate,IRIS,0.0087,liver,"Chevron Chemical Corporation. 1982a. MRID No. 00105197. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",liver adenomas and carcinomas,HEq,4,3.33,mg/kg-day,ppm,3.33,62,0,Mouse,CD-1,M/F,F,Oral diet,7,105,Weeks
241,30560191,Acephate,IRIS,0.0087,liver,"Chevron Chemical Corporation. 1982a. MRID No. 00105197. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",liver adenomas and carcinomas,HEq,4,13.3,mg/kg-day,ppm,13.3,61,15,Mouse,CD-1,M/F,F,Oral diet,7,105,Weeks
242,59536651,Polybrominated Biphenyls,HEAST,8.9,liver,"NTP (National Toxicology Program). 1983. Carcinogenesis studies of Polybrominated Biphenyl mixture in F344/N rats and B6C3F1 mice (gavage studies). Firemaster FF-1. Case No. 67774-32-7. NTP, Research Triangle Park, NC.",hepatocellular carcinoma and neoplastic nodules,HEq,6,0,mg/kg/day,mg/kg/dose,0,20,0,Rat,Fischer 344,M/F,F,Oral gavage,5,25,Weeks
242,59536651,Polybrominated Biphenyls,HEAST,8.9,liver,"NTP (National Toxicology Program). 1983. Carcinogenesis studies of Polybrominated Biphenyl mixture in F344/N rats and B6C3F1 mice (gavage studies). Firemaster FF-1. Case No. 67774-32-7. NTP, Research Triangle Park, NC.",hepatocellular carcinoma and neoplastic nodules,HEq,6,0.00247,mg/kg/day,mg/kg/dose,0.00247,21,2,Rat,Fischer 344,M/F,F,Oral gavage,5,25,Weeks
242,59536651,Polybrominated Biphenyls,HEAST,8.9,liver,"NTP (National Toxicology Program). 1983. Carcinogenesis studies of Polybrominated Biphenyl mixture in F344/N rats and B6C3F1 mice (gavage studies). Firemaster FF-1. Case No. 67774-32-7. NTP, Research Triangle Park, NC.",hepatocellular carcinoma and neoplastic nodules,HEq,6,0.00741,mg/kg/day,mg/kg/dose,0.00741,21,0,Rat,Fischer 344,M/F,F,Oral gavage,5,25,Weeks
242,59536651,Polybrominated Biphenyls,HEAST,8.9,liver,"NTP (National Toxicology Program). 1983. Carcinogenesis studies of Polybrominated Biphenyl mixture in F344/N rats and B6C3F1 mice (gavage studies). Firemaster FF-1. Case No. 67774-32-7. NTP, Research Triangle Park, NC.",hepatocellular carcinoma and neoplastic nodules,HEq,6,0.02471,mg/kg/day,mg/kg/dose,0.02471,11,2,Rat,Fischer 344,M/F,F,Oral gavage,5,25,Weeks
242,59536651,Polybrominated Biphenyls,HEAST,8.9,liver,"NTP (National Toxicology Program). 1983. Carcinogenesis studies of Polybrominated Biphenyl mixture in F344/N rats and B6C3F1 mice (gavage studies). Firemaster FF-1. Case No. 67774-32-7. NTP, Research Triangle Park, NC.",hepatocellular carcinoma and neoplastic nodules,HEq,6,0.07413,mg/kg/day,mg/kg/dose,0.07413,19,7,Rat,Fischer 344,M/F,F,Oral gavage,5,25,Weeks
242,59536651,Polybrominated Biphenyls,HEAST,8.9,liver,"NTP (National Toxicology Program). 1983. Carcinogenesis studies of Polybrominated Biphenyl mixture in F344/N rats and B6C3F1 mice (gavage studies). Firemaster FF-1. Case No. 67774-32-7. NTP, Research Triangle Park, NC.",hepatocellular carcinoma and neoplastic nodules,HEq,6,0.24711,mg/kg/day,mg/kg/dose,0.24711,20,16,Rat,Fischer 344,M/F,F,Oral gavage,5,25,Weeks
243,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,auditory system,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",squamous cell papilloma or carcinoma of the Zymbal's gland,Dose,4,0,mg/kg-d,mg/kg-d,0,36,0,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
243,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,auditory system,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",squamous cell papilloma or carcinoma of the Zymbal's gland,Dose,4,5.7,mg/kg-d,mg/kg-d,5.7,40,0,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
243,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,auditory system,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",squamous cell papilloma or carcinoma of the Zymbal's gland,Dose,4,11.4,mg/kg-d,mg/kg-d,11.4,38,1,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
243,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,auditory system,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",squamous cell papilloma or carcinoma of the Zymbal's gland,Dose,4,22.9,mg/kg-d,mg/kg-d,22.9,34,3,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
244,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal hyperplasia,Dose,4,0,mg/kg-d,mg/kg-d,0,36,0,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
244,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal hyperplasia,Dose,4,5.7,mg/kg-d,mg/kg-d,5.7,40,4,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
244,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal hyperplasia,Dose,4,11.4,mg/kg-d,mg/kg-d,11.4,38,12,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
244,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal hyperplasia,Dose,4,22.9,mg/kg-d,mg/kg-d,22.9,34,24,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
245,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal adenoma,Dose,4,0,mg/kg-day,mg/kg-day,0,36,0,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
245,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal adenoma,Dose,4,5.7,mg/kg-day,mg/kg-day,5.7,40,4,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
245,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal adenoma,Dose,4,11.4,mg/kg-day,mg/kg-day,11.4,38,15,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
245,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal adenoma,Dose,4,22.9,mg/kg-day,mg/kg-day,22.9,34,23,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
246,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal adenocarcinoma,Dose,4,0,mg/kg-day,mg/kg-day,0,36,0,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
246,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal adenocarcinoma,Dose,4,5.7,mg/kg-day,mg/kg-day,5.7,40,1,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
246,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal adenocarcinoma,Dose,4,11.4,mg/kg-day,mg/kg-day,11.4,38,9,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
246,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal adenocarcinoma,Dose,4,22.9,mg/kg-day,mg/kg-day,22.9,34,19,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
247,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal fibrosarcoma or myosarcoma,Dose,4,0,mg/kg-day,mg/kg-day,0,36,0,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
247,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal fibrosarcoma or myosarcoma,Dose,4,5.7,mg/kg-day,mg/kg-day,5.7,40,0,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
247,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal fibrosarcoma or myosarcoma,Dose,4,11.4,mg/kg-day,mg/kg-day,11.4,38,0,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
247,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,gastrointestinal,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",intestinal fibrosarcoma or myosarcoma,Dose,4,22.9,mg/kg-day,mg/kg-day,22.9,34,3,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
248,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,oral cavity,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",squamous cell papilloma or carcinoma of the oral cavity,Dose,4,0,mg/kg-d,mg/kg-d,0,36,0,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
248,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,oral cavity,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",squamous cell papilloma or carcinoma of the oral cavity,Dose,4,5.7,mg/kg-d,mg/kg-d,5.7,40,1,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
248,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,oral cavity,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",squamous cell papilloma or carcinoma of the oral cavity,Dose,4,11.4,mg/kg-d,mg/kg-d,11.4,38,1,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
248,60391926,n-Carboxymethyl-n-Nitrosourea,CalEPA,1,oral cavity,"Maekawa A, Ogiu T, Matsuoka C, Onodera H, Furuta K, Tanigawa H, Odashima S (1983).  Induction of tumors in the small intestine and mammary gland of female Donryu rats by continuous oral administration of N-carboxymethyl-N-nitrosourea. J Cancer Res Clin Oncol
106(1):12-16.",squamous cell papilloma or carcinoma of the oral cavity,Dose,4,22.9,mg/kg-d,mg/kg-d,22.9,34,3,Rat,Donryu,F,Both,Oral drinking water,NA,68,Weeks
249,60568050,Furmecyclox,CalEPA,0.03,liver,"BASF Wyandotte Corporation. 1984a. MRID No. 00142519. Available from EPA. Write to FOI, EPA, Washington DC 20460.",combined liver nodules and carcinomas,HEq,4,0,mg/kg/day,ppm,0,45,4,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,2,Years
249,60568050,Furmecyclox,CalEPA,0.03,liver,"BASF Wyandotte Corporation. 1984a. MRID No. 00142519. Available from EPA. Write to FOI, EPA, Washington DC 20460.",combined liver nodules and carcinomas,HEq,4,5,mg/kg/day,ppm,5,65,10,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,2,Years
249,60568050,Furmecyclox,CalEPA,0.03,liver,"BASF Wyandotte Corporation. 1984a. MRID No. 00142519. Available from EPA. Write to FOI, EPA, Washington DC 20460.",combined liver nodules and carcinomas,HEq,4,20,mg/kg/day,ppm,20,65,25,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,2,Years
249,60568050,Furmecyclox,CalEPA,0.03,liver,"BASF Wyandotte Corporation. 1984a. MRID No. 00142519. Available from EPA. Write to FOI, EPA, Washington DC 20460.",combined liver nodules and carcinomas,HEq,4,100,mg/kg/day,ppm,100,65,62,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,2,Years
250,60568050,Furmecyclox,IRIS,0.03,liver,"BASF Wyandotte Corporation. 1984a. MRID No. 00142519. Available from EPA. Write to FOI, EPA, Washington DC 20460.",combined liver nodules and carcinomas,HEq,4,0,mg/kg/day,ppm,0,45,4,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,2,Years
250,60568050,Furmecyclox,IRIS,0.03,liver,"BASF Wyandotte Corporation. 1984a. MRID No. 00142519. Available from EPA. Write to FOI, EPA, Washington DC 20460.",combined liver nodules and carcinomas,HEq,4,5,mg/kg/day,ppm,5,65,10,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,2,Years
250,60568050,Furmecyclox,IRIS,0.03,liver,"BASF Wyandotte Corporation. 1984a. MRID No. 00142519. Available from EPA. Write to FOI, EPA, Washington DC 20460.",combined liver nodules and carcinomas,HEq,4,20,mg/kg/day,ppm,20,65,25,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,2,Years
250,60568050,Furmecyclox,IRIS,0.03,liver,"BASF Wyandotte Corporation. 1984a. MRID No. 00142519. Available from EPA. Write to FOI, EPA, Washington DC 20460.",combined liver nodules and carcinomas,HEq,4,100,mg/kg/day,ppm,100,65,62,Rat,Sprague-Dawley,M/F,F,Oral diet,NA,2,Years
251,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,liver,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",liver tumors,Dose,4,0,mg/kg/day,mg/kg/day,0,80,6,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
251,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,liver,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",liver tumors,Dose,4,0.025,mg/kg/day,mg/kg/day,0.025,80,3,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
251,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,liver,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",liver tumors,Dose,4,0.05,mg/kg/day,mg/kg/day,0.05,80,11,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
251,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,liver,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",liver tumors,Dose,4,0.25,mg/kg/day,mg/kg/day,0.25,30,12,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
252,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,lung,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",lung tumors,Dose,4,0,mg/kg/day,mg/kg/day,0,80,6,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
252,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,lung,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",lung tumors,Dose,4,0.025,mg/kg/day,mg/kg/day,0.025,80,9,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
252,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,lung,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",lung tumors,Dose,4,0.05,mg/kg/day,mg/kg/day,0.05,80,20,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
252,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,lung,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",lung tumors,Dose,4,0.25,mg/kg/day,mg/kg/day,0.25,30,27,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
253,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,nasal passages,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",nasal tumors,Dose,4,0,mg/kg/day,mg/kg/day,0,80,0,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
253,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,nasal passages,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",nasal tumors,Dose,4,0.025,mg/kg/day,mg/kg/day,0.025,80,1,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
253,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,nasal passages,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",nasal tumors,Dose,4,0.05,mg/kg/day,mg/kg/day,0.05,80,2,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
253,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,nasal passages,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",nasal tumors,Dose,4,0.25,mg/kg/day,mg/kg/day,0.25,30,5,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
254,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,pancreas,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",pancreas exocrine tumors,Dose,4,0,mg/kg/day,mg/kg/day,0,80,1,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
254,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,pancreas,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",pancreas exocrine tumors,Dose,4,0.025,mg/kg/day,mg/kg/day,0.025,80,5,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
254,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,pancreas,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",pancreas exocrine tumors,Dose,4,0.05,mg/kg/day,mg/kg/day,0.05,80,9,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
254,64091914,4-(n-nitrosomethylamino)-1(3-pyridyl)-1-butanone,CalEPA,49,pancreas,"Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derived Nnitrosamines. Cancer Res 48:6912-6917.",pancreas exocrine tumors,Dose,4,0.25,mg/kg/day,mg/kg/day,0.25,30,2,Rat,Fischer 344,M,Both,Oral drinking water,NA,27,Duration
255,67747095,Prochloraz,IRIS,0.15,liver,"Nor-Am Chemical Company. 1983. MRID No. 00150409. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",liver adenoma/carcinoma combined,HEq,4,0,mg/kg/day,ppm,0,92,37,Mouse,CD-1,M/F,M,Oral diet,NA,2,Years
255,67747095,Prochloraz,IRIS,0.15,liver,"Nor-Am Chemical Company. 1983. MRID No. 00150409. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",liver adenoma/carcinoma combined,HEq,4,0.88,mg/kg/day,ppm,0.88,48,21,Mouse,CD-1,M/F,M,Oral diet,NA,2,Years
255,67747095,Prochloraz,IRIS,0.15,liver,"Nor-Am Chemical Company. 1983. MRID No. 00150409. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",liver adenoma/carcinoma combined,HEq,4,3.66,mg/kg/day,ppm,3.66,44,28,Mouse,CD-1,M/F,M,Oral diet,NA,2,Years
255,67747095,Prochloraz,IRIS,0.15,liver,"Nor-Am Chemical Company. 1983. MRID No. 00150409. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",liver adenoma/carcinoma combined,HEq,4,14.63,mg/kg/day,ppm,14.63,49,44,Mouse,CD-1,M/F,M,Oral diet,NA,2,Years
256,67747095,Prochloraz,IRIS,0.15,liver,"Nor-Am Chemical Company. 1983. MRID No. 00150409. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",liver adenoma/carcinoma combined,HEq,4,0,mg/kg/day,ppm,0,73,5,Mouse,CD-1,M/F,F,Oral diet,NA,2,Years
256,67747095,Prochloraz,IRIS,0.15,liver,"Nor-Am Chemical Company. 1983. MRID No. 00150409. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",liver adenoma/carcinoma combined,HEq,4,0.88,mg/kg/day,ppm,0.88,39,6,Mouse,CD-1,M/F,F,Oral diet,NA,2,Years
256,67747095,Prochloraz,IRIS,0.15,liver,"Nor-Am Chemical Company. 1983. MRID No. 00150409. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",liver adenoma/carcinoma combined,HEq,4,3.66,mg/kg/day,ppm,3.66,42,11,Mouse,CD-1,M/F,F,Oral diet,NA,2,Years
256,67747095,Prochloraz,IRIS,0.15,liver,"Nor-Am Chemical Company. 1983. MRID No. 00150409. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",liver adenoma/carcinoma combined,HEq,4,14.63,mg/kg/day,ppm,14.63,44,39,Mouse,CD-1,M/F,F,Oral diet,NA,2,Years
257,72178020,Fomesafen,IRIS,0.19,liver,"Huntingdon Research Centre. 1985. Two-year feeding study of fomesafen in mice. Huntingdon Research Centre, Huntingdon, Cambridgeshire, England. (Cited in U.S. EPA, 1986)",liver adenomas and carcinomas,HEq,5,0,mg/kg-day,ppm,0,127,30,Mouse,CD-1,M/F,Both,Oral diet,NA,2,Years
257,72178020,Fomesafen,IRIS,0.19,liver,"Huntingdon Research Centre. 1985. Two-year feeding study of fomesafen in mice. Huntingdon Research Centre, Huntingdon, Cambridgeshire, England. (Cited in U.S. EPA, 1986)",liver adenomas and carcinomas,HEq,5,0.01,mg/kg-day,ppm,0.01,63,26,Mouse,CD-1,M/F,Both,Oral diet,NA,2,Years
257,72178020,Fomesafen,IRIS,0.19,liver,"Huntingdon Research Centre. 1985. Two-year feeding study of fomesafen in mice. Huntingdon Research Centre, Huntingdon, Cambridgeshire, England. (Cited in U.S. EPA, 1986)",liver adenomas and carcinomas,HEq,5,0.06,mg/kg-day,ppm,0.06,64,17,Mouse,CD-1,M/F,Both,Oral diet,NA,2,Years
257,72178020,Fomesafen,IRIS,0.19,liver,"Huntingdon Research Centre. 1985. Two-year feeding study of fomesafen in mice. Huntingdon Research Centre, Huntingdon, Cambridgeshire, England. (Cited in U.S. EPA, 1986)",liver adenomas and carcinomas,HEq,5,1.3,mg/kg-day,ppm,1.3,64,27,Mouse,CD-1,M/F,Both,Oral diet,NA,2,Years
257,72178020,Fomesafen,IRIS,0.19,liver,"Huntingdon Research Centre. 1985. Two-year feeding study of fomesafen in mice. Huntingdon Research Centre, Huntingdon, Cambridgeshire, England. (Cited in U.S. EPA, 1986)",liver adenomas and carcinomas,HEq,5,5.6,mg/kg-day,ppm,5.6,64,42,Mouse,CD-1,M/F,Both,Oral diet,NA,2,Years
258,77094112,"MeIQ(2-amino-3,4-dimethylimidazo[4,5-f]quinoline",CalEPA,1.5,liver,"Ohgaki H, Hasegawa H, Suenaga M, Kato T, Sato S, Takayama S, Sugimura T (1986). Induction of hepatocellular carcinoma and highly metastatic squamous cell carcinomas in the forestomach of mice by feeding 2-amino-3,4-dimethylimidazo[4,5-f]quinoline.
Carcinogenesis 7:1889-1893.",liver tumors,Dose,3,0,mg/kg/day,mg/kg/day,0,40,0,Mouse,CDF1,M/F,F,Oral diet,NA,91,Weeks
258,77094112,"MeIQ(2-amino-3,4-dimethylimidazo[4,5-f]quinoline",CalEPA,1.5,liver,"Ohgaki H, Hasegawa H, Suenaga M, Kato T, Sato S, Takayama S, Sugimura T (1986). Induction of hepatocellular carcinoma and highly metastatic squamous cell carcinomas in the forestomach of mice by feeding 2-amino-3,4-dimethylimidazo[4,5-f]quinoline.
Carcinogenesis 7:1889-1893.",liver tumors,Dose,3,13,mg/kg/day,mg/kg/day,13,36,4,Mouse,CDF1,M/F,F,Oral diet,NA,91,Weeks
258,77094112,"MeIQ(2-amino-3,4-dimethylimidazo[4,5-f]quinoline",CalEPA,1.5,liver,"Ohgaki H, Hasegawa H, Suenaga M, Kato T, Sato S, Takayama S, Sugimura T (1986). Induction of hepatocellular carcinoma and highly metastatic squamous cell carcinomas in the forestomach of mice by feeding 2-amino-3,4-dimethylimidazo[4,5-f]quinoline.
Carcinogenesis 7:1889-1893.",liver tumors,Dose,3,52,mg/kg/day,mg/kg/day,52,38,27,Mouse,CDF1,M/F,F,Oral diet,NA,91,Weeks
259,77094112,"MeIQ(2-amino-3,4-dimethylimidazo[4,5-f]quinoline",CalEPA,1.5,stomach/forestomach,"Ohgaki H, Hasegawa H, Suenaga M, Kato T, Sato S, Takayama S, Sugimura T (1986). Induction of hepatocellular carcinoma and highly metastatic squamous cell carcinomas in the forestomach of mice by feeding 2-amino-3,4-dimethylimidazo[4,5-f]quinoline.
Carcinogenesis 7:1889-1893.",forestomach tumors,Dose,3,0,mg/kg/day,mg/kg/day,0,40,0,Mouse,CDF1,M/F,Both,Oral diet,NA,91,Weeks
259,77094112,"MeIQ(2-amino-3,4-dimethylimidazo[4,5-f]quinoline",CalEPA,1.5,stomach/forestomach,"Ohgaki H, Hasegawa H, Suenaga M, Kato T, Sato S, Takayama S, Sugimura T (1986). Induction of hepatocellular carcinoma and highly metastatic squamous cell carcinomas in the forestomach of mice by feeding 2-amino-3,4-dimethylimidazo[4,5-f]quinoline.
Carcinogenesis 7:1889-1893.",forestomach tumors,Dose,3,13,mg/kg/day,mg/kg/day,13,36,19,Mouse,CDF1,M/F,Both,Oral diet,NA,91,Weeks
259,77094112,"MeIQ(2-amino-3,4-dimethylimidazo[4,5-f]quinoline",CalEPA,1.5,stomach/forestomach,"Ohgaki H, Hasegawa H, Suenaga M, Kato T, Sato S, Takayama S, Sugimura T (1986). Induction of hepatocellular carcinoma and highly metastatic squamous cell carcinomas in the forestomach of mice by feeding 2-amino-3,4-dimethylimidazo[4,5-f]quinoline.
Carcinogenesis 7:1889-1893.",forestomach tumors,Dose,3,52,mg/kg/day,mg/kg/day,52,38,34,Mouse,CDF1,M/F,Both,Oral diet,NA,91,Weeks
260,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,adrenal glands,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Adrenal gland cortical adenoma,Dose,4,0,mg/kg/day,mg/kg/day,0,50,5,Rat,Wistar,M/F,M,Oral drinking water,NA,104,Weeks
260,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,adrenal glands,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Adrenal gland cortical adenoma,Dose,4,0.4,mg/kg/day,mg/kg/day,0.4,50,2,Rat,Wistar,M/F,M,Oral drinking water,NA,104,Weeks
260,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,adrenal glands,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Adrenal gland cortical adenoma,Dose,4,1.3,mg/kg/day,mg/kg/day,1.3,50,7,Rat,Wistar,M/F,M,Oral drinking water,NA,104,Weeks
260,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,adrenal glands,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Adrenal gland cortical adenoma,Dose,4,5,mg/kg/day,mg/kg/day,5,50,14,Rat,Wistar,M/F,M,Oral drinking water,NA,104,Weeks
261,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,adrenal glands,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Adrenal gland cortical adenoma,Dose,4,0,mg/kg/day,mg/kg/day,0,50,5,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
261,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,adrenal glands,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Adrenal gland cortical adenoma,Dose,4,0.6,mg/kg/day,mg/kg/day,0.6,50,10,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
261,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,adrenal glands,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Adrenal gland cortical adenoma,Dose,4,1.9,mg/kg/day,mg/kg/day,1.9,50,12,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
261,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,adrenal glands,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Adrenal gland cortical adenoma,Dose,4,6.6,mg/kg/day,mg/kg/day,6.6,50,16,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
262,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,liver,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",liver adenoma or carcinoma,Dose,4,0,mg/kg/day,mg/kg/day,0,50,0,Rat,Wistar,M/F,M,Oral drinking water,NA,104,Weeks
262,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,liver,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",liver adenoma or carcinoma,Dose,4,0.4,mg/kg/day,mg/kg/day,0.4,50,1,Rat,Wistar,M/F,M,Oral drinking water,NA,104,Weeks
262,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,liver,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",liver adenoma or carcinoma,Dose,4,1.3,mg/kg/day,mg/kg/day,1.3,50,3,Rat,Wistar,M/F,M,Oral drinking water,NA,104,Weeks
262,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,liver,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",liver adenoma or carcinoma,Dose,4,5,mg/kg/day,mg/kg/day,5,50,5,Rat,Wistar,M/F,M,Oral drinking water,NA,104,Weeks
263,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,liver,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",liver adenoma or carcinoma,Dose,4,0,mg/kg/day,mg/kg/day,0,50,2,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
263,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,liver,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",liver adenoma or carcinoma,Dose,4,0.6,mg/kg/day,mg/kg/day,0.6,50,2,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
263,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,liver,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",liver adenoma or carcinoma,Dose,4,1.9,mg/kg/day,mg/kg/day,1.9,50,4,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
263,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,liver,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",liver adenoma or carcinoma,Dose,4,6.6,mg/kg/day,mg/kg/day,6.6,50,10,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
264,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,liver,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Liver cholangioma or cholangiocarcinoma,Dose,4,0,mg/kg/day,mg/kg/day,0,50,1,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
264,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,liver,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Liver cholangioma or cholangiocarcinoma,Dose,4,0.6,mg/kg/day,mg/kg/day,0.6,50,4,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
264,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,liver,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Liver cholangioma or cholangiocarcinoma,Dose,4,1.9,mg/kg/day,mg/kg/day,1.9,50,10,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
264,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,liver,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Liver cholangioma or cholangiocarcinoma,Dose,4,6.6,mg/kg/day,mg/kg/day,6.6,50,34,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
265,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,mammary glands,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.","Mammary gland atypic hyperplasia, adenoma or adenocarcinoma",Dose,4,0,mg/kg/day,mg/kg/day,0,50,3,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
265,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,mammary glands,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.","Mammary gland atypic hyperplasia, adenoma or adenocarcinoma",Dose,4,0.6,mg/kg/day,mg/kg/day,0.6,50,2,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
265,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,mammary glands,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.","Mammary gland atypic hyperplasia, adenoma or adenocarcinoma",Dose,4,1.9,mg/kg/day,mg/kg/day,1.9,50,9,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
265,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,mammary glands,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.","Mammary gland atypic hyperplasia, adenoma or adenocarcinoma",Dose,4,6.6,mg/kg/day,mg/kg/day,6.6,50,13,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
266,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,thyroid,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Thyroid follicular cell adenoma or carcinoma,Dose,4,0,mg/kg/day,mg/kg/day,0,49,2,Rat,Wistar,M/F,M,Oral drinking water,NA,104,Weeks
266,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,thyroid,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Thyroid follicular cell adenoma or carcinoma,Dose,4,0.4,mg/kg/day,mg/kg/day,0.4,50,20,Rat,Wistar,M/F,M,Oral drinking water,NA,104,Weeks
266,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,thyroid,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Thyroid follicular cell adenoma or carcinoma,Dose,4,1.3,mg/kg/day,mg/kg/day,1.3,50,38,Rat,Wistar,M/F,M,Oral drinking water,NA,104,Weeks
266,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,thyroid,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Thyroid follicular cell adenoma or carcinoma,Dose,4,5,mg/kg/day,mg/kg/day,5,49,44,Rat,Wistar,M/F,M,Oral drinking water,NA,104,Weeks
267,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,thyroid,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Thyroid follicular cell adenoma or carcinoma,Dose,4,0,mg/kg/day,mg/kg/day,0,50,5,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
267,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,thyroid,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Thyroid follicular cell adenoma or carcinoma,Dose,4,0.6,mg/kg/day,mg/kg/day,0.6,49,18,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
267,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,thyroid,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Thyroid follicular cell adenoma or carcinoma,Dose,4,1.9,mg/kg/day,mg/kg/day,1.9,50,38,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
267,77439760,MX(3-chloro-4-(dichloromethyl)5-hydroxy-2-(5H)-furanone,CalEPA,6.4,thyroid,"Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J. (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)- furanone in the rat. J Natl Cancer Inst 89(12):848-856.

Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lotjonen S, Tuominen RK, Tuomisto J (2000). Carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy(5H)-furanone (MX) in Wistar rats. Combined frequencies of indicated tumours. Personal communication from Dr. Hannu Komulainen, Laboratory of Toxicology, National Public Health Institute, Kuopio, Finland to Dr. Thomas McDonald, California Environmental Protection Agency, February 8, 2000.",Thyroid follicular cell adenoma or carcinoma,Dose,4,6.6,mg/kg/day,mg/kg/day,6.6,50,47,Rat,Wistar,M/F,F,Oral drinking water,NA,104,Weeks
268,77500040,"MeIQx(2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",CalEPA,1.7,auditory system,"Kushida H., Wakabayashi K, Sato H, Katami M, Kurosaka R, Nagao M (1994). Dose response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett 83:31-35.",Zymbal's gland tumors,Dose,4,0,mg/kg/day,mg/kg/day,0,15,0,Rat,Fischer 344,M,Both,Oral diet,NA,56,Weeks
268,77500040,"MeIQx(2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",CalEPA,1.7,auditory system,"Kushida H., Wakabayashi K, Sato H, Katami M, Kurosaka R, Nagao M (1994). Dose response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett 83:31-35.",Zymbal's gland tumors,Dose,4,4,mg/kg/day,mg/kg/day,4,30,1,Rat,Fischer 344,M,Both,Oral diet,NA,56,Weeks
268,77500040,"MeIQx(2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",CalEPA,1.7,auditory system,"Kushida H., Wakabayashi K, Sato H, Katami M, Kurosaka R, Nagao M (1994). Dose response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett 83:31-35.",Zymbal's gland tumors,Dose,4,8,mg/kg/day,mg/kg/day,8,29,5,Rat,Fischer 344,M,Both,Oral diet,NA,56,Weeks
268,77500040,"MeIQx(2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",CalEPA,1.7,auditory system,"Kushida H., Wakabayashi K, Sato H, Katami M, Kurosaka R, Nagao M (1994). Dose response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett 83:31-35.",Zymbal's gland tumors,Dose,4,16,mg/kg/day,mg/kg/day,16,16,13,Rat,Fischer 344,M,Both,Oral diet,NA,56,Weeks
269,77500040,"MeIQx(2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",CalEPA,1.7,liver,"Kushida H., Wakabayashi K, Sato H, Katami M, Kurosaka R, Nagao M (1994). Dose response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett 83:31-35.",liver tumors,Dose,4,0,mg/kg/day,mg/kg/day,0,15,0,Rat,Fischer 344,M,Both,Oral diet,NA,56,Weeks
269,77500040,"MeIQx(2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",CalEPA,1.7,liver,"Kushida H., Wakabayashi K, Sato H, Katami M, Kurosaka R, Nagao M (1994). Dose response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett 83:31-35.",liver tumors,Dose,4,4,mg/kg/day,mg/kg/day,4,30,5,Rat,Fischer 344,M,Both,Oral diet,NA,56,Weeks
269,77500040,"MeIQx(2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",CalEPA,1.7,liver,"Kushida H., Wakabayashi K, Sato H, Katami M, Kurosaka R, Nagao M (1994). Dose response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett 83:31-35.",liver tumors,Dose,4,8,mg/kg/day,mg/kg/day,8,29,26,Rat,Fischer 344,M,Both,Oral diet,NA,56,Weeks
269,77500040,"MeIQx(2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",CalEPA,1.7,liver,"Kushida H., Wakabayashi K, Sato H, Katami M, Kurosaka R, Nagao M (1994). Dose response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett 83:31-35.",liver tumors,Dose,4,16,mg/kg/day,mg/kg/day,16,16,16,Rat,Fischer 344,M,Both,Oral diet,NA,56,Weeks
270,77500040,"MeIQx(2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",CalEPA,1.7,skin,"Kushida H., Wakabayashi K, Sato H, Katami M, Kurosaka R, Nagao M (1994). Dose response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett 83:31-35.",skin tumors,Dose,4,0,mg/kg/day,mg/kg/day,0,15,0,Rat,Fischer 344,M,Both,Oral diet,NA,56,Weeks
270,77500040,"MeIQx(2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",CalEPA,1.7,skin,"Kushida H., Wakabayashi K, Sato H, Katami M, Kurosaka R, Nagao M (1994). Dose response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett 83:31-35.",skin tumors,Dose,4,4,mg/kg/day,mg/kg/day,4,30,0,Rat,Fischer 344,M,Both,Oral diet,NA,56,Weeks
270,77500040,"MeIQx(2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",CalEPA,1.7,skin,"Kushida H., Wakabayashi K, Sato H, Katami M, Kurosaka R, Nagao M (1994). Dose response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett 83:31-35.",skin tumors,Dose,4,8,mg/kg/day,mg/kg/day,8,29,3,Rat,Fischer 344,M,Both,Oral diet,NA,56,Weeks
270,77500040,"MeIQx(2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",CalEPA,1.7,skin,"Kushida H., Wakabayashi K, Sato H, Katami M, Kurosaka R, Nagao M (1994). Dose response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett 83:31-35.",skin tumors,Dose,4,16,mg/kg/day,mg/kg/day,16,16,6,Rat,Fischer 344,M,Both,Oral diet,NA,56,Weeks
271,108171262,Chlorinated paraffins (Avg. chain length- C12:approx.60 percent chlorine by weight),CalEPA,0.089,liver,"National Toxicology Program (NTP) 1986. Toxicology and Carcinogenesis Studies of Chlorinated Paraffins (C12, 60% Chlorine) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Technical Report Series No. 308. NIH Publication No. 86-2564. U.S. Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant liver tumors,Dose,3,0,mg/kg/day,mg/kg/day,0,50,3,Mouse,B6C3F1,M/F,F,Oral gavage,5,103,Weeks
271,108171262,Chlorinated paraffins (Avg. chain length- C12:approx.60 percent chlorine by weight),CalEPA,0.089,liver,"National Toxicology Program (NTP) 1986. Toxicology and Carcinogenesis Studies of Chlorinated Paraffins (C12, 60% Chlorine) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Technical Report Series No. 308. NIH Publication No. 86-2564. U.S. Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant liver tumors,Dose,3,125,mg/kg/day,mg/kg/day,89.28571429,50,22,Mouse,B6C3F1,M/F,F,Oral gavage,5,103,Weeks
271,108171262,Chlorinated paraffins (Avg. chain length- C12:approx.60 percent chlorine by weight),CalEPA,0.089,liver,"National Toxicology Program (NTP) 1986. Toxicology and Carcinogenesis Studies of Chlorinated Paraffins (C12, 60% Chlorine) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Technical Report Series No. 308. NIH Publication No. 86-2564. U.S. Department of Health and Human Services, NTP, Research Triangle Park, NC.",benign and malignant liver tumors,Dose,3,250,mg/kg/day,mg/kg/day,178.5714286,50,28,Mouse,B6C3F1,M/F,F,Oral gavage,5,103,Weeks
